<SEC-DOCUMENT>0001104659-13-082969.txt : 20131112
<SEC-HEADER>0001104659-13-082969.hdr.sgml : 20131111
<ACCEPTANCE-DATETIME>20131112060208
ACCESSION NUMBER:		0001104659-13-082969
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20131112
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20131112
DATE AS OF CHANGE:		20131112

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			THERAVANCE INC
		CENTRAL INDEX KEY:			0001080014
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				943265960
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30319
		FILM NUMBER:		131206523

	BUSINESS ADDRESS:	
		STREET 1:		901 GATEWAY BLVD
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		6508086000

	MAIL ADDRESS:	
		STREET 1:		901 GATEWAY BLVD
		CITY:			S. SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADVANCED MEDICINE INC
		DATE OF NAME CHANGE:	20000302
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a13-23869_18k.htm
<DESCRIPTION>8-K
<TEXT>


<html>
<head>

  </head>
<body lang="EN-US">
<div style="font-family:Times New Roman;">
<div style="border-bottom:solid windowtext 1.0pt;border-left:none;border-right:none;border-top:solid windowtext 3.0pt;padding:1.0pt 0in 1.0pt 0in;">
<p style="border:none;margin:0in 0in .0001pt;padding:0in;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
</div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">UNITED STATES</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Washington, DC&#160; 20549</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center" style="margin:0in 0in .0001pt;text-align:center;"><hr size="1" width="25%" noshade color="black" align="center"></div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">FORM&nbsp;8-K</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center" style="margin:0in 0in .0001pt;text-align:center;"><hr size="1" width="25%" noshade color="black" align="center"></div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">Current Report Pursuant</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">to Section&nbsp;13 or 15(d)&nbsp;of the</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">Securities Exchange Act of 1934</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date of Report (Date of earliest event Reported):&#160; <b>November&nbsp;12, 2013</b></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center" style="margin:0in 0in .0001pt;text-align:center;"><hr size="1" width="25%" noshade color="black" align="center"></div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">THERAVANCE,&nbsp;INC.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Exact Name of Registrant as Specified in its Charter)</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center" style="margin:0in 0in .0001pt;text-align:center;"><hr size="1" width="25%" noshade color="black" align="center"></div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Delaware</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(State or Other Jurisdiction of<br>   Incorporation)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">000-30319</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Commission File Number)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">94-3265960</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(I.R.S. Employer Identification Number)</font></p>    </td>   </tr>  </table>
</div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">901 Gateway Boulevard</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">South San Francisco</font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">, California 94080</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(650) 808-6000</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Addresses, including zip code, and telephone numbers, including area code, of principal executive offices)</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center" style="margin:0in 0in .0001pt;text-align:center;"><hr size="1" width="25%" noshade color="black" align="center"></div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Check the appropriate box below if the Form&nbsp;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Pre-commencement communications pursuant to Rule&nbsp;14d-2(b)&nbsp;under the Exchange Act (17 CFR 240.14d-2(b))</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Pre-commencement communications pursuant to Rule&nbsp;13e-4(c)&nbsp;under the Exchange Act (17 CFR 240.13e-4(c))</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="border-bottom:solid windowtext 3.0pt;border-left:none;border-right:none;border-top:solid windowtext 1.0pt;padding:1.0pt 0in 1.0pt 0in;">
<p style="border:none;margin:0in 0in .0001pt;padding:0in;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
</div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\106747\13-23869-1\task6362986\23869-1-ba.htm',USER='106747',CD='Nov 12 02:12 2013' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 8.01 Other Events.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On November&nbsp;12, 2013 at the 18</font><font size="1" style="font-size:6.5pt;position:relative;top:-3.0pt;">th</font><font size="2" style="font-size:10.0pt;">&#160;Congress of the Asian Pacific Society of Respirology, Yokohama, Japan, GlaxoSmithKline plc (&#147;GSK&#148;) presented a poster on a Phase 3 study of the once-daily treatment combination of fluticasone furoate &#147;FF&#148;, an inhaled corticosteroid, and vilanterol &#147;VI&#148;, a long-acting beta</font><font size="1" style="font-size:6.5pt;position:relative;top:1.0pt;">2</font><font size="2" style="font-size:10.0pt;">&#160;agonist, (FF/VI 200/25 mcg) in asthma patients of Asian ancestry.&#160; In September 2013, the Japanese Ministry of Health, Labour and Welfare (MHLW) approved FF/VI for the treatment of bronchial asthma (in cases where concurrent use of inhaled corticosteroid and long-acting inhaled beta</font><font size="1" style="font-size:6.5pt;position:relative;top:1.0pt;">2</font><font size="2" style="font-size:10.0pt;">&#160;agonist is required).&#160; FF/VI is not indicated for the treatment of chronic obstructive pulmonary disease (COPD) in Japan.&#160; The MHLW has approved two doses of FF/VI - 100/25 mcg and 200/25 mcg.&#160; Both strengths will be administered once-daily using the ELLIPTA&#153;, a new dry powder inhaler.&#160; RELVAR</font><font size="1" style="font-size:6.5pt;position:relative;top:-3.0pt;">&#174;</font><font size="2" style="font-size:10.0pt;">&#160;ELLIPTA&#153; is the trade name in Japan.&#160; FF/VI remains in development elsewhere in the world for the maintenance treatment of asthma and COPD, with pending marketing authorization applications in a number of countries.&#160; FF/VI for the treatment of COPD is approved in the United States and Canada.&#160; FF/VI is not indicated for the relief of acute bronchospasm or the treatment of asthma in the United States or Canada.&#160; FF/VI is not approved or licensed anywhere outside of the United States, Japan and Canada.&#160; FF/VI is in development under the LABA collaboration agreement between Glaxo Group Limited and Theravance, Inc.&#160; The poster is filed as Exhibit 99.1 to this report and is incorporated herein by reference.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 9.01 Financial Statements and Exhibits.</font></b></p>
<p style="margin:0in 0in .0001pt;text-indent:.3in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.3in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Exhibits. </font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="78%" style="border-collapse:collapse;margin-left:44.1pt;width:78.5%;">
<tr>
<td width="15%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:15.32%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Exhibit</font></b></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.18%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="81%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:81.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Description</font></b></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:15.32%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.18%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="81%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:81.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.32%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit&nbsp;99.1</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.18%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="81%" valign="top" style="padding:0in 0in 0in 0in;width:81.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Efficacy   and safety of once-daily fluticasone furoate/vilanterol 200/25mcg compared   with twice-daily fluticasone propionate 500mcg in asthma patients of Asian   ancestry</font></p>    </td>   </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2<a name="PB_2_014346_7056"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='2',FILE='C:\JMS\106747\13-23869-1\task6362986\23869-1-ba.htm',USER='106747',CD='Nov 12 02:12 2013' -->

<br clear="all" style="page-break-before:always;">
<div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SIGNATURE</font></b></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">THERAVANCE,&nbsp;INC.</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date: November&nbsp;12, 2013</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/   <b>Michael W. Aguiar</b>  </font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.58%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="45%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:45.42%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Michael   W. Aguiar</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.58%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.42%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Chief Financial Officer</font></b></p>    </td>   </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3<a name="PB_3_014627_5335"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='3',FILE='C:\JMS\106747\13-23869-1\task6362986\23869-1-ba.htm',USER='106747',CD='Nov 12 02:12 2013' -->

<br clear="all" style="page-break-before:always;">
<div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EXHIBIT&nbsp;INDEX</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="11%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:11.1%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Exhibit&nbsp;No.</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="86%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:86.76%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Description</font></b></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:11.1%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99.1</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="86%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:86.76%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Efficacy   and safety of once-daily fluticasone furoate/vilanterol 200/25mcg compared   with twice-daily fluticasone propionate 500mcg in asthma patients of Asian   ancestry</font></p>    </td>   </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4<a name="PB_4_014711_5796"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='4',FILE='C:\JMS\106747\13-23869-1\task6362986\23869-1-ba.htm',USER='106747',CD='Nov 12 02:12 2013' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a13-23869_1ex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>


<html>
<head>


  </head>
<body lang="EN-US">
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 99.1</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">POSTER NO. PS108</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Efficacy and safety of once-daily fluticasone furoate/vilanterol 200/25mcg compared with twice-daily fluticasone propionate 500mcg in asthma patients of Asian ancestry</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Jiangtao L(1), Crawford J(2), Jacques L(3), Stone S(3)</font></i></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade color="black" align="left"></div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)Department of Respiratory Diseases, China-Japan Friendship Hospital, Beijing 100029, China</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)Quantitative Sciences Division, GlaxoSmithKline, Uxbridge, UK</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)Respiratory Medicines Development Centre, GlaxoSmithKline, Uxbridge, UK</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">INTRODUCTION</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Fluticasone furoate (FF)/vilanterol (VI) is a novel once-daily ICS/long-acting beta</font><font size="1" style="font-size:6.5pt;position:relative;top:1.0pt;">2</font><font size="2" style="font-size:10.0pt;">-agonist (LABA) combination therapy for the treatment of asthma.</font></p>
<p style="margin:0in 0in .0001pt 12.5pt;text-indent:-12.45pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Fluticasone proprionate (FP) is an inhaled corticosteroid (ICS) taken twice daily via the DISKUS</font><font size="1" style="font-size:6.5pt;position:relative;top:-3.0pt;">TM</font><font size="2" style="font-size:10.0pt;">&#160;inhaler for the treatment of asthma.</font></p>
<p style="margin:0in 0in .0001pt 12.5pt;text-indent:-12.45pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">FF/VI delivered via the ELLIPTA</font><font size="1" style="font-size:6.5pt;position:relative;top:-3.0pt;">TM</font><font size="2" style="font-size:10.0pt;">&#160;dry powder inhaler, has demonstrated 24h effectiveness in asthma patients in global studies(1),(2)</font></p>
<p style="margin:0in 0in .0001pt 12.5pt;text-indent:-12.45pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 30.25pt;text-indent:-12.25pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="2" style="font-size:10.0pt;">&#160;&#160; The 200/25mcg strength significantly improved lung function versus FP 500mcg twice daily over 24 weeks.(2)</font></p>
<p style="margin:0in 0in .0001pt 12.5pt;text-indent:-12.45pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 12.5pt;text-indent:-12.45pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Responses to pharmacotherapy can vary across ethnic groups,(3),(4) including in Asian patients.(4)</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">OBJECTIVES</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">To evaluate the efficacy and safety of once-daily FF/VI 200/25mcg administered in the evening, compared with twice-daily FP 500mcg administered in the morning and evening, in asthma patients of Asian ancestry.</font></p>
<p style="margin:0in 0in .0001pt 12.5pt;text-indent:-12.45pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">METHODS</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">A randomised, double-blind, double-dummy, active-comparator, parallel-group, 12-week multicentre study.</font></p>
<p style="margin:0in 0in .0001pt 12.5pt;text-indent:-12.45pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Inclusion criteria: aged <u>&gt;</u>12 years; FEV</font><font size="1" style="font-size:6.5pt;position:relative;top:1.0pt;">1</font><font size="2" style="font-size:10.0pt;">&#160;40&#150;90% predicted; reversibility of <u>&gt;</u>12% and <u>&gt;</u>200mL within 10&#150;40&#160; minutes following 2&#150;4 inhalations of salbutamol; treated with stable high-dose ICS or mid-dose ICS/LABA therapy for <u>&gt;</u>4 weeks prior to Screening.</font></p>
<p style="margin:0in 0in .0001pt 12.5pt;text-indent:-12.45pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Patients were randomised (1:1) to receive FF/VI 200/25mcg once daily via the ELLIPTA device (equivalent to a delivered dose of FF/VI 184/22mcg) or FP 500mcg twice daily via the DISKUS inhaler for 12 weeks.</font></p>
<p style="margin:0in 0in .0001pt 12.5pt;text-indent:-12.45pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Primary endpoint: mean change from baseline in daily evening peak expiratory flow (PEF) averaged over the 12-week treatment period.</font></p>
<p style="margin:0in 0in .0001pt 12.5pt;text-indent:-12.45pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Secondary endpoints (Weeks 1&#150;12, unless stated)</font></p>
<p style="margin:0in 0in .0001pt 30.25pt;text-indent:-12.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 30.25pt;text-indent:-12.25pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="2" style="font-size:10.0pt;"> &#160;&#160;Change from baseline in % rescue-free 24h periods</font></p>
<p style="margin:0in 0in .0001pt 30.25pt;text-indent:-12.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 30.25pt;text-indent:-12.25pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="2" style="font-size:10.0pt;"> &#160;&#160;Mean change from baseline in morning PEF (averaged over Weeks 1&#150;12)</font></p>
<p style="margin:0in 0in .0001pt 30.25pt;text-indent:-12.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 30.25pt;text-indent:-12.25pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="2" style="font-size:10.0pt;"> &#160;&#160;Change from baseline in % symptom-free 24h periods</font></p>
<p style="margin:0in 0in .0001pt 30.25pt;text-indent:-12.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 30.25pt;text-indent:-12.25pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="2" style="font-size:10.0pt;">&#160; &#160;Change from baseline in AQLQ+12 Total score (measured at Week 12).</font></p>
<p style="margin:0in 0in .0001pt 12.5pt;text-indent:-12.45pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">A step-down statistical hierarchy was applied to account for multiplicity across endpoints. Testing of each endpoint was dependent on the achievement of significance at the 5% level for the previous endpoint, in the following order</font></p>
<p style="margin:0in 0in .0001pt 30.25pt;text-indent:-12.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 30.25pt;text-indent:-12.25pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="2" style="font-size:10.0pt;">&#160; &#160;Evening PEF &gt; % rescue-free 24h periods &gt; morning PEF &gt; % symptom-free 24h periods &gt; AQLQ score.</font></p>
<p style="margin:0in 0in .0001pt 12.5pt;text-indent:-12.45pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Safety endpoints included incidence of adverse events (AEs), vital signs, electrocardiogram and laboratory evaluations.</font></p>
<p style="margin:0in 0in .0001pt 12.5pt;text-indent:-12.45pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">RESULTS</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Table 1. Demographic and baseline characteristics<br>  </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">(ITT&nbsp;population)</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="33%" valign="bottom" style="padding:0in 0in 0in 0in;width:33.48%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.14%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="23%" valign="bottom" style="padding:0in 0in 0in 0in;width:23.1%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">FF/VI&nbsp;200/25</font></b></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.14%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="17%" valign="bottom" style="padding:0in 0in 0in 0in;width:17.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">FP&nbsp;500</font></b></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.14%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="17%" valign="bottom" style="padding:0in 0in 0in 0in;width:17.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="33%" valign="bottom" style="padding:0in 0in 0in 0in;width:33.48%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.14%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="23%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:23.1%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">OD<br>   N=155</font></b></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.14%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="17%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:17.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">BD<br>   N=154</font></b></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.14%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="17%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:17.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Total<br>   N=309</font></b></p>    </td>   </tr>
<tr>
<td width="33%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:33.48%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Age   (years)</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="23%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:23.1%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">46.9 (12.93)</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.14%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="17%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:17.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">48.8 (13.41)</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.14%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="17%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:17.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">47.9 (13.19)</font></p>    </td>   </tr>
<tr>
<td width="33%" valign="top" style="padding:0in 0in 0in 0in;width:33.48%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Male,   n (%)</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="23%" valign="top" style="padding:0in 0in 0in 0in;width:23.1%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">59 (38)</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.14%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="17%" valign="top" style="padding:0in 0in 0in 0in;width:17.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">68 (44)</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.14%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="17%" valign="top" style="padding:0in 0in 0in 0in;width:17.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">127 (41)</font></p>    </td>   </tr>
<tr>
<td width="33%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:33.48%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Duration   of asthma</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="23%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:23.1%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12.39</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.14%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="17%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:17.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13.44</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.14%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="17%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:17.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12.91</font></p>    </td>   </tr>
<tr>
<td width="33%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:33.48%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(years)</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="23%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:23.1%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(12.857)</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.14%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="17%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:17.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(13.551)</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.14%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="17%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:17.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(13.196)</font></p>    </td>   </tr>
<tr>
<td width="33%" valign="top" style="padding:0in 0in 0in 0in;width:33.48%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Lung function parameters</font></b></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="23%" valign="top" style="padding:0in 0in 0in 0in;width:23.1%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.14%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="17%" valign="top" style="padding:0in 0in 0in 0in;width:17.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.14%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="17%" valign="top" style="padding:0in 0in 0in 0in;width:17.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="33%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:33.48%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">FEV</font><font size="1" style="font-size:6.5pt;position:relative;top:1.0pt;">1</font><font size="2" style="font-size:10.0pt;">&nbsp;(L)</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="23%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:23.1%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.78 (0.493)</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.14%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="17%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:17.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.77 (0.552)</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.14%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="17%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:17.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.77 (0.523)</font></p>    </td>   </tr>
<tr>
<td width="33%" rowspan="2" style="padding:0in 0in 0in 0in;width:33.48%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%   predicted FEV</font><font size="1" style="font-size:6.5pt;position:relative;top:1.0pt;">1</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="23%" valign="top" style="padding:0in 0in 0in 0in;width:23.1%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">67.51</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.14%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="17%" valign="top" style="padding:0in 0in 0in 0in;width:17.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">67.55</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.14%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="17%" valign="top" style="padding:0in 0in 0in 0in;width:17.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">67.53</font></p>    </td>   </tr>
<tr>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="23%" valign="top" style="padding:0in 0in 0in 0in;width:23.1%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(13.249)</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.14%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="17%" valign="top" style="padding:0in 0in 0in 0in;width:17.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(13.432)</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.14%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="17%" valign="top" style="padding:0in 0in 0in 0in;width:17.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(13.319)</font></p>    </td>   </tr>
<tr>
<td width="33%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:33.48%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%   reversibility FEV</font><font size="1" style="font-size:6.5pt;position:relative;top:1.0pt;">1</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="23%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:23.1%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">27.31</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.14%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="17%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:17.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">26.98</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.14%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="17%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:17.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">27.14</font></p>    </td>   </tr>
<tr>
<td width="33%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:33.48%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">at   screening</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="23%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:23.1%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(14.570)</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.14%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="17%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:17.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(14.262)</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.14%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="17%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:17.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(14.395)</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Data are mean (SD) unless otherwise stated; OD=once daily; BD=twice daily</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\eperez\13-23869-1\task6363209\23869-1-mm.htm',USER='eperez',CD='Nov 11 16:12 2013' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">RESULTS</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Efficacy</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 19.6pt;text-indent:-19.55pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">FF/VI and FP improved evening PEF compared with baseline<br> (<b>Figure 1</b>)</font></p>
<p style="margin:0in 0in .0001pt 19.6pt;text-indent:-19.55pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 45.0pt;text-indent:-21.95pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="2" style="font-size:10.0pt;">&#160; &#160;Change from baseline with FF/VI was 39.1L/min (standard error=3.01) and with FP was 10.5L/min (3.03)</font></p>
<p style="margin:0in 0in .0001pt 45.0pt;text-indent:-21.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 35.3pt;text-indent:-12.25pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="2" style="font-size:10.0pt;">&#160;&#160; The effect was statistically significantly better (p&lt;0.001) with FF/VI compared with FP (28.5L/min; 95% confidence interval [CI]: 20.1, 36.9).</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="668" height="693" src="g238691mmi001.jpg"></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 19.6pt;text-indent:-19.55pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Improvements in % rescue-free 24h periods were similar for FF/VI and FP</font></p>
<p style="margin:0in 0in .0001pt 19.6pt;text-indent:-19.55pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 45.0pt;text-indent:-21.95pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="2" style="font-size:10.0pt;">&#160;&#160; The equivalent number of rescue-free days per week was 2.3 with FF/VI and 2.2 with FP</font></p>
<p style="margin:0in 0in .0001pt 45.0pt;text-indent:-21.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 45.0pt;text-indent:-21.95pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="2" style="font-size:10.0pt;">&#160;&#160; The adjusted treatment difference (1.0%; 95% CI: &#151;7.3, 9.2) was not statistically significant (p=0.821) (<b>Figure 2</b>).</font></p>
<p style="margin:0in 0in .0001pt 45.0pt;text-indent:-21.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 19.6pt;text-indent:-19.55pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Due to the statistical hierarchy, significance for remaining endpoints could not be inferred.</font></p>
<p style="margin:0in 0in .0001pt 19.6pt;text-indent:-19.55pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 19.6pt;text-indent:-19.55pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">There were numerical improvements in the remaining secondary endpoints for FF/VI compared with FP (<b>Figure 2</b>).</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="657" height="830" src="g238691mmi002.jpg"></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\eperez\13-23869-1\task6363209\23869-1-mm.htm',USER='eperez',CD='Nov 11 16:12 2013' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">RESULTS</font></b></p>
<p style="margin:0in 0in .0001pt 5.05pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Safety</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 19.6pt;text-indent:-19.55pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Incidence of AEs, treatment-related AEs and serious AEs was low and similar for FF/VI and FP (<b>Table 2</b>).</font></p>
<p style="margin:0in 0in .0001pt 19.6pt;text-indent:-19.55pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 19.6pt;text-indent:-19.55pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">There were no fatal AEs.</font></p>
<p style="margin:0in 0in .0001pt 19.6pt;text-indent:-19.55pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 19.6pt;text-indent:-19.55pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">The only treatment-related SAE was asthma (FP 500mcg).</font></p>
<p style="margin:0in 0in .0001pt 19.6pt;text-indent:-19.55pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 19.6pt;text-indent:-19.55pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Pneumonia was reported by two patients (both with FF/VI 200/25mcg); neither required hospitalisation.</font></p>
<p style="margin:0in 0in .0001pt 19.6pt;text-indent:-19.55pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 19.6pt;text-indent:-19.55pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">There were no clinically significant changes in vital signs, electrocardiogram parameters or clinical laboratory evaluations.</font></p>
<p style="margin:0in 0in .0001pt 19.6pt;text-indent:-19.55pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Table 2. Summary of adverse events (ITT population)</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="70%" valign="bottom" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">FF/VI&nbsp;200/25</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">FP&nbsp;500</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="70%" valign="bottom" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">OD</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">BD</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="70%" valign="bottom" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">N=155</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">N=154</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">All AEs</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On-treatment</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">40 (26)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">41 (27)</font></p>    </td>
<td width="1%" valign="top" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On-treatment,   treatment-related</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5 (3)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5 (3)</font></p>    </td>
<td width="1%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On-treatment   leading to withdrawal</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2 (1)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2 (1)</font></p>    </td>
<td width="1%" valign="top" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Post-treatment</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (&lt;1)</font></p>    </td>
<td width="1%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SeriousAEs</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="top" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On-treatment</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (&lt;1)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2 (1)</font></p>    </td>
<td width="1%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On-treatment,   treatment-related</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (&lt;1)</font></p>    </td>
<td width="1%" valign="top" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Most frequent</font></b><font size="2" style="font-size:10.0pt;">(a)&nbsp;<b>on-treatment AEs</b></font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Upper   respiratory tract infection</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13 (8)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">18 (12)</font></p>    </td>
<td width="1%" valign="top" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Nasopharyngitis</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6 (4)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6 (4)</font></p>    </td>
<td width="1%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Rhinitis   allergic</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5 (3)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2 (1)</font></p>    </td>
<td width="1%" valign="top" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Oropharyngeal   pain</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4 (3)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (&lt;1)</font></p>    </td>
<td width="1%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade color="black" align="left"></div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)Occurring in <u>&gt;</u>3% of patients in either treatment group</font></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CONCLUSIONS</font></b></p>
<p style="margin:0in 0in .0001pt 11.0pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 19.45pt;text-indent:-19.45pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">FF/VI 200/25mcg once daily demonstrated clinically and statistically significant improvements in evening PEF compared with FP 500mcg twice daily in Asian asthma patients uncontrolled on high-dose ICS or mid-dose ICS/LABA.</font></p>
<p style="margin:0in 0in .0001pt 19.45pt;text-indent:-19.45pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 19.45pt;text-indent:-19.45pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">There were numerical improvements across the secondary endpoints with FF/VI 200/25mcg versus FP 500mcg.</font></p>
<p style="margin:0in 0in .0001pt 19.45pt;text-indent:-19.45pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 19.45pt;text-indent:-19.45pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">The safety profile of FF/VI 200/25mcg was broadly similar to that of FP 500mcg.</font></p>
<p style="margin:0in 0in .0001pt 19.45pt;text-indent:-19.45pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 19.45pt;text-indent:-19.45pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">The results are generally consistent with a previously published global study that compared FF/VI 200/25mcg with FP 500mcg.(2)</font></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade color="black" align="left"></div>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">REFERENCES</font></b></p>
<p style="margin:0in 0in .0001pt 11.3pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-17.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Woodcock A, et al. <i>Chest </i>2013;144:1222&#150;9.</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-17.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">O&#146;Byrne PM, et al. <i>Eur Respir J </i>2013;Oct 17:ePub ahead of print.</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-17.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Bjornsson TD,et al. <i>J Clin Pharmacol </i>2003;43:943&#150;67.</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-17.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(4)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Huang SM, et al. <i>Clin Pharmacol Ther </i>2008;84:287&#150;94.</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-17.95pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ACKNOWLEDGMENTS</font></b></p>
<p style="margin:0in 0in .0001pt 11.0pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 19.6pt;text-indent:-19.55pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">The presenting author, Dr Jiangtao Lin has received speaker&#146;s honoraria from AstraZeneca, GlaxoSmithKline and MSD, and has been a member of global advisory boards for Boehringer Ingelheim.</font></p>
<p style="margin:0in 0in .0001pt 19.6pt;text-indent:-19.55pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 19.6pt;text-indent:-19.55pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">The study was funded by GlaxoSmithKline (GSK study code HZA113714 (clinicaltrials.gov registration number: NCT01498653).</font></p>
<p style="margin:0in 0in .0001pt 19.6pt;text-indent:-19.55pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 19.6pt;text-indent:-19.55pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Editorial support (in the form of writing assistance, assembling tables and figures, collating author comments, grammatical editing and referencing) was provided by Laura Maguire, MChem at Gardiner-Caldwell Communications (Macclesfield, UK) and was funded by GlaxoSmithKline.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><img width="224" height="100" src="g238691mmi003.jpg">&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">DISKUS&#153; and ELLIPTA&#153; are trade marks of the GlaxoSmithKline group of companies</font></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">&nbsp;</font></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Presented at the 18</font></i></b><b><i><font size="1" style="font-size:6.5pt;font-style:italic;font-weight:bold;position:relative;top:-3.0pt;">th</font></i></b><b><i><font size="2" style="font-size:10.0pt;font-style:italic;font-weight:bold;">&#160;Congress of the Asian Pacific Society of Respirology, Yokohama, Japan, 11&#150;14 November 2013</font></i></b></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\eperez\13-23869-1\task6363209\23869-1-mm.htm',USER='eperez',CD='Nov 11 16:12 2013' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g238691mmi001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g238691mmi001.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+#`Q-#0T'R<Y/3@R/"XS-#+_
MVP!#`0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P``1"`*U`IP#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W^BBD)"J2
M3@#DF@!:ADNH(CAY5!';J:R[O4'F8I$2L?J.IJC7S^*SV,)<M!7\WL=,,/?6
M1O?VC:?\]?\`QT_X4?VC:?\`/7_QT_X5@T5Q?V]B?Y8_<_\`,OZO$WO[1M/^
M>O\`XZ?\*/[1M/\`GK_XZ?\`"L&BC^WL3_+'[G_F'U>)O?VC:?\`/7_QT_X4
M?VC:?\]?_'3_`(5@T4?V]B?Y8_<_\P^KQ-[^T;3_`)Z_^.G_``H_M&T_YZ_^
M.G_"L&BC^WL3_+'[G_F'U>)O?VC:?\]?_'3_`(4?VC:?\]?_`!T_X5@T4?V]
MB?Y8_<_\P^KQ-[^T;3_GK_XZ?\*/[1M/^>O_`(Z?\*P:*/[>Q/\`+'[G_F'U
M>)O?VC:?\]?_`!T_X4?VC:?\]?\`QT_X5@T4?V]B?Y8_<_\`,/J\3>_M&T_Y
MZ_\`CI_PH_M&T_YZ_P#CI_PK!HH_M[$_RQ^Y_P"8?5XF]_:-I_SU_P#'3_A1
M_:-I_P`]?_'3_A6#11_;V)_EC]S_`,P^KQ-[^T;3_GK_`..G_"C^T;3_`)Z_
M^.G_``K!HH_M[$_RQ^Y_YA]7B;W]HVG_`#U_\=/^%']HVG_/7_QT_P"%8-%'
M]O8G^6/W/_,/J\3>_M&T_P">O_CI_P`*/[1M/^>O_CI_PK!HH_M[$_RQ^Y_Y
MA]7B;W]HVG_/7_QT_P"%']HVG_/7_P`=/^%8-%']O8G^6/W/_,/J\3>_M&T_
MYZ_^.G_"C^T;3_GK_P".G_"L&BC^WL3_`"Q^Y_YA]7B;W]HVG_/7_P`=/^%'
M]HVG_/7_`,=/^%8-%']O8G^6/W/_`##ZO$WO[1M/^>O_`(Z?\*/[1M/^>O\`
MXZ?\*P:*/[>Q/\L?N?\`F'U>)O?VC:?\]?\`QT_X4?VC:?\`/7_QT_X5@T4?
MV]B?Y8_<_P#,/J\3>_M&T_YZ_P#CI_PH_M&T_P">O_CI_P`*P:*/[>Q/\L?N
M?^8?5XF]_:-I_P`]?_'3_A1_:-I_SU_\=/\`A6#11_;V)_EC]S_S#ZO$WO[1
MM/\`GK_XZ?\`"C^T;3_GK_XZ?\*P:*/[>Q/\L?N?^8?5XF]_:-I_SU_\=/\`
MA1_:-I_SU_\`'3_A6#11_;V)_EC]S_S#ZO$WO[1M/^>O_CI_PH_M&T_YZ_\`
MCI_PK!HH_M[$_P`L?N?^8?5XF]_:-I_SU_\`'3_A1_:-I_SU_P#'3_A6#11_
M;V)_EC]S_P`P^KQ-[^T;3_GK_P".G_"C^T;3_GK_`..G_"L&BC^WL3_+'[G_
M`)A]7B;W]HVG_/7_`,=/^%']HVG_`#U_\=/^%8-%']O8G^6/W/\`S#ZO$WO[
M1M/^>O\`XZ?\*/[1M/\`GK_XZ?\`"L&BC^WL3_+'[G_F'U>)O?VC:?\`/7_Q
MT_X4?VC:?\]?_'3_`(5@T4?V]B?Y8_<_\P^KQ-[^T;3_`)Z_^.G_``H_M&T_
MYZ_^.G_"L&BC^WL3_+'[G_F'U>)O?VC:?\]?_'3_`(4?VC:?\]?_`!T_X5@T
M4?V]B?Y8_<_\P^KQ-[^T;3_GK_XZ?\*/[1M/^>O_`(Z?\*P:*/[>Q/\`+'[G
M_F'U>)O?VC:?\]?_`!T_X4?VC:?\]?\`QT_X5@T4?V]B?Y8_<_\`,/J\3>_M
M&T_YZ_\`CI_PH_M&T_YZ_P#CI_PK!HH_M[$_RQ^Y_P"8?5XF]_:-I_SU_P#'
M3_A1_:-I_P`]?_'3_A6#11_;V)_EC]S_`,P^KQ-[^T;3_GK_`..G_"C^T;3_
M`)Z_^.G_``K!HH_M[$_RQ^Y_YA]7B;W]HVG_`#U_\=/^%']HVG_/7_QT_P"%
M8-%']O8G^6/W/_,/J\3>_M&T_P">O_CI_P`*/[1M/^>O_CI_PK!HH_M[$_RQ
M^Y_YA]7B;W]HVG_/7_QT_P"%']HVG_/7_P`=/^%8-%']O8G^6/W/_,/J\3>_
MM&T_YZ_^.G_"IHYXI?\`5R*WL#7-TH)!R#@CN*N&?UD_?BFO*Z_S$\/'HSIZ
M*R['426$4YSG@/\`XUJ5]#A<53Q,.>G_`,,<TX.#LPHHHKI)"L[59RL:PJ>6
MY/TK1K$U0YO/HHKR\XJRIX5\O70UHJ\RE1117Q9WA1110`4444`%%%9^M:Q;
MZ#IKW]TDKQ(P4B(`MR<=R*J$)5)*$5=L3:2NS0HKA_\`A:>A_P#/KJ/_`'[3
M_P"+K?;Q+9KJVGZ<8I_.OX1-$VT;0,$_-SG/'8&NJIE^*I_'!K?\-S*->G+9
MFS1117&;!1110`4444`%%%9.O>([#P[:I->L[%VVI%$`7;W`)'`]:NG2G5FH
M05VR9245=FM12(P=%8=",TM0,**R]:\0Z;H$"R7\^TOG9&HW._T']3Q67I'C
M[1-7NUM4:>WF<[46X0#>?0$$C\ZZ88/$3I^UC!N/>Q#JP4N5O4ZBBLMM>M4\
M1IH9CF^TO%YH?`V8Y[YSGCTK4K&=.4+<RM=77H4I)[!1114%!1110`4444`%
M%%96N>(++0(8GNA+(\S[(H85W.Y]AD>HJZ=.=62A!7;)E)15V:M%5=/O?[0L
MH[G[-<VV_/[JYCV2+@D<CMTS5JIE%Q;B]T-.ZN@HHHI#"BBB@`HK*UC7[71)
M+-+F.9S=R^5'Y:@X/'7)''-:M7*G.,5-K1[?(E23;2Z!1114%!1110`445@6
MGBZPO-%OM5CAN1!9L5D5E7<2`.@W8[^M:TZ-2HFX*^R^_8ER4=S?HJMIU]%J
M>G6]["KK%.@=0X`(!]<59K.47%N+W0T[JZ"BBBD,**H:SJT&B:7+J%RDCQ1;
M=PC`+<D#C)'K5BRNDOK"WO(@PCGB650PY`89&??FK]G/D]I;2]K^9/,K\O4G
MHHHJ"@HHHH`****`"BBB@`HK)U7Q!::1J&G65Q',TE_)Y<1C4$`Y4?-DC^\.
MF:UJN5.<8J4EH]B5)-M+H%%%%04%%%9/B#Q#:>'+..YO(YW223RP(5!.<$]R
M/2KITYU9J$%=LF4E%79K45QEO\3M!GG2)X[R!6./,EC7:OUPQ/Z5J^(/%NG^
M'#;?:X[B47"ED,"JPP,=<D>M=,LOQ49JFX.[V\S-5Z;3DGHC>HKB4^*.B.ZH
M+74,L<#,:?\`Q=:>O^--.\.7Z6=Y#=/(\0E!A12,$D=V'/!IO+<6IJ#IN[V^
M0*O3:O?0Z.BN4TGX@:3K&IP:?;V]ZLLQ(4R(H48!/.&/I75UC7PU7#RY:L;,
MN%2,U>+N%%%%8%A1110`4444`%;UA.9[4%CEE^4U@UJZ.3B8=N/ZUZ^2U7#%
M*"VE?\-3"NKPN:=%%%?8G$%8FJ?\?A_W16W6)JG_`!^'_=%>/GG^Z_-&^'^,
MI4445\>=H4444`%%%%`!7)_$?_D3KC_KI'_Z%765SWC73+S5_#4UI8P^;.SH
M0FX+P#SR2!79E\HPQ5.4G9)K\S*LFZ<DNQB:;XQUA;:SMQX1OFC"(@E!?!&`
M-W^KZ=^M:6J:Q?VWC[2-,BGVV=Q$6ECV*=Q^?OC(Z#H:Z'3XG@TVUBD&UTA1
M6&<X(`!KGM4T>_N?'VD:G%!NL[>(K+)O4;3\_;.3U'05UPJX:I6E[BBN676]
MW;3?KVL9.-2,5JWJOZT*EOJVM^(O$>H6VEWT5A9:>^QF:`2&5LD<Y[?*>A'%
M0Z-K^MSS^)HK^=?-L(F,2I&H5&&[D<9(X'7-3P:3K?AWQ'J%QI=C%?66HOO8
M-.(S"V2><]OF/0'BL[PG:SW>N^+;:ZD4S2YBD=!\H)+CC/;_``KM<:#I3E%1
M<%&-MK[J]^O??Y&2<^9)WO=^G6QK:5K>HW/PXGU:6XW7RPS,)=BC!4G'&,=O
M2LF]\4:Q!\.M+U9+O_39KHI))Y:?,H,G&,8'W1T':GV>D^*+7PK=^'AIMOMV
M2!;K[2"'!R=H7KD],G`&:CO_``OK,WPXTS28[/-]!<M))%YJ?*N9.<YQ_$._
M>JC#"1J7DX6=2_3X;/[EY";JN.E_A\]]#6U/5M5\-Z!/JE_>QW<]P46WMQ"$
M2%B"2,CE@!GKZ>]94GBJ_P!&^QWEUKVGZI#.X6XMH`@:`$9RI4Y('J?;UKJ/
M%6@MXA\/M9(ZI.C+)$6Z;@",'Z@D?C7/0Z!JM]/:02^'M(TR*%A]IN%BAE,X
M']U2IVY]_6L<)/"SI<U51O=WV6EM+:7_`/`=;[EU%44K1OY;_P!?>=]UKS3X
M@>'K>RTVXU5I99[NXNP`TC<1H=QVJ/3I_P#6KTL````8`[5S'CO2;[6?#Z6N
MGP>=,)U<KO5>`#SDD#N*X,JKNCBH/FLF]?0UQ,.:F]+LZ.#_`(]X_P#='\JD
MK+U:75K;2%;2+6*XO1M`CE("X[_Q#^=:41<Q(9``Y4;@.Q[UQ2A://=:M^OW
M&R>MCAK2./4OBOJ!NU606=LOD(PSM^YS_P"/-^===>:3I]_<0SW=G#-+"<QL
MZY*US_B#P_J8UN/7]`DB6]$?ERPR\+*/\>@YQT'(Q5>VA\<:KJ-O)?R0:5;0
MMN=8"&,@],9;/XG\Z]:JE6C"K3JJ*C%*S=FFEKIN[^7<YHOD;BXMW93U?[8?
MBI;)8/%'.]IM$DJ[E088DXR,G`X'K6CHNK:O;^+[G0-4NX[Y1#YT=P(A&W0<
M8''<_P"-3RZ1?-\18=5$'^A+:^69=Z_>YXQG/?TIO]BZ@?B%/J?E%+-[3REF
M#KPV`.F<_I6DJM&=-4Y<NE/ROS)[7WOY?@)1DI75_B_`QM5\0ZS"+ZXFUJST
MR2!B(-.5(YGD`QC<025)S_\`JJ;4_%FIM\/;+6;:1;:[EF\MRJ!@<%@<!@>N
MT&JFG^&O$%AI>I:0NE6;M<[O^)D\PR5(QC'WL]<9QU-/N/#6LR_#BTTA;$_;
M8;DNT?FI]W+'.=V/XAWKK<<$G!/DTDOY=8V[;VO_`#-LRO5L]]GWW_KL6==U
MGQ%X?CL=6N+ZWEMKB0+)9)``$!&<!^IX!YX^E7]9UC5;KQ7#X>TBXCM&$7FS
MW+1B0J.N`#QZ?GVI/'6B:CK.A6=MI]OYTL<P9EWJN!M([D=S2ZSH^JVOBJ'Q
M#I%O'=L8O*GMFD"%ATR">/3\N]<E*6&G"$GRJ=I]DKZ<MUMWLWOU-)*:;2O;
M3_@V_P"`5K;5]=MO'L&CZA>Q2VWD,Y,<(02#:Q#'J0<CH#CBJ,/BO4-:^V7M
MOKVGZ5#`Y%O:3A"TX`S\Q8Y`/3(]_2EA^W3_`!5M6U"*..1K5CY4;%Q&NU@`
M6XR??WIL'A74M$%W9VV@Z=JL<SEK>[G,>Z'(`^8,,D#K@>_K75R8:+7.HJ3C
M%_9MN^;?W>WZ&=ZCVO:[[W\O/^M3K/"VN'Q!H4-ZZ*DV2DJKT##T]CP?QKD_
M'UM>-XFT`K?;5FGVVZ^2#Y#;HP6_VLD@X/I[UV7A_3)-)T>*WG^SFX)+S&"%
M8D+'T"@#@8&<<XK(\6:-?ZGK7AZXLX/,BM+@O.V]1L7=&<\GG[IZ>E>?@ZM*
MEF#E!I1]ZU]MG;?^NG4WJQE*@D]]"AJNJ:_9^+-+T.WU)':>T'F2O`H!?+Y?
M`]`N<9QQ5S6-8U718]-T>&Y6]U:]D*_:98@BJN>NU>._Z&GZCHU_/\1=+U6.
M#=906Y227>HVM^\XQG/\0[=ZF\4Z#>:C<Z?J>F21K?6+[E20X61<@XS^'ZFM
M%4P[G1C)1MRW>B^+6U[=-M/O)Y9VDU??\--BA<ZIKGA?4K!-5OH]2L;R3RVE
M$"Q-$W'IP1_]>HTU77]0\::KHUI?QP01(&61X%<Q#"]!QDDMW)J2YTK7/%&I
M6#ZK8QZ;8V;^8T0G65I6X].`.WY]:LZ3H]_:^/-7U*:#;9W$06*3>IW'Y>P.
M1T/45?-0C3<I<OM.5[<MK\RM:VE[=A6FVDK\M_/M]YEZ'JGBC6Y=1TQ=2MX)
M;"0H]W]F#,YR0!MX4#Y6YQ6SX'U^Z\0:&\UX%,\,IB9U&-_`(..QY_2HO">C
M7^F:UXAN+R#RXKNX#P-O4[UW2'/!X^\.OK3?`&C:AHFCW,&HV_DRO<%U7>K9
M&T#/RD^E3C)8:4*J@HZ<G+:W5>]MOKTV0Z2J)QO?K?\`0I?$<R"30C"H:47?
MR*3@$_+@5)JFJZ_X8O[&XU"_M[VQNI1'+&L`C\D_[)Y)[]?2K7C;1M3U<Z5_
M9L89X+C>SE@!'TP>3ST[55U+2]?\3W]A!J-A;V5E:RB6619Q)YQ']T#D?CZU
M>'G1>'I1J./*E+FO:^^ENM_37Y"FI*<G&]]+=OZ]2UXAU34X=76U34[31K$1
M[_M<WER/*W'RJA;..>N.QK-T'QCJ%SHNN2R^7>RZ<NZ*94V^:#NY*CI]W/TJ
M:\T35[3QK/K$&F0:K!<(%02RJA@.`,_-]#T!X)IGA_P]X@L+C7C(T=K<7NV2
M&ZC*NF_+$C:<G'S8Y%5&.$6&L^5NT7T3O=<W>6V_X(3=3VFE^OY:>7]:LS[+
MQ3J\Z6UU;:[9WT\C@2Z9+"EOL!Y(5V(W8Z=?SK;\2>);F#7+31;2[M].:6/S
M9KRXVD1#G``)P3Q^HK%O_#.KZO:I9S>';&WO-P\S5(YT4/ZL449R?I6IK/A6
MZ74=/U.TMH-4:W@6WGM;HK^^`&`P+<9YK2?U)U8M\NTM/=M?I=KW;=N9)]R5
M[7E:UZ=_GY_=\B?P[XCN)=?GT2[OK;4=L?FPWMN%`<=PP4X!Y[>E87A:\GT_
MP+K]W:R>7/%<.R-@'!PO8\5T7AS1KV+5)]2O-.L-.C*[8+2WAB+1^I,BKD]/
M7O67I7AS5K;P7K>GS6FVZN96:&/S$.X$+W!P.AZU'/ADYQ35FZ=]59ZN_EZV
MT*M4T>OVO^!_6XNL>)=5LO"&A:C#/FYN'3SOD7]X,$D=,#/M4NJ:IXB\/ZOI
MDEW?V]U;7LHB>W2`((SD?=;DGKU)_"H]5\.ZK<^%-`LHK7=<6DB&=/,4;0`<
M\DX/X5I^,='O]5GT=K*#S1;W0DE.]5VKD<\D9Z=JF$L*I0A:-FYWVV^SKT\@
M:J6;UZ?\$I:KXENKCQ/-H]KJMKI$%LFZ6[N`C%VX^50QQW_0U>\)^(I]4N+[
M3[N:"XGLV&+FWQLF0]&XXS]/6J.J^&KJV\33ZQ:Z5::O!=(!):W#*I1N/F4L
M".WZFM/PMH]W8"YN[ZWLK::X;Y+>V@C7R4Z[2RJ"WYGI65?ZI]4]RU[*VU^;
MK_>[[Z=BH>T]KKW?I;IY?J3>,=1NM*\+W=Y92^5<1E-K[0V,N`>"".AK!UKQ
M%J]GIGA::UG4S7RQF<,BXE)5#@\?*"2>F.M;WC'3KK5?"]W9V47FW$A3:FX+
MG#@GDD#H*Q-4\/ZG<V?A*.*UW-8>5]I'F*/+P$SWY^Z>F:G`?5O9P]KRWYI7
MO;;ETOY7V\QUO:<SY;[+\Q;K5==T'Q/I5K?:A#>VVHN(RBVXC\LD@<$9)Y8=
M37:NZQQL['"J"3]*Y3Q3HVH:CXC\/W=I;^9!:7`>=MZC8-Z'."<G@'I75NBR
M1LC#*L"#]#7+BY4ITZ4U:[3YK675VT76QI24E*2>W3[CSJ'Q5J6KP7>HPZ]I
MVF)$Q$%A,(RTP`S\Q)R,].*LWOBW47\/:3XAM6\NW$_EWUNJ*P(SC()Y'0]_
MXA5:'PMJFCP7.GP:#INI"1R;>_F\O=$#Q\RL,G'7`_6NIB\.@^$I-'N3"9)8
MV$CPPK&N\\@A5`'!QV[5Z=>I@J<HRBHN-UV^&VM[:_\`@6M]CGA&M)--N]OQ
M_KMH4M8UJ]F\4Z1I&DW(C65?/N7"!LQ]1U''`/YBLVX\3W>J:[?V5KK=EHMM
M9-L$DZHS3-D@XWG&,CM[>M6/`WAO4=,GN;[6(]MT42WA!=6Q&H'<$^@'X57N
M/#%YI>NZA>6NAV6M6UZWF".=D5H6R2<;QTR>W7CTJ8+!PJ.BFFXQT?NV;;N]
M7H]-%<;]JXJ3OJ]M=%\M18O%]]=^"]6NEDACU&P<1F6$!D;+`!@#D<C/\ZAO
M=7\3VWA2U\0_VE;A=D9:V%N#O!P-Q;U)YP``,U<;PSJ2>"M2M&@LVU*[*GR[
M6&.%0`P(7("YP,G)]?SGU31-1N?AQ!I,-ONO5AA4Q;U&"I&><X['O5*>$C-*
M*C9U+.]G[ME??I>]GTZ":JM:W^'\2+6?$=^E[X3:TF\F#4W1IX]BMN5C'QDC
M(X8],4Z^U;6G\>'1K&ZBC@>V##S(@PC/4MV)/;&<<U!?^'M4G?P:8[7<-.$7
MVK]XH\O'EY[\_=/3/2M%=(OA\16U4P?Z$;3RQ+O7[WIC.?TK)/"P@FN5M1GV
MWYM/G;;R\BOWC>M]U^6I5T/7-3M_%.HZ%JUTEX+:'SEN!$(SC"G&!QT;]*AT
M74O$WB*&YU>UO+>VMD=E@LW@#"7`_B;J.H&1^56;?0K[_A8FI:E-;XT^XMA$
MLN]?F.U`1C.>Q[56T73?$GAR&YTFVM+>>T9V>&]><*(@?5>I/&<#OWJI/#N+
ME3Y.=Q@];6V]ZRV3VTW[:@N>]I7M=]_D7?`&LW^MZ+<7&HS^=*EP45MBKA=J
MG'R@>IJC\4&":+8.>BWBDX_W6H^%@(\-W1QP;MO_`$!*O^.M'O\`6=.LHK"#
MSGCNED<;U7"X(SR1ZU/[NCF_2,4_1+0/>GA>[L<WXB\867BK27TK3--O)KN5
ME*%XU^3#`Y&"?I^-.\4"YT:Y\'KY#75S:1@>5&3F1EV<#@]QZ5Z97&^,]*UF
M[U;2+[2+-+A[-F<AW50#E2,Y89Z=J>"QM%U84HQ4(+F>LNKC;?2P5:4E%R;N
M]-EYA:^,M9N+R"&3PA?PI)(J-(Q?"`G!)_=]JR?%][-I_P`1]+NK>SDO)8[0
M%8(\[GYD'&`?7/3M6A_:GQ#_`.@#IW_?8_\`CM6M0T;4;GX@Z3JJ6^;2"WV2
MR;U&UOWG&,Y/WA^=72]A0JN5H)<LM%.]]-M]+[(F7/.-KN]UNK%K0?$FI:MJ
M#6]WX=N]/C$9?SI2V"01QR@]?7M7251UFXO;72+F?3XHY;J-=R)(?E//.>1V
MSWI='NY;_1K*\G14EGA21E4$`$C/&:\>LHSC[:G%1C>UKMZ_/4ZX73Y9.[+M
M%%%<IH%%%%`!1110`5J:/_RV_P"`_P!:RZU-'_Y;?\!_K7I91_OD/G^3,JWP
M,U****^V.`*Q-4_X_#_NBMNL35/^/P_[HKQ\\_W7YHWP_P`92HHHKX\[0HHH
MH`****`"BBB@`HHHH`YR\\&6%SJ<NH075_87,N?,>SGV;\XZ\'T[5HZ-H5CH
M4$D=FKEI6W2RR-N>1O4G_/4UI45T3Q=></9RDVO\MC-4X)\R6H4445SF@444
M4`%%%%`!1110`45POB,#3?B)H.HY*K<`V[^G7;_[./RKG?&4]Q=^*[W4+8@Q
MZ.(5)S_%N'_LQ/Y5Z^'RIUW"T[*4;WMUO:V_<Y:F)Y$]-G^E[GKE%<%XJF36
MO$?ABPC8&*4BZ9>N4."/T5JV[SQGIMK>S6L<%[>-;G%P]K#O2'_>.?KTST-<
M[R^KR0<5=R3;5ME>R^\T5:-W?9'145F-X@TM-$&L&Z7[$1D.`>3TQCKG/&*I
M:?XOL+Z]BM'M[VREG&8/M<.P3#_9.3FL%A:[BY*#LM_EO]W7L4ZD$TK[G05B
M:QX6L-9O(KV22YMKR(86XMI=C@?D?4USVF7$5K\2O$4\\BQQ1VP9W8X``"5T
M-AXHL;[2KC5/*N+>Q@S^^G0`.!W4`DG\JZ7AZ^&DIT6]4M5_>6WF0IPJ*TO/
M\.H[2?#-CI%W)>+)<W5Y(NUKBZE\Q\>F?R_*MFN:A\;Z=)/`D]IJ%I%.VV&X
MN;?9%(3TP<]^M=+6&*CB%)2KWN^_E_D73<+6@%%<'X\N-<FL;^&");?2H$4R
MSEOFGSCY5]LGGZ=>U=-X7_Y%72O^O6/_`-!%54P;IX>-=R3N[6732^OGY"C5
MO-PML:U%%<WXJGUQHOLFD0HD;Q,\]VYQY:CLO^U^?X=:PH476FH72\V5.7*K
MG245Q_@`3'P*HMR@GW2^67^[NR<9]LU@:MX/ETW0KG6]3UB<ZQ&2RR1R_(23
MP`2`V3GMC%=T<!3]O*C.I9I\JTNV_3HC)UI<BFH]+GI]%9GAZYN+SP[I]Q=D
MF>2!6<D8)..OX]:P?%%P=2\4:+X>!S$[_:K@?WE7)`/M\I_2N:EA7.LZ3=N6
M]WY+<N51**EW_4[&BN'=0_Q:93T-CC]*YOQAX,T[P_9VDUI-=.TTXC82LI`&
M">,*.:[:.6TYU(4Y5+.237NWWOY]+&4Z\E%R4;V?<]<HKC8OAKHT,$\*W-^5
MG4*Q,B9`#!N/E]17+_\`"%Z;_P`)U_8?GW7V7[/YN_>N_./7;C'X5-'!86KS
M<M9^ZK_#T7_;PY5:D;7COY_\`]:HK.T31;;0--6QM7E>)6+9E(+9/T`JGJ7B
MS3M)U==,N4N/.>,2*4CW!LD@*`#DDD>E<*H2J5'"C>5O+IZ&SFHQ3GH;M%8F
MD>*+'5[R2R$5U:7D8W&WNXO+<CU`R:AO?&.GVM[+:06]]?S0?ZX64'F"+_>.
M15?4Z[GR<COO\NXO:PM>YT-%8P\4:9)H$VLV\C3VL(^<1K\X/'&#CGFL\^/M
M*$$5S]FU#[(^-UR+<F.,G^%FSU^F:<<%B)WY8/1V^?83JP6[.IHK'U'Q+8::
MVFAQ+,NH.$@>$`KSC!))''S#IFG:IXAM-(U'3[&XCG:6^D\N(QJ"H.0/FR1_
M>'3-1'#5I6M'>]OEO]Q3J15]36HKB+3_`)*]?_\`7D/Y)6E=^-].M9[A([6_
MNHK9ML\]M!NCC/<%B1TK>>`J\T8TUS7BGZ7Z$*M&S<M-;'2T5Q'C#Q?);^';
M2ZT9I"MXV!="/*JN#E<GH^1TQV/I4FNWVF:C::+<ZE;:K;%KL"&/RU1PX(Y<
M-_#]*J&756HRGHI-KN]/+03KQNTNEOQ.SHK(U?Q'8:-+%!,)I[N7F.VMX]\C
MCV%)I'B6PUF>6VB$]O>1#,EK<Q[)%'KC\OS%<WU:M[/VO*^7O_73S-/:1YN6
M^IL45S(\<:=(;I(;74)Y[:1HWAA@WN<'!;@X"^Y(I\UW8>,_"5Y]C8D.A4*Z
MX:.0#<,CZXZ5I]2K1:=6+C&Z3=MKD^UB_A=V='16#X.U=]:\,VUQ*<SIF*4Y
MZLO?\1@_C6]6-:E*C4E3ENG8N$E**DNH4445D4'6N6_X0/38Y)C:7NI644Q_
M>06UQM1OJ,'UKJ:*VHXBK1O[.5KD2A&?Q(J:;IMII%BEG91>7"G09R23U)/K
M5NBBLY2E.3E)W;*225D%%%%2,****`(;JUAO+=[>X3?$_#(2<,,]#[>W>I54
M*H50``,`#M2T4[NUN@K!1112&%%%%`!1110`5J:/_P`MO^`_UK+K4T?_`);?
M\!_K7I91_OD/G^3,JWP,U****^V.`*Q-4_X_#_NBMNL35/\`C\/^Z*\?//\`
M=?FC?#_&4J***^/.T****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`X[XD6[GP]#?1'$EG<I(&QT!X_F5K/\`"6EOJWA+6KJ95\_5GD((]LX_
M\>+5WL]O#=0M#<0QS1-]Y)%#*?J#1;V\%K`L%O#'#$OW8XU"J._`%>G#,7#"
M*A%:IWOY;V^_4YW0O5YWM8\P^'QFU3Q(MQ<)QIUD(%SU!S@?INJOH+W>F)JU
MM<>)8])GAF9IH9;5)&FX^\I8@G/H/8]Z]3MK"SLWE>UM(('E.9&BC"ES[XZ]
M3^=-N=-L+R5);JRMIY$^ZTL2L5^A(KJGF\)U)MP]V279VMKU36[9FL*U%:ZJ
M_P#6AY3>:5)%\/;6:W>YEL_MWGDS0!&1"NW=MW,"N1Z]ZTKT-JFJZ/;OXH.J
MRF42PK:V,?[K!!RY#@K_`/6Z5Z:44IL*C;C&W'&/2JUKIMA8N[VEE;6[/]YH
MHE0M]<#FE_;+:;E'WDY-?#U]5T\K7#ZK;9Z:=^GS/,=4T&Y\0>/-=M;>Y\DK
M$)"ISB0A4VJ?;.*WK35+/5OAY<VU_:S$V:"WNH+5!O0J1A@IP.P/X'TKLTLK
M6*ZDNH[:%+B08>98P'8>YZGH/RHBLK6">6>&VACFE_UDB1@,_P!2.M9U<T52
M$(./P<MNFJT?W_AH5'#\K;3WO?YGDMW(VG:3;2V6OVFK6A=3'IUY&LCID8`V
M'=C'3C'MUKUV!F>WC=TV.R@LG]TXZ57BTG38;DW,6GVD<Y.3*D*AL_7&:N5A
MC\;'$J*4=5?736_HDOGU+HTG3OJ<]XY_Y$O4O]Q?_0UJ/3+34+OP;HZ:=J7V
M"46\9:3R%EW#;TPW3Z^U=#/;PW4+0W$,<T3?>210RGZ@TL44<$210QK'&@VJ
MB#`4>@`Z5E'%<F'5)+52OK9K:VS*=.\^;RL<[_8OB?\`Z&[_`,IL7^-:TL<\
M.@RQW-Q]HF6W8/-L";SM/.!P*OTC*KJ58!E(P01D$5G/$RFUS):=HQ7Y)#5-
M1V_-LY#X?S1VW@9)YG"11M*[L>@`))-<TWB+2/$NL&ZU^_-OIUL_^C6`C=M_
M^TY4$?A^'U]-CL+**S:TCM($MF!!A6,!#GK\N,54_P"$=T/_`*`VG?\`@*G^
M%>A3Q]!5JM:47>3=FFKI/UOKYF,J,^6,4U9?B6[&ZMKVRAN;1@UO(N8R%*Y'
MT/2N1F_=?%RW,G'FV1\O/?AO\#79PPQ6\*PP1)%$@PJ(H55'L!6!XCTBZN-1
MTK5M/C\RZLI@'3<%WQ-PW)P,_P")KFP=2$:LXWLI*25_/:YI5BW%/JFF97_-
M7?\`MR_I3?B=_P`@S3?^OP?^@FNR^Q6OVS[9]FA^U;=OG>6-^/3=UQ1=65I>
MJJW=K#<*AW*)8PX!]1GO6D,?&->E5M\"2^ZY+HMPE&^[)ZXC_FKO_;E_2NWJ
M#[%:_;/MGV:'[5MV^=Y8WX]-W7%<N&KJCSW7Q1:^\TJ0YK>3N3UYWKUW;V/Q
M6TRXNF"PI;_,Q'"Y$@!/L"0<]J]$KDKW1+Z?XCV&JBV#6$=NT<DA=>"5<8VY
MR?O#MWKHRVI"$YN;TY)=;=-EYF>(BVE;NC-N)X=9^*&G3:7*D\=K;GSYXB&4
M??[C@_>`_&H_`VH6>A+JVGZO<Q6M\ER7<SMMWC`Y!/7N?QKN[2QL[!&2SM(+
M=&.66&,("?4XIMWIMA?E3>65M<%?NF:)7Q],BMI9A2E!T'%\EDM]=&WZ==B5
M1DGSWUN_34\RLHY)?#/B_48U9+"ZES;@C`8!R<@?0@?_`*JT%UW25^%QLVN(
MEN?LWE?9R0'+GH=O7!SG-=?XEL)K[PQ>V5G$&EDCVQQ@A0>1ZX`IFAZ+#!HN
MFK?V,!O;:%5W.BNR'V;G]#73+'T:E+VLUKSII)ZZ125_NW(5&49<J[?FSA]4
MAGT[P_X-DO0R+!/ND9AC8"P8`^GRC]*N>*=4LM1\8^&197,=PL=RFYXFW*"9
M$XR.,\=/>O0Y[>&ZA:&XACFB;[R2*&4_@:KC2=-`@`T^T`MVW0XA7]V>.5XX
M/`Z>@K&&:4[J<XOF7/L]/>O^5RGAW9I/33\#DK=BGQ9U%@I8BQ!"COPG%<W%
MJ27WAK5I9]5AT[+,J:7:1)%O8@8S@;F!.`?H>?3U865JMXUXMM"+IEVM,(QO
M(]"W7'`I@TS3Q<O<BQMA<.,-+Y2[F'N<9-%/,Z<;7AJE%=/L^J>_?=!+#R?7
MJ_Q/++]"_P`(=+*C(2]8M[<R#^HKH?&EW;WL7AZ:UGCFB-\H#QL&&>.XKLDT
MVQBM&M([*V2V;.Z%8E"'/JN,4T:3IHABA&GV@BB;?&GDKA&]0,<'WIO-*;J*
M;B])2?RE_D"P\DK7Z)?<<;<31Z/\5'O-3D$=M=6VVWFDX13A01GH.C?]]#UH
M25-9^*<%WI<@EMK2VVW,T9RA.&XR.#U`_`^E=S<6MO>0F&Y@BGB/5)4#*?P-
M);6EM9PB&UMXH(AR$B0*OY"L?[0AR7Y?>Y.3?2VU_6W^97L'??2]SC?A^@&H
M^(Y,?,;S&?H6_P`:3X<E4LM8+?=%XQ/TQ796]E:VC2-;6T,)E;=(8XPN\^IQ
MU-9VJ6+6N@W\6BV$2W4Z$*D*I'EFXW$\#(SGGTISQL:\JD;6]IR[]+::@J3@
MHOM?\3`^%L3IX:N'885[IBOOA5&?\^E=O6;H&E+HNAVNGJ03$GSL.['EC^9-
M:5<F/K*OB9U([-FE&#A346%%%%<AJ%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`5J:/_P`MO^`_UK+K4T?_`);?\!_K7I91_OD/G^3,JWP,U***
M*^V.`*P]3.;T^RBMRLR:))M7"2+E2O(SCM7EYO2E5HQIQW<DC:B[2;,JBM[^
MSK3_`)Y?^/'_`!H_LZT_YY?^/'_&O&_L'$_S1^]_Y&WUB)@T5O?V=:?\\O\`
MQX_XT?V=:?\`/+_QX_XT?V#B?YH_>_\`(/K$3!HK>_LZT_YY?^/'_&C^SK3_
M`)Y?^/'_`!H_L'$_S1^]_P"0?6(F#16]_9UI_P`\O_'C_C1_9UI_SR_\>/\`
MC1_8.)_FC][_`,@^L1,&BM[^SK3_`)Y?^/'_`!H_LZT_YY?^/'_&C^P<3_-'
M[W_D'UB)@T5O?V=:?\\O_'C_`(T?V=:?\\O_`!X_XT?V#B?YH_>_\@^L1,&B
MM[^SK3_GE_X\?\:/[.M/^>7_`(\?\:/[!Q/\T?O?^0?6(F#16]_9UI_SR_\`
M'C_C1_9UI_SR_P#'C_C1_8.)_FC][_R#ZQ$P:*WO[.M/^>7_`(\?\:/[.M/^
M>7_CQ_QH_L'$_P`T?O?^0?6(F#16]_9UI_SR_P#'C_C1_9UI_P`\O_'C_C1_
M8.)_FC][_P`@^L1,&BM[^SK3_GE_X\?\:/[.M/\`GE_X\?\`&C^P<3_-'[W_
M`)!]8B8-%;W]G6G_`#R_\>/^-']G6G_/+_QX_P"-']@XG^:/WO\`R#ZQ$P:*
MWO[.M/\`GE_X\?\`&C^SK3_GE_X\?\:/[!Q/\T?O?^0?6(F#16]_9UI_SR_\
M>/\`C1_9UI_SR_\`'C_C1_8.)_FC][_R#ZQ$P:*WO[.M/^>7_CQ_QH_LZT_Y
MY?\`CQ_QH_L'$_S1^]_Y!]8B8-%;W]G6G_/+_P`>/^-']G6G_/+_`,>/^-']
M@XG^:/WO_(/K$3!HK>_LZT_YY?\`CQ_QH_LZT_YY?^/'_&C^P<3_`#1^]_Y!
M]8B8-%;W]G6G_/+_`,>/^-']G6G_`#R_\>/^-']@XG^:/WO_`"#ZQ$P:*WO[
M.M/^>7_CQ_QH_LZT_P">7_CQ_P`:/[!Q/\T?O?\`D'UB)@T5O?V=:?\`/+_Q
MX_XT?V=:?\\O_'C_`(T?V#B?YH_>_P#(/K$3!HK>_LZT_P">7_CQ_P`:/[.M
M/^>7_CQ_QH_L'$_S1^]_Y!]8B8-%;W]G6G_/+_QX_P"-']G6G_/+_P`>/^-'
M]@XG^:/WO_(/K$3!HK>_LZT_YY?^/'_&C^SK3_GE_P"/'_&C^P<3_-'[W_D'
MUB)@T5O?V=:?\\O_`!X_XT?V=:?\\O\`QX_XT?V#B?YH_>_\@^L1,&BM[^SK
M3_GE_P"/'_&C^SK3_GE_X\?\:/[!Q/\`-'[W_D'UB)@T5O?V=:?\\O\`QX_X
MT?V=:?\`/+_QX_XT?V#B?YH_>_\`(/K$3!HK>_LZT_YY?^/'_&C^SK3_`)Y?
M^/'_`!H_L'$_S1^]_P"0?6(F#16]_9UI_P`\O_'C_C1_9UI_SR_\>/\`C1_8
M.)_FC][_`,@^L1,&BM[^SK3_`)Y?^/'_`!H_LZT_YY?^/'_&C^P<3_-'[W_D
M'UB)@T5O?V=:?\\O_'C_`(T?V=:?\\O_`!X_XT?V#B?YH_>_\@^L1,&BM[^S
MK3_GE_X\?\:/[.M/^>7_`(\?\:/[!Q/\T?O?^0?6(F#16]_9UI_SR_\`'C_C
M1_9UI_SR_P#'C_C1_8.)_FC][_R#ZQ$P:*WO[.M/^>7_`(\?\:/[.M/^>7_C
MQ_QH_L'$_P`T?O?^0?6(F#16]_9UI_SR_P#'C_C1_9UI_P`\O_'C_C1_8.)_
MFC][_P`@^L1,&BM[^SK3_GE_X\?\:/[.M/\`GE_X\?\`&C^P<3_-'[W_`)!]
M8B8-%;W]G6G_`#R_\>/^-']G6G_/+_QX_P"-']@XG^:/WO\`R#ZQ$P:*WO[.
MM/\`GE_X\?\`&C^SK3_GE_X\?\:/[!Q/\T?O?^0?6(F#16]_9UI_SR_\>/\`
MC1_9UI_SR_\`'C_C1_8.)_FC][_R#ZQ$P:*WO[.M/^>7_CQ_QH_LZT_YY?\`
MCQ_QH_L'$_S1^]_Y!]8B8-:FC_\`+;_@/]:M?V=:?\\O_'C_`(U!IBA9KI0,
M`,`/UK;"9=5PF+INHT[WV]'Y"G54X.QHT445].<@5GG_`)#2_P"Y_2M"L\_\
MAI?]S^E<.._Y=_XHFE/KZ&A1117<9A1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%9^G?\?%
MW_O_`-36A6?IW_'Q=_[_`/4UPXG_`'FCZR_])9I'X9&A1117<9A6>?\`D-+_
M`+G]*T*SS_R&E_W/Z5PX[_EW_BB:4^OH:%%%%=QF%%17*326LJ6\JQ3LA$<C
M)N"-C@D9&<'MFO'/$3^`="UF2R\6^,=>O=64*\G^D3`1Y&0`L("IQ@X]\]Z`
M/:**XSP#!:RZ>FIZ'XDU/4]#N`RQPZAEV1E;!*NP#@9!&#GVQ79T`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%9^G?\`'Q=_[_\`4UH5GZ=_Q\7?^_\`U-<.)_WFCZR_])9I'X9&A111
M7<9A6>?^0TO^Y_2M"L\_\AI?]S^E<.._Y=_XHFE/KZ&A1117<9A7G]U;>,-&
M\9:W>Z#X>TV[L=0,+F2:]\N1I%C"D]#@<`8_V<]Z[F]M$O["YLY'D1)XFB9H
MG*NH8$$JPZ'G@UYGXCT_P%IFJBVUCQAJ=E=I!$AA&JRJ0JHJJ2!W(4$D]22>
M]`'H>BSZI<Z7%+K%E#9WQ+;X89O-51DXPV!G(P:T*PO!_P#9/_"-6W]B:C-J
M&G[G\NYFF:5F.XYRS<G!R/PK=H`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*S]._X^+O_?\`ZFM"L_3O
M^/B[_P!_^IKAQ/\`O-'UE_Z2S2/PR-"BBBNXS"L\_P#(:7_<_I6A6>?^0TO^
MY_2N''?\N_\`%$TI]?0T****[C,*\ME;78OB#XF/A_PK8W\#/;_:9K^<1L9O
M*'W."=FW9QCKGGG`],NYI;>RGFAMWN98XV=($8!I&`R%!.`">G/%>.ZU!X<U
M+Q)=:OKNK^-O"=Y="..168P6X"KA0)%1DQU/W^K'H3B@#U;0&U!](B;5-/M]
M/NR6WV]O)O1>3C#8&<C!Z5I5B>$[6QLO#=K#IVL7&L6HW,E[<7(N'DRQ/+C@
MXSCVQBMN@`HHKAM#\9SZKXBU&":\M8+.VNKB""W;3YEDN%AX9DG+^6Q#9RH4
MD`=LYH`[FN?\*^)_^$F_MO\`T/[-_9FJSZ;_`*W?YOE[?GZ#&=W3G&.IK#\'
M>.UU?2'U37-6TVSC\A)VMY+22T,".V$8R2R%9%/`#*`">`:K_"2>&ZM_&%Q;
MRQS02^*+UXY(V#*ZD(001P01SF@#T2BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`K/T[_`(^+O_?_`*FM"L_3O^/B[_W_
M`.IKAQ/^\T?67_I+-(_#(T****[C,*SS_P`AI?\`<_I6A6>?^0TO^Y_2N''?
M\N_\432GU]#0HHHKN,Q&944LS!549))P`*K-J%@RE6N[8@\$&1>?UI-4M1>Z
M3>VA@BG$\#Q^3,2$DW*1M8CD`YP<5XY<V/A32G$&K_!_5UN.A.GVXNXC]'#C
M]0#[4`=[\,+F2[\$QS2N'8WET-P`&0)W`Z>P%=C7(>"I;E;9+2S\)R:!HD2,
MT:74@$K.3G`C7.T<DDD@Y[5U]`!7)W&AZ]JFOV%WJ$NG1PZ7/-/:26^\M,61
MD021G[H4,<X<[B/X>E=910!Q</@^?6]?_M;QA9:-=F&S%I#;1H9HF.[<TI61
M?E8\`+\VT9^8YK/^$D$-K;^,+>WBCA@B\47J1QQJ%5%`0``#@`#C%>B5Y_\`
M"S_F=?\`L:[[_P!DH`]`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`*S]._X^+O\`W_ZFM"L_3O\`CXN_]_\`J:X<3_O-
M'UE_Z2S2/PR-"BBBNXS"L\_\AI?]S^E:%9Y_Y#2_[G]*X<=_R[_Q1-*?7T-"
MBBBNXS(KJY@LK2:ZN94BMX$:261SA44#))/H`*YO_A97@K_H:-+_`/`A:VM<
MO[;2M`U'4+R/S+6VMI)98\9WJJDD8[Y'%<MIEI?:AX"75/\`A&="CUR>(SV]
MH8AY05CE%8XSNV$9Z<^G8`ZW3-4L=9L4OM-NXKJUD)"31-N5L'!P?J#5NN?\
M$ZS;>(/"-CJ=K8K8K*&$EJJ[?*D5BKKC`_B![5T%`!6>FO:-)JS:4FK6#:DN
M<V:W*&88&3\F<].>E:%>7R->^';UUTG7/[837;S4'EBC2/;`XC9@5*Y;*%50
MY8CIPIH`]&LM3L-2\[[!?6UUY$ABE\B57\MQU5L'@^QKB?A9_P`SK_V-=]_[
M)7-^%SK0.E#PG'IC7Q\*:>)3?NZPJ=[\D("6;[X`XZDD\8.Y\'?MG]G>+/[1
M\C[=_P`)+>?:/L^?+\S$>[9GG;G.,\XH`](HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`***YGQ9XIOO#?E-;:!=:C`8VDEGC
M;:D07U(5B..<D`>A/.*A!S?+'<4I**NSIJ*YGPGXIOO$GFM<Z!=:=`(UDBGD
M;<DH;T)52>.<@$>I'&>FHG!P?++<(R4E=!1114C,_6;S4;*S233-+_M*<R!6
MA^T+#M7!^;+<=0!CWKGM&\7:[K%X\:>%=D$%V;6ZF_M!#Y+*1OXV@M@'/'7M
M78UR?@7_`)F7_L.W7_LM;PY>1MQNUZ_YD2OS+4ZRBBBL"PHHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`*S]._X^+O_?\`ZFM"L_3O^/B[_P!_^IKAQ/\`
MO-'UE_Z2S2/PR-"BBBNXS"L\_P#(:7_<_I6A6>?^0TO^Y_2N''?\N_\`%$TI
M]?0T****[C,K:C86^J:9=:?=IOM[F)H95]588/\`.O/X=%^*&E6D.BZ;JWA^
M?3HD$,5_=12_:DC'`)4':S`8^N.:]%GGAM8))[B5(H8U+/([!54#J23T%8WB
M3Q$=#M+-[:U2\N;Z;R+:-IUAC9MC/EI""%&U#V.>,4`3>%_#]OX6\.6>CVTC
MRI;J=TLARTCLQ9F/N6)-:]9/AW6FUW2S<RVHM9XY7@FA69955U.#M=>&'OQ[
M@'(K6H`*IP:3IMK?SW]OI]I#>7'^NN(X5623_>8#)_&KE%`%6RTRPTWSOL-C
M;6OGR&6;R(E3S'/5FP.3[FN)^%G_`#.O_8UWW_LE>@5Y_P#"S_F=?^QKOO\`
MV2@#T"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BN+\<>(?$WATF\TW3[.;2HX5,T\_+*Y<KC`<''*]N]:'@[5M>U
MC3FN=;TZ"U614EMI('!65&&?N[F((X/)_BZ<5JZ,E#VEU;U(YUS<ITE%%%9%
MA116?K.AZ=K]FEIJ=OY\"2"15WLN&`(SE2#T)IJU]1._0T**\M^$>AZ=/IKZ
MS+;[M0M[MXXIM[#:IC7C&<'[S=1WKU*M*U-4YN"=[$PDY1N%%%%9%A15>_LX
M]1TZZL9F98KF%X7*'#`,"#C/?FO'+'P%I5U\1=3\//<7@M+6V69'5U\PDB,\
MG;C'SGMZ5O1I1FFY2M;R,YS<;61[71116!H%%%%`!17G'B3Q;XRT/7XK!--T
MN2&\G,=@_P`Q,HR``?G&#\R@Y`&<XXKM]#FU2?1X)=9MHK;4&W>;%$<JOS'&
M.3_#@]>]:SHRA%2;6I$9INQH4445D6%9/BG_`)%'6O\`KPG_`/1;5K5D^*?^
M11UK_KPG_P#1;5=/XT*6S#PM_P`BCHO_`%X0?^BUK6K)\+?\BCHO_7A!_P"B
MUK6HJ?&PCL@HHHJ!A7)^!?\`F9?^P[=?^RUUE<GX%_YF7_L.W7_LM:P_AR^1
M#^)'64445D6%%%%`'!S>.]=@URWT:7PCMU"XC,D4/]I(=RC=SG;@?=;J>U=O
M:R32V<,EQ!Y$[QJTD.\-Y;$<KD<'!XS7!:O_`,EOT#_KP;_T&>O0JZ*ZBE'E
M5KJ_7_,SIW;=V%%%%<YH%<=KGQ*T;0-8GTR[MK]YX-NYHHT*G<H88RP/0CM7
M8UY[\8O^11M/^O\`3_T7)6^'C&=11DMS.JVHW1UGAWQ%8^)]+^WV'FB,2&-T
ME7:RL,'!P2.A!X)Z^N:UJ**QDTWIL6KVU"BBBD,****`"L_3O^/B[_W_`.IK
M0K/T[_CXN_\`?_J:X<3_`+S1]9?^DLTC\,C0HHHKN,PK//\`R&E_W/Z5H5GG
M_D-+_N?TKAQW_+O_`!1-*?7T-"BBBNXS*&N7]MI>@ZAJ%[%YMK;6\DLT87=N
M15)(QWX%>;:?I,FK376EVNG6>FQB-;D:3<7*:AI\\>[`^4`&!@1_#QSG#<X]
M.U*X%II5Y<F,2B*!Y"C=&PI.#]:\STCQ(88](L?!/A'2[?4=6TX:K<Q[A!%'
M%G:!N5?F.XX]OQH`]!\.1O;Z-%;2:/#I)@)C^RV[*T0[Y0@#*G/<`^HK5K$\
M)^(?^$G\/0ZDUH]I,7>&>W=@QBE1BKKD=1D'!]*VZ`"N/F\9R#XBKX>B@0V,
M=C+//<$$GS4V'8ISCA7!/'\0]#785P=MX!OM-\8V6K66N7$EK!#=;DNA&S>9
M,X?'RQJ60G).6W<``XS0`>#O':ZOI#ZIKFK:;9Q^0D[6\EI):&!';",9)9"L
MBG@!E`!/`-5_A)/#=6_C"XMY8YH)?%%Z\<D;!E=2$(((X((YS6A#X/GUO7_[
M6\866C79ALQ:0VT:&:)CNW-*5D7Y6/`"_-M&?F.:S_A)!#:V_C"WMXHX8(O%
M%ZD<<:A510$```X``XQ0!Z)1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1169+XDT*"9X9M:TZ.6-BKH]T@92.""">#346]D)M+<TZ*9%+
M'/"DT,BR12*&1T.58'D$$=13Z0PHHHH`Y/XE_P#)/M4_[9?^C4K6\+?\BCHO
M_7A!_P"BUK)^)?\`R3[5/^V7_HU*UO"W_(HZ+_UX0?\`HM:Z'_NZ]7^2,_\`
MEY\C6HHHKG-`HHHH`\]^#O\`R*-W_P!?[_\`HN.O0J\]^#O_`"*-W_U_O_Z+
MCKT*NC%?QI&=+X$%%%%<YH%>>Z1_R6_7_P#KP7_T&"O0J\]TC_DM^O\`_7@O
M_H,%=%#:?I^J,ZF\?4]"HHHKG-`HHHH`\]^(7_(W>"?^O\_^C(:]"KSWXA?\
MC=X)_P"O\_\`HR&O0JZ*O\*G\_S,X?%+^N@4445SF@5D^*?^11UK_KPG_P#1
M;5K5D^*?^11UK_KPG_\`1;5=/XT*6S#PM_R*.B_]>$'_`*+6M:LGPM_R*.B_
M]>$'_HM:UJ*GQL([(****@85R?@7_F9?^P[=?^RUT.J:C;Z1I=SJ%VVV"WC+
MMR`3CH!D@9)P`.Y(K@_ASXJT^]U35]/42QSWM_/?P^9M`9&VX7KG?@$X&>`>
M:Z*<).E)I=C.4DII'H]%%%<YH%%%%`'GNK_\EOT#_KP;_P!!GKT*O/=7_P"2
MWZ!_UX-_Z#/7H5=%?:'I^K,Z>\O4****YS0*\]^,7_(HVG_7^G_HN2O0J\]^
M,7_(HVG_`%_I_P"BY*Z,+_&B9UO@9Z%1117.:!1110`4444`%9^G?\?%W_O_
M`-36A6?IW_'Q=_[_`/4UPXG_`'FCZR_])9I'X9&A1117<9A6>?\`D-+_`+G]
M*T*SS_R&E_W/Z5PX[_EW_BB:4^OH:%%%%=QF17,<,MK+'<!3`Z%9`QP-I'.?
MPKQ*SNOA1HFHSOH=[K%I*UM/;I<62W,J(A.UW0D-G:V#N&1G'6O9]3L4U32;
MS3Y'=([J!X&9#AE#*5)'OS7G>@>"?&$&H:,-7U#2%LO#UM)!IOV.-]\Y,?EJ
M9MW0``$A3R?7K0!VOA.ST:Q\,V4.@2++IA0O#*K[_,W$DL6[DDG/O6U6!X-\
M/2^&/#<6FSW*W,_FR32R(FQ-\CER%7L`3Q6_0`445"UY;)>1V;W,*W4B%TA+
M@.RC&2%ZD#(R?<4`35Y_\+/^9U_[&N^_]DKMK+4[#4O.^P7UM=>1(8I?(E5_
M+<=5;!X/L:XGX6?\SK_V-=]_[)0!Z!1110`4444`%%%%`!1110`4444`%%%%
M`!115'6'U*/2;A](C@EOU7,4<Y.QCD9'!')&<<@9QGBFE=V!Z%ZBO-;+Q/\`
M$*^U:YTV/1M)6>U:,7.\G;$'&5)(D.1CGY<FO2JNI2=/1M$QFI;!1116905Y
MKKG@OP]'XW\/6L>FJD%^UTUS&DCJK%4#+@`_*`3T7`KTJN3U_P#Y*#X/_P"W
MW_T4*WP\I1D[/H_R9G42:U\OS.ATS3+/1]/BL+"'R;:+.Q-Q;&22>22>I-6Z
M**Q;;=V:;!1112`Y/XE_\D^U3_ME_P"C4K6\+?\`(HZ+_P!>$'_HM:R?B7_R
M3[5/^V7_`*-2M;PM_P`BCHO_`%X0?^BUKH?^[KU?Y(S_`.7GR-:BBBN<T"BB
MF2RQP0O--(L<4:EG=SA5`Y))/04`<!\'?^11N_\`K_?_`-%QUZ%7G7P<EC/A
M>]A$BF5;UF9`?F`*(`2/0[3^1]*]%KHQ?\:1G1^!!1117.:!7GND?\EOU_\`
MZ\%_]!@KT*O.-'NK=OC?K>V>([[01)AQ\SJL6Y1ZD;6R.VT^E=%#:?I^J,ZF
M\?4]'HHHKG-`HHHH`\]^(7_(W>"?^O\`/_HR&O0J\]^(7_(W>"?^O\_^C(:]
M"KHJ_P`*G\_S,X?%+^N@44R6:*")I9I$CC49+NP`'XFN:N?'NC+.;;3OM&K7
M(_Y96$1D_P#'ONX_&L8PE+X46Y);G45R'Q%\1VNA^&I[65&DN=1AD@A1>!@K
MAF)]!N''4DCW(4S^-=8X@M;/0[<Y^>=O/FQV(4?*/H:PO%WP_>YT*XU*[U^^
MNKRSADF)G`:-E522JH,;,D#G)^AKHHTX1J+VC^XSG*3B^5%GPG\1-`3PM:07
M]S]CGLXDMWC=6;>%7`9<#D''3J#QZ$Z__"=V]P5&F:-K&H;LX>*T*I^+-C%5
MOAUX6M=&\/PWI*SW-_''<&0I@HI0$(.3T);D8SGV%=I2K.DJCY5?YA!3<5=G
M)_VMXQO`WV7PY:V0_A>]O`WYJ@S1_9/C*]`^U>(K.Q'\265IO_`,YR*ZRBL_
M:V^&*7X_G<OE[LXN_P#AXFIV4\5[XAUBXDD'RF6<&-&'0^7@`C/;^76N,\$^
M`]0EO=0OHM66RN]-N9+2)X8_,S*O#$AL?+@X]3GMCGV>N3\"_P#,R_\`8=NO
M_9:WIXBHJ<E?L9RIQYD,_M[Q%H9VZ[I'VRV!_P"/[31NP/5HSR/4D<5NZ3X@
MTK78O,TV^BGXR4!PZ_53R*TJPM7\(:/K$OVB2W-O>#E;NU;RI5/KD=3]<UAS
M0E\2MZ?Y%VDMM3=HKD/)\7Z!_J)H=?LE_P"6<Q\JY4>S=&_'DU<TWQKI%]<?
M9+AY-.ON]K?)Y3?@3P?P-#I.UXZKR'S+9Z&!J_\`R6_0/^O!O_09Z]"KS75+
M^RD^-FB.EW`RQVS0.5D!"R?OAL//#9(&.N2*]*J\0K*'I^K)I[R]0HHHKG-`
MKSWXQ?\`(HVG_7^G_HN2O0J\]^,7_(HVG_7^G_HN2NC"_P`:)G6^!GH5%%%<
MYH%%%%`!1110`5GZ=_Q\7?\`O_U-:%9^G?\`'Q=_[_\`4UPXG_>:/K+_`-)9
MI'X9&A1117<9A6>?^0TO^Y_2M"L\_P#(:7_<_I7#CO\`EW_BB:4^OH:%%%%=
MQF5M0EN;?3;J:RMA=7<<+O#;EPGFN`2J;CP,G`R>F:\XA\?^/[B^N[*'X=1R
M7%IM\]5UB(B,L,@$XQG!!QG."/45ZA7B_CO6M,\-^,[XZ=\09=`O[Q8WU"T&
MF_;$+!`JL.,(VT#CKT/'<`],\(ZY=>(O#D&I7MBEC<N\B26RS"7RRCE2"P[\
M<CJ#Q6Y7+?#O^R&\&6LFBWTU_:2R2R-=SH5>:0NQD8@@8RV:ZF@`KQB;5+B\
M^)[7S6^IP7LVEW\%O!-9SH(U0J(\94#YL,Q8'`+@$]*]GJ%K.V>\CO'MH6NH
MT*),4!=5.,@-U`.!D>PH`\A\+G6@=*'A./3&OCX4T\2F_=UA4[WY(0$LWWP!
MQU))XP=SX._;/[.\6?VCY'V[_A);S[1]GSY?F8CW;,\[<YQGG%=]9:98:;YW
MV&QMK7SY#+-Y$2IYCGJS8')]S7$_"S_F=?\`L:[[_P!DH`]`HHHH`***\M^+
MFAZ=!IJ:S%;[=0N+M(Y9M['<HC;C&<#[J]!VK6C352:@W:Y$Y.,;GJ5%9^C:
M'IV@6;VFF6_D0/(9&7>S98@#.6)/0"M"LW:^A2OU"BBBD,S-:\0Z3X>ABEU6
M\6W65BL8*LS,1UP%!.!Z].1ZBJ^C>+]"U^\>TTR^\^=(S(R^2ZX4$#.64#J1
M6A>Z7I^I>7]OL+6Z\O.SSX5?;G&<9'&<#\JY;X8V%G'X,T^^2T@6[D657G6,
M"1AYK<%L9(X'Y"MU&G[)R=[_`(=?\B&Y<UNAVE%%%8%A1110!R>@?\E!\8?]
MN7_HHUUE<GH'_)0?&'_;E_Z*-=96M;XEZ+\D1#;YO\PHHHK(L*Y/7_\`DH/@
M_P#[??\`T4*ZRN3U_P#Y*#X/_P"WW_T4*UH_$_1_DR)[?-?F=9116+K'BK1]
M#817=T&N3]RVA&^5B>@"CIGWP*SC%R=DBFTMS:JCJ>L:=HUOY^HWD-M'VWMR
MWL!U)]A7.B[\6^(2/LELF@V+?\MKD>9<L/9.B_0\U>TSP7I-A<?;)UDU&_/6
MZO6\U\^V>!^%:<D8_&_DOZL3S-[(\S^)>O7FO)92V]G>0Z*A(CFFB9%FE/?K
M@C:/ER`>7K=\`:;XPC\-1FVO+:TLI':2%+N)G;:0.5&>%)R0/J>^:Z7XE_\`
M)/M4_P"V7_HU*UO"W_(HZ+_UX0?^BUKJE7_V=**Z^IDH?O6V^AF/I_C1EP-=
MTU#ZK9G^II1I7C#'/B:T_P#!>/\`XJNHHKE]J^R^Y&W*CD5T#QB1\_C4`^VE
MQ'^M8_BOPOXLN?#=XK^(Y-4`56-FEA'&90&!X(.<C&<#DXQWKT:BJCB)1DG9
M?<O\B7335OU9X5\,M$U;4-2NKNQO)M/@2$Q-=I$KAF)4[,-[#)QTP/49]-_X
M1SQ!_P!#C=_^`D7^%8OP=_Y%&[_Z_P!__1<=>A5MBZTO;-::>2(HP7(CE)/#
M?B4K^Z\9W"MGJUC$PQ^E1?\`"->+/^AXD_\`!;'_`/%5V%%<_MI>7W+_`"-.
M1?TV<@/#7BP$'_A.'X]=-C_^*KQ_0_#^M?\`":6VFQ6\D&H6MPKR%D#"$*P.
M\\X*C@]<'(QG(KZ/KSW2/^2WZ_\`]>"_^@P5U8?$22GHMNR_3U,JE-7CZFQ]
MB\;Q#]WK&DS]?];:LN?3[IIJR^/HL^;;:!/TQY4DJ'WZUUE%<OM>Z7W&W+YG
M*-K'C&'[WA6VN.<?N=15?_0A2CQ1KD:YN/!U^IQDB*>.3^6*ZJBCVD?Y5^/^
M8<K[G@GCKQ7J5_XK@D\B6Q_LUE>VAFC`DC<A6+-U!)(&.V`..N>_TC4_&'B[
M2;>\M9=.TFTE4CSE0S2LP.UBJG@#(/!Y]S67\1]'T^;QAX89[9=U_<B&Z*DJ
M94#Q@`X[X8C/7&.>!CTV**."%(88UCBC4*B(,*H'```Z"NNM5A[*'+'7^OU,
M80ESRNSF(O`>G32K/K%U>ZO.IW`W<Q**?9!@`>W-=):VEM90+!:6\4$2]$B0
M*!^`J:BN*524MV;J*6P5D^*?^11UK_KPG_\`1;5K5D^*?^11UK_KPG_]%M13
M^-!+9AX6_P"11T7_`*\(/_1:UK5D^%O^11T7_KP@_P#1:UK45/C81V04445`
MPKD_`O\`S,O_`&';K_V6NLKD_`O_`#,O_8=NO_9:UA_#E\B'\2.LHHHK(L*I
M:EI.GZO;F#4+.&YC["1<D?0]0?<5=HIIM.Z#<^<+CP=JD7B\>'%C_P!(DD(A
MDD^19(^2)._&T$X&3P1U&*]C70_&$;`CQA'*,8Q)ID8_D:R=7_Y+?H'_`%X-
M_P"@SUZ%7=B<1.2A>VU]D<]*FDWZG*BQ\;1J-NLZ5*0>?,M&7(_`TQE^(,9;
M8_AR5>Q99E)_`<5UM%<OM7V7W&W)YG+?:_&Z-\VEZ/(,?P7+K_,5YC\2M7UZ
M[U*UL=7MA91QQ"5;>.82(Y)8>9D=^",'I@XZ\^[UYU\8XHSX7LIC&IE6]55<
MCY@"CD@'T.T?D/2NC"5%[9>ZC*M%\CU.A\!7UUJ7@C3;J]G:>=E=6D?[S!79
M1D]S@#GJ>]=)3(HHX(4AAC6.*-0J(@PJ@<``#H*?7).2E)M=3:*LD@HHHJ1A
M1110`5GZ=_Q\7?\`O_U-:%9^G?\`'Q=_[_\`4UPXG_>:/K+_`-)9I'X9&A11
M17<9A6>?^0TO^Y_2M"L\_P#(:7_<_I7#CO\`EW_BB:4^OH:%%%%=QF%>?W5M
MXPT;QEK=[H/A[3;NQU`PN9)KWRY&D6,*3T.!P!C_`&<]Z]`KQ'QS#>3^*]7N
M]2\1>(--L;&[LT,5C,T42V4J!3*,#!(ESD\G"D8Z8`/7M%GU2YTN*76+*&SO
MB6WPPS>:JC)QAL#.1@UH5Q_PPN!<^!K9UFN;B,3SK'<W,C.]P@E8+(2W/S#!
M]J["@`HHKCX_$FKVGC5='U%=-EAFMI[K99[S):1(5"-*S'YM^3T5<%2/FZT`
M=A7G_P`+/^9U_P"QKOO_`&2I/!WCM=7TA]4US5M-LX_(2=K>2TDM#`CMA&,D
MLA613P`R@`G@&J_PDGANK?QA<6\L<T$OBB]>.2-@RNI"$$$<$$<YH`]$HHHH
M`*\]^,7_`"*-I_U_I_Z+DKT*O/?C%_R*-I_U_I_Z+DKHPO\`&B9UO@9Z%111
M7.:!1110`5R?PT_Y)]I?_;7_`-&O765R?PT_Y)]I?_;7_P!&O6J_A2]5^3(?
MQKT?Z'64445D6%%%5K[4+33;62YO+A(8HT+L6/8#)P.I^@II7T0'.:!_R4'Q
MA_VY?^BC765XYX=^(]JGC'4[Z]LC;V^J>5N*R&0P^7&5'`7+;CCTQGO7;_\`
M"97=YD:1X8U6[_NR3J+>-OHS?X5U5Z%125UT7Y)&-.I%K[SK**Y,?\)S?MTT
MG2HB/]J>4']%H'@V\O,'5_%&JW7]Y(&%O&WU5?\`&L?9Q7Q27Y_U]YIS/HCH
M+W5=.TU=U[?6UL/^FLJK_,UXSXK^(5S<^+[:\TOR?(TN5Q:R%,^:&`5]W)!4
MX.,8.#V/3U&R\#>&K`[H])@D?.2\X,I)]?FS7+^*/!^AW'CGP]`+(0QZ@]PU
MT(6*"3RT5@,=%SSG&"<GG/-=.%E1C-WN]'^7^1E54W'0U+:V\2^+;2&[N]17
M1],N(UDC@L3F9T89&Z0_=X/8?45OZ/X9TC0@386:)*?O3O\`-(V>N6//]*TX
MHHX(4AAC6.*-0J(@PJ@<``#H*?7+*JWHM%V-5%+5[A111691R?Q+_P"2?:I_
MVR_]&I6MX6_Y%'1?^O"#_P!%K63\2_\`DGVJ?]LO_1J5K>%O^11T7_KP@_\`
M1:UT/_=UZO\`)&?_`"\^1K4445SF@4444`>>_!W_`)%&[_Z_W_\`1<=>A5Y[
M\'?^11N_^O\`?_T7'7H5=&*_C2,Z7P(****YS0*\]TC_`)+?K_\`UX+_`.@P
M5Z%7GND?\EOU_P#Z\%_]!@KHH;3]/U1G4WCZGH5%%%<YH%%%%`'GOQ"_Y&[P
M3_U_G_T9#7H5>>_$+_D;O!/_`%_G_P!&0UZ%715_A4_G^9G#XI?UT"BBBN<T
M"LGQ3_R*.M?]>$__`*+:M:LGQ3_R*.M?]>$__HMJNG\:%+9AX6_Y%'1?^O"#
M_P!%K6M63X6_Y%'1?^O"#_T6M:U%3XV$=D%%%%0,*Y/P+_S,O_8=NO\`V6MG
M7Y]8M])DDT*T@NKX,NV.=]JXSR>HR?;(]<\8/&^$H?&^FZM-'>Z+9QV-]>R7
M=U(9EW(7'.W:[<<#`P?0D=1T4X7IR=U]YG)VDM#T6BBBN<T"BBB@#SW5_P#D
MM^@?]>#?^@SUZ%7GNK_\EOT#_KP;_P!!GKT*NBOM#T_5F=/>7J%%%%<YH%>>
M_&+_`)%&T_Z_T_\`1<E>A5Y[\8O^11M/^O\`3_T7)71A?XT3.M\#/0J***YS
M0****`"BBB@`K/T[_CXN_P#?_J:T*S]._P"/B[_W_P"IKAQ/^\T?67_I+-(_
M#(T****[C,*SS_R&E_W/Z5H5GG_D-+_N?TKAQW_+O_%$TI]?0T****[C,*R[
M_7M%LM2M]*OK^V2]O/EBMG8%Y`?]GTX/7BM2O+/$.E:]I/C&_P!3LO#/]MQ7
MUS;7,=Q%,B2PB)0IA._^$X)!''S'-`'IEE<6MW90W%C+%+:R(&BDA8%&7L01
MQBIZYGP#HEUX?\)06=Y!#;SM--.;:$Y2W$DC.(U/3"AL<<5TU`!7)R:+X@U'
MQ%8W]_-IT,>F/.]M):F0M/YB%561#]T*#DX=MQ`^[7644`<7#X/GUO7_`.UO
M&%EHUV8;,6D-M&AFB8[MS2E9%^5CP`OS;1GYCFL_X200VMOXPM[>*.&"+Q1>
MI''&H544!```.``.,5Z)7G_PL_YG7_L:[[_V2@#T"BBB@`KQ_P",>K71U&RT
M?*BT$*W1`7YF<EUY/H`#T]3G/&/8*\U^,=C:G0K+4/(7[6MRL`E'WMA5VVGU
M&0#STYQU-=6":597,JZ?([%WPW\06NM`M9=1TW5)[K!62:VLBT<F"1N!''UZ
M<YX`K5_X3FT_Z`^N_P#@O>N@L;&UTRQALK*!8;:%=J1KT`_J>Y)Y)YJQ6<IT
MW)M1_$I*26K.7_X3FT_Z`^N_^"]Z/^$YM/\`H#Z[_P""]ZZBBES4_P"7\1VE
MW//?%/Q&>QT5VT[3;^"ZD81I->6IC2/()R,\,W'`_'G&#SWPX\8ZC;6,FB1:
M9+J1B_>6Z0[4**6^?<Q/3<PQ]3SC&/5=6T?3]<L39:E;+<0%@VUB001T((P0
M?H>A([URWPLTRSM?!UO?PP[;F\W>>^XG?LD<+P3@8'I73&I25"2Y=;K^OS,G
M&?M%J6QJ/C>[3,&A:;8D]/M=V9,?]\"@Z5XSNPOVCQ'9V?\`>6TL@_X9<UUE
M%<WM;;)+Y7_.YKR]V<I_PA+SL&U#Q)K=SZHMQY2'\%%/C^'?A9`^[3!*SC#/
M+,[,?Q)X/N*ZBBCVU3HPY(]CR?PKX"L;?X@:I')<2S0Z-)#)`I&TLSC>I8C^
M[CMC)P>!P?6*Y/0/^2@^,/\`MR_]%&NLJ\3.4Y+F?1?DB:44EIYA1117.:!7
M)Z__`,E!\'_]OO\`Z*%=97)Z_P#\E!\'_P#;[_Z*%:T?B?H_R9$]OFOS.LHH
MHK(L****`.3^)?\`R3[5/^V7_HU*UO"W_(HZ+_UX0?\`HM:QO%W@R\\4W*E-
M?GLK3R5C>T5"\;D,6W$;P,\CM_"*O>$_#M]X;LY;2ZUJ74H#M\A9(]OD@#!`
M)8G&-O'08XZFNEN'L%'FUO>VIDN;VE[:'0T445S&H445C>);G7K73HW\/64%
MW=F8!XYV`4)@Y/++SG;W[TXQYG83=E<Y;X._\BC=_P#7^_\`Z+CKT*O./AWI
MGBOPY+_9E_H\2:9-(\KS^>A>-]H`X#'(^4#&.^<\8KT>M\5;VK:=[D4O@284
M445SF@5Y[I'_`"6_7_\`KP7_`-!@KNK][J/3KI[&-9;M87,$;GY6?!V@\C@G
M'<5Y9;6/Q#M?%5WXA30;,W=U"(71ID\L`!!P/-SGY!W]:ZL/%-2NTKJVK]#*
MH]5H>MT445RFH4444`>>_$+_`)&[P3_U_G_T9#7H5>9>/]4T^3Q=X3V7]JWV
M2_/VG;,I\G$D6=_/R]#U]#7I%M=6][;K<6D\4\#YVR1.&5L'!P1QU!KIJIJE
M"_G^9E!KGD2T445S&H5RWC'2?$VKPK;:)J-G;6DL+Q7,<Z?,X;C[VUN,9'`!
M'J<\=3150FX2YD*2NK'+>#M)\3:1"UMK>HV=S:10I%;1P)\R!>/O;5XQ@<@D
M^HQSU-%%$YN<N9A%65@HHHJ1A1110`4444`%%%%`'GNK_P#);]`_Z\&_]!GK
MT*O+]4UG2I/C#HE\FI6;6D=DRO.LZF-3B;@MG`/(_,5ZA73B$TH7[?JS*F]9
M>H4445S&H5Y[\8O^11M/^O\`3_T7)7H5>>_&+_D4;3_K_3_T7)71A?XT3.M\
M#/0J***YS0****`"BBB@`K/T[_CXN_\`?_J:T*S]._X^+O\`W_ZFN'$_[S1]
M9?\`I+-(_#(T****[C,*SS_R&E_W/Z5H5GG_`)#2_P"Y_2N''?\`+O\`Q1-*
M?7T-"BBBNXS"O&_$C:1??$'7+;Q'\0=3T7[.(/LEK97XMT6-HP3NRI&_=D^N
M"IZ$8]<U"6>#3;J:UCCEN(X7:*.1]BLX!(!;L"<<]J\_U+4=>FO/-3PEX8NR
M\41>6?4(]V_8N]>5.0K94'N`#0!U7@Z+3H?#%M'I6LW.L689]E[<W`F>3YCG
M+@#.#D?A6]61X9>YDT*%KNPL["8EMUO9R"2)?F.,,``<]3QUK7H`*IV^K:;=
M7\]A;ZA:37EO_KK>.96DB_WE!R/QJY7F>O+9P>*M)N]%-I+%+:ZE;VT>G*H\
MNX*;Y)'*G#?,@4C`(8\DD\`'H5EJ=AJ7G?8+ZVNO(D,4OD2J_EN.JM@\'V-<
M3\+/^9U_[&N^_P#9*YOPN=:!TH>$X],:^/A33Q*;]W6%3O?DA`2S??`''4DG
MC!W/@[]L_L[Q9_:/D?;O^$EO/M'V?/E^9B/=LSSMSG&><4`>D4444`%>>_&+
M_D4;3_K_`$_]%R5Z%7GOQB_Y%&T_Z_T_]%R5T87^-$SK?`ST*BBBN<T"BBB@
M`KD_AI_R3[2_^VO_`*->NLKD_AI_R3[2_P#MK_Z->M5_"EZK\F0_C7H_T.LH
MHHK(L****`.3T#_DH/C#_MR_]%&NLKD]`_Y*#XP_[<O_`$4:ZRM:WQ+T7Y(B
M&WS?YA1116185R>O_P#)0?!__;[_`.BA765YEJR?$&Z\26FHQZ#8'^SI)Q;;
M9U*NKC;ELN">`,<+[CM6^'C>3U2T>_FF9U'9'IM%5-+DOI=+MI-3@B@O6C!F
MCB?<JMW`/_Z\=,GJ;=8M6=C0****0!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`9DOAO0IYGFFT73I)9&+.[VJ%F)Y))(Y-7K:UM[*W6WM((H($
MSMCB0*JY.3@#CJ34M%-R;T;%9(****0PHHHH`****`"BBB@`HHHH`****`"B
MBB@#D_\`A6GA'_H$?^3,O_Q5=3%%'!"D,,:QQ1J%1$&%4#@``=!3Z*N52<_B
M;8E%+9!1114#"N.\5^"]1\4RM'+X@\G3Q(LD5K]B5O+8+MSOW`G.6//K[5V-
M%7"I*F^:.Y,HJ2LS/T:SU&RLWCU/5/[2G,A99OLZP[5P/EPO'4$Y]ZT***EN
M[N-*P4444AA1110`5GZ=_P`?%W_O_P!36A6?IW_'Q=_[_P#4UPXG_>:/K+_T
MEFD?AD:%%%%=QF%9Y_Y#2_[G]*T*SS_R&E_W/Z5PX[_EW_BB:4^OH:%%%%=Q
MF0W=I!?V4]G=1++;W$;12QMT=&&"#]037E=]H/P^MO%*Z';>"%NV26**[NHU
MQ%;-(,JI).2Q&#@#N*]:KR;QM!%IFNZKJ&F>+XM,D5K:[U"SDLS<XEX2)U`.
M0S!0-O.<`T`=OX'N-%N?"=I)H%D]C8;G46CH4:&0,0ZLIZ$-G-=%7,^`(=.A
M\&V;:9J#ZA#,TDTEW(NUI97<M(2O\)W%AM[8Q734`%4[?2--M+Z>^MM/M(;R
MX_UUQ'"JR2?[S`9/XU<HH`JV6F6&F^=]AL;:U\^0RS>1$J>8YZLV!R?<UQ/P
ML_YG7_L:[[_V2O0*\_\`A9_S.O\`V-=]_P"R4`>@4444`%<!XX\(>)O$UV8;
M;5+/^RMRRQV\Z[&C<*5/S*A)')/)_BQC@&N_HK2G4=.7-$F45)69C>&K;7K7
M3I$\0WL%W=F8E)(%`4)@8'"KSG=V[ULT45$I<SN-*RL%%%%(9@^)[WQ):0VX
M\.:7!>RNS>:T\@54`Q@8++DG/7/&.G-8?P^M?%.DP)I&KZ9!;Z;!"YBE616D
M9R^[!PYX^9NPZ"NZHK55;0Y++]2'#WN:X4445D6%5-4COI=+N8],GB@O6C(A
MDE3<JMV)'_Z\=<'H;=%-.SN!YQIOA?Q]9:Y+J+:WI>^[DB-VVS=YBIP!M\L?
MPY'!7/J.M>CT45=2JZCNTB8P4=@HHHK,H****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"L_3O^/B[_`-_^
MIK0K/T[_`(^+O_?_`*FN'$_[S1]9?^DLTC\,C0HHHKN,PK//_(:7_<_I6A6>
M?^0TO^Y_2N''?\N_\432GU]#0HHHKN,PKS+6/!.JW/CE[OS[#^QIM0AU5P[E
M9FFABV)$1T*;@&Z_A7IM>)>./!D6H>*=9UG6="U#4X[>[M)HS`[D26101R1H
M%.=RMN<@8/3G!.0#TKP1I-QHWAM8+R:WEO)KB:YN/LYS&DDDC.54^@W8_"NC
MKC_AC;-:>!;2'^SWL(5EF-O!*A1Q"9&*%P>=Q4@FNPH`*X^;Q-JFD>*[#3-6
M_L^2/4C<-!#9JYDMXXE+!W9CA@0,<*N"<9;K785Y[X>\*^(['QGJWB#5HM)N
MKN^9HX+L7DK&T@`^2-8C$`>0-WSC//X@$W@[QVNKZ0^J:YJVFV<?D).UO):2
M6A@1VPC&260K(IX`90`3P#5?X23PW5OXPN+>6.:"7Q1>O')&P974A"""."".
M<UH0^#Y];U_^UO&%EHUV8;,6D-M&AFB8[MS2E9%^5CP`OS;1GYCFL_X200VM
MOXPM[>*.&"+Q1>I''&H544!```.``.,4`>B4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%9^G?\?%W_O_`-36A6?IW_'Q
M=_[_`/4UPXG_`'FCZR_])9I'X9&A1117<9A6>?\`D-+_`+G]*T*SS_R&E_W/
MZ5PX[_EW_BB:4^OH:%%%%=QF175S!96DUU<RI%;P(TDLCG"HH&22?0`5XU?:
MUX,\2>,-9FU_QDRVD*Q?V=%:Z@\4(CV#<PV]9-^[(ZXQQTKVB2-)8VCD17C<
M%65AD,#U!%4/[`T;_H$V'_@,G^%`&%\,[R6^\"V<\FHOJ$?F3+!<RMND>$2,
M(]Y_O[0,]\]><UUU16]M!:0B&VACAB'1(U"J/P%2T`%%%4X-6TVZOY["WU"T
MFO+?_76\<RM)'_O*#D?C0!<KS_X6?\SK_P!C7??^R5VUEJ=AJ7G?8+ZVNO(D
M,4OD2J_EN.JM@\'V-<3\+/\`F=?^QKOO_9*`/0****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"L_3O^/B[_P!_^IK0K/T[
M_CXN_P#?_J:X<3_O-'UE_P"DLTC\,C0HHHKN,PK//_(:7_<_I6A6>?\`D-+_
M`+G]*X<=_P`N_P#%$TI]?0T****[C,*\G\1:F/\`A.=6LM9^($WAZ*%87LK:
MW=$#1,G+,6!^;<&XZXP>A%>L5Y+KZZUH/CG6KVU\#:7JEGJ+0F.ZO-0MXG=U
MC"MCS#D#H-N.H)_BX`._\)/;R>'+=K77)-;A+/MOY'5FD^8Y&5`''3\*VZQ_
M#$E[+H$#ZAHL.C7)+;K*&5)%C^8X(9.#D8/XUL4`%>427$GB3QA=GPW:1VND
M^&H[P/<0*$%U>RQD,@"]0"<D]V_"O5ZR;;PKX=LK\7]KH.EP7JL6%Q%9QK("
M<@G<!G)R?SH`\Q\+G6@=*'A./3&OCX4T\2F_=UA4[WY(0$LWWP!QU))XP=SX
M._;/[.\6?VCY'V[_`(26\^T?9\^7YF(]VS/.W.<9YQ7?66F6&F^=]AL;:U\^
M0RS>1$J>8YZLV!R?<UQ/PL_YG7_L:[[_`-DH`]`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`JIJ$=[)`HL9DBEW9+
M..-N#QT/M5NBA:`8&A7&IW[?:)KI3;HQ4IL&6.!Z#@<_I6_6'X5_Y!<O_78_
M^@K6Y5S^(<MPHHHJ!!139&=8G9$WN%)5<XW'TSVKGXM7UE[YK7['`TL8#.@.
M#MX[[L=Q5*+8TKG14445(@HHHH`****`"BBB@`HHK*UFUNI(GN(;^2!(8F;R
MT!&XC)Z@CVII78T:M%9FBV\\5J)IKR2X\]$<!\G9QGN3Z_I6G0U9B84444@*
M][;R75JT45R]NY(.].OTK'TBTNY+J2634IV2WG:(H22'Q]2?6N@K,T;_`)B'
M_7[)_2K3=F-/0TZ***@04C,J*69@JJ,DDX`%+10!F?\`"0:7_P`_7_D-O\*T
ME974,K!E89!!R"*QOL5I_P`)'Y7V6'R_LF[9Y8QG?UQZUM54DEL-V"BBBI$%
M%%<QXGT^*-?MP9_-DD52"1MQM/M["JBKNPTKG3T56L+"'3K?R(-Q4L6)8Y)/
M^<59J6(****`(IKF"WV^=-'%NZ;V"Y_.DBN[:=BL-Q%(P&2$<$X_"H-5@BET
MZX:2)'9(7*%E!*G';TJKX=@B728)A$@E8,"X4;B-Q[_@*JRY;CMI<UZ***D0
M4444`%9^G?\`'Q=_[_\`4UH5GZ=_Q\7?^_\`U-<.)_WFCZR_])9I'X9&A111
M7<9A6>?^0TO^Y_2M"L\_\AI?]S^E<.._Y=_XHFE/KZ&A1117<9A7CWB6Z\(Z
M=X\UJ7XAVSR1RI$-*EGMY)8?)V#<B;0=K[]Q.?4<UZ]++'!"\TTB1Q(I9W<X
M50.I)/05YS=>)/$6E>/-:C&A:KKNC.MN]J;<1;;=]F6V\Y(.1R3U!^M`&Y\-
M8[N+P1:+<QW,:>9,;6.Z)\U+?S&\H-GG.S;U[8KK:S]%U&;5=+BO+C3KG3I'
M+`VUT`)%P2.<$CGK^-:%`!117(V/BZ\N?'&I:-<Z:;.SM+$W2/*<R2XE9-P`
M.`IV$@'DC!XSB@#KJ\_^%G_,Z_\`8UWW_LE2>#O':ZOI#ZIKFK:;9Q^0D[6\
MEI):&!';",9)9"LBG@!E`!/`-5_A)/#=6_C"XMY8YH)?%%Z\<D;!E=2$(((X
M((YS0!Z)1110`4444`%%%%`!1110`4444`%%%%`!1110`445@7&HZW%>+`+.
MWS*S>4-V=P'/7<.WKBFHW&E<WZ*AM3<-:QFZ5%G(RRIT'M4U(04444`8GB"&
MY2![V&]EB6-54Q(2`3NZY!]_3M5G18+B.S62>[><3*LBAQRF1R,YY[?E2>(/
M^0'<_P#`?_0A5K3?^07:?]<4_P#015W]PKH6:***@D****`,/PK_`,@N7_KL
M?_05K<K#\*_\@N7_`*['_P!!6MRKG\3'+<****@05AVO_(X7O_7$?R2MRL.U
M_P"1PO?^N(_DE5'J-=3<HHHJ1!1110`45@:AJFK6=ZL`M[=EE<K">?FY&._!
MY%;%FUR]HC7<:QSG.Y5Z#GCN>V*IQLKC:)Z***D056U+_D%W?_7%_P#T$U9J
MMJ7_`""[O_KB_P#Z"::W!!IO_(+M/^N*?^@BK-5M-_Y!=I_UQ3_T$59H>X,*
M***0!69HW_,0_P"OV3^E:=9FC?\`,0_Z_9/Z52V8^AIT445(@HHHH`S/^9H_
M[<O_`&>M.LS_`)FC_MR_]GK3JI=!L****D05A^*O^07%_P!=A_Z"U;E8?BK_
M`)!<7_78?^@M50^)#CN;E%%%2(****`*VI?\@N[_`.N+_P#H)JKX?_Y`=M_P
M+_T(U:U+_D%W?_7%_P#T$U5\/_\`(#MO^!?^A&K^P/H:=%%%0(****`"L_3O
M^/B[_P!_^IK0K/T[_CXN_P#?_J:X<3_O-'UE_P"DLTC\,C0HHHKN,PK//_(:
M7_<_I6A6>?\`D-+_`+G]*X<=_P`N_P#%$TI]?0T****[C,IZMIEOK.CWFF7>
M[[/=PO!)L.#M8$'!]>:\^TWX6:M8:CJ,Z>.-9C2Y:(JT13S'"1A/WA*X)&,#
M';%>FUQE[XQU'_A+6TO3M+CEL+2YAMKV\EEVD22*&"QKWP"N23CF@#H]%TZ;
M2M+BL[C4;G49$+$W-T09&R2><`#CI^%:%8GA37V\2Z!%J$EF]G<"22"XMF8-
MY4L;%'7<.",@X-;=`!7.'0;U?'UUK\<MN()-)2RC5MQ82+*[Y*\#;AAWSUZ=
M:Z.B@#BX?!\^MZ__`&MXPLM&NS#9BTAMHT,T3'=N:4K(ORL>`%^;:,_,<UG_
M``D@AM;?QA;V\4<,$7BB]2..-0JHH"```<``<8KT2O/_`(6?\SK_`-C7??\`
MLE`'H%%%%`!1110`4444`%%%%`!1145Q;Q74#0S+NC;&1DC.#GM0!+17/6NC
MV$FJW\+P9CB\O8-[<97)[UT-.22&T%%%%(05F7O_`"'-*_[;?^@BM.LR]_Y#
MFE?]MO\`T$54=QHTZ***D04444`9GB#_`)`=S_P'_P!"%6M-_P"07:?]<4_]
M!%5?$'_(#N?^`_\`H0JUIO\`R"[3_KBG_H(JOLCZ%FBBCI4B"FR21PQEY75$
M'5F.`*I7&L6-NVSSO,D[)$-Q/Y5G:G/J%_ITJ1Z>Z0G'W^7/(Z**I1;W&D+X
M5DC^P2Q;U\SS2VS/.,+SCTK?KBM`%['=//:6XE&PJ=W`/(.`>F>E="-;2(XO
M;:>U/]YEW+^8JZD?>T'):FI14,%U;W*Y@F20?[+9J:LB0K#M?^1PO?\`KB/Y
M)6Y6':_\CA>_]<1_)*J/4:ZFY1114B"BBB@##US_`)"FD?\`7;_V9:W*P]<_
MY"FD?]=O_9EK<JY?"AO9!1114""JVI?\@N[_`.N+_P#H)JS5;4O^07=_]<7_
M`/0336X(--_Y!=I_UQ3_`-!%6:K:;_R"[3_KBG_H(JS0]P8444C,%&6(`]2:
M0"UF:-_S$/\`K]D_I1J6KPVEG(\$\#SC&U"V<\C/`/I6)H^MO'>M'-Y*0SRO
M+(Y!X)';GID"M(Q;BV4D['745#'>6TW^KN(G_P!UP:FK,D****`,S_F:/^W+
M_P!GK3K,_P"9H_[<O_9ZTZJ70;"BBBI$%8?BK_D%Q?\`78?^@M6Y6'XJ_P"0
M7%_UV'_H+54/B0X[FY1114B"BBB@"MJ7_(+N_P#KB_\`Z":J^'_^0';?\"_]
M"-6M2_Y!=W_UQ?\`]!-5?#__`"`[;_@7_H1J_L#Z&G1114""BBB@`K/T[_CX
MN_\`?_J:T*S]._X^+O\`W_ZFN'$_[S1]9?\`I+-(_#(T****[C,*SS_R&E_W
M/Z5H5GG_`)#2_P"Y_2N''?\`+O\`Q1-*?7T-"BBBNXS"O$_'T]D/'%_'9:?X
MUAOHEAENYM$@5X9\*"DASW7[N[C[I':O;*\_UG2?&>D^(]0U#PM?Z(\&J%'F
M@U;S`875`F4*=00H.#T/UH`C^&?BO0KNRMM!TW3-8T\BW:Z@.IPX-VA8%I0^
M2')9\D^_%>B5PGA?P5?Z3K&FWMUJL-Y!964\8*(0TD\\WF2MZ!!A0H^M=W0`
M5%]JM_M?V3SXOM(3S/)WC?LSC=MZXSQFI:\S.G#3/B?XC^PM.]Q/X=-QNDD9
MV,C32X`ST`P``.``!0!Z%9:G8:EYWV"^MKKR)#%+Y$JOY;CJK8/!]C7$_"S_
M`)G7_L:[[_V2N;\+G6@=*'A./3&OCX4T\2F_=UA4[WY(0$LWWP!QU))XP=SX
M._;/[.\6?VCY'V[_`(26\^T?9\^7YF(]VS/.W.<9YQ0!Z11110`4444`%%4M
M2EO((#-:B`K&K-()<YP!GC'XU#I%W?7T*W$XMQ`ZG:(PV[(..<\8X-/ETN.V
MES3HHHI""BBB@#,LO^0YJO\`VQ_]!-:=9EE_R'-5_P"V/_H)K3JI;C84445(
M@K,O?^0YI7_;;_T$5IURE_KN-7B<6^?LCR+_`*S[^>,]..E7!-O0<5<ZNBLE
M/$%F\2$>8\I4%HXT+%21TSBG?VI=RC_1]*N&_P"NI$?\Z7*PLS4HK+W:U*>$
MM(%_VB6/^%']G7\O^OU63'I$@3]:+>86*OB34(H[62Q*OYLBJP(`VXW?7V-+
MI^NV:Z?!%B4RHBIY:IEF(`Y&.U4-<T62!&NTG:2)%`8S.6<DG'ITY%:WAZS:
MTTT,^PF8B0%?[I`P#5M1Y"M+"_:=5NN+>T2V3^_.<G_OD4#1C.=U_=S7)_N9
MV)^0K5HJ.;L3<A@M+>U7$$*1C_97&:FHHJ1&'X5_Y!<O_78_^@K6X0",$9!K
M#\*_\@N7_KL?_05K<JY_$QRW*$^C6,[;_)$;]GB.TC\JA^Q:E;?\>M_YJCHE
MRN?_`!X<UJT4N9A=F5_:=U;_`/'[I\H4?\M(3O'U]JQ+'5]_B(W/D8^T[8MN
M_P"[G:,YQSTKL*XVVT16UV2Q>;<D*AV.W&X?+QUXZ]:N#CK<J-CLJ*RO[.O;
M7FQOF*CI%<#</SZBC^U9[;C4+*2,?\]8OG3_`.M4<O8FW8U:*@M[RVNUS!,D
MGL#R/PJ>I$8>N?\`(4TC_KM_[,M;E8>N?\A32/\`KM_[,M;E7+X4-[(**CFN
M(;=-\TBQKZL<5G?VO)<G;IUH\_\`TU?Y4'Y]:E)L+&K7-^(M5**EO:7*$.KK
M,JX;@X&/;O5_^S+F[YU&\9E_YXP_*GXGJ:34-(L%TV8K;*IAB=D*DC!QU/KT
M'6JCRIZC5DS,T34=3EB>&*);A8PJKN8*(QS^)Z?I6KLUJ7[TUI`/]A2Q_6GZ
M-9V]M812PQ[7FB1I#DG)Q[_4UHT2DKZ(&]3+_LNZD_X^-5N6_P"N0$?\J4:#
M89W2I),WK)(36G12YF*[*$VC6,ML\`@2,-CYHU`8<YZXK+T;1[8W$\S%V,%P
M\2JV"I`&.1CKS71UF:-_S$/^OV3^E-2=F--V)I-(T^7[UI$/]T;?Y5!_8-JO
M^HEN8/\`KG*1_.M2BIYF*[,O^S;Z/_4ZK,/:5`]&W6HONR6<P_VE*G]*U**?
M,%SSK[;=^;YOVJ;S-NW?YASCTSZ5V7]JSJ/WFEW8_P!P!J@^Q6G_``D?E?98
M?+^R;MGEC&=_7'K6U5SDG;0J31F?VY"/]9:WD?\`OPF@>(--SAIRA]&C8?TK
M3I"`1@@$>]1==B="DNL:<_2[B_$X_G6!XAU:.Z)LXE5DC<.)5?(;Y?\`Z_KV
MKIWM+:3[]O$WU0&N4\0:6UK.]V@B2W=E543@@[?3&.QJZ?+S%1M<Z*RU6WN[
M..=WBA9LY1I!D8)%6#>V@&3=0@?]=!5'3]$MX+-$N;>&289W-C.>3CK[59_L
MK3_^?.#_`+X%0^6Y+L/_`+2L?^?VW_[^K_C2'4[`#)O;?\)`:!IE@!Q96_XQ
M@TO]FV/_`#Y6_P#WZ7_"CW0T,[6-9M4TZ1(9(YVE!C(5^5!!YIOAB[\ZQ:VV
M8\C^+/WMQ8].U2:SI<$NF.8DCA,(,F4C'(`/%1^&+3R;%KG?GS_X<?=VEAU[
MU?N\@].4W****R)"BBB@`K/T[_CXN_\`?_J:T*S]._X^+O\`W_ZFN'$_[S1]
M9?\`I+-(_#(T****[C,*SS_R&E_W/Z5H5GG_`)#2_P"Y_2N''?\`+O\`Q1-*
M?7T-"BBBNXS"O$O%%EX)E^(^O'QCI^J:C(1`;:2**X,<*>4,QCRR._S9Z?-Z
M@U[;7COBW7/%,OB[48;/Q=%H>GV5]:V30_8TD*QS1@B=BW)'F';V&._!R`>@
M^"(M"A\*6L?ANUFMM+#/Y44RR!@=YW9$GS=<]:Z&N5^'FHW&I^$(9KO4'U&Y
M2>>&6Z95`E*2,NY0O&WCCVKJJ`"H19VHO6O1;0B[:,1&?8/,*`DA=W7&23CI
MS4U%`%6RTRPTWSOL-C;6OGR&6;R(E3S'/5FP.3[FN)^%G_,Z_P#8UWW_`+)7
MH%>?_"S_`)G7_L:[[_V2@#T"BBB@`HHHH`K:E_R"[O\`ZXO_`.@FJOA__D!V
MW_`O_0C5K4O^07=_]<7_`/0357P__P`@.V_X%_Z$:O[`^AIT45'-/%;H7FD6
M-?5CBH$25#=RM!9SS*`6CC9@#TR!FJ!U>2Y)73K5Y^WFO\J#_&FR:3=7L3?;
MKYLL#B.(813[^M4HVW';N8=GKT\>I23ND6+AD$N%/`'''/I6_P#VP9/^/:PN
MY?\`:*;5_,UD:?H6W6)4^T_\>;QOG9]_/S>O'2NKJYN-]"I6,OS]9F_U=G;P
M?]=9-W\J/L6J2_ZW4A&/[L,0_F>:U**CF[$W,O\`L.!_^/B>YN/422G'Z5C7
M?AY8]3@@2?:ERTA7Y,[`!G'7GTKK:S+W_D.:5_VV_P#0151F[C39>M8!;6L4
M`.?+0+G&,X&,U+1169(4444`9GB#_D!W/_`?_0A5K3?^07:?]<4_]!%5?$'_
M`"`[G_@/_H0JUIO_`""[3_KBG_H(JOLCZ%FBBBI$%%%%`&'X5_Y!<O\`UV/_
M`*"M;E8?A7_D%R_]=C_Z"M;E7/XF.6X4445`@K#M?^1PO?\`KB/Y)6Y6':_\
MCA>_]<1_)*J/4:ZFY1114B*-QI%E<MO,7ER=I(SM8?E4'V;5+/\`X][I;J,?
MP3C#?]]#K^-:M%/F8[G%ZMJEU)J,)EMTA>U8,J$YYX/)[].U;%I<ZMJEJDB>
M1;1MG,H&XGG'`[?C537M/B;5[1BSYNY`K\C@#:../>N@L[2.QM$MXBQ1,X+'
MGDY_K6LFN56*;5D58=%MD?S9R]S-_?F.[].E:(``P!@"BBLFV]R+A5;4O^07
M=_\`7%__`$$U9JMJ7_(+N_\`KB__`*":%N"#3?\`D%VG_7%/_015FJVF_P#(
M+M/^N*?^@BK-#W!A1112`*S-&_YB'_7[)_2M.LS1O^8A_P!?LG]*I;,?0TZ*
M**D04444`9G_`#-'_;E_[/6G69_S-'_;E_[/6G52Z#84445(@K#\5?\`(+B_
MZ[#_`-!:MRL/Q5_R"XO^NP_]!:JA\2''<W****D04444`5M2_P"07=_]<7_]
M!-5?#_\`R`[;_@7_`*$:M:E_R"[O_KB__H)JKX?_`.0';?\``O\`T(U?V!]#
M3HHHJ!!1110`5GZ=_P`?%W_O_P!36A6?IW_'Q=_[_P#4UPXG_>:/K+_TEFD?
MAD:%%%%=QF%9Y_Y#2_[G]*T*SS_R&E_W/Z5PX[_EW_BB:4^OH:%%%%=QF%>:
M^(]=U/4M?UC1M'^'\&OP6RQ6]]<7-W%"')42*F''S`!@?8D].I]#O8);FPN;
M>"Y>VFEB9$G0`M$Q!`8`\$@\\^E>8+X<NX?$>J0P_$C5CJD%JDUZD=I$<1C.
MS(V[2V,^^,=L4`=WX22YB\-6D=WH4.ARH&7^SX95D2(!CC#+P<CG\:VZP?!M
MS'>>%K.YBUF76$DW,+R:,([?,?E90!@K]W&.U;U`!3)9%AA>5_NHI8_04^FR
M"0Q.(F59-IVEAD`]LC(R/QH`X7P=X[75](?5-<U;3;./R$G:WDM)+0P([81C
M)+(5D4\`,H`)X!JO\))X;JW\87%O+'-!+XHO7CDC8,KJ0A!!'!!'.:T(?!\^
MMZ__`&MXPLM&NS#9BTAMHT,T3'=N:4K(ORL>`%^;:,_,<UG_``D@AM;?QA;V
M\4<,$7BB]2..-0JHH"```<``<8H`]$HHHH`****`,[6[N.UTN7>&/FJ8EVCH
M2IZ^U9>C:Y:6VGQVLHE$B!CPN0Q+9P/?FM#Q#:276EG85'E-YK;CU`4]/>L_
MPSITJ,+]C&8I(V51D[@=WT]C6JY>34M6Y30\_5+[_40K9Q'_`):3<O\`@O;\
M:?#HMNKB6Y9[J;^],<C\!TK2HJ.;L3<0````8`["EHHJ1&99?\AS5?\`MC_Z
M":TZS++_`)#FJ_\`;'_T$UIU4MQL****D05F7O\`R'-*_P"VW_H(K3K,O?\`
MD.:5_P!MO_0151W&C3HHHJ1!1110!F>(/^0'<_\``?\`T(5:TW_D%VG_`%Q3
M_P!!%9WB.\MTT^6T:3$[JK*N#R-P[].QJSHUY;W-A%%#)N>&)%D&",''O]#5
MV?(5T-&BBBH)"JFH6DMY`L<-T]LP;<73.2,'C@CU_2K=%"=@,?3-%FTV<,M^
MSQ<[HMF`W'7KUZ<^U;%%%-MO5C;N%%%%(05AVO\`R.%[_P!<1_)*W*P[7_D<
M+W_KB/Y)51ZC74W****D04444`8>N?\`(4TC_KM_[,M;E8>N?\A32/\`KM_[
M,M;E7+X4-[(****@056U+_D%W?\`UQ?_`-!-6:I:K/%%IUPLDJ(SPN$#,`6.
M.WK36XT2:;_R"[3_`*XI_P"@BK-4M*GBETZW6.5'9(4#A6!*G'?TJ[0]P844
M44A!69HW_,0_Z_9/Z5;O4NI+5ELY4CFR,,XR,=_\X-9=AIVKVUQE[R$0O*99
M0JY+$]>J]ZI+1ZC6QN4445(@HHHH`S/^9H_[<O\`V>M.LS_F:/\`MR_]GK3J
MI=!L****D05A^*O^07%_UV'_`*"U;E8?BK_D%Q?]=A_Z"U5#XD..YN4445(@
MHHHH`K:E_P`@N[_ZXO\`^@FJOA__`)`=M_P+_P!"-6M2_P"07=_]<7_]!-5?
M#_\`R`[;_@7_`*$:O[`^AIT445`@HHHH`*S]._X^+O\`W_ZFM"L_3O\`CXN_
M]_\`J:X<3_O-'UE_Z2S2/PR-"BBBNXS"L\_\AI?]S^E:%9Y_Y#2_[G]*X<=_
MR[_Q1-*?7T-"BBBNXS"N"U70O&>E>(M1U+PA/HLD.JLDES#JBR9BD5`@*%.H
M(4<'H>G6N]KB-;^)5MI6O76CVGAW7]8GM`GVA]-L_-2)F4,%)SUP0?Q^M`&W
MX2T&3P[H$=E<7(N;IY9+BXE5=JM)(Y=MH[#+8%;E9F@:NVNZ/#J#Z;?:<9"P
M^S7T7ERI@D<KVSC(]B*TZ`"BBB@`KS_X6?\`,Z_]C7??^R5VUEJ=AJ7G?8+Z
MVNO(D,4OD2J_EN.JM@\'V-<3\+/^9U_[&N^_]DH`]`HHHH`****`*VI?\@N[
M_P"N+_\`H)JKX?\`^0';?\"_]"-6M2_Y!=W_`-<7_P#0357P_P#\@.V_X%_Z
M$:O[`^AIT445`@J&ZN%M+62=D=U09(09.*FHH`YFRURU&KW4OES;;EHU0!02
M,#'(!_EFNFHHJI-/8;=PHHHJ1!6++::S-=V]PQL`\&[:`7P=PP<UM44T[#3L
M16_G^0OVGR_.YW>7G;UXQGVJ6BBD(****`"BBB@`HHHH`****`"BBB@`HHHH
M`CGC:6"2-7,;.I4..JDCK6&/#ERLS3#5I1*PP7"G<1]=WL*Z"BJ4FMAIM!11
M14B"BBB@##US_D*:1_UV_P#9EK<K#US_`)"FD?\`7;_V9:W*N7PH;V04445`
M@JI=Z;9WS*US"'91@')!Q^%6Z*$[;`5K33[6PW_9HMF_&[YB<XZ=3[U9HHH;
MN`4444`%%%%`!1110`4C`LI`8J2,!AU'OS2T4`8'_"/7?F^;_:\WF;=N_:<X
M],[NE;R@JH!8L0,%CU/OQ2T4W)O<;=PHHHI""N;\47EN]N+19,SI*K,N#P-I
M[].XKI*@DLK2:0O+:PNYZLT8)-5%I.[&G9BVUU!>0^;;R!TSC(['Z5-4<4$4
M"E88DC4G)"*`,_A4E2_(04444`9VLWEO;6$L4TFUYHG6,8)R<>WU%5O#EY;O
MI\5HLF9T5F9<'@;CWZ=Q6K-;07&WSH8Y=O3>H;'YTD5I;0,6AMXHV(P2B`''
MX55URV'=6L34445(@HHHH`*S]._X^+O_`'_ZFM"L_3O^/B[_`-_^IKAQ/^\T
M?67_`*2S2/PR-"BBBNXS"L\_\AI?]S^E:%9Y_P"0TO\`N?TKAQW_`"[_`,43
M2GU]#0HHHKN,PKR[Q'=ZCX>\9ZE<6?C'POI,=^L4AL]07]X2J!?,/S`Y.,9Z
M84>E>HUY/XG\"74^OZSK(\.V.L.;RTOK?S=A>9%012VY#=MH+#/!)'&10!WO
MA._GU/P]!=7.IV&I2LS@W5@"(7PQ'RY)Z=#SU!K;KF/A_8:AIOA"WM]1M%LI
M?-E>.T4J?(B:1F1"5X)"D"NGH`*I:N9AHM^;?/GBWD\O'7=M./UJ[10!XWX7
M.M`Z4/"<>F-?'PIIXE-^[K"IWOR0@)9OO@#CJ23Q@[GP=^V?V=XL_M'R/MW_
M``DMY]H^SY\OS,1[MF>=N<XSSBN^LM,L--\[[#8VUKY\AEF\B)4\QSU9L#D^
MYKB?A9_S.O\`V-=]_P"R4`>@4444`%%%%`&9KE_#9V#Q2;B\Z.B!1[=3[<BJ
MGAO4(I+6.Q"OYL:LQ)`VXW?7W%;U%5S+EL.^E@HHHJ1!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`8]
MQX;LKFXDG9YE:1MQ"L,9/7J*T;.TCL;1+>(L43."QYY.?ZU/13<FU9CNPHHH
MI""BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`*S]._X^+O\`W_ZFM"L_3O\`CXN_]_\`J:X<3_O-'UE_
MZ2S2/PR-"BBBNXS"L\_\AI?]S^E:%9Y_Y#2_[G]*X<=_R[_Q1-*?7T-"BBBN
MXS"O'O%&MV>F?$6>?Q)JUY8_9;JU;382[+;O;E1YLF!P[;BP.>1@8KV&N#U3
M7/%&H^(]2TS0_#^EW%MIK1H\VHSE"[L@?*J%/&#C/M0!H?#:>]N/!%I)>SW5
MP/,E%O-=C$TMN)&$3/[E-O)KK*S]%DU672HGUJWM;>_);S([60O&!DXP2`>F
M*T*`"BBF2R+#"\K_`'44L?H*`'UY_P#"S_F=?^QKOO\`V2I/!WCM=7TA]4US
M5M-LX_(2=K>2TDM#`CMA&,DLA613P`R@`G@&J_PDGANK?QA<6\L<T$OBB]>.
M2-@RNI"$$$<$$<YH`]$HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`*S]._P"/B[_W_P"IK0K/T[_CXN_]_P#J:X<3_O-'
MUE_Z2S2/PR-"BBBNXS"L\_\`(:7_`'/Z5H5GG_D-+_N?TKAQW_+O_%$TI]?0
MT****[C,*\,\5:GX/MOB=KZ^*?$6L6MRB6Z0+8M+&B1^6&V'8,DY8MSQ\XQS
MG'N=9]_KNDZ79_;+_4[.VMM_E^;-,JKN_NY)Z\'CVH`S?`UQH]UX3M9M"O;N
M]TYFD\N>[=VD8[SG)?YN#D<UT5,AFBN(4FAD22)P&1T8%6!Z$$=13Z`"J-Y9
M7<]S%/;:I<6PC4_Z.L<;12GMORI?'^ZRU>HH`XN'P?/K>O\`]K>,++1KLPV8
MM(;:-#-$QW;FE*R+\K'@!?FVC/S'-9_PD@AM;?QA;V\4<,$7BB]2..-0JHH"
M```<``<8KT2O`]!TKXD7VL^+Y?!_B#3=/T\>([U9(KJ,,QEW#+#,3\;2HZ]C
MQZ@'OE%>/_\`"/?'/_H<]#_[\K_\CT?\(]\<_P#H<]#_`._*_P#R/0![!17C
M_P#PCWQS_P"AST/_`+\K_P#(]'_"/?'/_H<]#_[\K_\`(]`'L%%>#[OC/_PF
M7_"+_P#"7:5]N_L_^T/,^SQ^7Y?F>7C/D9W9[8QCO6Q_PCWQS_Z'/0_^_*__
M`"/0![!17C__``CWQS_Z'/0_^_*__(]'_"/?'/\`Z'/0_P#ORO\`\CT`>P45
MX_\`\(]\<_\`H<]#_P"_*_\`R/6/K[?&?PY_9?VSQ=I3_P!I:A%I\/DV\9VR
M29VELP#"\')&3[4`>\45X_\`\(]\<_\`H<]#_P"_*_\`R/1_PCWQS_Z'/0_^
M_*__`"/0![!17C__``CWQS_Z'/0_^_*__(]'_"/?'/\`Z'/0_P#ORO\`\CT`
M>P45XGJVG_&W1M&OM4N/&&C-!96\EQ(L<"%BJ*6(&;<#.!ZBC2=/^-NLZ-8Z
MI;^,-&6"]MX[B-9($#!74,`<6Y&<'U-`'ME%>/\`_"/?'/\`Z'/0_P#ORO\`
M\CT?\(]\<_\`H<]#_P"_*_\`R/0![!17C_\`PCWQS_Z'/0_^_*__`"/1_P`(
M]\<_^AST/_ORO_R/0![!17@^@-\9_$?]J?8_%VE)_9NH2Z?-YUO&-TD>-Q7$
M!RO(P3@^U;'_``CWQS_Z'/0_^_*__(]`'L%%>/\`_"/?'/\`Z'/0_P#ORO\`
M\CT?\(]\<_\`H<]#_P"_*_\`R/0![!17C_\`PCWQS_Z'/0_^_*__`"/6/N^,
M_P#PF7_"+_\`"7:5]N_L_P#M#S/L\?E^7YGEXSY&=V>V,8[T`>\45X__`,(]
M\<_^AST/_ORO_P`CT?\`"/?'/_H<]#_[\K_\CT`>P45X_P#\(]\<_P#H<]#_
M`._*_P#R/1_PCWQS_P"AST/_`+\K_P#(]`'L%%?/_C&]^,_@G0_[7O\`Q/8W
M-J)5B?[':1N8]V<,V8``N0!G/5E'>N@_X1[XY_\`0YZ'_P!^5_\`D>@#V"BO
M'_\`A'OCG_T.>A_]^5_^1Z/^$>^.?_0YZ'_WY7_Y'H`]@HKQ_P#X1[XY_P#0
MYZ'_`-^5_P#D>C_A'OCG_P!#GH?_`'Y7_P"1Z`/8**\'\+-\9_%WARTURP\7
M:5':W6_8D]O&'&UV0Y`@(ZJ>];'_``CWQS_Z'/0_^_*__(]`'L%%>/\`_"/?
M'/\`Z'/0_P#ORO\`\CT?\(]\<_\`H<]#_P"_*_\`R/0![!17C_\`PCWQS_Z'
M/0_^_*__`"/6/IS?&?4_$>M:'#XNTI;K2/(^T.]O&$;S4+KM(@R<`<Y`_&@#
MWBBO'_\`A'OCG_T.>A_]^5_^1Z/^$>^.?_0YZ'_WY7_Y'H`]@HKQ_P#X1[XY
M_P#0YZ'_`-^5_P#D>C_A'OCG_P!#GH?_`'Y7_P"1Z`/8**\'U%OC/IGB/1=#
MF\7:4UUJ_G_9W2WC*+Y2!VW$P9&0>,`_A6Q_PCWQS_Z'/0_^_*__`"/0![!1
M7C__``CWQS_Z'/0_^_*__(]'_"/?'/\`Z'/0_P#ORO\`\CT`>P45X_\`\(]\
M<_\`H<]#_P"_*_\`R/6/XI;XS^$?#EWKE_XNTJ2UM=F](+>,N=SJ@P#`!U8=
MZ`/>**\?_P"$>^.?_0YZ'_WY7_Y'H_X1[XY_]#GH?_?E?_D>@#V"BO'_`/A'
MOCG_`-#GH?\`WY7_`.1Z/^$>^.?_`$.>A_\`?E?_`)'H`]@HKQ__`(1[XY_]
M#GH?_?E?_D>L?PLWQG\7>'+37+#Q=I4=K=;]B3V\8<;79#D"`CJI[T`>\45X
M_P#\(]\<_P#H<]#_`._*_P#R/1_PCWQS_P"AST/_`+\K_P#(]`'L%%>/_P#"
M/?'/_H<]#_[\K_\`(]'_``CWQS_Z'/0_^_*__(]`'L%%>#Z<WQGU/Q'K6AP^
M+M*6ZTCR/M#O;QA&\U"Z[2(,G`'.0/QK8_X1[XY_]#GH?_?E?_D>@#V"BO'_
M`/A'OCG_`-#GH?\`WY7_`.1Z]0T.'5+?0[*+6[J"ZU-(E%S-!'L1W[D#^N!G
MKA<[0`:%%%%`!6?IW_'Q=_[_`/4UH5GZ=_Q\7?\`O_U-<.)_WFCZR_\`26:1
M^&1H4445W&85GG_D-+_N?TK0K//_`"&E_P!S^E<.._Y=_P"*)I3Z^AH4445W
M&9D>*8[^7PEK$>E[O[0:RF%OM.&\S8=N/?/2O&O#Z>']9N=-DGTN1/"7A72'
M>\2\MV*_;'XD#(0=[##$]>?PKWMF5%+,P55&22<`"JK7^GNI5[NV93P09%(-
M`'+?"N"6#P#:!H)8('FGDM89<AD@:5C&,'I\I'X5VE<E\-]2N]5\'1W=[<O<
M3&ZN4\QSDE5F=5'X``5UM`!1110!0US58]#T#4-6F1GCLK>2=D7JVU2<#ZXK
M(\->(+[4-3O-+U-+?[7!;6]V'MD94*3!L+@L3E2A&<\\'`Z5K:[I4>NZ!J&D
MRR-''>V\D#.HR5W*1D?3-9/AKP_>Z?J=YJFI/;_:I[:WM%2W=F0)"&PV2`<L
M7)QCC@9/6@#IJ***`"BBB@#D[;Q1J,_Q(?P])IRV]@+"6YCFD.99625$W``X
M"?,<9Y.,\=^LKGY-"NG^(<'B`20_9(]*DLBF3YF]I4<'&,8PI[Y]JZ"@`HHH
MH`*Y;QIK6L>'=*NM8M'TQ+"RMS-*MR':2=P?]6N"H3(X#'=R?NUU-<'XV\+:
M[XD\1:3)''I]UH5B?/>PN+V2`SSY^4L5B?*KQQWR:`.WMIOM-K#/M*>8BOM/
M49&<5+34+F-3(JJ^!N"G(![X.!G\J=0`4444`4=7?44T]VTMK)+G(S)>EO+C
M7/S,0O+8&3C*Y]1UK/\`!VN7'B+PY%J%S'$KF66,20@B.94<J)$!)(5@,@9/
M7J>M:.I_VF+0-I/V1KE7!*7>X(Z]UW+DJ3_>PV/0UG>$]#N-#TZZ6[DB-Q>7
MLU[)'`28XFD;.Q"0"0/7`R<G`S0!O4444`%%%1SQ>?;RPB1X]Z%=\9PRY&,C
MWH`Y;0?%TVM^.-;TA($73["&)H9L'=,Q9U<YSC:&0@<=B>XKK:XGPQX&NO#?
MBJYOEU:>YTXZ?#:0QS"/S/D+?>V1J,`'@@Y.3G/%=M0`4444`%<3_P`)?<S>
M/[O1%N[6TLK66"#,VGS2&XE=-[()@XC1L%<`@DY/!KMJY77-$UK7KZ*SN7L$
MT>*]@O$FB9Q<?NV#>64(*G+#[^X<<;>]`'54444`%%%%`'+>+O%!T.ZL+"*]
MTZPGO$EE^UZD?W$21[<Y&Y<EF=5'S#J3SC!Z&Q>XEL+>2[$`N&C4R"W<O'NQ
MSM8@$CT.!6%XF\/W.H:CI^K:?':37UE'/"L-W(R1NDJ@-\RJQ!!4'[IR,CC.
M1H>&=';P_P"%],T=I_/:SMDA,N,;BHQG'84`:M%%%`!5:_6\:RD%A<6]O<<%
M9;B$RHHSSE0Z$\9_B']*LU0URVO+S0-1M=/DCCO9K:2.!Y20JN5(4G`)P"1V
MH`RO!.KZIKNB/J.HM:/%+.XLY+:!HA)"IP'*L[XW$$CGH17252T?3TTG1+#3
MD"A;6WCA`7I\J@<?E5V@`HHHH`*X'PCXYU#Q#XB:PGAL]A2X:6"`-YVGM%+Y
M828EB"S\D<+T/WAS7?'D5PGAGP5J6CZOIDMW<6SVVDVMQ;02QNQEN_-=6+2@
MJ`I&WL6R23QTH`[NBBB@`HHHH`X/7_'-YI&MZDBQ6@T_2WLHYTD#>=/]H<+N
M0@X`7/<'<01E<5WE<?XH\+7OB/44C>'2!9$P_P"F-$?MD*K('=%."&#[0.J[
M>>&KL*`"BBB@`KDO^$JU#_A8BZ#)IHM]-^Q33K<RGYYF1D!*@'A/G(YY)'8#
MGK:Y^\T&XNO'%CK.^+[)!I\]I(A)WEG=""!C&,*>_I0!E^%O&5WK6H:?'=PP
MI!JU@^H68C0AHD5U79(2Q#,0ZG(P.HQQD]I7%^%_!EUHNH:?)=3PO!I-@^GV
M9C8EI49U;?("`%8!%&`2.ISS@=I0`4444`<IXS\3ZEX>;35L--$Z7-Y!#/<R
MG$<2/*J8`!!9SN..PQD^A35?%&HV7CS0]"BTY5L+Z25);N8\N5A:0",`]B!D
MGZ`=ZN^+M$N=?TNUMK5XD>&_MKEC*2`5CE5V`P#S@<4FM:%=:EXI\-:I#)"L
M&ES3R3*Y(9@\+(-N!@\GG)'%`'04444`%9^M7]SINE2W-I827UPN`D$;!<DG
M&23P%'4GT'>M"HYXS+;RQKC+H5&?<4`<C8:_KVK^`]*UVWDTBS>>S-U>2W,<
MC1QX7.%0,,CKDEQCWK<\,:R?$7A?3-8:#R&O+=)C%G.TD=`>XKAM4\!^)+KP
M'X;\+PS6#VEHJ#58_M<D/VD+C$:N(F(4G))P#P*]&TZ.2'3;:*6V@MGCC">3
M!(9(X\#`"L54D`>PH`LT444`%%%%`!6?IW_'Q=_[_P#4UH5GZ=_Q\7?^_P#U
M-<.)_P!YH^LO_26:1^&1H4445W&85GG_`)#2_P"Y_2M"L\_\AI?]S^E<.._Y
M=_XHFE/KZ&A1117<9D-W:07]E/9W42RV]Q&T4L;='1A@@_4$URO_``JKP+_T
M+-C^1_QKL**`*6DZ1I^A:='I^EVL=K:1DE(H^BY.3^I-7:**`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`***P]9\1'1]?T+3GM/,@U6:2#[0),>2ZH74;<<[L$=1C'>@#<HKA=%^)
MEIK'B'Q+IALC!#HL;R"X:7(N$1F5V"[1@!EQG)K:TGQ79W7A#3O$.K/:Z1#>
M0I+BXN5")NY4;V"@DC';O0!T%%5Y[^SM;%KZXNX(;15WF>20+&%]=Q.,>]8V
MO^++;2-!M=7LUBU&WN+F"!&AG&QA(X3<&`(.,Y]Z`.AHJM!J%E<W5Q:V]W!+
M<6Q`GBCD#-$2,@,!RN1SS3-1U?3='@6?4]0M+&)CM$ES,L2D^F6(H`N45Q_C
MOQ]:^"M/LI5@AO;N^F$5O;O>);JPZER[<*HXYZ9(SC.:Z:*\4:9'>WGE6H,2
MR2[I04CR,D;^A`]:`+5%<]J_C31-+\*7?B**^MKZRMU.&M9T<2-T"*V<9SVJ
M_IVO:7J<=H;;4+.66ZA\^*..X5V9`<,5P>0#P2.]`&E15$ZSI0T^34#J=F+*
M,LKW/GKY:D'!!;.`0>#6!I?CW3]0\1Z_ILS6MM:Z4UJL=Z]VNRX,ZEE`R`!T
MP.3G-`'6T57-_9KJ"V!NX!>M&95MS(/,*9QN"]<9XSTJQ0`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!6?IW_'Q=_[_P#4UH5GZ=_Q\7?^_P#U-<.)_P!YH^LO_26:1^&1H4445W&8
M5GG_`)#2_P"Y_2M"L\_\AI?]S^E<.._Y=_XHFE/KZ&A1117<9A1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`5POQ966W\%C6K:'S;K1KR#4(ESC.QP&Y]-K-GVKNJ*`/G
M36='OM(\#>$KV#)N]>MI].NBPY+7A\U?R.>*Z+XLZ:+35O#K7>HIIN@VMG)!
M]IETI;^&.4;0H:)@0"1@`XXQ7M-%`'@.LZ->6OPL\*+)?7D6DP7TDUS<7FDK
M(88FWE&>VW."@R<`]`PX'2F+ITT/PBNVTW4IIDO->MY+*YETU;./)D0!XXE8
M@1DC(^5>_P`M?0-%`'`?"^(Z/;ZOX;OD3^V;&\>6ZN`N#>K*2R3G/)R.#Z%<
M5C>-YM$TSXD+J/C:Q-QH!TKRK.66V,\$4_F'>"H!PY&W!(_&O6**`/!7T-3X
M9\!1:II@\N3Q(4@@O(072T=G*QL&R0I`4[3[>E>E?$S3[:]\`7MK.EX+<&-L
MV5NLS1[7!#&,D!T!`)7TS7844`?/5BMKK'@CQS#IFGV-[:_8XY8[ZPT^6UAE
MD7/"PO\`*'4#.Y`#SSGBMZ/Q%X?T?Q3X0\06Z-#H$^D36=N]M92!3/Y@R@15
MSDL#VYZ^]>ST4`>`6YBD^'OA_4M5LIGT*W\0W4^IP-&7"(7DP9$&<@,1GK5C
MPYHVD^*;WXH:=H=J+6QN8;-K*,6YA"N$=E94(!4%QN'`X->[UGZWI0UO2)]/
M-[>V0F`_TBQF\J9,$'Y6[=,'V)H`X/X5W=QXJN]2\:7T#12SQ0Z?`KCE5B4&
M4CV,K-^0KTRL[0M$L?#NC6^E:=&4MH`0NXY9B3DL3W))))]ZT:`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`*S]._X^+O_`'_ZFM"L_3O^/B[_`-_^IKAQ/^\T?67_`*2S2/PR-"BB
MBNXS"L\_\AI?]S^E:%9Y_P"0TO\`N?TKAQW_`"[_`,432GU]#0HHHKN,PHHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BJ>I2:E%;JVEVEI<S[P&
M2ZN6@4+@\AEC<DYQQCN>>.<+1?%5W=::FK:U;:3I.F.K;9FU,NP8$C!#1(H&
M%8YW=NGH`=316:/$.B&:TA&L:>9;Q0]JGVE-TZGH4&?F'TIT^O:/:ZDFFW&K
M6$-_)C9:R7*+*V>F$)R?RH`T**Y_3_&FA:A<:K"-1M8CIMW]DE,EP@RVT-D<
M],EEY[HWI5R#Q-H-T]JEOK>FS/=DBV6.[C8S8.#LP?FP1SB@#4HJE-K&F6^H
MPZ=-J5G%?3?ZJV>=5D?_`'5)R?PJ-_$&BIJ"Z>^KV"WK2&-;<W*"0N`"5"YS
MG!!Q[CUH`T:*P-,\8Z)JEYJ5M%?VR26%ZMDX>=/G=@NW`SW9B@[EE8=JWZ`"
MBBL;6O%>B>'IHH=4OU@EE4LJ!&=L=,D*#@?7K@^AIQBY.T5<3:6K-FBJFF:G
M9ZQI\5_83>=;2YV/M*YP2#P0#U!K.\0:W>:7=:39V%C!=W6HW#P()[DP(FV)
MY"2P1ST0CIWH::=F/<W**YR\UK7K"TMO/T?33?75VMM#%'J3F/!5FW,Y@!'W
M2,!3]:DFU?6-.TB]O=4TRPCDB51;16U^\HFD8[0K,T*;,L5&0&ZGCCE`;]%8
M=GXDBDT34=1OX19G39)TNHS)OV>62<YP."NUAQT84S1/$5QJ>J/IUUIPM+B/
M3[:]D`F\S:TID!3[H^[Y?7OGH,4`;]%<MJ_BN^THZC=MHC?V1IK@75U+,8W9
M=JLSQ1[")%7=@G<N2K`9Q3;OQ;>07=Y+#I"2Z18W26MS=FZVR!CMW,D>TAE7
M>,DNIX;`..0#JZ*Y6Z\775O<S3II22Z/!>I8RW0NOWHD9U0L(MF"BLP!.\'@
M\<59O_$5W%J5Q8:?I+7LL;Q0JPE*H)'5G/F$(WEHJA#NYR7``Z9`.AHKDSXP
MN3:RPQZ9#_;$6H)ISVKW9$7F,H?(E$9)78=WW,\'@5L#5QI]@D_B*73=+D9F
M``O=T9P"W#NJ9.`21C@`T`:E%9UOK^C7<UO#;:O832W*&2!([E&:51U90#\P
M]Q4HU?3#JATL:C:'4`N\V@G7S0OKLSG'OB@"Y16<NOZ,VHMIRZO8&^5Q&;87
M*>8'()V[<YS@$X]C46KZRVGSVMC:6PN]2N]Y@MS*(UVJ!N=VP=J#*@D`G+#`
M-`&M17)W_C&?1]-U5M4TR.'4K&QDOTMXKK?'<1IUV2%`>#@'*#&X=<U9BU_5
M;6XLQK6E6EK;7DBPQ3VE\TX61A\H<-$F`>@(SR0.*`.CHHHH`**S/^$@TO\`
MY^O_`"&W^%:=-IK<+!17+Q:_KVH:GJMOI>C:;)!I]W]E:2ZU)XF=O+23(58'
M`&)`.O8TV+Q%KU]JNJVFG:)I\L>FSK;R//J;QL[&))#M40,,?.!RPZ=J0'54
M5EZ5KMMJWABVUV%'CMKBV%R%DP&52N<&LBT\4:I'X:E\0ZWI%G8Z<EA]MQ#?
M--,/E#!"AB0`XST8\X'.<@`ZNBN3E\87.FI>#6]*2VFBLFO8(K:Z\XS("%*\
MJF'#,@(Y'S#DU;L?$=S'=75MXAL[32G@MENO-6]$L)B)(8EV5-I4CGC'(Y-`
M'0T5D'Q5X="%SK^EA1-]G+?;(\"7^YU^][=:M7VKZ9I9A&H:C:6AG;9$+B=8
M_,;T7)&3["@"[16=?Z_HVE3K!J.K6%G,Z%UCN+E(V*CDD!B.!@\U7\2ZY+H6
MDQ7=M:QW<LUU!;1QO,8E+2R*@)8*V`-V>`:`-FBN:3Q)?VMQ>6FK:5!;W4-D
M][%]ENFGBE1.&!<QH5;)'!'(.1G!Q##XIU6WMK"_UG2+.UTV\,2">UOVG:)I
M2HCWJT28!+`$@G!(XQR`#JZ***`"BBB@`HHHH`****`"BBB@`HHHH`****`"
ML_3O^/B[_P!_^IK0K/T[_CXN_P#?_J:X<3_O-'UE_P"DLTC\,C0HHHKN,PK/
M/_(:7_<_I6A6>?\`D-+_`+G]*X<=_P`N_P#%$TI]?0T****[C,****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`K@8=)N)O"'AJUN+&9FAU6.66)HC
ME`LCL&8=@.#DUWU%`'EVIZ'<-JWB.SOY_$:Q:G<J\$>EVD4L<T?EHH'FO$WE
M,I!^\Z@=5Y)J+Q5'JES!J]C'I]X'-]%,L%GI)*SHC1GSGG((=L+T7#_*`!QF
MO5J*`/-I-,GFUC4K2?3;IU;Q1;WX)MW,;1>3$`X;&T@-&<\\8YQD9CO]%NOL
MOBAHM,G\V?Q-8SQ%8#NDC5K4LZ\<J,29(X&&]Z]-HH`\NO-$G?5-=L=0N?$D
M?V_4/.B73K*%XIDPFQO.:%O+9-N/F=2-@(ZBK%]HUT^D>-6739FN+C6X)8/W
M!+2(BVQ#+QR`0_(Z$'T->DT4`<EX>E?3-:\3Q7=I>I]IU=9876TD='1X845@
MRJ1C<C9.?EQEL"NMHHH`*\<\3?"2YM?)D\.M+>(?EEAGD174_P!X'Y01VQU'
MOGCV.BMJ->=%WB1.G&:LSSWP1\-UT.6SU?4)Y?[4CW-Y,;+Y:!E*[3QEB`3R
M"!GUQDZ_BW26U;6_"T9CO#;QWTKSR6LLD31K]FE`)DC(906*CJ,YQWQ75T5-
M6K*K+FD.,%%61R>N^'8FL]&T^#^TI+<:FLDK_;KAY47RY.?-+EU&<#[P'..]
M2WFAK!+I.G6B7<]HU^+JY>[NIKG8(U++AI&8C]X(\#('4]:Z>BLRCC-;T2[F
M\2BVMX)&TS6'BEU!T"A8S`<G=W/FJ(X\>B'I5ZRM;A/B/K-TT$HMY-,LT24H
M=C,LDY(!Z$@,,CW'K72T4`<'K>M#4M?FTC4=.UB#1K.1'>2'3+F;[<XPP4&.
M,@1@XSSEB,8QG-;41="SU_P\NF:C)<:E?^9;2I:N86BDV$NTN-B;</D,0?EX
M!R*]%HH`\VN8;JWL-3\,Q:;J,MU=ZW]IBE^ROY!BDN%F9S*`4`4%A@D,2N,<
MBM*35+_P[H%SJ"Z-=3ZCJFHRL(X;667RE)*1R2A%+`"-$S@9SP*[>B@#SW['
MH\VDV<ESH=_K$(OWGU":YL)XI/-:)E,OV=D!F7!$>T`@`CKMJO#H]T^J:(\6
MGRIHZZ^UQ9V_V9D%K;BS9060@&,>:"0"!C<.F<5Z510!Y[!HDEM:,8-,>.1_
M%1NFV0$$H9>9.GW=O\73'M5CPY&-.N)=+U+1KNXU(ZM<W4=W]C+Q*LCN4F\Y
MAL!",%P#N'3&*[JB@#RB`&T;P)H]W872:I8ZH4N;B2U94=O(FW,LA&U]Y^;Y
M2>G.#79:Y;SV/B?3?$*6\]S;V]M/:7$5O&9)$61HW$@4<M@QX(`)^;@'%7;'
MPMH^FW:7-K:NK1DF)&GD>.$G.?+C9BD><G[H'6MB@#S;Q=:7?BBQU?5+*POE
M@M]#O+.WCEM7CFN99=I.V-@'P/+`&5Y+<=.=6_N1XIATK3+*SU)!#>6US<37
M-A-;+&L3B3&957<25"X7/7)Q7:44`%5-0T^+4H%AF9U56W`H0#G!'<>]6Z*$
M[`<-_P`(_JG_`#Z_^1%_QKLK.TCL;1+>(L43."QYY.?ZU/15RFY;E.39Q6B^
M&H[G7_$E[>C5(&?5M\'E7UQ;QR(((,-L1U5QN##.#G&.V*9I?A>&^\2^*;K4
M(]3B274$,0CO;BWBF3[/""=J.JN,A@20>A';%=Q14$F7J.GQ1^%[K3;/3TFA
M6S>"*R24P*Z["HC#CE,CC(Z5Y_JWA\:OIU_:^%M(ETV"32+N&\BDLWMO/N&$
M?E`[U'F,-LGSC/7J<UZI10!YMKT%YXKNKC4=/TZ_3[)I$L(BNK5[=I9FEBD$
M:B0#/^J(R.,L.:B\5_:?$^F^(;O3]+U01KH4EK&L]E)#)-*[;MJ1NH9L!1R!
MCYN">:].HH`X#6-#:3Q#XH>/3&>&7PU';0L("5=LSYC4XY.-G`_V?:FM"VFZ
MZ]YJVD7FH65YHEO9QQ16;7'SJ7,D3J`0N[<O+87CDC%>@T4`>2^,,Z;X;\<Q
M7^EW;G4H?/LW6V9XXXUMT4*SJ"D91E8X)&<\9S74^/+62Z\'V<:V]Y,J7UE)
M*MHDC2K&LR%V41_/D*"<KR,<5L77A31KS4)+V:U<RRLKS(MQ(D4S*``9(PP1
MR``,L#T'I6S0!YO#IYDU74;C0XM<-A+H\\-T-3%T6DFX\H1BX^?(!DSM^7D=
MZM27<NO>%M-T&PL-12Y/V5;B2[T^>WCA2-D9SND50QPI`"YY([<UWU%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`5GZ=_Q\7?^_P#U-:%9^G?\?%W_
M`+_]37#B?]YH^LO_`$EFD?AD:%%%%=QF%9Y_Y#2_[G]*T*SS_P`AI?\`<_I7
M#CO^7?\`BB:4^OH:%%%%=QF%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`5GZ=_Q\7?^_P#U
M-:%9^G?\?%W_`+_]37#B?]YH^LO_`$EFD?AD:%%%%=QF%9Y_Y#2_[G]*T*SS
M_P`AI?\`<_I7#CO^7?\`BB:4^OH:%89\1M)?7MK::-J-V;.012R1&$+N*AL#
M?(I/##M6Y7-^'"%UKQ020`+]22>W[F.N]&+Z&W87]OJ5J+BV8E-Q5@P*LC`X
M*L#T(-&H7T&FV,MY<DB&(9;:,GKC^M<1*YEM;THAFAU37-MJC2;(90(P#O.T
MYC+1MP/O<=C67>V\"Q^+=.>+3S;VT5K(MO;18B@D+,#@'@-C&2,52@+G/5**
MX75K.TN=3U.!+/3Q;:=:1H6ON8[?Y25,,8``X/+;@<@`8Q6]X-GEN?!FCS3R
M-)(UJFYV.2>.I-)QLKC4KNQN45Q/B$&#Q!<:<&8)XAMXX1CC#(X60@^OE/G_
M`(!6(MU>7.A7]S`Y,VBV"Z:902I63S,3,"`<81$.1G&::A<3G8]1HK@H[5[+
M4T6WMM+L(IM/G>6"RNGF^T+@;9&_=*,@_P`1.3N/6J<5BD'ASPFMM96KIJ*1
M&^$SF)+EO)+(LKA6)&XG`(.<`4<H<YZ317,>%8Y;?4=8MMMG#;QR1[;2TF>1
M+=ROS*"44`$;3M7ID],U/XMDS8V5J(S*]U>)"L;2;(G."V)#M/R?+R!UX'<U
M-M;#OI<Z"BO*[Y3;P>+]-B>UBABBLR(;%2D<+ESG`SPW`)(QVXK:U9;3PYK5
MVUG'):V[:+<3S+:85F='0!^01OPQ^8@]><U7(+GZG<2.(XGD.<*"3CVJOIM_
M%JNEVNH0*ZQ7,2RH'`#`,,C.">:X)(#I?B30XTATZT>\M;CSH[/)>51%N#2/
MQOY'4CKFBSO5\,Z!X?U\H3!-I*6MP`,Y=8]\1_,,O_`Q1R!SZGH]%<(WAIT@
MT^%H]+U&XALR]QIU\V`SNVYY5X.TEBPR5_$572=M:O\`2(8],M[BP-@[0V>I
MW;;&D63:QSLD\T@`8SV;-'*',>AU3L=2AU":]BB616L[@V\F\``MM5LCGIAA
M^M</IT9O+K2-/U.2VN=*>>\\J,2-+$SJP\N,EU7S`H\S'!!VY[5M>"4MHG\0
MQV;!K=-6=4PVX#$<>0#Z`Y&.V,4.-D"E=G545SGB7Y=9\,N>%&HD$GIDPR`5
MCW,$>JZGX@@CO+5,ZC;+LN#F*=EA7,3#/.<'CGIT-)1&Y';S2/$JE())B7"D
M(5!4$X+')'`ZG'/H#4E>=SM%!:_V<-,BT^:VUBP:6.VF,D!+2K@QC`V],E=H
MZYYSFHKVQMAX<\6ZIY0-_;7UP]O<'[\)7:1L/\//7'7O3Y1<YZ317"7EO8WW
M_"67.LA//M,K;R2<-;Q>2I5HS_#EBW(ZGBNF\,_\BIH__7C#_P"@"DU9#4KL
MU:*XC7(8M1UK5Q)!921V5J@>743O2$E2P:),#'7EMP)(`&,5M^#9Y;GP9H\T
M\C22-:IN=CDGCJ30XZ7!2UL;E%<K>:?::A\0D2\@2>--+WB.0;EW>;PV#W'.
M#VS7-VR7LNCPZF\&F0ZF;X*U^]W(;@2^;@PE!"3C'R[,XQS[T*-Q.5CTZBO.
M)K333HOBW4,H=3MKRX,$N[,D$G6,)W7+8Z=<]ZEGBNM2US6/[1L-.N3;PPF/
M[;=M$;=#&"7C`C;'S[_F!!RN.U/E#G/0JJS7\$&H6MDY;S[E7:,`<83&[)_X
M$/SKAK97UB2SM[];+4'MM*BFGFU#)@&[=B1(V0,6(7EF(P,#N:K^&XX-0;PA
M>7,4%S<?9[P)-(@)/ER`1\G)X[<\9-'('/V/2ZJ:GJ$6E:=-?3J[11`%@@!)
MR0.,D>M>=Z='>/H^F:FT.FP:C)>()+\W4C7#R&3#Q,@B)P>5V;L+U[4_4+:Q
MN/!VJZEJ(3^UQ?21-,QQ*I$^$C!Z[=FWY>A!S[T<FHN>YZ9117F^K:=;2V'C
MF_DB5KFWG+02G[T++!&0R'^$Y[CGBE%7*D['I%%>?ZS%)HM]<_V+&89Y-!GE
M;RA\TDBM&%<_WG`9N3SS3M-@-CJNCW%K;Z7:)-'(TIM+N2:2\CV$EF'E*"0V
M#N8]>.]/ETN+GUL=]17ET9\F+PQJT4=G!-?:A"%F+;[NXC<G=YC@+G@\C!`X
M'85J0VL6BWUO?36EEJ4<]_LCU.VF(N=\DA`5_P"^HR!@-C"_=XHY`4SO:*\Z
M,T<7@*]CD=5<ZTT84GG=]L!Q]<<_2I)[7:?&NIVUNLFIVLS&UEV;GB/V=,E/
M0\]NN!Z4<@<YZ#17G]C:FUU#29+5-*TY+B&4RRVMY)*]S'Y9)=OW2@D-AM['
MU&>:L:%;1Z%J>E02V%E*]VC1PZG82G-QA-Q:9?XLX)W9;DCIFCE!2.XHJO?S
MK:Z==7#>9MBA=SY8RV`">/>O/;:$V&J^$[B..QMI;N4[O)<R3SQF)CF63`W]
ML\'YCQC'*4;C<K'I5%>:6MC;P>$+75HXE74%UC"W('SA3>%"H/7:03\O3FHO
M$9$FC>(-92.TB>WN7CAO+HE[I9%;;MCP%\L9`VC)X))SFGR:D\^EST2TU*&\
MOK^TC60264BQR%@,$L@<8Y]&'I5RO/[F*5[KQ'J4";[K3KZWO(P!RP6WCWJ/
MJA8?C4HMX_$=G>ZJEU;1I?WT<=LMSQ'<PQ941L,Y(9O,;'N.#THY1J1V\TCQ
M*I2"28EPI"%05!."QR1P.IQSZ`U)7G<[106O]G#3(M/FMM8L&ECMIC)`2TJX
M,8P-O3)7:.N><YJ>ZMX=+O9M6G@L=5MCJ'_'Y#.4N[=BX`CR/O!2=NW<.."I
MYR<H<QWM%%<]XL<64&GZR6*KIUVCRG_ID^8W_(/G_@-2E<INRN=#5&;5(K:6
MVBN(I8I+FX-O"K`'>0&;/!.`0I/.#[9K@[+S9-1BT:59"=8N8=8D5OX8_F=U
M/IAHHUQ_M4_[':7-]IK7-M!*?^$DNUS)&&XQ*<<]L@'Z@>E5RD\_8[K3=3AU
M6*>2!9%$-Q);MO`&61BI(P3QD<5=KS*73[6+PGXAU=85_M"WU6YDAN#]^(B?
MHIZJ/4#KDYKTVE)6'%M[E6VU"WN[J\MX2Q>TD$<N1@!BH;`]>&%6J\VU");!
M?%<UA!#!(VIV\<LB?NB(66(R9=02JG<Q)`.,D]:CUBUDL+'6X(;;3+"W;1I6
MDM+&=Y`QR-DF/+55.-P]6]\57(3SV/3:*XJYT+31K'ARV6SA$$JSRSQ[>)F\
MM1E_[V>"<YSCFLQM*L[30=2NX80+BTUD):R9^:W3ST&R,_PK@D8''-3RH?,S
MTBBN#U*UBTZ]O=:FM;'5;=+O>UQ%.4O+8Y4>6I'4`\;-RYSC!R<]Y2:L4G<S
MK35X[W5+NR@MKAEM&\N6X(41A\!M@^;<3AA_#CWK1KS=K6VLQK30016T,FOQ
M6]U+"@0BW*Q%E+#D*6//^\:3Q5%;Z7_;=EI*);VO]C--/!`-J1R!U$;!1PK$
M%^G7`/:JY;O0CGLKL])JDVIPIK<6E%9//DMVN`V!MVJRJ1G.<Y8=J?I^G6>F
MVWDV5M%!&QWL(U`W-@`L?4G`R:YW5;+3]0^(&GP:C%%,ATZ8I#,`RNWF)U4\
M'`R<'TSVJ4DV4VTCK**\]B8W=O9:8L:W4#ZE=+:)<2G[.\*9^_P2X&3M7H<#
MG`JMIUH;V+5=-CO=-2*#6$\FU/%M-^Z!,`7/3J<#/*D[<<57*+G/2ZJ:GJ$6
ME6$EY.KM'&5!"`$\L%'4CN:X*\N&CL1I<&F6]D(]6BBOH%O&%JP9"R@.%^16
M(0%=HY."/FS2WL$UG:Z]:K%8VENJ6K&QLI7D2%S+]X9C15W#&5'/&>]'('.>
MAQR.\DJM#)&$;"LQ7$@P#D8)..W.#QZ<U)7G6HPI<:O?0R;MC^([56"L1D>0
MF1D>O2FZR'TB;Q!9:4BVMF!8,T43&*.-7D99""H.P%5&2!P,FCD#GL>CT5R&
MA6LEAXI,$-MIEA;M9;I+.QG>0,=PV28\M54XW#U;WQ77U+5BD[A6?IW_`!\7
M?^__`%-:%9^G?\?%W_O_`-37!B?]YH^LO_26:Q^&1H4445W&85GG_D-+_N?T
MK0K//_(:7_<_I7#CO^7?^*)I3Z^AH5FW'A[1+NY:YN='T^:=SEI9;9&9C[DC
M-:5<J?$=_%_;M],+8:=I$LD;1K&QEFVQAQAMV%Y8#H<^U=ZOT,I-=3HY[*UN
MK4VMQ;0S6Y`!ADC#(0.@P>*BCTC388GBBT^T2-XQ"RK"H#(,_*1CE>3QTY-<
MQ:^-4CO+9+O4]'NTN8Y&*6$F7MRJ%\-\S;A@$;L+R!QSQ.-<UQ$T2\EBLOLN
MJ3QH8E1M]NKJ6&6W88X'7`P?6GRM$\R9O'1=*+V[G3+,M;+M@)@7,0]%X^4?
M2K4$$-K`D%O%'%$@PL<:A54>P'2N3T_7;J=X=.L+>QM[JXN[PE_*/EI'%*5+
ME0069B1GD9))]J+GQ/JL,T.GK!:'4%U-+&9V#")E>(R"11G(XQP2>A&><T<K
M#F1U<EM;S30S2P1O+"28G9`6C)&"5/;(XXHAM;>W$HA@BC$KF238@&]CU8XZ
MD^M9FCZA>SW^HZ?J'D//9LA$T"%%D5UR/E)8@C!'4UL4GH4BI;:5IUDLJVMA
M:P";F410JN__`'L#G\:>UC9O8BQ>U@:T"!!`8P8]HZ#;TQ[5B7.KZK<7NJ)I
M2V?E::`KB=&9II"@?:""-@`(YPV2>@Q65#XVDNHK")[_`$C39Y+"*\GEO3A&
M+@X1%WJ>Q).3@$<'-/E;)YDCLK6TMK&!8+2WBMX5Z1Q($4?@.*+JTM[VW:WN
M[>*>%_O1RH&4_4'BN4MO%=_JTNB1::MDAOX[GSI'W2K&T15<K@KN4DGTR"#D
M=YX?$>HS"'3Q%;+JDE[-:&7:QA`C7<9-N<]-OR[NIZT<K'S(W4T;2XXFB33;
M-8V18R@@4`JIR%QCH"<@58:V@><3O!&TH0QB0H"VTX)7/H<#CVKAUUNXT*]U
M^:^:S%W+?VUNLC-Y<&6A7YVR25`4$D9/3&>]3S>-GM[+5Q%=Z9J5Q8V@NHY[
M,_NG&2"K*'8J00/XN013Y6+F1T]OH>DV846VEV4`5BZ^5;HN&(VDC`ZX)'T-
M07VB)>I9V@:&'3;=TD-M'#@L4(*`$'"J"!QMYQU%7+`7PMR=0DMWE)R/(C*!
M5P.#ECD@YYXSZ"IKB4P6TLJIO9$+!-P7<0,XR>!]34W=RK*Q!?:7I^IJBW]A
M:W:H<J+B%9-OTR.*6ZTVQO;9;:[LK>>W7&V*6)748Z8!&*Y:S\82_P!H:?'<
M7%E<P7HDS]DA?$!5"^/,W%9/ND<8Z9IX\0ZX;'1]4\JQ^Q:G<P((=C^9!'(>
M"6W88X([#!/>JY63S(Z>?3[*YLQ9SV=O+:C`$,D2LG'3Y2,4ZVL[6R1DM;:&
M!6.YA$@4$X`R<=\`#\!7&7/CU(EO+U;_`$A+>UG:+[#+)_I4JHVUF!W<$X)"
M[3D8Y&>.Y5@ZAE.5(R#2::W&FGL175I;7UNT%W;Q7$+?>CE0.I^H/%0C2-,%
MM);#3K002@"2(0+M<`8&1C!P`!7.:]XIO--FU+R9;&/[!'Y@MI(VFEN%V[B<
MHW[H=0-P/3)P*F36]7U'4[VVTX6444%G!<JT\;.6,@8[3AE_N]>WH:.5V#F5
MS>ATK3K>V2VAL+6.W202K$D*A5<'(8`#`.><T]K"S:">!K2`PSDM-&8QMD)Z
MEAW)]ZYVQ\1W^NO91:8EM;N]C'>W#7"-(%WY"HH5EY^5OFSP,<'/$W@0R-X4
MB,JJLAN;DNJG(!\^3(![T--;@FF[(=JWAJ;5;N21[JS,;J41IK!))K<$8(BD
MR-O<\AN36[;6\=I:PVT(Q%"BQH/0`8%<]XB:^'B3PTEM<QQ1O=2!E>-FW8A<
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MTZ_EBEO+"UN)(>8GFA5RG^Z2..@Z4-I6G,D*-86I6&4S1`PKB.3.=Z\<-DDY
M'.:YFSU"]U3Q=HEY%-'%:W6CM<FW:,L0&:(D9W`9Y'..`",'.1U-]>1Z?I]S
M>S?ZJWB:5\>B@D_RI--#33U&+I>GI?F_6PM1>$8-P(5$A'^]C--GT?3+JY-S
M<:=9S7!7:99(%9BOIDC.*P?[:UZ";0WNH[#R-4G".D:/N@!C9PN[=ACQUP.A
MXYR(;;Q+JTFE)J$D=FPN;MK&V@5&!\SS2@=GW'Y<*Q(`SQUHLQ<R.QJNUC9O
M'<1M:P,ER<SJ8P1*<`?,/XN`!SV%<QJ_B35-"@U&&Z%G/=PV+7EM+'$R1N%8
M*RLA8D8++T;G/;%:FIZQ<6>L6UG&D1CELKBX)8'.Z/9@=>GS'-'*Q\R-;[/!
M]H6X\F/SE0QK)M&X*2"5!ZXR!Q["H;72]/L9I9K.PM;>68YE>&%49^_)`Y_&
ML#3]=U<6FBWVI)9?9]4,:>7`C!X6=-RG)8A@2.F!C/4UU5)IH:LRA'H>D12O
M+'I=BDDCB1W6W0%F!W!B<<D'G/K3TTC38[]K]-.M%O&SNN%A42'ZMC-5]1U*
M6PU?2X6""TNVDB=R#E9`NY.<X`(5^H]*P].\6W=_:VX,$4=U-J`A"%&P+<IY
MH<C/7RL<]-QZ=J=FQ72T.CDT;2Y;E[F33;-YWQOE:!2S8((R<9."`?PJS';P
M0O*\4,<;RMOD95`+MC&3ZG``_"N)MO'R2Q6M^;_26M[B=8Q81R9NHT9]JN3N
MY(R"5VC`SSQ1<^/4B6\O5O\`2$M[6=HOL,LG^E2JC;68'=P3@D+M.1CD9X?)
M(7/$Z^UTO3[&:6:SL+6WEF.97AA5&?OR0.?QI+72--L)Y)[/3K2WFD^_)#"J
M,W?D@9-<?INM-%XKUK2[#RVOKN_616E!\M(Q#&2QQC)P#A0?4]!7>#IUS2::
M'%IA5&#1=*MGWP:991-YGFYC@53O_O<#KR>?>H=?U*;2=,^W1(CI%-'YX8$X
MB+@.PQW`)/X5C7GBRYMKO78A;Q%+6%38GG,TF=C!N>@D9!QCK0D^@-I;G2C3
M[(6PMA:0>0'\P1>6-H;=NW8QC.[G/KS4,NBZ5<7$EQ-IEE)/*I225X%+.I&"
M"2,D8[5S-[XR>"?4$74-&MWT\^6UO=2;9+IPH9MGSC8,G`)#9(ITWC6&YNC'
M::GI-A&EM%/NU%\&4R+O"J-ZX`4C+<]>E/ED+FB=)=:>3;3IIYM[.:?'F2^1
MNR,;>@(R0``"<XP.#THM]'L;?1H=)^SQRV442Q"*90X90.X/6N)G\6VPUO1]
M;\HYN])D2*'=D&5IHQM+=``0<MTP*[ZT%R+2(7C1-<[?WAA4JF?8$DXI--#3
M39%#I6G6]LEM#86L=ND@E6)(5"JX.0P`&`<\YI#I&FF_%^=.M#>#I<&%?,'_
M``+&:P-32_?Q_9?V>]O')_9DP:2>,NJKYL?\(923P!U'7/M4ECXDNYM1LX+J
M"%(Y)Y[*9DR=MQ'RN#_=90QP1G.!FBSW"ZV-NQT^.QEO9$(+7=P9WVJ%`.U5
M_DHY[G-6)X(;J!X+B*.:&0;7CD4,K#T(/6J&AZC-JMC)>2(BQ//(+?:/O1*Q
M56/)Y."?H167XB6\;Q1X=%B85FS<_/,I95&P9.`03],CZTK:COH=#]DMA<)<
M"WB\Y$,:2;!N5?[H/4#@<>U1RZ9I\\#02V-M)$TGFM&\2E2^<[B,=<\YZUS\
MOB:[M[:\@N/L<5Y:7:6LURYVPJ&0.LFPMN.00-@).>^.:JKXNOOLVIQJD%Q<
M64T"?:4MI4C"2_\`+0QDEB%P<X/..HI\K%S(ZPZ?9-;2VYM+<P2L7DB,8VNQ
M.22,8))Y-6*Y23Q4UIH$E^]]I-\&GCA@N+:0QQ9<@9D!9M@7DGYCP.U9&L^)
M5O\`0M?TM]0TV_<:7)<)<6#?*1]UE9=S8(RO?G/;%-1;$YI'=?8;3[5)=?98
M/M$J>7)+Y8WNO]TGJ1[5#!HVEVMI-:6^FV<5M-_K88X%5'XQ\R@8/'K7.7^O
M76G7EVEG:69F\^QMP[H09/-X^8@\X[>GO4]UXGNM%_M>/4UMIWL;>*XCDA4Q
M+()&90K!F;;\R]<]#GBERL=T=,;>!I(I##&7B!$;%1E`>#@]J8;&T:*2)K6`
MQR/YCH8QAGR#N([G(!SZBN=TKQ0+C6[?39-2TG4&N8GD1].?/E,N"48;VSD$
MX;CH>!6_J4GDZ7=R[$?9"[;'&5;"G@CN*330TTQKZ1ILE^M^^G6C7BXVW#0J
M9!]&QFKE<C8:QK%_=KI^GIIULD>F6]RK/"[*&<-\@4./E^7CGCW[5;;6+[4]
M=\.ZB98K>VGTV>>6W*,V"#'NYW`$\\'''/7/#Y63S([(6ELJS*MO$!.Q:4!!
M^\)`!+>IP`.?2H(M'TR"RDLH=.M([63[\"0*$;ZJ!@UR=GX[6?[!=O?Z0T%[
M,D8L8I<W,`<X4L=QW$$C*[1C)Y..;MEK^KSZ3?ZK*NG^1;RSPI"<QDE)"H=I
M&?:%P#D8[9!YQ3Y6@4HLZRJEYI>GZA_Q^V%K<_+M_?0J_&0<<CID`_A7+Q>-
M#;7-REW-;WL$>GR7RSVMO)""$(RGS,P;.X<@_45<EF\1RZ%<W$\NFQI+9-*O
ME1R!X&QG;][#\<;LI@C.#TI<K0^9,W;C3;"[M%M+FRMIK9<;898E9!CIA2,4
MUM(TUH)8&T^T,4N/,C,*[7P,#(QS@<5R,.NR:+::?/?0VURT6A271F2(K*0I
MCP@)8X!W#/J0#QTK6?5M6TVZLTU,6;QWP=8_L\;J89`A<*V6.\84C(V\CISP
M68N9&U%IMA!9&RALK:.T((,"1*$.>OR@8I(=*TZWLS9PV%K':D[C`D*A"<YS
MM`QU`KF],\0ZS-9Z!?WB6)M]598FBA1E>)F1F#;BQ!'R_=QQGJ<5U])IH::9
M7-A9M(9&M("[2B8L8QDR`8#9Q]X``9ZT_P"RV_FRR^1%YDJA)'V#+J,X!/<#
M)_,UQ]UXQNK6=9&DL7C%\MK)9Q(TDD8+[=S2JQ0'!!VD=\9S4MSXBUE(-?O8
M4L?LVD3LAC>-R\RJBN1NW`*<-UP<^@I\K%S(Z.#2;"RM)K>PLK2UCE!W+%`J
MJQ(QDJ,`U)I]FFG:;:V41)CMXDB4GN%``_E7/W>K:EJ9U:/3!:+;V46V03JQ
M:9VC#[000$`##DAN3TXYT/"7_(FZ'_UX0?\`HL4-.VHTU>R-FL_3O^/B[_W_
M`.IK0K/T[_CXN_\`?_J:\_$_[S1]9?\`I+-H_#(T****[C,*SS_R&E_W/Z5H
M5GG_`)#2_P"Y_2N''?\`+O\`Q1-*?7T-"L6+PY!]FUJVN9#-!JL[RNH7:4#(
MJ;0<\_=SGCK6U6:WB#2TLUNVN@L#7/V0,4;_`%N\IMQC/W@1Z=^E=ZOT,G;J
M58-'O]R_VCJC7EO#&R)!%%Y1ER"/WIWD.<?[HSSCICG;2SOKVXT*SC>^^R:=
M<K)Y=S8/`T2(C`!Y"2LC#(`V<=2<]:Z^XUK3K4W0GN0AM2BRY4\,_P!U1QR3
MQP,GD>M-AUW39[2XN1<^5';?Z\3HT31=QN5P&&>V1SVJDV2TC,B\*O:^3/:7
MZQWL-Q<3)*\&Y"LSEF1EW`D=.00<K^%*OA7,]O=RWIDO%OUOKB7RL"5A&8PJ
MKGY5`(QR3QWS4MYXGMO[#U6[T]RUU96CW`AN8)(CPI*DJP5BI(ZC\ZO6>K6]
MS+#:^8#>-;K/)&BDA`PX)/09.<`G)Q[47D%HE6ZLKNPFU74K%UENKH0K'$T1
M8`K\O.&'!SUXQUYQ6U6!?>)$T[Q.NG7`/D/9^>OE0/+*S[\8"H"2,<]/QK1M
M]9T^ZGMX8+I9'N(FFBP#AT4@-@],@D9'7VJ6F4FCF]8CN+;4]36Q-]`;Z,"1
M4TYIUF?9M#1R*=L9QA3Y@QP#CO5G3/#-]IUAI\EE?16E_'816ESYL/G1OL'!
MP&7!!+8.>AZ5T-M>V]YYWV>3?Y,K0R?*1AUZCGKCVK!L/&EA-;S37GG6P%\]
MI"&M909"-VT`%<EB$/`Y!P.I&:N[:$V5]2Y%H#1:CI=XU]-,]C%-&QF^9I3(
M5)).>,;>F,8..,5"WAEED>Y@O?+O%OI+R"4Q;E3>NTHR[AN!'N.W3%6Y_$>F
M6XC\R68-)'YNP6TK.B?WG4+E![L!4MSKFGVJPEIGE,Z>9&MM"\[,G'S!4!.W
MD<].:7O#]TRD\*RL;V:YU,O>7%S%=QS1P[!#(BA1A23E<`C!['&>]27WAV]U
M72]2MK_5M\M[`(`8H2D,(&>5C+G).>26[#H*6\\56T-YHL=L'N(-2E=?-CB=
MPH"L>-H/.X`$'H,D]"1*?%^A@G=>E4$K0F5H9!&LBD@J7V[0V1P">>V<BG[P
MO=V+XDNQJXA"J;,6^XML((DW8`#9P1C/&,C`YYI^H64>HZ;=6,K,L=Q$T3%#
M@@,"#C\ZKPZ]ILT%U-]I,26F//$\;1-'D9!*N`<'L<<]JB3Q-I+6MU<FXDC2
MUB\Z99H)(W5.?FV,H8C@\@=JFS*NC//AF]GN]*GO=4CF332VR"*T\M9%,90[
MLN?FP>HP.O%8D-C?77]BZ;;F_6SL+R*407%@T30QID@/*24DQ@`;/;.:ZR#Q
M'IES*\44TK2+$9POV>0&1!U:/Y?W@Z?=SU'K2>&]9_M_0K?4#$T32#YD:-E`
M/MN`W#W'%5=VU)M&^A5'AV[@\ZUL]5:VTV:9IGB2(^<I9BS!)0PV@DD_=)&3
M@CC'05AQ^*--BAM_M%\LLMR\PA$-K(#)Y;[654^8DC@>^"0,=(M0\6V=O8V-
MW:B6YBN;I;<[+>1BG.&!4+D,/[I`.>U)IL:<41WGA>ZN(]7M8-4$-EJA9YD-
MOOD5F0*=K[@-I`'!4]^:MZ9H!TZ\N;@W0E,]I;VQ`CVX\H,-W4]=W3MCJ:GN
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MF4R*0,G[IQ]<5%I7BF/5+>.4DVA;4'M%66VE_>`%\`$XPQ"Y)Y`P01FM!?$6
MEO>"V6Y)<R&$/Y3^49`<;/,QLW9XVYS1[RT#W7J4[CP]>:G9WD&JZLTIN(#`
MHMHC#&@X.[86;<V0.2>G``R<K%H-])KEAJM_J<4TEG')&L<-KY:$.`">78@Y
M`[XXZ"IW\4Z-'/)$UVV8I3#*PAD*1/G&'?;M7VR1GM6Q1=H+)G.Z5X9ETYM,
M$E^DT>G>:D($&TE'``#'<<D8/(`SGH*DF\-^;I5]9?:\?:KW[7O\O[O[Q7VX
MSS]W&??I5P:A*?$S:;M3R19BXW8.[=O*XZXQ@>E0:YJ\NGW6GV<+V\,EZ[H)
M[G)CCVKGH"-Q/89'?GBB[N%DD12Z#>+)>)8:J;2UO9#),@AW2(S#YC$^X;,]
M>0V#R,58AT00WNJW`N"1?QQIM*Y,>U"N<Y^;.<]J6WO+ZR-S_;36B6T**XOT
M/E1MDG*E68E2..<D'/X4^V\1:+>SK;VFL:?<3OG;%%<H[-@9.`#D\`T:AH4K
M'PW)I\VC2PWJEM/L?L,FZ'(E3Y.1\WRG*#^]P?QK8O(H[BQN(98C-')&R-&N
M,N",$#/'-8NE>)X9O#NEW^HG;=7T(D$-M"\C,<<[44,Q`_'%:$FNZ:EE!=BX
M\R*<[8A#&TCR$9R`B@L2,'(QQ@YH=[@K6T.4L[34;_4=!A$UY);:;+O87.GO
M;LBB-E&]V.)'R0,IQU/H:W(?"Z1^'X],:Z8R17374-PJ8*2&4R*<9.<9P?49
MZ9JZ/$&F&Q^V"X;RO-\G;Y3^9YG]SR\;MW^SC-9^I^+[.TT^&ZM5EGWWL5K(
MGV>7?$69=VY-NX-M.0"`3D8SFG[SV%:*W$N?"K:HMZ^K7PGN+FT-FK00^4D2
M$Y.U2S')(!))/0=*;-H&H-<C4KS44NIH+&:V6*&U\L-OVG/WF.?E_'C&.^[=
MW]M869N[J7RH1CYF!SDG`&.N22!CKFJT6O:;+:W-P;@Q);`&83Q/$\8/3*N`
MPSVXY[4KL=HF/H&A7K:3H8U*[+PV4,4L5L;<I(L@CP!(Q8YVY.``O;.<5O:;
M+=S6S/>(JR>;(JXC*90,0IP2>H`/7\NE4T\4Z.ZW)-RZ-;0-<S1RP2(\<:]6
M*LH/TXY[9J\=1M1+:1&7Y[L$P#:?G`7<>W''K0[O<%9;%/Q'HAU_1WLENGM)
M=ZO'.B[BA!SD#([9'XU%#X;B@\3?VNLY\L6H@2VV\*PXWYSR=H"XQ4T'B/2K
MF[BMHKAR\Q*Q.T+K'*1U"2%=K'KT)Z&FP^)M(G\\I=-Y=OO\V5H76-"C;6!<
MKMR#VSGD'H:/>V#W;W*UIX=N[.*"QBU9DTNWD#QPQQ%)=H.1&9`W*#IC;DC@
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MFWSJ8=[JY4*6C;<-A(`ZAN>:=)HEU!>27.EZC]F>>-(YQ/"9]VT8#@[@0^.,
MG(.!D&MNBB["R,!_"T$UU"]S<274*:<]A(D_SO*'927+D]?E]._;%:FEVD]C
MIEO:7%T;J2%=GG%=I<#ID9/.,9/?K5NBB[8))&-J&C7D^MP:K8ZA';30V[P;
M)8#*CAF5LD!E/\/8C^AR=<T3RO#+:9;&ZFU*YN//CN8XCQ/O#&1B!M11[D<#
M`R:Z^BA28G%%>QLXM/T^WLH!B*"-8T'L!@50U?2+F_U#3[ZTOA:S61D*AH?,
M5]X`PPW#CCL?Q%:]%%QVZ'-/X4D)CO%U!?[56\^V-</!NC9]GE[?+W`[0G`^
M;(ZY-/M?#NH6MYJ5^FLC[;?>26?[*-BF,$8V[ON$$#&<\?>YKHJ*?,Q<J.;/
MA/SWO+J[NU_M"X>%Q-:P^4L;1$LA"EFR<DYR3GIQ3[OP_?:GI^HP:AJ^^2[M
M3;+Y,!2&('/S>67.6YZENV!BNAHI<S#E1SUYX7^UWDEQ]LV[[FTGV^5G'D'.
M.O\`%Z]O>IK[PW#J%_J$\\[".\M8K?8BX:,HS,'#>N6';MWK;HHYF/E1EV>G
MZ@EZES?ZI]H\N,QQQ0Q&%#G'S.-QW-Q[`9.`,U>O+?[797%MNV>;&T>[&<9&
M,XJ:BBX6,72M`_LS4#=?:?-S906FWR]O^KW?-G)Z[NG;'4U5L_"K60T?R[U6
M.GP26TF^#(FC<J6P-WRGY1SSWXKI**.9ARHP+'P_>62VMFNKM_9=HP,,*1%9
M2J_=1Y-WS*/3:"0`"3SEH\++_P`([<Z2UVQ\VY>Y64)C:QE\U05SR`<`\\^U
M=#11S,.5'-2>%I[_`%1KW5M0CN1)92V4D$5OY2;'(.5RS$'CG)/;&,59M=&U
M%+4V=YK`GM%@:!4CM@CL",!G8ELD#^Z%&>H[5N44<S#E1S"^$!/'!%J-XMQ'
M'ILFG,L4)CW(Q3#?>."`GXDYXZ5.OAZ[N+FVEU/4UNELU;[,J6_E_,RE=[G<
M=S!2>FT<DX].@HHYF+E1@V_AOR-)T*P^U[O[*DC??Y>/-VHRXQGY<[L]^E;U
M%%#=QI)')R^#[J32XM*&KJMA;SK-"HMLO\LF_:[%OF^H"GUS5V3PUYFF>(+/
M[7C^UY)'W^7_`*K=&J8QGYL;<]NM;]%/F8N5'/S^';D2W9L-2%JE[$J7*FW#
MDL%V;T.X;6P`.0PX'%:FD6']E:-8Z?YGF_9;=(?,V[=VU0,XYQTJY12NQV6X
M5GZ=_P`?%W_O_P!36A6?IW_'Q=_[_P#4UP8G_>:/K+_TEFL?AD:%%%%=QF%9
MY_Y#2_[G]*T*SS_R&E_W/Z5PX[_EW_BB:4^OH:%<%J>AWMYK&KZ<MO*+$I)J
M%O/M.U;AHP@5>Q(;>WMD>M=[17>G8R:N>?G3-3O-`L]6DANK:\DU3^T+F&%`
M9D3:8UPKJ065=AP0>AP,XIE[HM[JD6H7EJ^K3MFUQ+=I'#),(I2Y"Q&)<$<X
M+@Y)QC`KT.BJYR>1'G][97.I6NL74+:W=L-(N+=&O+=82S.,A%C$2,QXZ],\
M#.3C4\+6%SH%XVGR1W$UO>1+=+<R*2RRA55TD;''0%<^X'2NLHI.6E@4+.YS
M-]<-I_C47DMC>2VK:=Y1GM[9Y=K>83MPH)Y]AZ9K(GM+S1O#"ZX;<K=6=_/?
MK;DX(AE=MT9QQG:P./4"N]JK>:=;7[0FY1G$3[U3S&"$]MR@X;!`(R#BA2&X
ME;P]8/INA6EO-@W&WS)SC&96.YS_`-]$URJVMT;ZUMS976Z#Q')<NQ@;9Y;K
M*5<-C!'(Y!X)`.":[VBA2!Q.-OK6[L?$NI7;7.KPP7B1&(Z?:QSABJE2C;HW
M*G/()POS'FJEK87&ER:;!<0ZE;6L>GJB_8XQ-*TA9B8I)$CR`H(Q]U<YYXKO
M:*.8.4\[T2SO;+3O#<MQI][&+74KLS1M&TCQAQ*%)QDD$L/FY'.<]ZLKIMU_
MPB4<)LIO-.N><T9B.[9]KSNQCIMYSZ<UW=%/G$H'"Z_H^H7^JZVUM#.!LT^5
M&50/,\N1V94+`J6`QP<C.,]:JZI8W6IV.KW4!UR\9=+EMT:\MUA+,V#L6(1(
MS'CKT'09R<>B44*8.!S\UK,?$?AZ58'\N&UN%=PAPA(CP">V<'\J=X-$D7A:
MSM9H)X9[9?)E2:)D^8>F1\PYZC(/K6]14WTL5;6YP>@Z=>1:IH+S6<Z+"=3+
ML\1`3?."N<CC<.1ZBIIK6Y@M[B8V=P4C\0"Y8)"S,8_ERZJ!EA]`:[:BGS"4
M;(\_NM/O(5URSDDUIOM\\LD5O:V\317"R`<-(T3>60/E.XC`'&:U=.L+RTOO
M$0CM3([6MO'`9QE9F6$C!;`##/!^O:NKHHY@43SN&UN9K[PPR0ZQ,]M<YN6G
MMVBB@S&PVA`JKM!X!`(`&,\\[7AR:;1+!-'N-/OI;M+F3+Q0$QNKR,PD,APF
M,,,C.[CH:ZJBARN"C8X6TM;M4LK9K.Z62W\02SR$PMM$;F8JP;&",,.0>,@&
MFI;7G_"'Q>&/L%U_:*R+&9#"WE8$N[SO,^[T&[&=V>U=Y11S"Y3AKS3[MO!W
MB^!;.<S7%W<M%&(CNE!"X*C&3G'&*[1)T:9H-LF]$#$F-@N#GHV,$\=`<C\:
MEHI-W*2L<W>W(T_QE]JGM[QH'T\1B2"TEF&[S"<'8IQQZU+J=[:W]G"+G19[
M[2YBPF\RT??$P^Z?)9-Y'7D#(P/7-;]%%PL<CH6F/::A>OH0GLM+D@7RXKV&
M38L^XY*QN58+CJ/E'3'2MNW@UM9U-WJ&GRP8.Y(;%XV/'&&,K`<X[&M.BARN
M)1L><:5INH:?::%>3OJMG&NE+:R?9+599(G#;L-&T;L`>.@ZJ,U9CL;JR33Y
M9(M3AM9+FYGFF2%9KI2Q!48CCRBO@DA1QP":[ZBJYQ<AY[IVG@6NJM?Z?K4:
M'5_M%O,BLT\?[I0)>Y8=00`W7!'!Q/<?VO<Z2QF6]O+6UU2UF@EFM"EP\2NK
M.3&`"<<X^4$XZ5W=%'.'(96N1V]WHK"YM+NXA+(^RW!$J$,"&`R#E2`<#GCH
M>E<Q+;ZSJ%K<0QO>W]A;2VMS"U];>1-*4EW21X*KN&U002HR3C)KO**2E8;C
M<X/47/B#6]5@M+2YC>?0)88VN(6A+L6(`VN`<`GJ?6K'GW5]?Z"+?3+S_18)
MEF-S;M&BR>5@*2P&03W&1[UUOV*W^WB^\O\`TD1>3OR?N9SC'3K4]','*>;P
MVMU*/#(%OJ[36U[&]TDELT4-M\C*510JJ5!(`*Y``Z\\W!HVH7'@FYMXX)X[
MA=5DN?+VA7=%N2_RAA@DJ,C(P>*[RBGSBY#ATL%U2ZNKFY37=0MEL7@?[5$E
MNS[BI*(GEQLQ&,[LX!X&<UHZ#-J!U=HHKC4+G2?)9B^HVIADCDW#:JEE4N,;
MLD@XXYKIZ*3D-1"BBBI*"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`K/T[_CXN_]_P#J
M:T*S]._X^+O_`'_ZFN'$_P"\T?67_I+-(_#(T****[C,*SV.-:7/]S^E:%59
M["*XE\QV<'&."/\`"N3&4ZDXQ=-7::?;8N#2;N6=R_WA^=&Y?[P_.J/]DP?W
MY/S'^%']DP?WY/S'^%1[;%_\^E_X%_P!\L._X%[<O]X?G1N7^\/SJC_9,']^
M3\Q_A1_9,']^3\Q_A1[;%_\`/I?^!?\``#EAW_`O;E_O#\Z-R_WA^=4?[)@_
MOR?F/\*/[)@_OR?F/\*/;8O_`)]+_P`"_P"`'+#O^!>W+_>'YT;E_O#\ZH_V
M3!_?D_,?X4?V3!_?D_,?X4>VQ?\`SZ7_`(%_P`Y8=_P+VY?[P_.C<O\`>'YU
M1_LF#^_)^8_PH_LF#^_)^8_PH]MB_P#GTO\`P+_@!RP[_@7MR_WA^=&Y?[P_
M.J/]DP?WY/S'^%']DP?WY/S'^%'ML7_SZ7_@7_`#EAW_``+VY?[P_.C<O]X?
MG5'^R8/[\GYC_"C^R8/[\GYC_"CVV+_Y]+_P+_@!RP[_`(%[<O\`>'YT;E_O
M#\ZH_P!DP?WY/S'^%']DP?WY/S'^%'ML7_SZ7_@7_`#EAW_`O;E_O#\Z-R_W
MA^=4?[)@_OR?F/\`"C^R8/[\GYC_``H]MB_^?2_\"_X`<L._X%[<O]X?G1N7
M^\/SJC_9,']^3\Q_A1_9,']^3\Q_A1[;%_\`/I?^!?\``#EAW_`O;E_O#\Z-
MR_WA^=4?[)@_OR?F/\*/[)@_OR?F/\*/;8O_`)]+_P`"_P"`'+#O^!>W+_>'
MYT;E_O#\ZH_V3!_?D_,?X4?V3!_?D_,?X4>VQ?\`SZ7_`(%_P`Y8=_P+VY?[
MP_.C<O\`>'YU1_LF#^_)^8_PH_LF#^_)^8_PH]MB_P#GTO\`P+_@!RP[_@7M
MR_WA^=&Y?[P_.J/]DP?WY/S'^%']DP?WY/S'^%'ML7_SZ7_@7_`#EAW_``+V
MY?[P_.C<O]X?G5'^R8/[\GYC_"C^R8/[\GYC_"CVV+_Y]+_P+_@!RP[_`(%[
M<O\`>'YT;E_O#\ZH_P!DP?WY/S'^%']DP?WY/S'^%'ML7_SZ7_@7_`#EAW_`
MO;E_O#\Z-R_WA^=4?[)@_OR?F/\`"C^R8/[\GYC_``H]MB_^?2_\"_X`<L._
MX%[<O]X?G1N7^\/SJC_9,']^3\Q_A1_9,']^3\Q_A1[;%_\`/I?^!?\``#EA
MW_`O;E_O#\Z-R_WA^=4?[)@_OR?F/\*/[)@_OR?F/\*/;8O_`)]+_P`"_P"`
M'+#O^!>W+_>'YT;E_O#\ZH_V3!_?D_,?X4?V3!_?D_,?X4>VQ?\`SZ7_`(%_
MP`Y8=_P+VY?[P_.C<O\`>'YU1_LF#^_)^8_PH_LF#^_)^8_PH]MB_P#GTO\`
MP+_@!RP[_@7MR_WA^=&Y?[P_.J/]DP?WY/S'^%']DP?WY/S'^%'ML7_SZ7_@
M7_`#EAW_``+VY?[P_.C<O]X?G5'^R8/[\GYC_"C^R8/[\GYC_"CVV+_Y]+_P
M+_@!RP[_`(%[<O\`>'YT;E_O#\ZH_P!DP?WY/S'^%']DP?WY/S'^%'ML7_SZ
M7_@7_`#EAW_`O;E_O#\Z-R_WA^=4?[)@_OR?F/\`"C^R8/[\GYC_``H]MB_^
M?2_\"_X`<L._X%[<O]X?G1N7^\/SJC_9,']^3\Q_A1_9,']^3\Q_A1[;%_\`
M/I?^!?\``#EAW_`O;E_O#\Z-R_WA^=4?[)@_OR?F/\*/[)@_OR?F/\*/;8O_
M`)]+_P`"_P"`'+#O^!>W+_>'YT;E_O#\ZH_V3!_?D_,?X4?V3!_?D_,?X4>V
MQ?\`SZ7_`(%_P`Y8=_P+VY?[P_.C<O\`>'YU1_LF#^_)^8_PH_LF#^_)^8_P
MH]MB_P#GTO\`P+_@!RP[_@7MR_WA^=&Y?[P_.J/]DP?WY/S'^%']DP?WY/S'
M^%'ML7_SZ7_@7_`#EAW_``+VY?[P_.C<O]X?G5'^R8/[\GYC_"C^R8/[\GYC
M_"CVV+_Y]+_P+_@!RP[_`(%[<O\`>'YT;E_O#\ZH_P!DP?WY/S'^%']DP?WY
M/S'^%'ML7_SZ7_@7_`#EAW_`O;E_O#\Z-R_WA^=4?[)@_OR?F/\`"C^R8/[\
MGYC_``H]MB_^?2_\"_X`<L._X%[<O]X?G1N7^\/SJC_9,']^3\Q_A1_9,']^
M3\Q_A1[;%_\`/I?^!?\``#EAW_`O;E_O#\Z-R_WA^=4?[)@_OR?F/\*/[)@_
MOR?F/\*/;8O_`)]+_P`"_P"`'+#O^!>W+_>'YT;E_O#\ZH_V3!_?D_,?X4?V
M3!_?D_,?X4>VQ?\`SZ7_`(%_P`Y8=_P+VY?[P_.C<O\`>'YU1_LF#^_)^8_P
MH_LF#^_)^8_PH]MB_P#GTO\`P+_@!RP[_@7MR_WA^=&Y?[P_.J/]DP?WY/S'
M^%']DP?WY/S'^%'ML7_SZ7_@7_`#EAW_``+VY?[P_.C<O]X?G5'^R8/[\GYC
M_"C^R8/[\GYC_"CVV+_Y]+_P+_@!RP[_`(%[<O\`>'YU0T[_`(^+O_?'\S2_
MV3!_?D_,?X58MK2.UW;"QW8SN-9\N(JUZ<YP24;];[JW8=XJ+2>Y/1117I&0
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
C`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110!_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g238691mmi002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g238691mmi002.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0`617AI9@``24DJ``@```````````#_
MVP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+#!D2$P\4'1H?'AT:'!P@)"XG("(L
M(QP<*#<I+#`Q-#0T'R<Y/3@R/"XS-#+_VP!#`0D)"0P+#!@-#1@R(1PA,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C+_P``1"`,^`I$#`2(``A$!`Q$!_\0`'P```04!`0$!`0$```````````$"
M`P0%!@<("0H+_\0`M1```@$#`P($`P4%!`0```%]`0(#``01!1(A,4$&$U%A
M!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*%A<8&1HE)B<H*2HT-38W.#DZ0T1%
M1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J#A(6&AXB)BI*3E)66EYB9
MFJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?H
MZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!`0$!`0````````$"`P0%!@<("0H+
M_\0`M1$``@$"!`0#!`<%!`0``0)W``$"`Q$$!2$Q!A)!40=A<1,B,H$(%$*1
MH;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U15
M5E=865IC9&5F9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::G
MJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W
M^/GZ_]H`#`,!``(1`Q$`/P#W[&!1144TRP1EW/`J)S4(N4G9($KZ(>6"@EB`
M!W-5GU"V0XWY^E9,]S)<-ESA>RCH*AKYS$9[+FM1CIW9U1PZ^T;/]J6_HWY4
M?VI;^C?E6-17+_;>)\ON+^KP-G^U+?T;\J/[4M_1ORK&HH_MO$^7W!]7@;/]
MJ6_HWY4?VI;^C?E6-11_;>)\ON#ZO`V?[4M_1ORH_M2W]&_*L:BC^V\3Y?<'
MU>!L_P!J6_HWY4?VI;^C?E6-11_;>)\ON#ZO`V?[4M_1ORH_M2W]&_*L:BC^
MV\3Y?<'U>!L_VI;^C?E1_:EOZ-^58U%']MXGR^X/J\#9_M2W]&_*C^U+?T;\
MJQJ*/[;Q/E]P?5X&S_:EOZ-^5']J6_HWY5C44?VWB?+[@^KP-G^U+?T;\J/[
M4M_1ORK&HH_MO$^7W!]7@;/]J6_HWY4?VI;^C?E6-11_;>)\ON#ZO`V?[4M_
M1ORH_M2W]&_*L:BC^V\3Y?<'U>!L_P!J6_HWY4?VI;^C?E6-11_;>)\ON#ZO
M`V?[4M_1ORH_M2W]&_*L:BC^V\3Y?<'U>!L_VI;^C?E1_:EOZ-^58U%']MXG
MR^X/J\#9_M2W]&_*C^U+?T;\JQJ*/[;Q/E]P?5X&S_:EOZ-^5']J6_HWY5C4
M4?VWB?+[@^KP-G^U+?T;\J/[4M_1ORK&HH_MO$^7W!]7@;/]J6_HWY4?VI;^
MC?E6-11_;>)\ON#ZO`V?[4M_1ORH_M2W]&_*L:BC^V\3Y?<'U>!L_P!J6_HW
MY4?VI;^C?E6-11_;>)\ON#ZO`V?[4M_1ORH_M2W]&_*L:BC^V\3Y?<'U>!L_
MVI;^C?E1_:EOZ-^58U%']MXGR^X/J\#9_M2W]&_*C^U+?T;\JQJ*/[;Q/E]P
M?5X&S_:EOZ-^5']J6_HWY5C44?VWB?+[@^KP-G^U+?T;\J/[4M_1ORK&HH_M
MO$^7W!]7@;/]J6_HWY4?VI;^C?E6-11_;>)\ON#ZO`V?[4M_1ORH_M2W]&_*
ML:BC^V\3Y?<'U>!L_P!J6_HWY4?VI;^C?E6-11_;>)\ON#ZO`V?[4M_1ORH_
MM2W]&_*L:BC^V\3Y?<'U>!L_VI;^C?E1_:EOZ-^58U%']MXGR^X/J\#9_M2W
M]&_*C^U+?T;\JQJ*/[;Q/E]P?5X&S_:EOZ-^5']J6_HWY5C44?VWB?+[@^KP
M-G^U+?T;\J/[4M_1ORK&HH_MO$^7W!]7@;/]J6_HWY4?VI;^C?E6-11_;>)\
MON#ZO`V?[4M_1ORH_M2W]&_*L:BC^V\3Y?<'U>!L_P!J6_HWY4?VI;^C?E6-
M11_;>)\ON#ZO`VEU.W/=A]14T=U#-PC@GTZ&N?HK2GGM9/WXIK[A/#QZ'3T5
MEV-^2PBE.<\*Q_K6I7T6%Q4,3#G@<LX.#LQ:***Z21#6-J<I:X$8/"C]36S6
M!>_\?DGUKQ\[J..'275F^'5Y%>BBBOD#M"BBB@`HHHH`****`"BLGQ'K?_"/
MZ-)J'V?S]C*OE[]F<G'7!KG$\=:U(BNG@V_96&0P9R"/7_5UV4<#7K0]I!:;
M;I?FS*5:$'RR>OS.YHK&;6;Q=6T^S&D3F&ZA$DMQSM@."=K?+C/'<CK6S7/4
MI2IVYNI:DGL%%%%9E!1110`4444`%%<9?^/_`"KZX@T[1KK4(K5BL\\>0J8Z
M]%/'7KCI71Z+K%KKNF1WUH6V/D%6ZJPZ@UU5<'6I052:LG_6O8RC5A)\L7J:
M%%%<;K'C;4=(N[I&\,W4EK`^W[47948>N=F/UJ</A:F(ERTU=^J7YM#G4C35
MY'945R&B^,=1U>]MHF\-74%K/_R]%F9`,9SG8`1^-=?2KX:I0ER5%9^J?Y7'
M"I&:O$****P+"BBJ5IJUE?7]W9VTPDFM,";:.%))&,^O!JE"4DVEHMQ-I:%V
MBBBIL,****`"BBF2RQP0O-*ZI'&I9V8X"@<DFFHMZ(D?1533M1MM5LEO+-R\
M#LP5B,9P2"?S%6Z<HN,G&2LT---7045A>*O$?_",Z;%=_9?M/F3"+9YFS&03
MG.#Z5/+J]VGB*UTU=+F>UFBWO>C.R,X8[3\N/X1W'WA6RPM5P51+1WZKIN0Z
MD4^7K_F:U%<U-XJGD\1RZ/INDO>/!@SR&=8P@..1D<XS21>*[B]\0W&F:;I+
M7,5K*([FX,ZQ^7S@D*1SC![\XJ_J->U[=+[K;S[7%[:'?R.FHHHKDL:A1110
M`4444`%%%%`!1110`445D^(]>A\.:2;Z:-I27$<<:G&YB"<9[#`-72ISJS4(
M*[9,I**N]C6HK/TB\OKZS,U_IWV"3=\L?G"7<N`0V1TZGCVK0I3@X2<7NO._
MXK0:=U=!1114C"BBB@`HHHH`****`"BBB@`HHK$_X2'_`(J_^P?LO_+#S?/\
MS]-N/ZUI3I3J7Y%>RN_1$RDHVN;=%%%9V*"BBBBP!1110`4444`%%%%`!111
M0`5OV<IFMD<_>Q@_6L"M?2?^/9_][^@KVLCJ.-=PZ-?D<^(7NW-&BC-%?7'&
M)7/WO_'Y)_O5T%<_>_\`'Y)_O5X6?_P(^OZ,Z,/\3(****^4.P****`"BBB@
M`HHHH`Y/XC_\B=<?]=(__0JS]-U'QV+:S1-%L3:[$`<N,[,#G_6=<>U=#XLT
M>XU[0);"U>))7=6!E)"\'/8&M2RA:VL+>!R"T<2H2.F0`*]6GBXT\)&%E)W>
MCOIHNS1S2I.55N[2LMCEM7O;J+XD:+:QW,R6\D+%X5D(1C\_4=#T'Y53T^34
M/%GB;5<ZK>65GITGEQ1VKA-QR1EN.?NYP1WK9U'0+J[\9Z9K,<D(M[6(HZLQ
MWDG=T&,?Q#O69%I=S9^*K^;PYJVEDW1W7=K.Q9HF!Y(53GJ3UQUQ753J4I4T
MH64U%:VT3OK?1ZM&<HRYM=K_`*?YE'1+S55N_%L%YJ$\\EK"_EL9#A2`V&49
MPO0'BKNCW]Y+\+;B\DNYWNA!.1,TA+@@M@[NO%4O!MG]HUSQ5!+,T\<C&)YP
M,;R2X)_G5JV\*>(;;0;G0EU"P%BROY<@1O,8GG:>R@GKU.,UOB'0]HX2:33B
M]K:6UMH1#GY4TF]U^)D:AJ^I1?"[1[U+^Z%T]VP>83-O89EX)SDC@?D*VM=N
M+SPGX:EOUU&[N;^\9(PT[[DB8@DE$Z+P#^E,O/!>HW'@33]#2:U%U;7!E=R[
M;""9.AVYS\X[>M=)X@T*+7]%?3Y7\MN&CD`SL8=#_,?0UC4Q.'4HK1QYFWIT
MNK?(J-.I9][*WK8\^D\41:1]CO-/\27NIS,X^V6UPK;"N,DIN`V\^A]/2O5@
M0P!!R#R*Y6'1?$UU/:1ZEJ\,5I:L"38ETDN`/[YX`_#U-=77'F-6C-P5.UU>
M[3OZ;)&N'C)7YMOZ\SE]?U6S\/6[66F643:G>Y\JW@C`+,>-[`?Y/YXM^$-$
MDT'P]%:3D&=F,LH!X#'M^``KF$\*>,8=8N=4@U+38[JX)W.<N0/[HW1G`Z#C
MTKH8[/Q6/#DL#ZG:'5S+E)PHV!..,;.O7M6U>,515.%1/F:N[N]_NV1,&W-R
ME%Z;'1USWCG_`)$O4O\`<7_T-:W;=95MHEG8-,$`D8="V.3^=9WB339M8\/W
M=A;M&LLR@*9"0HPP/.`?2O.PTHT\1&4GHFOS-ZB;@TNQD6\LD'PN66&1HY$T
MTLKH<%3MZ@CI5#PZUVGA=?$U_J5_<20V\K);&8B)@NX#</XB<$Y)[CT%;RZ+
M<CP3_8N^+[3]C,&[)V;MN,YQG'X4_1=$:S\*1:-?&.3]T\<OEDE2&)Z$@=C7
MH/$TE"5WJY?.W4Q5.3:\E^)YXGB3S]*DU*;Q3>PZUEFCM$1O(`!X4KMVG([Y
M[C/2NCU+Q#-?>&=(O#JL.F177_'RZ%O-;!VL(@%)ZYYXQQ4L'AKQ+8:<=&L=
M6M8M.W$I<;7%Q&I.<#''7W[FK.M^%KVYGTJ\TV]4WFG`*#>EG$G3ECR<]?\`
MZU=E2M@Y5(V:M=M/316T6W?U,HPJI/T_KJ8N@:I=)XU&E0W^J3Z?/"Q']H9\
MP':3E21G&1_/ZTSP1I?_`!5NNG[=>_Z'<E<>=Q/\SC,G'S'C/U)K8MO#6MCQ
MA::]>W=G*1&5FCC#*$RI&$X.1SG)(J?3O#VJ:3XIOKZUFLVL+^7S)UDW>:O+
M'"XXZMWI5<31Y91A))N*^;3UZ;V"%.5XN2V;^ZQSGAZ/5=<T+5I9=>U&+[-(
MYB\N8YW!<_,QYV].`1WI;636=3\#S:Y/KE['/;!C"D+!%8*?X\#+$\UT?AGP
MU>:+I&I6ES+`TET[,AC8D`%<<Y`ING^&+VT\"7&AR2VYNI%D`=6.SYCQSC/Z
M4JF,H\[LU;F5M%M;7H"IRLKWV?W]##U7Q;>C0=`1KLVC7Z[KJ[5<LB@@$@`=
M3R>*71O$<5MXJL["PUJZU33[L%7^U[B\3]L,R@XZ<5JOX-N6T/2$CNHH=5TS
MF.506C;G.#P#CIV]:OZ;I>NR:P-1UG48P(TV1VED[B$_[3`]3R?TI3KX-4I*
M*773NVW9[/IYC4*O,F_+_@]3!TE=2UKQ3XAL7UB^@M(IN!#)\R_,P`4G.T>N
M!S@>E5=/NKW4?#?BK3+S4+F7^S@_ES;\.P`?Y6/<'9R/0FNGT'0+K2]?UJ_G
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M(0A.V3DCIG@?D*AUOPOXH\0Z9#!?7VFB2%P52(.%?C&YF(SGV``Y-:USX>NY
M_'&GZVLD`MK:W,3H6.\G#C@8QCYAWKN>)I>R49R3:4]N[M;H8>SES-I-*Z_X
M)S.AZ%YOC?6+;^U=43[-L/FI<8>7IPYQ\PH\&Z>(O$_B"4WU]BPN#D";_7X:
M09DX^8\9[<DUU6E:%=6/BK5M4EDA,%X%$:J3N&,=>,?K4?A_P[<Z7K&NW=T\
M#PZA,7C5"20NYSAL@=F'3-14Q\7":ONHKYZ7*5!J2=NK_6QQ</B9-3@N[_4/
M$MYI]\&/V6UMP_E*`.-P"D-D\5;U?Q1J-WX&TK4H9Y(;S[7Y<IA8KO*ANH'8
M\'%;4/AG7](@N=.T74;1-/N'+!IP_G09X.PC@G'<_I4VN^$[W4-`T_3X+WSI
MK:<2R3W<C$OP<\X)ZGIZ5J\1@N>+5M]/)6[67XDJG5L[[V_'[RKXBN+SP?X=
MDGBU&\N[Z\E6,R7,F]8C@DE%Z*.O'T]*PSXG@TB[L;C3_$MYJ8>0+>P72L5V
M]V3<HV]^![5WOB708O$6D-92/Y;A@\4F,[6'].2*S8=(\37=[:-JFK016MJV
M2MB75KC_`'SQZ#@<<GZUCA\3AG2O4MS:WV5]-.C_``9<Z=3GTVTM^IF3R:C>
M_$F\TR+5+JVM3;*66-\[1A2=H.0I)[X[GUI_AW4+W3_%NL:+<7UQ>VUM"9HW
MN&W.,;>,_P#`OT[5K0:!=1>.KG7&DA^RRVXB5`QWYPO48QCY3WIECX<NK?QO
MJ6LRO`UI=0>4J`DOGY.HQC'RGO4O$4'%P=K<BZ=5;KW&H33NN[^XQ=$AU?Q=
MIMSJ[ZU>6<WFLMK#;R;8DP!C<,?,,T[Q+KNL:)I6E6%Y>10WERY6YO(`6"HI
M`W`8'.#DX'8XJW;>&M?T2.YLM$O[,6$[EE-RK>9!D8^7'!/U]*GO?!\USI5@
M@U2:35+&3SH[N<E\MD$@Y)..!CZ5?ML/[52E).%]%;5*VE].C)Y9\K23YNIA
M:9XDALO$]A9Z?KMWJEA=GRY5O`Q:-SP"&8`]<<?6JFHZU<+K.H0ZWJ>L:;,L
MC?9/LQVPA1G;N`Y8=.1UKL;#2]?FUB._UG4HECA4JEI8LZQN?[SYZ_3Z54N-
M"\16\EU%97UE?V5PQ81ZKOD,61C`/.1R>M7'$855>E[+6_6_I;83IU.7YFMX
M7O)[[0+>:XO+:\EY4S6Y.&],@@$''48KF/BI:YTBUN_/GXG6+R=_[LY5SNV_
MWN,9]":Z3PMX>7PWI)LQ/YTCR&21\8!)`'`^@%5_&F@77B/1X;.SDA21+A92
M9F(&`K#L#SR*X:%:E2S#GA+W;[[:&LX2E1Y6M;&5K-Q?Z2VD>'=.U"Y,M[(2
M]Y<OYDBKD<`X]S^5,U)]0\&ZCILJ:K>7]C=2^5/'>2>8P/'*G''?\O>MSQ%X
M;.LBSN+:Y^S7]D^^&7&1VX(_`51_X1S5]8U.SNO$-U9F&S;?';V8;:[<<L6^
MG^<UT4\10<4Y-6L[JVK;O:VA+A.[MY6\C,']HZM\0=6TK^U;ZVLDC60B"4@K
M@+@*3D+DMDXZXKO((A!;QPAW<(H7=(Q9C@=23U/O6!IV@75IXSU/69)(3;W4
M01%5CO!&WJ,8_A/>NCKAQU:,W",'HDMN]M?F:T8-7;WNSRO4=:N%UG4(=;U/
M6--F61OLGV8[80HSMW`<L.G(ZUK:CXIO]/\``-O=I>VUU>S2>0+F#)`X)R00
M,-@=".M:%QH7B*WDNHK*^LK^RN&+"/5=\ABR,8!YR.3UJ*+P!`OA)]&DNBTS
M3?:!.%X5\8''ICBO4E7P34'.UDUHNUM>FASJ%5<UO,YX^)X-(N[&XT_Q+>:F
M'D"WL%TK%=O=DW*-O?@>U;UW>7NO^.+C08K^YL;.T@\QVMFV22'Y?XNWWA^5
M78=(\37=[:-JFK016MJV2MB75KC_`'SQZ#@<<GZT[4O#E^GB$Z[HEQ;Q7;Q^
M7-%<J3'(..<KR.@_(5$\1AG/2W-9V>ZO?2^G8:A4MY76GE]Y'OUCPMI.JW%[
M>)?VL*[K1I&)EST`<XY&2._K69;V&LWGA@^(#X@OEOVA:X2)'`@`&2%V8QTK
M:L_#M]<0Z@==U%[EKY#&8(780P@_W`>_3G';W-9R>&_$T&DMH<.IV)TUE,?G
MO&_GJAS\H'3VZU%.K25_>CS75W;1JVJ6G<J49=G:W?J96L^)]0O?!^BZE;S/
M;W3W6R01L55RN>N.H.`<5;UT:GX;UC2+J/6KRZ-W.(IXIV!C/*YVJ``O?W]Z
MOZMX,>30]*TS3)(E2RG$K-.Q!;KD\`\DFKOBG0+K6YM+>VDA06EP)9/,8C(X
MZ8!YXJHXG#)QC&RBW*]UT>Q+IU+-O?3_`()EZE=7VN>.GT"'4+BQM+6$2RM;
M-L=R0IX;_@0_6JNGVUQ:?%3R;BZ>Y*VAV2R`;RN.-V,`D<C-;.K>';\^(4UW
M1+FWBO-GERQW(/ER#W(Y]/R%067A?5%\6-K.H7EO,);=HY!%N4J2,84$'@#'
M).:<,115-J,DER6M;6_7IU!PG?5/?\#G=2U2>9=3N)/$%])?PEC#!I3.;>)1
MR-YV@'OD^@/TI^K>(=5D\`:+J*W4J7;W15WB8KY@7>`#CKG`R*TK/P=KMCIE
M[HL&H6*Z;<%CYIC8S<@#&.@SCKS22^"]4E\(Z=I'G68GM+HREM[;2I+'CY<Y
M^;TK?VV#7+JG9K[K>BZD<E2[T>J_&X_Q'I&IZ/H#ZE:ZUJ<]W#(LTWF7#;"O
M\0"C`"Y.<>@I?$.M3ZO+H&G:5=2P/J!6>1X9"C+'CU'/][_OFNTNH8;BTFAN
M`##(A60'IM(P:\Y^&VF&34KW4&D,T-H#:VSGH0222/3C'_?5<N'JPJ495JF\
M-M-[JR7R-)Q<9J$=G^AZ4!M4`9X&.3FEHHKP3M"BBB@`HHHH`****`"M?2?^
M/=O]X_R%9%;&D_\`'NW^^?Y"O7R3_>EZ,PK_``&A1117V)Q"5S][_P`?DG^]
M705S][_Q^2?[U>%G_P#`CZ_HSHP_Q,@HHHKY0[`HHHH`****`"BBB@`HHHH`
M*Q=1\):%JMR;B\T]'F/WG5F0M]=I&?QK:HK2%2=-\T)-/R=B91C)6DKE33M,
MLM)MA;V%M'!%U(0=3C&2>I/N:MT45,I2F^:3NQI)*R"BBBI&%%%%`!1110`4
M451U;5[+1+(W=_-Y<0(4<9+$]@.YJH0E.2C%7;$VDKLO45A:;XKL=1OELG@O
M+*Z==T<5Y#Y9D'JO)!_^M3)_&.GP:G=Z=Y%Y)=VV!Y44.]I21GY`#D_C@5O]
M3K\SCRNZ5_EW(]K"U[G045CZ+XET_7(KAK<RPO;G$T5PNQX^O7G'8]ZQ[_QG
MIE]IFI1017K0"&2,7GD'R2Q7`&[MG/<"JA@:TIN'*[JU_*XG6@E>YV%%>?\`
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M?:N:=&I3ERR5F7&2DKH6BN"T.1]5T7Q-KTP.^[66.+/\,:(<`?G^E1>&O#EG
MXD\!V-O>23HD4\CJ86`.<D<Y!KOE@(P3<YV2:3TOJU=]>ABJS=N5;IL]"HKR
M72/!>FW_`(IU;2Y9[I8+/'ELCJ&/U^7'Z5OZS\/=)739KH7%[OM;4A!O3!V*
M2,_+6E3`8>%14W5=W;IWVZDQK5)1<E'\?^`=W17F/@KP7IVIZ5::O--=+<+,
M6"HZA,JW'!7/;UKTR6011/(V2$4L<>U<F+PU.C5=.$N9K1Z6U^\UI5)3CS-6
M'45RD?Q`TN:R^U06>I3(N3+Y=ON\D>KD'`''K6R-?TPZ+_:_VM!8[<^8<_3&
M.N<\8J)X.O"W-%K6WS[#C5A+9FE17,P>.-+EFB6:"^M(9SB&YN8-D4GIALU9
MU7Q9IVCZO#IMVMQYLT7FJZ)N7^(`<'.25P`!W%-X.NGR\KOO]VXO;0M>YNT5
MAZ5XJL=4OVL##=V=X!N$%Y%Y;L/4#)J?3=?M=4U/4+"".99;%]DI=0%)R1Q@
MGT[XJ)X6M&]XM65WZ/J4JD7:SW-6BN4OO$-IK6A>);:VCG1[&WDCE,B@`G#C
MC!/]T]<5#X3U2TT?X=6-Y>R^7"OF#.,DDRM@`5N\#-4N=K6Z5K=U=$>VBY6Z
M6O<[&BN=LO&5A=ZC#8S6E_8SSC,(O(-@D^G)K&A\77LGCVXL7M+YK.-/+2".
M#YU8E/WC\_=ZX/H1QS1#+Z\G).-K*^O;R!UX*VN[L=W17+Z'_98\6Z[]E^V?
M;,K]H\W;Y?MLQS^=.F\<Z6DLH@M[Z[@A.)KJWM]T4?KELU,L%5<^6";T3VMN
MAJK&UV['345C7OBC3;+04UD,]Q9N0%,(!)R<="1CWJG+XYTJ&>%98KQ+:8[4
MO&@(A)]F/7Z@$5,<'7DKJ+ZKYK=>HW5@MV=+17'^*YSHGB#1M;0@([FTN>VY
M&Y'Y<G\*["HJT'"$:B=U)?BG9H<9W;CV"BBBL"PHHHH`****`"BBB@84444"
M*6IZ39:S:?9;^#SH=P?;N*\COD$'O4MC86NFVB6MG`L,"=$7_/)JQ15^TGR\
MEWR]NGW$\JO>VH4445!04444`%%%%`!1110`5L:3_P`>[?[Y_D*QZV-)_P"/
M=O\`?/\`(5Z^2?[TO1F%?X#0HHHK[$XA*Y^]_P"/R3_>KH*Y^]_X_)/]ZO"S
M[^!'U_1G1A_B9!1117RAV!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!7"?$F&X\O2+M)&BMX+@^;($W^63MVL1WQ@_GCO7=TUT61"CJ&4
M\$,,@UTX2O\`5ZT:EKV_56,ZD.>#B>;M&VI>*]'C?Q,VJW$+^<C6ME&$C4$$
MAV5QC./0_KSI:"@/Q.U]R.5B4#\=G^%=?::=96`86=G;VX;[WDQ*F?K@4Z.R
MM8KF2YCMH4N)>))5C`9_J>IKNJ9DI*44M+673K?H81H--._6_7M;J>?V5O-=
M:YXWM[<$S21,J`=R=W%+HFMZ5;_#>:QGFB6[6*:)K9CB1W8MC"]3G(^GX5W\
M5E:P3RSPVT,<TO,DB1@,_P!2.33/[,L#<O<_8;;[0X(:7REW,#ZG&33>94Y*
MTXNVCT?5*WW,?L)+5/O^+N>37W_))M-_["!_E)6_XRUC3=4\*6=E8RI/=RR1
MB.W3ET(&""O53VK5\;>'9[_PW;V&BV,0\NZ$GE1;(U`VN"><#J1720Z=9QS+
M=?8X%N]H5IA&N_I_>ZUU5,?2Y8U;7:;:5UI>UKF4:,[N/2R1Q-__`,2;Q_I-
M]JG%JUH(5G;[J2!2#SVY/_CU/O;B#6_B/I+Z2Z3BTC+7%Q$0RA>>-PZ]<?\`
M`J[J>WANHFBN(8Y8VZI(H8'\#3+6RM;*/R[2VAMTZ[8HP@_(5QK,8Z2<?>2:
MWTL^MC;V#O:^E[GGWA__`%OCW_>D_P#:U6-#4#X179_O07!/YM_A7;QZ=90F
MX,=G;H;C_7[8E'F]?O<<]3U]32I86<5H;..T@2U((,*Q@(0>HV].:=3,HR;M
M'JG]RL)4&NO1_BSS.[5F^#5B>NV<D_3S7%;'BJ;1M1TS2));N>,*^V&_M-KI
M`^%R'.01V/'/RUVBV-FEG]C2T@6UP1Y`C`3!Y(V]*2/3[*&T:TBL[=+9LYA6
M)0ASU^7&*K^TH<W-9IIMJSZ/_(/J[M:_1+[CSS2;F[M?&>G6IU&QUT.A7[2J
M*\L*@'^/DCKZGJ?6O0M21Y=+O(X\[V@=5QZE32VFG6-AN^QV=O;[NODQ*F?R
M%6:Y<5BXUJD9J-K+RUU[(TITG"+3>YPGA-E;X870!Y6*X!^N"?ZBM#X=?\B;
M;?\`723_`-"-3^'M%GTBZU>QD@5M+GE\Z`D@@AAAD*^V`.E;]M:V]G"(;6"*
M"(<A(D"J/P%;8S%0DIPCKS-._P`MO4BE3:LWT5CC?#7_`"4+Q)_P'^==3K?_
M`"`=1_Z]9?\`T$U/%96L-Q+<16T,<\O^LD2,!G^IZFI71)8VCD571@596&00
M>H(KFK8E5*T:B6R2^Y)&D*?+%Q]?Q.6^'7_(FVW_`%TD_P#0C727G_'C<?\`
M7-OY4ZVM;>SA$-K!%!$.0D2!5'X"BY1I+69%&69&`'OBHJU55Q#J+1-W_$<8
M\L%'LCSSP)KFDZ=X3NHKVXB@D61W*R$`R@@?='\73&!6$-,U#_A6*S>7(81?
MFX*<_P"KV;=WTS_C7<^$/#AM/#B6>M:=`TR3M(J2JDFW.,$=175A5"[0`%QC
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M^'Y5GT[QW,F=LD;,,C!P?-/2D.H/8?#/0]D%N_FW$B^=/")5A^=_F`((S_\`
M7KTI=-L4^T;+*W7[3GS\1*/-SG[W'S=3U]32C3[);+[&MG;BUP1Y`C&SDY/R
MXQUK6>:4Y2NXZ73M?LK?\$A8>25K]&OO=SS*_EA/C7P_MUQ]5<3)OERNQ26&
M`H7@?KVK9@GAL?BYJ4EU-'"DUJJQF1@H8XC``SU/!_*NP&D:8(XHQIUH(X6W
MQKY"X1O4#'!J2XTZRNYHYKFSMYI8_N/)$K%?H2.*4\SA+3E=K-=.KO?0:P\E
MK?K?\#B-.@FN?$WC."W;;/)"4C.<88@@?K1X.UW2-,\'R6M_/%!<6[2":"7Y
M78Y/`4\DXX_"NYBL[6"XEN(K:&.:7_62(@#/]3U-1SZ7I]S<+<3V%K+.N-LD
MD*LPQTP2,UE+,*<XN,HNVFSUNE^3*5%IW3UU_%GE8M+FU^$\K7`95GO%DB5O
M[G`S]"03^O>M_P"(B"/P/IB*``L\0&/3RWKNKFTMKR'R;JWBGBR#LE0,OY&F
MW-C9WD"P75I!/$I!6.6,,H(&`0#[&K_M52G&;CLV_O)^KV32?1(XSXE*9?#&
MG1*-TCW2!1W/R,/ZBNY0%44$Y(&":Y[6-(N=6\2:3NBVZ;99G=MPP\F1M7&<
M\8STQUKHZY<55C*A3@GJKM_-[&L(OGD_0****X#8****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`*V-)_P"/=O\`?/\`(5CUL:3_`,>[?[Q_
MD*]?)/\`>EZ,PK_`:%%%%?8G$)7/7AS>2?[U=#69'$DNHSAT#`<\UY&:T'7C
M"G%VN_T-:,N5MF7170?8[?\`YXI^5'V.W_YXI^5>9_8-7^=?B;?6(]CGZ*Z#
M[';_`//%/RH^QV__`#Q3\J/[!J_SK\0^L1['/T5T'V.W_P">*?E1]CM_^>*?
ME1_8-7^=?B'UB/8Y^BN@^QV__/%/RH^QV_\`SQ3\J/[!J_SK\0^L1['/T5T'
MV.W_`.>*?E1]CM_^>*?E1_8-7^=?B'UB/8Y^BN@^QV__`#Q3\J/L=O\`\\4_
M*C^P:O\`.OQ#ZQ'L<_170?8[?_GBGY4?8[?_`)XI^5']@U?YU^(?6(]CGZ*Z
M#[';_P#/%/RH^QV__/%/RH_L&K_.OQ#ZQ'L<_170?8[?_GBGY4?8[?\`YXI^
M5']@U?YU^(?6(]CGZ*Z#[';_`//%/RH^QV__`#Q3\J/[!J_SK\0^L1['/T5T
M'V.W_P">*?E1]CM_^>*?E1_8-7^=?B'UB/8Y^BN@^QV__/%/RH^QV_\`SQ3\
MJ/[!J_SK\0^L1['/T5T'V.W_`.>*?E1]CM_^>*?E1_8-7^=?B'UB/8Y^BN@^
MQV__`#Q3\J/L=O\`\\4_*C^P:O\`.OQ#ZQ'L<_170?8[?_GBGY4?8[?_`)XI
M^5']@5?YU^(?6(]CGZ*Z#[';_P#/%/RH^QV__/%/RH_L&K_.OQ#ZQ'L<_170
M?8[?_GBGY4?8[?\`YXI^5']@U?YU^(?6(]CGZ*Z#[';_`//%/RH^QV__`#Q3
M\J/[!J_SK\0^L1['/T5T'V.W_P">*?E1]CM_^>*?E1_8-7^=?B'UB/8Y^BN@
M^QV__/%/RH^QV_\`SQ3\J/[!J_SK\0^L1['/T5T'V.W_`.>*?E1]CM_^>*?E
M1_8-7^=?B'UB/8Y^BN@^QV__`#Q3\J/L=O\`\\4_*C^P:O\`.OQ#ZQ'L<_17
M0?8[?_GBGY4?8[?_`)XI^5']@5?YU^(?6(]CGZ*Z#[';_P#/%/RH^QV__/%/
MRH_L&K_.OQ#ZQ'L<_170?8[?_GBGY4?8[?\`YXI^5']@5?YU^(?6(]CGZ*Z#
M[';_`//%/RH^QV__`#Q3\J/[!J_SK\0^L1['/T5T'V.W_P">*?E1]CM_^>*?
ME1_8-7^=?B'UB/8Y^BN@^QV__/%/RH^QV_\`SQ3\J/[!J_SK\0^L1['/T5T'
MV.W_`.>*?E1]CM_^>*?E1_8-7^=?B'UB/8Y^BN@^QV__`#Q3\J/L=O\`\\4_
M*C^P:O\`.OQ#ZQ'L<_170?8[?_GBGY4?8[?_`)XI^5']@U?YU^(?6(]CGZ*Z
M#[';_P#/%/RH^QV__/%/RH_L&K_.OQ#ZQ'L<_170?8[?_GBGY4?8[?\`YXI^
M5']@U?YU^(?6(]CGZ*Z#[';_`//%/RH^QV__`#Q3\J/[!J_SK\0^L1['/T5T
M'V.W_P">*?E1]CM_^>*?E1_8-7^=?B'UB/8Y^BN@^QV__/%/RH^QV_\`SQ3\
MJ/[!J_SK\0^L1['/T5T'V.W_`.>*?E1]CM_^>*?E1_8-7^=?B'UB/8Y^BN@^
MQV__`#Q3\J/L=O\`\\4_*C^P:O\`.OQ#ZQ'L<_170?8[?_GBGY4?8[?_`)XI
M^5']@U?YU^(?6(]CGZV-)_X]G_WS_(4ZYM84MY&6-00I.<4[3O\`CR3\?YFN
MC`8">%Q:4G?W6_Q2(J5%.&A<HHHKZ(YA*S[;_D*7'T_PK0K/MO\`D*7'T_PK
MAQ?\2EZ_HS2&S]#1HHHKN("BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`KWG_'I+_NFH]._X
M\8_Q_F:DO/\`CTE_W33-._X\8_Q_F:X7_OJ_PO\`-%_8^9;HHHKM($K/MO\`
MD*7'T_PK0K/MO^0I<?3_``KBQ?\`$I?XOT9<-GZ&C1117<0%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110!7O/^/27_=-,T[_`(\8_P`?YFGWG_'I+_NFF:=_QXQ_C_,UPO\`
MWU?X7^:+^Q\RW1117:0)6?;?\A2X^G^%:%9]M_R%+CZ?X5Q8O^)2_P`7Z,N&
MS]#1HHHKN(,CQ#KMIX:T:;4KT2M'&558X4WR2.QPJ*.Y)(`JAI_C;2-0\,7N
MNXN;>WL/,%Y#<0E)H&099&3^]@CCWIWC/0KOQ%X?:TL)H8+V&>*ZMFF4F,R1
MN'4-CG!Q@D=,]ZX&ZT^?37.D:]>P.]Y=/XB\0/;J?(B@C"[8E!Y*LZ*.>2%:
M@#U?3[PW^GV]YY$T`GC6013`!TR,X8`D`_B:MUS7ACQEI_BH7*VEK?6D]L$9
MX+Z`PR;'SL<#G*L`<&N*UV+5=;^-3>'X?$&JZ;I[Z,)I5LIRAR).JYR%8G'S
M8SC([T`>M45XAXN\1:A=>-KSPTLOC$V.CVT*[O#D>Z>65D#;Y7SG;@@8[D$T
M^]U_QW>?#"&7[#KD-U#J)M[Z1+4P7LEH!D2(N.&((!8`X()Z9-`'ME%>/>!/
M%UC%;:[);^)=:U$6-G)<G2M;AW7D+1YW'S`?G!Z;>V1TJ3POHGBKQ)H&E^+(
MO&>H0ZG>2>=+;.0UD(MQ^18<=<`#.?7ZT`>NT5P&CZA>R?&;Q'8/>7#V<-A;
MO';M(QC1B!DJN<`FN!C\=:WI?@;7KB.]OKB[N?%,FG6\I)GD@C*AL1JQZX!"
MKTR:`/?:S]8U:TT+2+G5+^0QVMM&9)&"DD#V`ZFO+?`VKZW9^,+?3H[3QM-H
MMU#(9YO$=J2T,RKE2LG92%Q@]R/6LCQE\0]$^)'@36[?2SK5G)IL*W;J^R-)
MAO";'VLVY?FSCCD`YXH`];\,>)8_%&F'4(M+U*PBW[434+?RFD&T,'4`G*G/
M!]C6]7ADVG:I:>(_`GARS\4:]%;:E9SO/(;PM)@Q9('&/E`(4D';P1TJUXRU
MK4-/\1Z9X,AN?%D]C;::+B>XT;$NH7#;MH+/V48Y(ZDXH`]IHKP]_&_BO2?A
MMJKW,&K17B7Z6FG76I6)2X:&3HQ7[KN`&&0<9(S5KP7J_B"U\9V-E%:^-[C1
M[M7%W+XBM#^XD"Y5D<9PI(QM)`&>]`'IGB3Q-IGA331?ZG(ZQM((HTC0O)+(
M>BJHZDX/Y51\->-].\2WL]C':ZCI^H6Z"26RU&V,$H0G`;'((^A[BM+7/['A
ML?[1UN&U:VL3]I66YC5Q"R]'7(X;T(YKS3PCJ4FO^+=;^)NHPM8Z';6+6MGO
M7#21*=S.?7H?SQVH`[W6/&6EZ+XETG0+GSGO]38K"D2@A`/XGR1@'D#&>AJ6
M+Q793>-9_"RPW/V^&R%ZSE5\HIN"X!SG=EAVQ[UX>-6TR_\`&/A;Q=?ZS8?;
M[_4WEGC^V(186JKB*-QGY.,DYQR3WKK;_3)M=^/=_:6^JWFGI)H"E[BQ=5E9
M/,3A6(.WD@Y'/%`'L5%>>?";5M2O])UK3]3O9;V72M4FLH[B8YD>-<8W'N>O
M-9>L1ZKK?QIN-`A\0ZGIVGG1!-(EG/M.?,`RF<A6Y'S`9P#0!ZO17AEUXXU[
MPIX9\:Z4VH2W][H=S!!9W\X#2>7-G!<_Q,H!Y/4FK7A#5_$5MXSTVV@M_&\^
MEW8D6_?Q#9X6)]N5>-@#L7((VDX&>_8`]IK+T75_[9L6NO[.O[#$K1^5?0^5
M(=IQNQD_*>QKS7X8VNJZ_?:IJVH>)-8>/3M:N88+3[2?*<;5R'!R6497"Y`7
M!]:P[#Q=KX\"Z190ZI<C4-8\0OI_VZ5S*\$9D`^7=GU`'H,XH`]ZJI?WD>GZ
M;<WLJLT=M$\SA1DD*"3CWXKSBU?5?`OQ$T303KFHZSI>MQRY&IS>;-!+&N=R
MO@?*>!M^IK#L%UWQAX2\2^+W\1ZA;L!=Q6NG(P%J(44_+(A'WB,C=P1^E`'K
M/A_6[;Q)H5IK%G'*EO=Q^9&LP`<#..0"1V]:U:^?I+O7K7X?>"/L_P#;R>'F
MM'^WR:$0+E7S\G..!^0.3D]*]$^%VN6NLZ%<"T\276MQP2@*;V#9<VZD<)(V
M?WAZ_..O/I0!V-_>?8=/N;LPR3+!$TIBB`+N%!.%R0,G'&2*YN7XB:+'\/E\
M:%;DZ:P!$:HOFY+[-N-V,AL]^U=:Z+(C(X#*P((/<5\X:,R7J:3\-)"I^S^)
MY_.B89WVL/SD,#V8EO\`OGVH`]BN_B'H]EX!A\8O'=/ITJH5C15,N6;;C&[;
MD'.>>QKK(W\R)'VLNY0=K=1[&OG13Y<&F_#X\?8?%<K>5OY:TC'F9/U#DCW`
MI+;QEXIUNP?Q'81^-9-7>5C;P6=EYNE>6'_U9`Y;C(+=<T`?2%87B?Q/9^$]
M)74;Z*XDA:=(`L"J6W.<`\D#'XUYCXO\4ZGJGC%=&*>+(+"WT^*XDA\.0?Z3
MYT@!_>,>54`XQZYS6=XDUK7-0^#TLGB"RU*&XM-9B2)KVU,,UQ"&#(Q7`&[!
M(..,CK0![Y17EG@#5]5\6:GXBUZYN;NWO;9S;6NARR.D=L-F5:1.`68YY(['
MVQQF@^)KZPUNQ_X2GQ-XIT777GVSQZE!YNGSKN`VH@V[,C;\PX&<YYH`^AJY
MR'QCI=SXWG\)P-+)J$%M]IE=0IC09`V$YSN^8'&.AZUMW<#7-E/`DK1-+&R"
M1>J$C&1]*\B\+>&K'PI\=#IMB974:`9)9IGW232-,-SL?4T`>RU7N[N"QM)K
MNZF2&WA0R22.<*B@9))]*XNZ^,/@2RNYK6YUW9/!(T<B&SG.UE.",A,=12W$
M?AKXLZ-#-:ZE/=:3:79,T4:O$L\BJ"$<,`2HW*>GIS0!K:)XTTC7/";^)HWE
MM],C\PL]RH4JJ$@G`)XXX[UF:+\3M%UO4[2R%EJUDMZ2+&XOK0Q0W>`3F-\G
M/`SSCJ._%8_P5M;>]^$%I;7<$5Q;R2SK)%,@=&'F'@@\$5EW%^OQ%^(>CZ5H
M-NJ>'?#%TMQ/>(NU'EC^[''QC;QCCJ,D<`$@'LE%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`%>\_X])?]TTS3O^/&/\?YFGWG_'I+_NFF:=_QXQ_C_,UPO_?5_A?YHO['
MS+=%%%=I`E9]M_R%+CZ?X5H5GVW_`"%+CZ?X5Q8O^)2_Q?HRX;/T-&BBBNX@
M*XM_!MQJ-CXI75+B,7FN!X%DARP@@"E8E&0,XR6/NQ^M=I10!Q?@[PUK6F:E
M?:KK]W8RWUQ##:HMB'$:Q1;L$[N=QW<]AVJX/"./B,WB[[=UT[[#]E\K_;W;
MM^[\,8_&NHHH`XGQ!X'N[[Q#_P`)!X>U^;0M4EA%O<R);).D\8Z91B!N'&&]
M!4\_@V[/ARVTZU\4ZU!?V\AF34'G,CNYSQ(I.UT_V.G%=?10!Q.A>`Y;'6[G
M7->UF37-6GM?L?G-;);HL.<E0B<9/J363#\*;RWCBTN'QAJ47AN"?SHM.CB5
M9$.<[1.#NV\GC%>F44`<+J_@&[N?&!\1Z1XEN](N)[<6UXD<"2^<@QC!?A6X
MZX/MCG-+3?A+8VGA#4_#UUJ5Q<1W=^;^&Y5=DMN^%"D,2<L-OWN,Y/`KT>B@
M#D?#GA76=-U(W^M^+;[69EC\J.+RQ;0*OJ8U)#MU^8^M:/B[0/\`A*O"NH:)
M]I^S?:T">=Y>_9A@<[<C/3UK=HH`XZ7P1YGBKPSK8U``Z':R6_D^1_K]T93.
M[=\N,YQ@TOB;P5-K&KVFN:3K$VC:W;1-"MU'`DRO&3G:Z-]X#G'/&>]=A10!
MQ;^`8K_P==:!K6L:CJDMU)YTM[+(=Z2@@@Q+R(U!'"CCJ*DT#PIK6G:HE[K7
MC#4-7,49C@A\L6\(4]W1#^\8?WF]:["B@#C?B'X*G\>:'#I4>KMIT*SB:4B#
MS?,P"`I&Y>`3GOR!Z5'X=\'ZYI@^QZUXF@UG1A;&W&FG2(8(P.`/NDY``(VX
MQS7;44`<'K/PL\.ZCJ^CW=MINEV4-C.TL]O%I\>VZ4@#:V,#`Z\@UIVWA`6W
MQ$N/%BWHQ+IPL!:"+`4!U;=NS_LXQCOUKJ:*`.7\(^$O^$5?6V^W?:O[3U&2
M^_U6SRM_\/WCG'KQ]*X?5],N]3^/-S%I^K3:9>QZ`)(;J*-9-K>:!AD;AEP3
MP?;D8KV"B@#@K3X7Z</"NK:/J=Y-J%SJ\GG7U^RA9'EZJRCD*%/('/4U:T'P
MAK&G:I#=ZQXPU+54MD,=M;!!;Q`'C,@0_O6`[M]<5V=%`'+^"_"1\(6>I6WV
MW[7]NU"6^W>5Y>S>%&W&XYQMZ\=>E8EM\*[1/"*:'<ZE,\L.H-?VU[`@BD@D
M+9&`2PXZ>_M7H=%`'$Z!X%N;/Q`NO>(M>FU[588S#:2O;)!';H>NU%)&XY(+
M>AQ6;-\+YEDU>TL/$]Y9:'JADDGTU8$<>:XY(D/S!#QE1C/3->D44`>?Q^`-
M3L-!TBRT?Q?>Z=>:;`;?SHX0\$P)SEX&8KNY.#G//?BF#P+=:-X9\120:U?S
M^(-64//J,,020R*,*$1"-HY/?C)YQ7H=%`%'28;BVT>R@NW,EU';QI,[-N+.
M%`8D]^<\URFF?#J'3_B=J'C3[>9#=Q%$M/)QY3$("V_=S]UN-H^][<]S10!P
M<?PVM$^*,OC;[6&=XBOV0P\"0H$+A]W]W/&._6JEO\,KZPF>RTOQCJ6G>'I)
MS,VG6T2I(I+%BL<XPR+G'`'3/KFO1Z*`.+U_P-<W^NQ:]H6O3Z)JRV_V:2<0
M+<)-%G(#(YY(]<U#J?P]DU3P?%H4WB"^GE6[2[DO;W,[LRMG:!N`5>P`X'O7
M=44`<K)X/5?&MQXAMK^2V6]M#:7UM&A'GX^Y('!!1U'&>>!QBL"X^&.IZG&F
MF:UXTU#4M`CD6064]M'YKE2"`\_WF'7L.OM7I-%`"````=!7,#PCCXC-XN^W
M==.^P_9?*_V]V[?N_#&/QKJ**`"FL-RE?48IU%`'"Z1X`N-&^&4_A"VUIEEE
M65!?"WP5#L2<)O\`0D?>]ZR_"GPX\2^$4M+.R\;J-,BG$LMH-&B!F&[+*9"Q
M;D<9R2.W2O3J*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@"O>?\>DO^Z:9IW_'C'^/\
MS3[S_CTE_P!TTS3O^/&/\?YFN%_[ZO\`"_S1?V/F6Z***[2!*S[;_D*7'T_P
MK0K/MO\`D*7'T_PKBQ?\2E_B_1EPV?H:-%%%=Q`4444`%%%%`!1110`4444`
M%%%%`!1110`444A(`))P!WH`YD>*Y+B]OK:P\.ZO?)97!MI)X6ME0R!02%\R
M92<;ASCKGTK?MY9)K>*62WE@9U#&*0J60G^$[21D>Q(]ZX/P7;^([CP\-1L=
M5TR&#4KF>^1+C3))7`DE9AEUG4'C&.!Q@5E^*[NWN=&\0ZY<V5I,;5VM+2:]
ME_>1W$>4Q!'L_=$OA@V\L>O0"@#UBBO.K^XU+2O$EYI]M,#J.KZ=:0VK-R5G
M4RK)*1QD*F&/^Z!WIMCI>AQ0:]'K4$+V>ANEM:1W(W>1$L*,)5W?\M'=W.\<
MD@#.10!Z/17F_AV^GMVCU/Q)*J3:'H4"7$D[`.LLHWRY]\1QCW.:K>'=%BU7
M4])M=3A#>1I4M_>V<F61YKR;>0X/#8V/P0>U`'J-1RRK#$\KG"(I9C["O.)[
M329[U]8<)>6]WJ<5O97]ME+NQD4K%Y2AAP@=#D+C(9LJ1DGI_'UW+9>`M;F@
M)$YM'BBQUWN-BX]\L*`(]*\6W6L6=G>VOA76?L=VB21SN]H!L;!#$>?NQ@YZ
M9]J5/%LEQ+=#3_#FKW\%O/);F>!K4(SH2K!0\RL<$$=.U.TO3_$.E6MI%<ZK
MI#6-K$J-%%IDD;[%7&`YN&`Z==I^E8?@BQU^X\)65S#JMC;6E^)+W9]@=IU\
MYVD_UAFVD_/UV8]J`.TTV_M]6TZWOK5F:WG0.A92IP>Q!Y!]0:NU1TK3K?1]
M+M=/M0P@MXQ&F]MS$#N3W)ZDU>H`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`K$UGQ"FD7ME9)87E_=WOF&*"U,0;:@!9B9'0`#<._<5MUPFHI
MJ.I?%!4TV[M+:33-)RSW5LTZDSR]`%D0@XA'.>_2@#JM-O[F^60W.D7NGE"`
M!=/"Q?W'E2/^N*T:XO5VU&673M#U%[74;F\F>;;`CV5N\,87<DF3,6Y;.T8W
M8P<`'/+6]S!9Z;J.HVB6<.EZ;XCM4BCM"!;Q+^[CF9`.%'[U\]!D$]Z`/7:*
M\U6)M5U/3K_4<Q0>(+L_(Q*$VL4;-!`>A^<YD93UR5/'%5[ZV@2^U/0M,C@M
M]$OKRRT]+>-`(1+EY+H(HP!F)0#COGOF@#U*BO+_`!7*FLWNOI$ZO$+>VT*)
MXAN99+F4></3A3$?PK9U?0M->\L=(L[?3I71OMEUIUW&=E\F/++NV"'=>"-P
M;D#..&`!V]<Y<^)GBUNZTJST/4M1EM(XWG>V:!43?G:,R2IDX4G@<<>M.\(_
M96\-V\EDMREM(\C)'<.&:++ME`1_`IR%Z_+CM6!H,&NWNL>)=5TS4].AAN-3
M:$+<V#SL?)18N&69!C*MQCKGGF@#:N?%;VUQ86C:#JCZA>QRR+9HUOYD:1E0
M69C,$P=ZXPQ/-7H]=,>EW>H:GIUUI4-JAD?[6\))4#)8>7(XQ]2*Y@PZ[?\`
MQ%D^S7VG1W&F:3%%+-+I[R1N\TC,VQ1,I3B)>K-6C,M]J6HVVAZC<VUV("+V
M]>UMVA0H#^ZC*F1SDN"QYY"8QS0!JZ1KT.L2W,*VMU;2VWE>;%<!0P,D:R#[
MK'H&P?<'J.:KOXLLEF>-(;J0#44TY71!MDE898J21E4YW'MM8#)%<[KNIS>'
M_'5XMH0]]K>GP164)Q@SI(ZECZA5D#'V4U9DTRWM/%'A#086=X]/BN=0=FQE
MV51'N;W+3LQ]Z`.ZHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`KWG_'I+_NFF:=_QXQ_C_,T^\_X])?\`=-,T[_CQC_'^9KA?^^K_
M``O\T7]CYENBBBNT@2L^V_Y"EQ]/\*T*S[;_`)"EQ]/\*XL7_$I?XOT9<-GZ
M&C1117<0%%%%`!1110`4444`%%%%`!1110`4444`%,90ZE6`*D8((X(I]%`%
M>UMH+*VCMK6&."")0D<42A511T``X`JI/H&C7-Y)>7&DV,MS*GER3/;(SNO]
MTL1DCVJIX5GFN=(N))I9)7&I7Z!I&+$*MW*JCGL%``'8`"MZ@"JUE;/>1WC6
M\+7,2%(YB@+HIQD!NH!P,CVJ*XTC3+N^@OKG3K2:\@_U-Q)`K21_[K$9'X5?
MHH`SKO1=*OYVGO-,L[B9HC`9)K=78QGJF2,[3W'2K,=M!%/)-'!&DLBJKNJ`
M,P7.T$]P,G'IDU8HH`SQHNE)J9U)=,LQ?D8-T(%$I'IOQG]:FN;6WO8?)N;>
M.:+<K;)$#+N4AE.#W!`(]"*M44`1NBRH4=0R,"&5AD$>AIL,$5M#'#%&L<4:
MA$1%"JJ@8``'0`5-10`4444`%%%%`!1110`4444`%%%%`!17*_$.&\N/`NI1
M6.LP:-<MY6R_GNC;)%^]3.9!RN1E??..]=50`4444`%%%%`!1110`56CM+>.
MZENDMXEN)E59950!W"YV@GJ0,G&>F35FB@"EJ.E:?JUN+?4K"UO80=WEW,*R
M+GUPP(S36TG37M)[1]/M6M;@YFA,*E)#@#YEQ@\`#GT%7Z*`*EWI]G?VK6EY
M9V]Q;,,&&:,.A'^Z1BH)=%TF;2UTN;3+-]/0`+:O;H8@!R,(1CCZ5I44`4H]
M.L4&$L[<#S1-@1*/W@``;I]X``9Z\"F:CH^F:S$D>J:=:7T:-N1+J!90IZ9`
M8'!K0HH`C1%B0(BA44`*JC``]!45M:6]G&8K:WB@C+LY2-`H+,<L<#N222>Y
M-6:*`*T=K!%/-/'`B338\V14`:3`P-QZG`X&:=';PQS2S)$B22D&1U4`N0,#
M)[X'%3T4`59+*UENX;Q[:%KF%66*5HP7C#?>"MU`.!G'7%.^S6_VO[7Y$?VG
M9Y?G;!OV9SMSUQGG%6**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@"O>?\`'I+_`+IIFG?\>,?X_P`S3[S_`(])?]TTS3O^/&/\
M?YFN%_[ZO\+_`#1?V/F6Z***[2!*S[;_`)"EQ]/\*T*S[;_D*7'T_P`*XL7_
M`!*7^+]&7#9^AHT45RGB?QO;>&-0M+!]'UC4KFZC>5(],MA,P52`21N!_B%=
MQ!U=%<?IGCR+4+74;F;PYXBTR.PMFN7;4+$0B15&2J$MRV!TXK+B^*\=Q$DL
M7@CQI)%(H='32@RLI&000_((H`]$HKG/$WB^R\*V$%[>VMY,DF24MD5GC55W
M,[`L/E`ZXR>1Q6^)(S")@X\LKNW9XQUS0!)17+6'CC3M1N-!ACMKU#K:7$EJ
M75`-D."6;#'`8$%<9R#SBNIH`****`"BBN)U?XC6VDZ]=Z1%X=\1:G/:",S/
MIUD)D7>NY<G<"./4=C0!VU%<6WQ#MH?#<^N7/A[Q!:+'<I;+:W%D([B5G("E
M$+?,,MCKUS4-E\2[&XOX+:^T#Q'HR3N(H[G4].,4)<G"KN!."2>,\4`=U111
M0!SW@W_D"7/_`&%=2_\`2V:NAKGO!O\`R!+G_L*ZE_Z6S5T-`!1110`4444`
M%%%%`!1110`4444`%%%%`!115>XN[>U\K[1/%%YL@BCWN%WN>BC/4GTH`L44
M44`%%%%`''_%#^R/^%=:K_;WV[^S/W/G?8=GG?ZY-NW?\OWMN<]LUU^*X;XN
M3QVGPOUF:>S@O47R<P3EPCYGC')1E;CKP1T].*ZB76M+BOA8RZC9I=EE40-,
MHDR<8&W.<G(Q]::3>P7L:5%%%(`HHHH`***A26.1Y51U9HVVN%.2IP#@^AP0
M?H10!-1110`4444`%%%%`!1110`4444`%%%%`!1110`445#-/%;0/--(L<4:
MEG=S@*!U)-`$U%8_AW7[/Q-H\>J:>7-K+)(B,X`+;'*%A@G@E<CV(Z56\2^*
M[/PO#;M<6]]>W%RY2WL[&`S32D==J\<`<G)H`Z&BL/PYXELO$UA+<6B7,$D,
MGE7%M=1&*:!\`[74]#@CVJUJ6JP:9)9QRAWEO+A;>"*/&YV/)/)'"J&8^RGJ
M<`@&E117*>(O&O\`PCVI+9_\(SXCU+,8D\_3K'SHADD;=VX?-QT]Q0!U=%<Y
MX5\66_BRWNYK?3-3L/LD_D21W\`B??@$C`8],C.:@\0>.+#P_?QV!L-4U&\9
M!+)!IMJ9VAC)(#O@C:N0??VH`ZJBL_2-5L];TNWU*PE,EM<+O1B"#Z$$'D$$
M$$=B*L7=Y;V-G->74R0V\"&261S@(H&23^%`%BBN0T?X@:;K6I1VBV&K6`G_
M`./2XU"R:&*[X)_=,>IP,X."1TK>UC5K/0]+GU*_F\JU@`+,`222<``#DDD@
M`#J30!HT5RFA>.K+7+\63:9K.F7$@8VXU*S:`7`49)0\@\'..N.<5MZ=JEOJ
M:W/E962VG:">)\;HW'8X)Z@AAZAA0!H4444`%%%%`%>\_P"/27_=-,T[_CQC
M_'^9I]Y_QZ2_[IIFG?\`'C'^/\S7"_\`?5_A?YHO['S+=%%%=I`E9]M_R%+C
MZ?X5H5GVW_(4N/I_A7%B_P")2_Q?HRX;/T-&O-O&7_"0?\+)T'_A&O[,^W_V
M==9_M+S/*V;XL_<YST_6O2:Q+C0C<>+K'7?M&W[):S6WD^7G?YC(=V[/&-G3
M'>NX@Q+G_A*?^$"\1_\`"4?V/Y_V&?R?[+\W;M\IL[O,YSGTK)\(?\+*_L?0
M=W_")_V1]GM\X^T^?Y&U?^`[]OX9]J[W5K#^U=%OM/\`-\HW=O)!YFW=MW*5
MSCC.,]*-)L/[*T6QT_S?--I;QP>9MV[MJA<XYQG'2@#"EMDUWQOJ$%Q'OL[+
M3!:G)X+W!)D&/4)''_WU7.B_NU^&C>&ED;^UUNO^$>#!_GZ[1)GU\C]Y7=:7
MI:Z=/J$_F"2:]NC<2.$V_P`*JJ]3G"JHS_*J'_"*QGQF/$!NF*B+BT*#:)\%
M/.#>OEDIC'3O0!@:Q9P:=\2OA[96L8CM[>UOXHT`X55BC`'Y"MSQPU];^%Y]
M1TZ6=+C3G2\*0L094C8,\9`/(9`PP?:I]3\.G4?%>AZ[]J\LZ4MRH@\O/F^:
MJK][/RXV^ASGM6W)$DL31R*&1P593T(/44`>?>(-3UK6=4O1X7N)2]AHQGB6
M-@%FN)_]5G)P2J*S`'C+"LGP#K-M_P`)-#92>)/$R7EQ%(TND>(X?GD<8^:)
M\`*!AOE&<CL,&NE\-?#VW\.>%]1T:WU2\\R\E9_MD;&.6(`!8U4Y/W%51Z'G
MC!Q1I?@S5DUJUU'Q#XJFUH6#,]E$;*.W\IRI4LQ3ESM..<>M`';5Y6__``F/
M_"S?%O\`PBO]A;,67G_VIYV<^2=NWR_QSGVKT33;:^M()5O]0-](T\CH_DK'
MLC)RJ8'7:.,]3533=!.G^)-;U?[3YG]I^1^ZV8\KRT*]<\YSGH,>]`'(^.)=
M?B^'UA+JL%A<ZTFJ6C&"Q=DAD87`V*K2<C(V@D]#GM3=0_X37QK;1Z/J7A2#
M0K!KB&:>[DU..X;;'(K[45!]XE0,GCFNO\1Z$?$-C;VOVGR/)O(+K=LWY\J0
M/MQD=<8SV]ZW*`"LC7]0U/3=,:?2-'?5[S>%6V6XC@&.[,[G``'H"<D<8R1K
MT4`<KX`EN)_"@FO+;[)=27]\TUOY@D\IS=S%DW#AL'(R.N*ZJN>\&_\`($N?
M^PKJ7_I;-70T`%%%%`!1110`4444`%%%%`!1110`4444`)7D_P`:>NB?]M__
M`&G7K%8/B+PKIGB?[)_:*2G[*Y=-C[=P.-RGV.!TP>."*UP\U3J*<MD9U(N4
M6D9/@SQ!XFU>[N8M;T7[%!'&&2;RGBRV?NX<DMD9.1TQSU%5?%?BCQ=I>N-:
MZ3X?-S9B-66?[/)-O)Z\H0%P>,'GC/0BN^[<4#/>CVD>?FY5;L/E?+:Y@^%-
M2U75-$6YUG3C876]E\O!7<HZ-M/*]Q@^F>A%<3=>-/'L=Y,B>%BJ+(RJ/L<T
MF`#_`'U;#?4<'J*]3.<\=*,41J1BVW%._P"`.+:2N<=X[FOV^'-Y<)-)I=YL
M@D<I=>6T1\Q"R"0$9)&5X/.<#.<5X+++)/,\TTC22R,6=W.68GDDD]37NWQ6
MAL[CX9ZS'J-[)9VA2-GF2#S6!$J%5"97)9@%Y(`W9)`%,N?A9X<N=3:[VW,2
M-('-M%(%B]P!MR`?0$8SQCBNC"8F%)-26YE6I2G:QEVOBCQ1!X`T6]T^P?5;
MF5I$FE=&E90KLJY5<,20/O?[/.2U:?@_Q'XHU?5I+?6]&-E;+`763[++%E]R
M@#+$CH3Q[5V-I;0V5G!:6Z;((8UCC7).U5&`,GGH*L_2N>52+32BM310:MJ<
M#XJ\4>+M+UQK72?#_P!ILQ&K+-]GDFWD]>4("X/&#SQGH16UX/U76=8TB6XU
MNP^Q7*SE%C\EXLIM4@X8D]2>?:ND'O12<TX<JBK]QJ+3O<\JNO&GCV.[FC3P
ML519&51]CFDP`?[ZMAOJ.#U%3?"J>XN=7\3W%U%Y-S+/&\T>TKL<M*6&#R,'
M/!KT[%96F:!8:1?:C>6B,LU_-YTY9B1GGH.PR6/U8]L`:>VBX./+9O\`S(Y)
M*2=[FO1117.;!1110`4444`%%%%`!1110`4444`%%%%`!6;JNCV&MV\4&HVZ
MW$$4JS")_N,RYQN'1@,YP>,@>E:5%`'&?"X`>"(P!@"^O<`?]?,E.NOF^+^E
MA^BZ)<E,_P![SH0?TK3\.:`_A[P\VF)>"1_-GE6;RMNTR2,X^7)SC=CKSBLO
M5O".J:G9:7-#XDEM?$&GH4&JQVB$2AL;PT7W<':#C/!%`!H8*?$SQ:B+B)H+
M&1L#@R%9`3]=JK^0HGN$E^*0$[L(=+T5KA1C@-+*0S>Y"Q8_$UI>%_#LF@6]
MR]YJ4VIZE>2B6[O)4"&1@H4`*.%4`<`53UA&TOQKI.NDD6MS$VEW)XVHSL&A
M8\_WP4^L@H`R_P#A=OP]_P"AA_\`)*X_^-U?U?QG:S?#^;Q!H$ZW/VD>182-
M&RAYV?RERK`'`?U]*[&L/7]"_MR32@;D1165_'>O&8]WF[`VU>HQ\Q#9Y^[0
M!+X=T6+P]H%GID3%S"G[R1CEI9#R[L>Y9B23[U%KEKJJ65S/X9ATN/6)]BF:
M]1@C*/[Q0;B0"<9XJ[JMM>WFEW$&FZA_9]VZXBN?)67RSGKL;@_C7/:WX0U*
MYU635O#WB.71+^X1([QA:1W$=P$!VDH_1AG&0>G%`"?#MXH_##6(CDCNK"[F
M@OE=PY^T;M[D,``0Q?<,`<$#`K1\;:1<:_X+U?2K0J+FYMV2/<<`MU`)[9QC
M\:HKH=YH'AZWM-$O;AKM[^.:ZN9(UEDN=\@,Q?/"Y7/(Z`#':N@U73;;6-+N
MM-O$+VUU$T,H!P2K#!P>QH`\S\0>*=2UB+0K4>&-4TOR=;LA/-?(L:[A*HVP
MX8F3//.`-H->H75G;7L82[MX9HU=9`LJ!@&4Y5L'N"`0>U<EI'@C4+;4K.XU
MSQ/=:S;Z>Y;3[>2VCA$+;2H9RO,C!21DXZDXJUXC\,ZQX@T?6--7Q&UM%?N@
MA9+12;:(`!X\A@6W$$Y)XSB@"O'+'XN\76-W9AFTO0Y)'%V/N7-PR-&40_Q*
M@+98<;L`=#4UK,;7XK:A9JQ\J\TF&[9<<!TD://U*E1_P&JN@>%/%ND7MG]J
M\;I>:;;_`"M8IHT$"LN,!0RG*XX/'I5_0X3J/B[6=>96\@(FG6I.,.L99I''
ML78K_P``H`ZJBBB@`HHHH`KWG_'I+_NFF:=_QXQ_C_,T^\_X])?]TTS3O^/&
M/\?YFN%_[ZO\+_-%_8^9;HHHKM($K/MO^0I<?3_"M"L^V_Y"EQ]/\*XL7_$I
M?XOT9<-GZ&C1117<0%%%%`!1110`4444`%%%%`!1110`4444`%%%%`'/>#?^
M0)<_]A74O_2V:NAKGO!O_($N?^PKJ7_I;-70T`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`<=\4+O3[+X=:K<ZKIG]IV2>5YEIY[0>9F5
M`/G7D8)!XZXQWKL:YWQK_P`)%_PB%]_PBF?[;_=_9L^7_P`]%W?ZSY?N;NO\
MZZ*@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`*]Y_QZ2_[
MIIFG?\>,?X_S-/O/^/27_=-,T[_CQC_'^9KA?^^K_"_S1?V/F6Z***[2!*S[
M;_D*7'T_PK0K/MO^0I<?3_"N+%_Q*7^+]&7#9^AHT445W$!1110`4444`%%%
M%`!1110`4444`%%%%`!5>[N[:PM9+J[N(K>"(;I)9G"(@]23P*L5SNN:I8VH
M\O6M/F73D*/_`&A+'%)!')N&TD9+*5.#O*!5QDD4`8EEX>\&P6`O-9M?#5U)
MJ5_<S07DT<,GV@33R21JKL/G;8RC`STXR!6[_P`()X0_Z%30_P#P70__`!->
M17`2'0YC<@M:7&F:S::;.RY^V323J8V7L7E&6`7`./E&*]TL5D2PMEESYJQ*
M'SUS@9H`R/\`A!/"'_0J:'_X+H?_`(FN2U/P/X8O?B#X?6PL_#,4=@ES)J&F
M"*)99E>,+&QB"_,%;G+8QGBO0KZYEM;-YH;*>\D4C$%N8P[<XX+LJ\=>2.E>
M9RZSI^O_`!&BLK>2RTN/2'EN)D+QBZN+UX2I58U)+[%)W$9R1@$XH`Z;3]!^
M'6K/-'IND^%KUX"!*MM;6\ACSG&X*#CH>OH:T?\`A!/"'_0J:'_X+H?_`(FN
M?^'D[6TDVB6.JG6-&L+*W$-V8T4Q2G<&A.T#D!5;:V67=\QY%>@4`<I?^%_`
M6EVK76H:#X;L[<$`RW%G!&@)Z<L`*S=&\(>#=+T/0[#5-+\-2ZC):Q1"1K>%
MC=2J@W,A907R03GJ<YIWCKQ?!X<L?-N]&S<I<+%IEQ>-#Y+3L"-X;>6C"@ME
MF"\9&>:XK[%'I]@MBM_#J)N=-L(=.GB82)<3K=NTGE;<@[203CH!GH.`#U#_
M`(03PA_T*FA_^"Z'_P")H_X03PA_T*FA_P#@NA_^)KH*HW]W/96PE@TVZOWW
M!?)MFB5@/7]XZ+C\<\]*`.);X>^&!X^DU$66A?8(=*,-QIAM8QY4AEW).4QC
ME1(NX@'Y>"<G&KIWAWX?:Q$\VEZ-X8OHT.UGM;6WE53UP2H.#7-KH]M8^(?'
M]K%=7%NMWI,$D]TR/<2*S^>&?:,EL#HH[``5T?@>_ENX=1M8M2_M33+.2.*R
MU`(@\U?+4LN4`5MK<9`]CD@T`:'_``@GA#_H5-#_`/!=#_\`$UD>)O`OA1O"
MVJK#HGA^QGDM98XKN2UBB6&1E*JQ<+E<,1R.:[>O.?B3;_VSX*U.>^T^]M/[
M/<-`LTR;)FW*!)B-VR`"<!L$9SC/0`OZ;X)\%:5:Z;H=WIGA^YU)+5$S-:0B
M:YV*`TFT@L<D9/7KUK7_`.$$\(?]"IH?_@NA_P#B:X_5TN/^$SO+7</MMQK6
MG7%FA^\UM&B>:5_V1B4'TW<_>%>H4`<__P`()X0_Z%30_P#P70__`!-<]/X7
M\#Z5XIE?4;#PO;0WEM!#9VD\,",TJO+O948`'<)(AD9)VX/05WCLRQLP1G(!
M(1<9/L,X'YUYMKNJ3VWB-=6AO+O3]:D@MK>#0KF")FN4\]M^'4ONR"3^[8%-
MH+<'%`'7?\()X0_Z%30__!=#_P#$T?\`"">$/^A4T/\`\%T/_P`37044`>:_
M$3P%X:F\#ZA#9:?X<T:Z<Q"._GACMDB/F*3F0+D9`(]\X[UU"^!_!SJ&7PMH
M3*1D$:?"01_WS6;XXF@L]2\-7^H2+'I=M?RM<RRG$<>ZVE5"QZ#YF`!/=@.]
M7OA]!/;?#[0(+I'CF2QB#)("&7Y1@$'IQVH`F_X03PA_T*FA_P#@NA_^)H_X
M03PA_P!"IH?_`(+H?_B:Z"B@#S[1/"_@:;7-=MDL/"U[,;L21VL4,$KVT:Q1
M1LK)C*?O%<XZ9;U)KH?^$$\(?]"IH?\`X+H?_B:YSP5.;/6CI&FZK)JNFM%<
M75TTD*QFSN&FW!"-H92V]SM?)^7(P.*]#H`Y_P#X03PA_P!"IH?_`(+H?_B:
MYSQ+\./#>J2Z9;Z;IVAV5U97]O?3PK:1J9[96(=&VC.T@GJ""5`/7(]#KR?7
M]'EA\4^-(-,-S)=WOAKS1F0L[2-),`JYZ#`"@#H`*`.NL_"O@34K?S[#0/#M
MU"&*>9!9P.NX<$9`QD5:_P"$$\(?]"IH?_@NA_\`B:RO!,MM=:IKMW8%6L)'
MMD1XQ\C2)`JO@]R/E4^A7'45VM`',7/@[P39VTMS<^&_#\$$2EY));&%50#J
M22N`/>N8T7P9X,\-R7D.OIX8EN-4U*>ZL8KB*$%(78".*/?R0`!PHP"Q`SU.
MS\4M,@U#X>:PTYF"VMK+<*B2%59PC8W`?>`)S@\9`/:L76KM]+UNTU"QUIUU
M=[*SM[?23:J1=(93OPQ&6X8D["-FT%N#B@#K_P#A!/"'_0J:'_X+H?\`XFC_
M`(03PA_T*FA_^"Z'_P")KH*:2%!)(`'))H`X*Y\*>"=2OK-]-T[PP8]-NFDU
M)(X(>(_(E7:X4=G9&PV!\N>H%:]GX0\#ZA:1W5GX=\/7-O(,I+#90.C#U!"X
M->9_VI9^+&UC4=&FLK>RLXH[.TTVVD3S9;5;J)YYFB7D*0"`,=&/K7I'@EQ.
M-=O(G62RNM4DEM)$.4>/9&"RGH07#G(Z]:`+G_"">$/^A4T/_P`%T/\`\35*
M^\-?#_3/)%_HOAFT,[>7%]HM;>/S&_NKD#)]A76UYM\4M8L(88-"$FG6VIZQ
M#):_;KXJB6MJV/-;>Q'7C"@\D`]J`&^%O!7@SP[I]EX:UJ/PWJ&N(TN#-#"9
MYT,CLAVL-V=F..<8(!(&:ZO_`(03PA_T*FA_^"Z'_P")KDK>X72O&RQZ5KSW
ML]]>017&F-;J-ELMN`)0V-Q`V@^8#L.XK@GFO3:`.>/@7P>!D^%=#Q_V#H?_
M`(FLG3].\+V&MIX@T0Z!9Z;:V=S:WTUF8HP'9X67>4&W"B-\[CQN'J:ZZZ:)
M;69IT\R$(?,787W+CD;0"3QVQS7D]S-9-K-W>V,D5QX>2\TR>6Z50([<(SCR
MB%`"I'A&.1E<G<?0`]:@N(KF!)X)4EBD4,DD;!E8'H01U%3URW@".5/"H:0$
M1RWEU+!GO"T[M&1[%2"/8BNIH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`KWG_'I+_NFF:=_QXQ_C_,T^\_X])?]TTS3O^/&/\?YFN%_
M[ZO\+_-%_8^9;HHHKM($K/MO^0I<?3_"M"L^V_Y"EQ]/\*XL7_$I?XOT9<-G
MZ&C1117<0%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110!7O/^/27_`'33-._X\8_Q_F:?>?\`
M'I+_`+IIFG?\>,?X_P`S7"_]]7^%_FB_L?,MT445VD"5GVW_`"%+CZ?X5H5G
MVW_(4N/I_A7%B_XE+_%^C+AL_0T:***[B`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`*]Y_
MQZ2_[IIFG?\`'C'^/\S3[S_CTE_W33-._P"/&/\`'^9KA?\`OJ_PO\T7]CYE
MNBBBNT@2L^V_Y"EQ]/\`"M"L^V_Y"EQ]/\*XL7_$I?XOT9<-GZ&C1117<0%%
M4[Z_L]+M'N[^\@M;9,!IIY!&BY.!EB0!R<4R/5=/ETPZG%?VSZ>$,ANUF4Q;
M1G+;\XP,')SVH`OT50TW5]-UF!KC3-0M;V%6V.]M,LJAL`X)4D9P1Q[U?H`*
M***`"BJ5YJ-CIPB:^O;>U$T@AB,\JIO<]%7)Y8X/`YJ[0`4444`%%4[_`%&R
MTJU-UJ%W;VENI`::>18T!/`RS$"J>G^*-`U:Y^SZ;KFFWMQM+>5;7<<C8'4X
M4DXH`V**Q+WQ9X=TV[DL[_7]+M+J/&^&>\CC=<@$94G(R"#^-/M?$^@7UM=7
M-IKFFW%O:J&N)8KJ-EA4YP7(.%'!Z^AH`V**P(_&WA2:58XO$^C22,0JHM_$
M2Q/0`;N36_0`45F'7M'`C;^U;$"6X-K&3<I\\P./+'/+YXV]:TZ`"BJL%]:W
M4T\,%S#+-;L$F2.0,T3$9`8#H<<X-6J`"BJ5YJ-CIPB:^O;>U$T@AB,\JIO<
M]%7)Y8X/`YJ[0`455GO;6TE@CN+F&&2X?RX5DD"F1L9VJ#U.`3@5:H`**I2:
MC8PW\5A)>VZ7LREXK9I5$CJ.I5<Y(&#TI#JVG#5!IAU"T_M`IO%IYR^;M]=F
M<X]\4`7J*I1ZC8S7\MA'>V[WL*AY;995,B*>A9<Y`.1UJ[0`4452@U&RNKRX
MM+>\MYKJV*BXACE5GBSR-Z@Y7.#C-`%VBBB@`HJ-W6)"[L%102S,<`#U-1VE
MW;7]K'=6EQ%<02C='+"X=''J".#0!8HHJI<7UI:2P17-U##)</Y<*22!3*V,
M[5!ZGV%`%NBJ.HZMIVD0"?4K^ULHB<"2YF6-2?3+$59AFBN(5FAD22-QE71@
M0P]01UH`EHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`KWG_'I+_NF
MF:=_QXQ_C_,T^\_X])?]TTS3O^/&/\?YFN%_[ZO\+_-%_8^9;HHHKM($K/MO
M^0I<?3_"M"L^V_Y"EQ]/\*XL7_$I?XOT9<-GZ&C1117<0>=?''_DDNK?[\'_
M`*.2N,LIAIWP[O\`P.LI\V35K?3X1G+&&ZV2G_QTR\^U>A_%30]1\2?#W4-*
MTFU^TWLSQ%(]ZIG;(K'EB!T![U@7'@359OC#HNO1PXTF&SC:Z?S%&;A$=%!7
M.20&7G'3(S0!S_PNURT\#_"SQ-J5XK/%8ZO*BHI^9VV1*JY]SCG\:ZA/&OBO
M0K[2IO%^EZ9!I>K3K;P-92.TMI(X)59=W#>A*\<$^U96F?#75+WX?>*_#VHQ
MK93W^KRW=HY=64K\A1CM)P"5(P>1Z5;N-#\9>-+K1-/\0Z/::58:3>1W<]S%
M=K,;QXP0/+0<HIR?O<X(]*`+=GXN\7ZQX\US0=+M-'%II5U`))[GS0WDL#N`
MVDY<]0>`-ISG(J$^-O&.IZ[XKTG0].T9WT65=LUVTBC803@A2=SG:<<J!CFM
M7PAH&J:5X^\:ZG>VIBM-2FMVM)?,5O,"JX;@$D8R.H%'ACP_JFG:_P"-[FYM
MO+AU.Z$EFWF*?-781G`.1R1UQ0!S^I>/O[8\">$=>.C:=,]_K,5LT-Y%YRP-
MF12\?(PPV\'MFKS^,O&6I>+?%&A:%I^C.VE&(Q37C2*`K*20P4G<QZ#&T#!S
MFL&U\!^)H_AGX0T=M,Q?:=KBW=U%Y\?[N(/(=V=V#PPX!)YZ5V/A;P_JFG_$
M#QKJ=W:^7::DUL;27S%/F;$8-P#D8)'4"@#(3XK3S?#C2]?ATQ'U?5+L6%M:
M>8?+,VXKDMUVX&<>IQGO4T'C'Q?8>/?#WAG7K#28_P"T$F>6YM&D=7"HS`)N
M(*D$8((;J,'TY4^$-0T/X0Z'%J=Q8Z5K.D:I]MMX[Z\CCBE<.S!-^[;DKR.>
MW;FM&>[U_4_C-X*FUG3+?3Y%@NF6RBN!.T2^4P+NX`')P`!QQU.>`#<^.W_)
M*M0_Z[0?^C!7E-L_@[7O$&B1?#KPUK%EJT5_%+)<22L42$'YBV9'X_+ZGI7L
M_P`5]!U/Q+X`O-+TBV^TWDDL3+'YBID!P3RQ`Z>]=Q0!\V^,[_P78?&/Q0?&
M6D7NHQ.MJ+9;5BI0^0FXG$B=>/6NATR7P9>?"7QI>^#='O-.A:V:&X%U(S,Y
M5"5QF1\`;SZ=:NZQ8?$;1/B9XBUKPKX?L[VSU);=1)=3(!B.)5X'FH1SN'/I
M6DO_``L;Q-X-\3Z=XDT&QL[B:R\NP2UD7]Z[!@P),K`?P]<=:`/.O`=]\*[V
M]T#39/#.J-KSF&-KDRL(C<#&7XF^[N&?N_A7O7C+59-#\&:QJD+`3VUI(\1;
MH'Q\OZXH\)6-SIG@S1+"\B\JYMK&"&6/<&VNJ`$9&0>1VJ+QUILNL>!-<L(%
MW336<@C7U8#('YB@#RJ_T]=,\$?"B(!P\NL6=S(6))+R'S&)SWRQKW8D`$DX
M`[UXOJUCKWB?X8^`=0\-V<>H7VGR6URRO*BKNB3!SN9<_,N"`<U>@U?XQW@G
MM]0\*Z5#!);3A9()DWB3RF\O&9SU?:#QT)Z=:`,RP\6ZIH6D6>LZ9!!?2^*?
M$LHVW((S$7\N,(01MX08)!Z]#6U;^-/',OBK4O"/]E:$VLQ1"ZAG6>46R0G'
MW^-S-EE'`7.3TQR[5O!6JKH_P[L+&V$_]BW]K+>L)$78J;=[<GGG/`R:U++P
M]JL/QMU#Q"]KC2YM(%M'<>8O,F^,[=N=W13SC'%`',W/Q!N=6\&^'=3O=#TN
M2]D\01Z?<0W4/G1Q2#=F2+GY6'8Y.,GKUK6?QEXRU+Q;XHT+0M/T9VTHQ&*:
M\:10%922&"D[F/08V@8.<U@#P%XF'A/3;(Z9_I$/BS^TI$\^/BWY^?.['?IU
M]J[+PMX?U33_`(@>-=3N[7R[34FMC:2^8I\S8C!N`<C!(Z@4`<QK^O3>.?@8
M?$ZVZ6>HV<JW<6/G$<L,N-RDCNN?SQS7JNDWR:KHUCJ,>-EU;QSKCT90P_G7
MCS:5JGA+]G2[TC4[(Q:C,[6Z6XD5R6EF`7!4D'@YZUVVCW.LZ-XET;PF+6W_
M`+&AT12MQR9?-BVH0?FX7!7JO/."<'`!E?$H+IGC+P+XB.<0ZD;&3'3;,N,_
MAAJX433GXDCX@@SFW/B3^QMO\/D^7Y>_Z?IGWKU+XH>'K_Q-X&N;/2X_,U*.
M6*>U`D"'>KC.&)`!VEL'(KGC\/M3'P+7PVB.-:$8NMGF+N^T>9YFW?G;_LYS
M[YH`YJS\9+HWBCQ9K5NUF+_5]7_LVS:^E$4$2VZ?-)(W]W#)P.>177^'_B@)
M(M;@UR;29KO2K0WK3Z-<^=!<1?[&3D,#M!!/<=,USL?PQUE/!/AVYET^UOM=
MTRZGN[K3[PHT=T)6RZ$\KNPJ8)XS70Z9X/NM8T?6X;_PIH/A@7]HUK;QV,2/
M<)GJ9)4`4KD*=H'UZ4`9FD_%R^>_TF;4V\//I^KSQPQVVGWYEO+,N/E,RG@\
MX!P!COSQ60?&,?A+XB^/1!$MSJ]]<V4&G6A;'FRE&')XPH)&>1U`[UK^&?".
MN6DFE:9=^`O"ULECL6XUB1(YWN%4?>C50KK(<#YF/7G%%[\,;C7O$7CJ[OK)
M87OO(?1[XNI=)$4Y*X.Y/F"@YQD4`:OB_P`<ZUX7BT#2Y3HT>L:DKF6\NV>*
MQ@*@$CJ6[X!SZ'OBNE\'ZMK6KZ;)+K5G8I(K@0W6GW(FM[I",[TY+*/9O:N;
MU:U\5ZKX5T=]2\(:5K$\:8U#3;R5%E\T?*)(I=S(H/).><''M2_"_P`&ZAX8
MGUB[N+)=)M+]XS;Z2ET;D6VT'),AX))/;TZ]*`+GQ-TWQ!K&AS6NG7T5EI`M
M)Y-1DQF60*N5C3T#<Y/I^1N_"K_DE_A[_KU'\S6[KUO->^'M3M;=-\\UI+'&
MO`W,4(`R>.IKD]$\`V.I?#;0M!\6:9YDED@9H//8;)!N'WHVYX8]R.:`._KQ
M/Q%INOI\5/">JZ]?1,LNJRPV-I`/D@@'()/=VXS]!]!V-I\(/`EA>V][::%Y
M=Q;R++$_VN<[64Y!P7P>1WJ7QCH6I:MXK\(7EE;>;;Z=?/+=/O5?+4J`#@D$
M_AF@!WB?PUX9;5'\6^)F^T065F8C;W@22V09SN"%>7)XZ\\<=*Q_@HDY\)WU
MSY30:==:E/-IT#<>7`2,`#L,Y_R:R_BCH/C#Q)XETV"TT*34O#=IMFFMX[V*
MW^TRY.0Q8YP!@?=[MCKD>@>%+O5;K2RFJ>&TT$P$106J7<<ZF,`8(*``#MCV
MH`Z"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@"O>?\>DO^Z:9IW_'
MC'^/\S3[S_CTE_W33-._X\8_Q_F:X7_OJ_PO\T7]CYENBBBNT@2L^V_Y"EQ]
M/\*T*S[;_D*7'T_PKBQ?\2E_B_1EPV?H:-%%%=Q`4444`%%%%`!1110`4444
M`9VKZ-INNZ=)8:I917=K)]Z.09&>Q'<'W'-97AWP%X8\)W$D^BZ1%;3N"ID+
MO(^#C(#.20.!P*Z:B@`HHHH`****`"BBB@#.TG2+'1+(VFG6WV>W,CR^6&8@
M,[%FQDG`R2<#@=JT:**`"BBB@`HHHH`S=2T6PU<V9U"W\_['<+<P!F8!9%SM
M8@'!QGOFKGD1"=IA&@E90K/M&X@9P"?3D_G4U%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`5[
MS_CTE_W33-._X\8_Q_F:?>?\>DO^Z:9IW_'C'^/\S7"_]]7^%_FB_L?,MT44
M5VD"5GVW_(4N/I_A6A6?;?\`(4N/I_A7%B_XE+_%^C+AL_0T:***[B`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`**Y[P;_R!+G_`+"NI?\`I;-70T`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%<)\7(([OX7Z
MS#/>062-Y.9YPY1,3QGD(K-STX!Z^G-=W0`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`%>\_P"/27_=-,T[_CQC_'^9I]Y_QZ2_[IIFG?\`
M'C'^/\S7"_\`?5_A?YHO['S+=%%%=I`E9]M_R%+CZ?X5H5GVW_(4N/I_A7%B
M_P")2_Q?HRX;/T-&BBN.\4>+=7T;7+#2=&\.?VS=W<$L^W[:EML5"H/+*0?O
M#O7<0=C17&67BCQ,NGZK>:YX/_LJ&RM'N(S_`&E'/YS*"=GR#Y>!UYK+M/&W
MCR^LH+RV^&OF03QK+$_]NP#<K#(."N1P>]`'H]%<IXO\5W/AC3X)X-).H3LD
MDTL"S;#'%&NZ1@=IW8RHQQG/6NB6]MVT\7PE7[,8O.$F>-F,Y_*@"S17%:9X
MZDU"[\+02:3Y(\00W,Z-]HW&*.,!D)&T9WJP..,9[UVM`!1110`445P>I^-?
M$<?BC4=&T+P;_:XT\1&6?^TX[?!D3<!M=?KT)Z4`=Y17#7?C/Q#IGA:34]3\
M'FTOS>16MO8'4HW\[S&50WF*I"\MC!':H(_'7B+3[B!_$W@J72--EE2$WL>I
M17(C=V"KN50"%)(&>U`'H%%%%`'/>#?^0)<_]A74O_2V:NAKGO!O_($N?^PK
MJ7_I;-70T`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`<+
M\7&M(_AAK!OX)Y[4>3OC@F$3M^_CQABK`<X_A/IQUKNJY7XAS7EOX%U*6QT:
M#6;E?*V6$]J;E)?WJ9S&.6P,M[8SVKJJ`"BBB@`HHHH`****`"BBB@`HJI/?
MV=I-#%<W<$,L[;84DD"M(>!A03R>1T]15NBP!114,TT=O"\TTB1QHI9W=@%4
M#J23T%`$M%9&F>(=(UF>:'3]0@N)(6971&^;C`)`/5>1\PR#ZUKT--.S0DT]
M@I:*IWE_9Z?")KVZ@MHBVT//($7/7&2>O!_*A*^B&7****`"BBB@`HHKG?$_
MB.30H[2"RTV;4]4O79+6SB<)O*C+%G;A5`QDGU%`'145R.F>-HIM)U>YUC3I
M](NM'4O?VLCK(4&S>&1EX<$9P>,D'BJ=AXXU8W=J^L^$KK2M+NY8X;>]DO(I
M#N?A!)&#N3)P._)&<4`=U16;K6K6VA:/=ZI=[S#;IN*HN68]`JCN22`/<US^
MB^,M2NM:@TO7/#-UHLUXDDEDSW,<RS*@!(.W[CX.=I]#S0!V5%5;^^MM,T^X
MOKN416UO&TLKGHJ@9)KD]0\::C$UE9:9X8N=0UJ>U%Y)9?:HXEMHRV!YDC<!
MCSP`>5/IF@#MJ*X]/'=O'X?O=0OM/N;:]L9UM;C3P5DD$[[=B*RG:V[>N"#C
MGG&#2^'_`!;J5_J_]D:]X>FT34)(FN+>,W27"31J5#$.N,,"P^4CI0!U]%9.
MOZY!X>TI[Z>*68[TBBAB&7FE=@J(ON20.:Q_#WBV_O\`67T?7?#\VB:@T37%
MO&UPDZ3Q*0"0Z<!@6&5]Z`.NHHKF?&7BVV\&Z*+Z:!KF9Y`D-NC8+DGDYP<`
M#DG'\Z`.FHKF/%'B>YT.6SLM,TB75]7O-Q@M(YEB&Q<;G9VX4#([<D@5-X7\
M2-K\%W'=Z=+INI6,PAN[.5U<QL5###+PRD$8/>@#H:*Y+Q%XMO--U5-'T+09
M];U0P?:'A2X2".&/=M!>1N`20<#J<&K$7BU)O#MSJHL)EDL9-E]9N1YMOMP9
M.%SN(4[@!]X8QUH`Z6BHXY4EC62-@R.`RL.A!Z&I*`*]Y_QZ2_[IIFG?\>,?
MX_S-/O/^/27_`'33-._X\8_Q_F:X7_OJ_P`+_-%_8^9;HHHKM($K/MO^0I<?
M3_"M"L^V_P"0I<?3_"N+%_Q*7^+]&7#9^AHUYMXQL=7U+XDZ#!HNM_V/=?V=
M=-]H^RI<?+OBRNUCCGCGVKTFLF?1+>X\1VFMO)*+FUMY($0$;"KE221C.?E&
M.?6NX@Y^YTW7-,\!^(TUSQ%_;4KV,YCE^QI;>6OE-QA"<^N:R?"'ASQH-'T&
MZ/CTG3_L]O(;+^QX>8MJGR_,SG[OR[NO>O0-2LHM3TNZL)F<1W4+PN4(#!64
M@XSWP:--LHM,TNUL(6<QVL*0H7(+%54`9QWP*`,&WB35?'FKO*L<EO864=B!
MU(>7,DH/U7R:Y7=,O@D^!=^+PZC_`&(N<Y-J?WFX?]NV>?45Z+I^FQ:<;HQ,
M[/=3M/(SXR6.!C@#@``#V%5/^$;L3XI_X2',OVS[/Y&S?^[ZGY]O][!*YSTH
M`YO7X8[?XI>`H8@$CC@U!44=`!%&`*UO'MA/>>$KF:T4M>V#)?VP!P3)"P<#
M\0"OXU?OO#]IJ'B#2M:EEF6YTM9EA1&`1A*H5MPQD\*,8(_&M<@,""`0>"#0
M!YAJ3W7C[4K^?0+Q4%EHWEV<ZR8`N;E0QY'((C51D<CS*SO`\%CX>\5V5K=^
M&M;\-7]XDD>TWIN;.\DQDEG)/[S"DC&._7BNVTCP!X?T?PS?>'[>WD>POI7E
MF61OF);'0J!C;@8[C`[U'HO@"PT?58]1EU36M4FAS]F74[TSI;9!!,8P,'!Q
MDY.*`.PKRIM(\1ZI\3?%IT+Q1_8JQBR$J_8([GS283@_.1MQSTZYKT73=._L
MR"6(7EY=F2=YM]W+YC+N.=BG'"CH!V%0V.AV]AK6IZM'),UQJ0B\Y6(VKY:E
M5VC&1P><DT`<7XVM-:L/A_86]SJD.IZP-4M-EW/;B&-W-P"FY$Z*.`<<D"I)
MO#_CSQ*(M/\`%-WX>ATD31S3+I:3-++L<.$S)PHRHYZUV.MZ);Z]9PV]R\B)
M%<Q7*F(@$M&X=0<@\9'-:M`!6?J,FI16X;3;2TN9]X#)<W+0*%P>0RQN2<XX
MQW//'.A10!S/@@S-X=D:>..*8ZEJ!D2-RZJWVR;(#$`D9[X&?05TU<]X-_Y`
MES_V%=2_]+9JZ&@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@#E?B'#>7'@74HK'68-&N6\K9?SW1MDB_>IG,@Y7(ROOG'>NJKC_BA_9'_
M``KK5?[>^W?V9^Y\[[#L\[_7)MV[_E^]MSGMFNPH`****`"BBB@`HHHH`***
M*`/&OB;]L_X6'I'V#_C\\B'[/T_UGFOMZ\=<=>*[?P;)XL,%VGBB)=P93;R`
MQ[F!SN!\LXP,+VSR>O;9N]"TR_U.UU&ZLHI;NT/[F5AROI['!Y&<X/(P:U*W
MG74J<8);=3*,&I.5SS?7_P#A9']O7?\`8ZA=/W#R%5K=AC`YRX#9)R2#T/`)
M&#65\0+OQ&/`ND1ZM$L4LLK+?%&'+KGRP0K8(8`L<<94=.!7KE4[^PMM3LYK
M*[A66WF&UT<<$?T/<$<@\T0KJ+BW%:?>$J=T]7J?-FA7%[;:]8S::,W@G00K
MNVAV)P%)R.#G!Y'!-?0_B.36H]$G.@V\<U^<*@D<+M!ZL,\$CT)`^N,&MI?@
MOP_HM\M[I^GK%<*I57:1W(!ZXW$X/;(YP2.]=%6F)Q$:LU**V[DTJ3A%IO<\
M[\-R?$:/6X!K,$<M@V5E,CPKL']X>7SGCI@@Y[=14^,,EZ-*L(UAC^P&?<\V
M_P"<2[6VKCTVECGGIVQ\WIW%9VK:/8ZY9&SU*W6>#<&VMD$$="",$'Z'H2.]
M9QKKVBJ.*5NQ;IOE<4R+PK_R*6C?]>,'_HM:UZBAACMX4AAC6.-%"HB#"J!P
M``.@J6L&[MLM*RL+1110,*H7EQ&,V$=]#:W]S&_V8,5+Y`Y=4)^8*2"?UZU?
MK!\1^%K#Q+!"MW)=6]Q;,7MKNSF,4T#$$$HP]0>AR/:@#GO!T=YHOBW6M&U:
M[34M1EMX;^35!&8FE0ED",F2J[=IP%P,'IG)-J>9/&^KVT-JF_0-/N4N);L\
M+=3QG*)%_>16P6;H2`HSSBQ:>`]-M-%U+3UOM3FGU*+RKK49[GS+IUQ@#>P.
M,`G`QCD\5F:;\+(-*>T%MXO\7""U9#';'4AY6U2,(5"`;>,8]*`.VO;RVL(#
M/=W$-O"&53),X1<D@`9/&22`/<UPNI6^I:-\0M(U74]135+2]NWLK*W,'E-8
M;T9MRE3B3(3:2PS@\$<@]/=>&;*__MB+4)[N\M=55$EM)YB8H@J[<1`8*9^\
M<'KSQ6=HO@'3]'U--1EU+5]3GA+&V_M*]:=;;(P?+!X''&3DX[T`-^(K,?#M
MI;C<8[G5+*"7!ZHTZ9!]CT_&M?7=?M=!MHVF5Y[F=O+M;2$;I;B3'W5'\R>`
M.213?%>C-KWARZL8F5+G"RVSMT29&#QD^VY1GVS7.:AX(A\8WECXDGU3Q'HN
MH&S6'R;2Y$!A&<LI^4G.>O.#@>U`&MH-D-"L[B_UNYM8-0U6[$UQ^\VHLC`(
MD2DGYL`*H_O')QSBL-+?4]!^).GSZOJ$>K+JIN+6SD,'DR62@>;L`!*NI"8+
M8#9`[&MBS\"V4.AWFD:AJFL:S;W3JY?4KPRR1%>A1@`5P0#QWI=!\#6&A:@=
M0?4=6U2]562&?5+LSM`C8RJ9`"@X'O[T`4OB-:WUU_PC45E=FSD;6(U-QM#>
M7F*4`@'@G)XSWQ4.E6U]X5\;V6CG7-4U:SU2VN+AAJ4HED@DC,>"K`#"D.1M
MQC(XK?E\+65WHUUI6H3WE_!<3O.6N9RTD3%MP",,%0IQMQTP*K>'?!=GX=NY
M+S[?J>IWSQ^5]JU.Y,\J1YSL4X`49P3@<X'I0!U%>`^*/B#X6UC3_$,]WJ0&
MJ-FRL+0V\N885D7<=VW;N<KN//0*.H->Q^%]/N],T&*UOKFYN9UDE;S+J;S9
M=K2,R!G[D*5''''%6=<T>WU_1KG2[IY4@N`%=HB`PP0>,@CMZ4`<K;:E::O\
M2]$U*SF\ZSN]`N'MY"I7=^^A.<$`CCU%6]$5_P#A9GBR1/\`4_9[%&QT\P+(
M3^.TK^8K0\3>%++Q1#;"XN;ZRN+5R]O>6,YBFB)ZX;G@@8.14>F>#[+2?#]Y
MI-I>:BCW@8SZ@;@F[=V&/,\S'W@`,''&.E`&/K1UC2?&\^I^'[&SUBXN;***
M[T][Y;>:-5=]DHR#\IW,#G^[Q3?`,=[=7'B]]52'S+C5"DBP$F,$01AE!/7;
M]TGN0>!TK5U_P/9:\UI.VI:M8WUI%Y"7UA=F&=HSC*LV#N!(!Z=:FN-/'AOP
MA-8:!:N]QM9+<$LQ::0X\R1N3]YMS,?>@"M\-;B6X^'6B-*6+)`8@6.251F1
M2?P45UM9NAZ5%H>A6&EV_P#JK2!(5)[[1C/X]:TJ`*]Y_P`>DO\`NFF:=_QX
MQ_C_`#-/O/\`CTE_W33-._X\8_Q_F:X7_OJ_PO\`-%_8^9;HHHKM($K/MO\`
MD*7'T_PK0K/MO^0I<?3_``KBQ?\`$I?XOT9<-GZ&C1117<0%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`'/>#?^0)<_\`85U+_P!+9JZ&N&\.>+/#NF6%
MY9W^OZ5:W4>J:AOAGO8XW7-W,1E2<C((/XUL_P#"=^$/^AKT/_P8P_\`Q5`'
M045S_P#PG?A#_H:]#_\`!C#_`/%4?\)WX0_Z&O0__!C#_P#%4`=!17/_`/"=
M^$/^AKT/_P`&,/\`\51_PG?A#_H:]#_\&,/_`,50!T%%<_\`\)WX0_Z&O0__
M``8P_P#Q5'_"=^$/^AKT/_P8P_\`Q5`'045S_P#PG?A#_H:]#_\`!C#_`/%4
M?\)WX0_Z&O0__!C#_P#%4`=!17/_`/"=^$/^AKT/_P`&,/\`\51_PG?A#_H:
M]#_\&,/_`,50!T%%<_\`\)WX0_Z&O0__``8P_P#Q5'_"=^$/^AKT/_P8P_\`
MQ5`'045S_P#PG?A#_H:]#_\`!C#_`/%4?\)WX0_Z&O0__!C#_P#%4`=!17/_
M`/"=^$/^AKT/_P`&,/\`\51_PG?A#_H:]#_\&,/_`,50!T%%<_\`\)WX0_Z&
MO0__``8P_P#Q5'_"=^$/^AKT/_P8P_\`Q5`&3\5[]--^&>LW$EC:WR!(T:WN
MU9HV#2HO.T@@C=D$$$$`CI7;5YM\0O%NF:AX&U&U\-^+-*75G\K[.T&KPPN,
M2H6PY<8^4-WYZ5U/_"=^$/\`H:]#_P#!C#_\50!T%%<__P`)WX0_Z&O0_P#P
M8P__`!5'_"=^$/\`H:]#_P#!C#_\50!T%%<__P`)WX0_Z&O0_P#P8P__`!5'
M_"=^$/\`H:]#_P#!C#_\50!T%%<__P`)WX0_Z&O0_P#P8P__`!5'_"=^$/\`
MH:]#_P#!C#_\50!T%%<__P`)WX0_Z&O0_P#P8P__`!5'_"=^$/\`H:]#_P#!
MC#_\50!T%%<__P`)WX0_Z&O0_P#P8P__`!5'_"=^$/\`H:]#_P#!C#_\50!T
M%%<__P`)WX0_Z&O0_P#P8P__`!5'_"=^$/\`H:]#_P#!C#_\50!T%%<__P`)
MWX0_Z&O0_P#P8P__`!5'_"=^$/\`H:]#_P#!C#_\50!T%%<__P`)WX0_Z&O0
M_P#P8P__`!5'_"=^$/\`H:]#_P#!C#_\50!T%%<__P`)WX0_Z&O0_P#P8P__
M`!5'_"=^$/\`H:]#_P#!C#_\50!T%%<__P`)WX0_Z&O0_P#P8P__`!56=.\2
MZ%J\[6^EZUIU].JEVCM;I)6"Y`R0I)QD@9]Q0!KT444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`5[S_`(])?]TTS3O^/&/\?YFGWG_'
MI+_NFF:=_P`>,?X_S-<+_P!]7^%_FB_L?,MT445VD"5GVW_(4N/I_A6A6?;?
M\A2X^G^%<6+_`(E+_%^C+AL_0T:***[B`HHHH`****`"BBB@`HHHH`****`"
MBBB@`JCJ6I6ND6$U_>RF.VB&78(S'DX&`H))R0,`9J]7*>+;:>_L)K6]L+B7
M2-T,CR:;<-]KRLBM@1!/NC&25<OC.T9Q0!%8:[HGAS1X_ME[/&EW=W=RGGV,
MT+JKSO*Q9&7<B)Y@!=@%Z'(R*Z\$$`@Y![UXSJ.GZ[)9W$LMCJMW!>:9J>F:
M>)8GDG42NA@$V?F4$*WS/C``W$&O7K*)H+&WA?EXXE4X]0,4`6:**PM?_P"$
MA:TD@T*#3S)+$R_:+J[>(Q,>`558GW>O)'/K0!0L-7T6P;7]334_M$4^J[)%
MB@=F29(8HC$H4$R']UGY1W([$UT=E>6VHV4-Y:3)/;3H)(I4.0RGD$5Y5H^B
M:IH_DS3Z*UO9Z;XA>Y:*U,MP[QM;&,NH\M6D&YE.X`DDMP,<]]X+LKBP\(:=
M;WD30W`C+/$^-T>YBP4X[@$#\*`.@II(4$D@`<DFG50U"74H4C;3[2WN6W?O
M%GN##A?5<(V3['`]Q0!SNG>(-!N=9U;7+?50\7V*VBD1H'3")),5D0L!YBN9
M2H*@@E>"<\=%IFJ6>L62WEC,9(2S)DJ4964D,K*P!5@0000"*\WU>QO==U*_
MU33]*U"&$K927<-[`ZRM+!<JY2,-G($88XC)0DC&22:[+PA#.MC?W,UO-`MY
MJ,]S#'.A1Q&S?*2IY7.,X(!&>0#0!TM%%4[^2^CM6;3[>">XR-L=Q,T*$=\L
MJ.1_WS0!R.H'1]9^(.A7R:P([C03>*T#6S[)F>,*ZB4X7<@&2!N/KBNGTK6[
M#6HI)+"8RK&P5P4:-AD9!PP!P0<@]".037FVKIJOC3Q%JEK=65_8I96=U::4
MAL[CRYKB2%D>9IB@0)@E5R1G.>XKJ?"%M=/JVIZG);7-M!+:6ELD=Q"T3;XE
M?>0IQQEP,]#MX)&#0!V=%%5[@W`MY&MHXY)PI*))(45F[`L`2![X/T-`'+^,
M++3M;U?PUI<^JI:7\&IQ:G!!Y1D:<0!BR\$;00?O'TZ&MG3_`!!I>IWT]G9W
M?FSP$AQL8`[6VL58C#@,-I*DX/!YKGKS2)V\<^&=7ETJ**]8W`OIK8M,B`0E
M4!D**<<\9`Y)_&AX1TJ^A\1:<)[*X@_LNTO+>XDEC*K(\MPKH4;HX*J6)!.,
M@'!XH`]'HHHH`X[XEV=AJG@>\TJ_U%K!+UXXTE2V>X<LKB3"Q)\S'"'IT`)Z
M"NIM;N"]M(;NVF26WF021R(<JZD9!!],5S/C"*>+4?#VK):W%Q;Z?>2/<);P
MM*X5X)(P0B@LWS,HX!QG/0$U<\#Z=<Z1X&T33[Q"ES!9QI(A.2C8Y'X=*`.B
MHHHH`Y_Q5)8W6C3:%=WZ6DVLPRV-N2N]B[HPR%'7`YZ@>XJ'PY?Z7IUM8^%8
M=0%S>:=9I;EO*9!+Y2JC%2?E)!QN4,2N1FJ/C#14NM?\+ZE;V#3746J1K+/'
M&6,<`BF/)'W5W,.?4CVK+\/:7?VWB:SMI;.=/L-YJ5S-<&,B-DGDS'M<\,2&
MR0,XV\XXR`>D4444`8^K^(=+T-X4U"Y:.28,R*D+RMM7&YR$!*H,C+'`&1DU
MGZ1J.D:1<+HO]I)-=75U<7,9$;!"9I))PF_E=VUS@9RP7(&*R_B/J&I"QM="
MT^TOQ%JF^*\U"ULI;@6L./FXC4G>V<#CU-9=IHUQ:Z\EG:V%Y]FFU6UOX)V@
M=42VCM50[V8#:P*[=A^;GIC.`#U"BBB@#,U76[#1;9+B^F9%DD$<:QQ/*\C$
M$X5$!9C@$\`\`GH*Q[+5]$TRZGOCJJ2PZ[<)>P,D;%53R880689`4E!\S;1E
M@.O73UZ]AM=/*7-IJ-Q;7!,,K6$;O)$I!^;$9\S';*`D9SP.1YI+X=UJ/0?L
M4UC.)[_0H],MU@A)6!UFD*^9MX3]VZ$DX&4/.<4`>QT4@X`%+0`5Q\6O:%#?
MW?B5=4\RUNXX[!5CMY&(:WDG+L,`DJ/,.3C`"9S@\;'B*WU.[T*ZMM)>!;R9
M0@::5HU"D@/AE5B#MS@X.#BO,M$T75M'L[:>?1)H+6UFU:VCM;19)B/.<>60
MNP'9\A4-C&"&.T$X`/88Y4FC62-@Z.`RL#D$'H14E9/AFPGTSPMH^GW1W7%K
M90PRG.<LJ`']16M0`A.!D]*X\>(-$O[ZW\31WUPMG9VLMLI?3YU6?SY(2IB9
ME'F',.`$#9WCVSU-V-UI,H61LHPVQD;CQT&>,_6O*[72[NS\E=+L];/AW3)K
M&46U]'*\RR(SB7RT?YF55,9PF5)!V`F@#U#3[ZWU.RBN[67S()!E6`(]B"#R
M"#D$'D$5<KF?!%E<6/AW;=1-$\UW<W*QN"&1))G=00>AVL,CM734`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`5[S_CTE_P!TTS3O^/&/
M\?YFGWG_`!Z2_P"Z:9IW_'C'^/\`,UPO_?5_A?YHO['S+=%%%=I`E9]M_P`A
M2X^G^%:%9]M_R%+CZ?X5Q8O^)2_Q?HRX;/T-&BBBNX@****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@"O>?\>DO^Z:9IW_`!XQ_C_,T^\_X])?]TTS3O\`CQC_`!_F:X7_`+ZO
M\+_-%_8^9;HHHKM($K/MO^0I<?3_``K0K/MO^0I<?3_"N+%_Q*7^+]&7#9^A
MHT445W$!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!1110`4444`5[S_CTE_W33-._X\8_Q_F:?>?\>DO^
MZ:9IW_'C'^/\S7"_]]7^%_FB_L?,MT445VD"5GVW_(4N/I_A6A6?;?\`(4N/
MI_A7%B_XE+_%^C+AL_0T:***[B`HK-UC6-/T/2[C4=3NDMK2%=TDKYP/3`')
M)/``Y)Z57T_Q/HVJ:$^N66HPRZ9&C.]QR`@49;<#@J0.H(S0!M455L;V#4;"
MWO;5F-O/&)(V9&0E2,@X8`CCU%6J`"BBB@`HHHH`***JW-];6LMM'//'')<2
M>5"K-@R-@G"CN<`GZ`T`6J***`"BBB@`HKGO$GC3P_X1C@?7=32T\\D1*4=V
M;'4[4!./?&.16['*LT2R(<HZA@?4&@"2BBB@`HHKFM>\>^%_"]Y'9ZSK,%M<
MR8(BVL[`'H6"@[1[G`H`Z6BJ]I=V]]:17=I/'/;S*'CEC8,KJ>A!'6LJQ\5:
M)J=WJMM97ZS3:20MZ%1L1'YN,XPWW&Z9QB@#=HK-T76]/\1Z1!JVE7'GV4^[
MRY=C)NVL5/#`$<@CD5I4`%%%%`!1165KWB'3/#&E/J>KW/V:S1E1I/+9\$G`
MX4$_I0!JT444`%%9>H:]IVE7]A97MR8KC4)3%:IY;-YC`9(R`0/QQ6I0`445
MD:EX@TO2+_3["_NO)N-2E,5JIC<B1QCY=P!"GD8R1GM0!KT5@WOB[0]/\1VG
MA^ZOA'JMVH>"W\IR6!SCY@-H^Z>I'2K'_"1:7_PD@\/?:O\`B:F#[5]G$;'$
M><;BV-HY[9S0!K4444`%%9<>O:=/KT^AQ7.[4;>%9Y8?+;Y4)P#NQM/T!S6I
M0`444QF6-2S$*JC)).`!0`^BLO1-=TWQ'IBZCI5S]ILW9E64*R@E3@_>`/45
MJ4`%%9.L:_IF@I:MJ=XMN+J=;:#*EB\C=%``)_'H.]1>(?%.B>%;-;O6]0BL
MXG.U-V69S_LJH+'KS@<4`;=%9.A^(-)\2V`OM&OXKNV)VEXSRIP#A@>5."."
M`>:UJ`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`KWG_'I+_NFF:=_QXQ_C_,T^\_X])?\`=-,T[_CQ
MC_'^9KA?^^K_``O\T7]CYENBBBNT@2L^V_Y"EQ]/\*T*S[;_`)"EQ]/\*XL7
M_$I?XOT9<-GZ&C1117<0<IX]TB_UKPP8],ACN+NWN8;J.WD<()?+D#E-QX!(
M&.>,]:X9K*_6VET;5HX-.E\1ZE+JVIVZ2AUM+&-4\Q6<8!+%54D?WSZ&O9*\
M_N_"FHZ[9^+[J\1;:^U2%K"R5V#"*W0$)DJ2!N8LQ],CTH`Z/P[XHT+Q/;2R
M:'J$-W%;MY;A%*E#VX(!QQP>AQQ7GOQ!\;ZMI'C:/16\0KX9TQK0317YTW[7
MYTF<%.>@''('&.>M=#X&T;78=:U+6-:TV'3'FM;:SCM8KA9=PA##S"5&`#D8
M'4"K'BK1O%]]>R-H]YHEYI\T81]-UJU+1(<$%E9!N.>.&R.OTH`PM:\6:_I?
M@71?$XU73;N*WOD74Y=-Q+#<6Q?:2"5RK`[1@="3]*U_^$@U'4_BM_8NG7>W
M2=-T[[1?!%1O,ED_U:$D$CY2&X(SWK.MO"FD^#/ACJVCZ_JUI!#J33-++D0Q
MK(Z\)$K'L%R!U.#Q47P1T:YM_!4NL7Y9[W5W#EY!\QA1=D8)[\`D'_:H`Y&V
M\;?$$_"Q/&LFNV96UN-AMVL4)NE,@3+L,!<$XPH!P,YYKK8?$/BW2?'_`(<L
M]6U*TN['Q#%(_P!CBMP@LF5`VU7^\_4<MUYX%0)\,M97X)R>"S=6']I-+Y@D
M\Q_)QYP?KLW=!_=ZUT6L>$=0U#QAX0U>*6U%OHJ3+<*[,'?>@4;!MP>1W(H`
MX_2=9^(NN^%M9UNUUVVB73+JX\F!K"-FO%CY*%N`JX^48&[.<FLWQ!>:OXP\
M2_#?5['5QIDFI07!@46J3"TE51YC#=]\-P,'IMSW-/\`!FC>+-4\&ZW9Z#JF
MGP6=]JEU!<B[C<R0J<*S1,IZD'H1UY!%==K/P[U&VLO"3>&+NS6\\-AUA&H!
MO*F#JH8ML&0<KGCU-`$*:OXL\8>)-:L?#^MVVDV>B2K;/,UFL[W<X!W@AN$7
M(QQS_3$U/XE>)+GP1I5Y8&"TUQ-?72+U-H:*1PK$CY@<*WR\CD<X-=+-X3\5
MZ/KVHZIX5U'2HQJS))>VVH1.4BE`PTD13DD]<-^-4;KX6747A?1-+L+V&:ZM
M=;CU6_N;G*>>V#O("@\\@`'L.M`%9M4\?1_$2;P<?$5C(;NP^VI?'3@ILQN(
MPD>[#\C'SD]<]L&[X2^(WV3PUJUQXSU&)6TO5'TUKR.W;]\1T)1`<$\]!BMQ
M_"U\WQ9C\5B6W^PKI?V(Q[F\W?O+9QC&,'US[56\*^`ET^+Q!;Z_;:=J%OJ6
MKRW\,31^<JJWW=P=<!ASTS]:`.!UV>]\6_%?PIJ7A[Q7Y=KJ$-R=-G_LY3]D
M$<;+(-KX+[F5N6`QGCH*Z/P1J_B[Q%JVLW%SK\46EZ3J\T+0?8D9YXU_Y9[@
M!M`&#G!8DG)K>NO`[+X^\+ZSI<.GV6E:3%<I):Q+Y9S(C`;%5=O5LGD=^M2^
M`_"E[X:BU^._>WE&HZI->1^2S'$;@8#9`YX[9'O0!Y9+\:;Z2*77(?$MG$ZR
MD1>')-.<[X@V,M<`'#E>>N*Z/QI\3C'XB@TBU\20>'+3[%'=O?O8->22-(`5
MC5`"`-IR2?6M32O!7C;PY#_86@:]IEKX?^T-+%</;L]Y`C,6,:JV8V],MSR3
MQTK4UWPKXA@\5#Q-X5OM/6_FM5M+JWU-',4H4Y5\Q\AA^5`$WPS\9/XS\.SW
M4S1/<6MT]K)+"I1)@`"LBJ>5!!'![YJIXSO/#/@*TU?Q!)9(^KZN@@\LR,S7
M3!<*N"2%4#&<`#IU.*ZG0+/5[+2A'K>J#4KYF9GE2!8D4$\*J@=`.YR3^E>=
M>(/`GC74?B2?%-K-X>NH;8!-/M]1DG*P``<[44#=G<>IY/L,`#]'FU;P+\(-
M&T@*S^(]0)M[&!@28Y)6+#=Z!%.3V&*S/AKHZ^']7^).EK-)-]FCMU:60Y:1
MO+F+,?J237<W/@J#QAI5B?'NG6%WJ5L9-O\`9\T\<*AB.GS`GA5SGN.*PO"W
MPGMO#?B+Q'?PPVJ07,7DZ6J3RLT",K!P^[KD[>[=#T[@'$:!JWBSPK\%]'\2
MZ?JMHNFV<KJ=-:U#&=6N'4EI2<@[B<!0..YKWR>X/]E2W,1PWD&13UP=N17F
M[_#;6&^!R>"1<6/]IJV3+YC^3_Q\&7KMW?=./N]?SKT2XC,6A2Q,062V*G'3
M(6@#Q_2_$GQ"N?AE!XW.O6<L=J)9)+)[%`;J-9"K%G&-I`!P%`Z<DYJUXK^*
MI.IZ58VFNQ^&[2[TV/4)-0DL3>/F3!2)4`('&221^7?)\#>&_%?B/X2Z=I5E
MJNGV^A7YE%R98'-Q"HF8%8R/E8-@YS@C)YKN=4\#:KIFNZ?KG@RXT^WO+;3U
MTQ[?45<PR0J1MY3D$8'UP*`.0O/BEK-Y\)M4U>QOH4U+3]16T%[#;@+/&6&)
M!'(#MW*>A'Y5N^-]3\7^#_AQ?:K-X@CFU&2ZB:%X[*-%MT8C,0!#;@.<,>:N
M>*/!/B?Q+\.KC1;W6;6\U6>Y6<R21^3!$H;.Q=BEB`.[9)]:V/B7X5OO&7@V
M?1M/DMHKB26-PUPS*F%.3RH)_2@#%O\`6?$WBGQMJOASPWJ\.B6VC)&;F[>U
M6XDFD<9"A6X"XSD]<CT-9LGQ0U:#P1J32V]J?$=EJO\`8XQD123$D!P.O0,<
M>WI6YJWA'Q'IOBR^\1>#KS34GU-$2]M-31S$Q086163Y@W;'3DFJI^%:OX&U
M#29=39M8OKW^T9;]8\#[3NR"%[+V_$F@#"URS\3:=XX\`6_B#5H-6W7TCK=1
MVH@96VC*$*<$<C!P.AR*H+\1?$%UXDU&"?Q;INA7EK=O##HVHZ?M@EC!X9[C
MDJ2#[9(&!@UU$G@[QIK7B+PQK.OZCHS/I-PSR06:R*A4@?,"P.YS@?W0.U1^
M(_`_C/Q#%<:5>ZCX=U#39F;9?7EB?MMNI)P$"`)D#C=P>30!Z="QDA1VV;F4
M$[&ROX'N*\Y^-47V?PIIVNHN9-&U2WNP`<9&[;C\ROY5K-;:SHWB'PAI.EWN
M[18+:2&^A=0TCJD6(Y"Q7(&X*.""21P1G&OXOT1O$7A'5='C,?FW5NR1&7.T
M/U4G`)P&`[&@#Q/Q6'U;7_$OCZV9ID\.ZC90VGE$\K&1YH/ME@<_7MG-K5_&
M;Z+XV\5^)X'3+3VNBV5S*A>.W4KOE8J.2%V9P.I85W7A?X<2Z1\*+WPE>O;&
M\O4G\Z:`DIO?(1LD`G`"=NU8^D?""[M/A_'I,]_;Q:Y#J8U.&\BW2QK*N`N0
M0I(VCGCJ<\T`1>#/B:TOB&XTFZ\20>([06$EVM\E@UG(CQ\M&4(`(V\@CTKF
MH?C1?1QQZY-XELYG:4"3PXFG./+B+8^6X(&7"\\G'6O5]#TOQA=37;^+M3TU
MK66`VZZ?ID1\HY',C.XW[L$C`..]8FA^$?'>APVV@V?B'38M!M9,Q70MB]Z8
M]V?+(8&/H2-W)'Z4`<EXN\<1>"_BAK^H1*LMW<Z3!%9JP^1I"00S'CY0.3R,
MUTOC+7_$O@SP1H[SZQY]S=7"QW^L"T21;96'WDC4*I`XQGKCU(K9NO`?]I^.
M-<U34OL\VE:GIBV7E!CYH((R>F![$'-067AOQMIW@S3]*MM;T\7^G.T:^;"9
M8+V`#"++E=R$#`^4GIW[`$GPY\07FM)>";Q3IGB&VC"M#<P0FWN5SG(EAP`H
MXX/?%:_C+PY=>*=-BTU=3GL;!I"U\(>'GBP?W8/8$]?;C!S6)X+\#7^D>*+[
MQ+JW]DP7MU;_`&?[)H\+1VX&[<7.[EF.!SCUKT!QN1@.I&*`/+?@SJ-CI7P@
ML;O4+N"TMA/,&FN)%C0$R$#+,0*[3_A._"'_`$->A_\`@QA_^*K&\"^!O["\
M`6_AOQ!!I^H>7*[NFSSH6RY8<.HR1]*V?^$$\(?]"IH?_@NA_P#B:`/,OBGX
M<NH?$6B^(;[4I;EI=>M;:SM>D=M"02P`[LS*"3[`<UZ1XDMO#FGRP^+-<2-)
M-)1_)N9';]V&X("YP6/0<$YQBJ7C[PO?>*K?18[&2"-K#58;V4S,PRB!LA<`
M_-R.N![UB_%'P5XF\9W>E1Z7/IHTVS?SIK:]ED59Y,\!@BG*X&.H/S'IUH`B
M^$WVW5+OQ-XK>W>TL-:O%>TMG&/D0,#)CIEL@$^JGKQ7J-<UX4B\60)/#XD3
M08XD5%M$T@2@*!G<&$G;[N,>]=+0`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`%>\_X])?]TTS3O^/&
M/\?YFGWG_'I+_NFF:=_QXQ_C_,UPO_?5_A?YHO['S+=%%%=I`E9]M_R%+CZ?
MX5H5GVW_`"%+CZ?X5Q8O^)2_Q?HRX;/T-&BBBNX@****`"BBB@"CJ.EZ?J]N
M+;4["VO8`P<17,2R+N'0X8$9Y-6T18T"(H55&``,`"GT4`%%%%`%.RTZRTZ-
MHK&T@M8V<R,D$2H"QZL0!U/K5RBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`IC*LBE6`96&"",@BGT4`5+"PM-,M$M+"T@M;:/.R&WC$:+DY.%``'))_&K
M=%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110!7O/^/27_=-,T[_`(\8_P`?YFGWG_'I+_NFF:=_QXQ_
MC_,UPO\`WU?X7^:+^Q\RW1117:0)6?;?\A2X^G^%:%9]M_R%+CZ?X5Q8O^)2
M_P`7Z,N&S]#1HHHKN("BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HKGO
M!O\`R!+G_L*ZE_Z6S5T-`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!17'?%"TT^]^'6JVVJZG_9ED_E>9=^0T_EXE0CY%Y.2`..F<]J[
M&@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`*]Y_P`>DO\`
MNFF:=_QXQ_C_`#-/O/\`CTE_W33-._X\8_Q_F:X7_OJ_PO\`-%_8^9;HHHKM
M($K/MO\`D*7'T_PK0K/MO^0I<?3_``KBQ?\`$I?XOT9<-GZ&C117'>*/%NKZ
M-KEAI.C>'/[9N[N"6?;]M2VV*A4'EE(/WAWKN(.QHKC++Q1XF73]5O-<\'_V
M5#96CW$9_M*.?SF4$[/D'R\#KS67:>-O'E]907EM\-?,@GC66)_[=@&Y6&0<
M%<C@]Z`/1Z*Y3Q?XKN?#&GP3P:2=0G9))I8%FV&.*-=TC`[3NQE1CC.>M=$M
M[;MIXOA*OV8Q><),\;,9S^5`%FBN*TSQU)J%WX6@DTGR1X@AN9T;[1N,4<8#
M(2-HSO5@<<8SWKM:`"BBB@`HHK@]3\:^(X_%&HZ-H7@W^UQIXB,L_P#:<=O@
MR)N`VNOUZ$]*`.\HKAKOQGXATSPM)J>I^#S:7YO(K6WL#J4;^=YC*H;S%4A>
M6Q@CM4$?CKQ%I]Q`_B;P5+I&FRRI";V/4HKD1N[!5W*H!"DD#/:@#T"BBB@#
MGO!O_($N?^PKJ7_I;-70USW@W_D"7/\`V%=2_P#2V:NAH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HJA)JEE%JD6F2742WLR-)'`3\S*.IQ^
M?UP<=#B_1:P''?%"[T^R^'6JW.JZ9_:=DGE>9:>>T'F9E0#YUY&"0>.N,=Z[
M&N.^*":@_P`.M572K+[=>GR?+M_LBW6_]ZF?W3*P;`R>0<8SVKL:`"BBB@!*
M*R-9\1:5X?BBEU2\%NLK%4!5F9B.N`H)P/7IR/45+I.L6.N60O-.N%G@+%=R
M@@@CJ"#@@_4="#WI\LK7MH*ZO8TZ***0PHHHH`**3-9FF:[IFM>>--O8[G[/
M)Y<NP_=/]0><$<'!P>*$FT*Z-2BBB@84444`%%%%`!1110`4444`%%%122QP
M1/+*ZI&BEF9C@`#J30!+17.>$?%47BVPO+V"VD@A@NY+9/,/S2*H4A\8&,[N
ME1^)?$\VBW-IIVEZ3-J^KW:O)%:1RK$`B8W.[MPHR0/<F@#IZ*P/#VO-K<$\
M5W82Z;J5JRI=V<KJYB8KN!#KPZD=&'H>A%6=5U@:==:?:1P^?=7TXBCCR5`4
M?-(Y.#@*H)]R5'&<T`:U%%<GXB\67NF:I'H^B:#/K>JM!]I>%+A($BCW;07D
M;@$D'`QSM-`'645A>'-?.NVUQYUE+87]I+Y%Y:2,KF&3:&QN7A@0P((]:S=?
M\6ZE8ZO_`&1H/AZ76]0CA6>XC%TELD,;$A27?JQ*G@#H,T`=?163X?UN#Q!H
M\6HV\<L.YFCDAE&'BD1BKHWN&!%:I(`))P!WH`6BN7TCQIIVN^*;[1-./GK9
M0++)=*WR,Q8J57CYL8Y(.,Y'8UFW/CC5I-2NXM#\(WFJZ?8S/!=7HNXH1O3[
MXC5SF3!R#R.1B@#NJ*I:5J5MK.E6NI6;E[:ZB6:(D8)5AD9'8UQUQXT\4RZI
M?P:'X'_M6RM+EK;[7_:T4&]UQN^1ER,$X[]*`.^HK(FU?[+K5CIUS#Y0O(V,
M,N_(,JC+1XQUVY8'OM;ICG7H`****`*]Y_QZ2_[IIFG?\>,?X_S-/O/^/27_
M`'33-._X\8_Q_F:X7_OJ_P`+_-%_8^9;HHHKM($K/MO^0I<?3_"M"L^V_P"0
MI<?3_"N+%_Q*7^+]&7#9^AHUYMXQL=7U+XDZ#!HNM_V/=?V==-]H^RI<?+OB
MRNUCCGCGVKTFLF?1+>X\1VFMO)*+FUMY($0$;"KE221C.?E&.?6NX@Y^YTW7
M-,\!^(TUSQ%_;4KV,YCE^QI;>6OE-QA"<^N:R?"'ASQH-'T&Z/CTG3_L]O(;
M+^QX>8MJGR_,SG[OR[NO>O0-2LHM3TNZL)F<1W4+PN4(#!64@XSWP:--LHM,
MTNUL(6<QVL*0H7(+%54`9QWP*`,&WB35?'FKO*L<EO864=B!U(>7,DH/U7R:
MY7=,O@D^!=^+PZC_`&(N<Y-J?WFX?]NV>?45Z+I^FQ:<;HQ,[/=3M/(SXR6.
M!C@#@``#V%5/^$;L3XI_X2',OVS[/Y&S?^[ZGY]O][!*YSTH`YO7X8[?XI>`
MH8@$CC@U!44=`!%&`*UO'MA/>>$KF:T4M>V#)?VP!P3)"P<#\0"OXU?OO#]I
MJ'B#2M:EEF6YTM9EA1&`1A*H5MPQD\*,8(_&M<@,""`0>"#0!YAJ3W7C[4K^
M?0+Q4%EHWEV<ZR8`N;E0QY'((C51D<CS*SO`\%CX>\5V5K=^&M;\-7]XDD>T
MWIN;.\DQDEG)/[S"DC&._7BNVTCP!X?T?PS?>'[>WD>POI7EF61OF);'0J!C
M;@8[C`[U'HO@"PT?58]1EU36M4FAS]F74[TSI;9!!,8P,'!QDY.*`.PKRIM(
M\1ZI\3?%IT+Q1_8JQBR$J_8([GS283@_.1MQSTZYKT73=._LR"6(7EY=F2=Y
MM]W+YC+N.=BG'"CH!V%0V.AV]AK6IZM'),UQJ0B\Y6(VKY:E5VC&1P><DT`<
M7XVM-:L/A_86]SJD.IZP-4M-EW/;B&-W-P"FY$Z*.`<<D"I)O#_CSQ*(M/\`
M%-WX>ATD31S3+I:3-++L<.$S)PHRHYZUV.MZ);Z]9PV]R\B)%<Q7*F(@$M&X
M=0<@\9'-:M`!61KYUT:8W_".QZ<VH%P`=1=UB5>YP@)8]@..N<\8.O10!ROP
M_P#MG_"*#^T?(^W?VA?_`&C[/GR_,^US;MF>=N<XSSBNJKGO!O\`R!+G_L*Z
ME_Z6S5T-`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`>2>/?[6_
MX6;I?]A_\A+[!^YQL]9=WW_E^[GK78^#?^$I^R7/_"4>5YGF#R-NS?C'.=GR
MXZ8[_>SQBMJ32[*75(M3DM8FO84:..8CYE4]1G\_IDXZG-X9S[5M.LI04$EI
MUZF<86DY7/%?B:OBU=*UK^V9%?PQYJDLHCP$,BF,<`29#;`?<=QS7IUDFO2^
M$U2\D@BUQK=AO4#:LN#M)X(R.,X!&<XXQ69\3_[(_P"%=ZK_`&]]M_LW]SYW
MV'9YW^N3;MW_`"_>VYSVS77]:F57F25DK>0U"SO=GEEK_P`+7^UP^9Y7E^8N
M[S?L^S&>=VWYL>NWGTYKLO%J>(7T53X<D5;Y95+`A,NF""!O&W.2#SC@'Z'H
M?I1QVIRK<S4N5*WE^8E3LFKL^:_%7]O?VVW_``D?F_;_`"UQOVXV=MNWY<=>
MG?/?-6_!O_"5?;+K_A%_-\SRQY^-FS&>,[_ESUQW^]CC->Y:QX9T;7E1M2T^
M*=TQM?E7`&>-RD'')XSBI-)T'3-"MS#IEE%;J?O%1EGY)&YCRV,G&3QFNQXZ
M/LN3EU_`Q5!\U[_YF5X._P"$J^R7/_"4>5YGF#R,;-^,<YV?+CICO][/&*Y_
M7/\`A9G]MW?]E^7]@\S]SY7D8V=O]9\V?7/?..,5Z0:!QVKC56TW+E6O2VAN
MX75KLQ]-_MS_`(1F+[=]F_MOR#G.?+\SG;NV_ANV\9SCC%<):_\`"U_M</F>
M5Y?F+N\W[/LQGG=M^;'KMY].:]2XSS2_6B%;EO[J=^Z_()0O;5F'XJ_M[^Q'
M_P"$<\O[?YBYW[<[.^W=\N>G7MGOBN$^"W76_P#MA_[4KUBJ&FZ79:3;O!86
MD=M$TC2%8Q@%F.2?Z>P``X`IQJJ-*4+;V$X7DI7V-"BBBL30****`"BBB@`H
MHHH`****`"O.OB+XLT73=0T[0-<O?LFGWBM/>.8GD\V)3@0@("?G;J<8VJ1U
M(KT6B@#SGX8^)]%UNX\1Q:7<^<3J<ETJB)T'E.%"M\P'4J>.O'2KGBF/4K#Q
M=IVMZ';VNI:DME-:OI<MVMO+-"SHV^,MQ\K`9SV/K72:?HD&FQZBMO+.#J%S
M)=2,7&4=P`=I`X`P,=:RM3\#6.JZ3I]I/J>K)=Z>NVWU.*ZVW8R`&S)CG=@9
MR.:`,CP4^JW/CWQ5=:M%!#,8;.-H8)#(L!`D81E\#<P5E8G`^_6C)*7^*LK2
M1R.MEH>^%5&23),=^T>O[I!6SH&@67AVR>VLC-(9)#+-//(9)9G/!=W/+'``
M_"J&LV<UKXJTG7[:"68!6T^[6-2S"*1E*O@`Y"NHSZ!F/:@#&_X6G_U(?CC_
M`,$__P!G6N_C2UC\/V>I3:=J-O=7K-';:7<0>7=RR`D;?+R<9QG).`IR2*ZF
MN,\1_#VU\2>((M9;7M>T^[B@^SI_9UV(0J9)/\)/)Z\\X'I0!I>%='N=.M;N
M[U'RO[4U*<W5V(LE(VVA512>H55`SW()[US6J6.LZ[X\U,>'=7309[&V@AN[
MO[*MPUUNW.B[&(4!03\W4EL=!6Y8>"_L.A7^E?\`"2^([C[80?M=Q?;[B''_
M`#S?;\O3TI/$/@>RUZ[2^34M7TN^"")[K2[LPR2H,X5^"&`))Z9H`9\/'V>'
M9[!X42YT^]GM;EXV++-*&W-(">?F+9P>A)':NK=%D1D<!E8$$'N*YJ?PTMAX
M?L]+T-[FU6&\BF+Q3E6<"0-(9&/+[ANR/XLUU%`'#:7;6]E\6+VUM8(X+>+0
M;9(XHD"JBB:7``'`%:'B'6YGN'\/:(%FUB>/#L1F.RC;CS93^>U>K'VR1IIH
MEM'XEFUX//\`:IK1+1D)&P(K,P(&,YRQ[^G%<E)\*K;^T;V]M_%GBRTDO9VN
M)EM-1$:ES[!.PP!GL`*`.ST;2[?1-&LM+M<^1:0K"F3R0HQDUY]_PB,]CH5[
MK^F>.-2=H6NM0@%K)&+)F9FD(=`#Y@SD$EOIBNVM_#_V6/2$&KZK+_9N[F6Y
MW&ZRI7]_Q\^,Y'3D"L2?X9Z-/J,LWVS5X["9R\VDQ7K)9R,3EB8QZGDC.#Z4
M`5O%.HR7O@OPSKGD>3=F_P!.N53J8VD959?^^9&7\:[^N:UO3Y=5UO1;%82M
MA9S"_G;9\C%`1%&#TSO(?V\L>HKI:`"BBB@"O>?\>DO^Z:9IW_'C'^/\S3[S
M_CTE_P!TTS3O^/&/\?YFN%_[ZO\`"_S1?V/F6Z***[2!*S[;_D*7'T_PK0K/
MMO\`D*7'T_PKBQ?\2E_B_1EPV?H:-%%%=Q`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`<]X-_P"0)<_]A74O_2V:NAKAO#GBSP[IEA>6=_K^E6MU'JFH
M;X9[V.-US=S$94G(R"#^-;/_``G?A#_H:]#_`/!C#_\`%4`=!17/_P#"=^$/
M^AKT/_P8P_\`Q5'_``G?A#_H:]#_`/!C#_\`%4`=!17/_P#"=^$/^AKT/_P8
MP_\`Q5'_``G?A#_H:]#_`/!C#_\`%4`=!17/_P#"=^$/^AKT/_P8P_\`Q5'_
M``G?A#_H:]#_`/!C#_\`%4`=!17/_P#"=^$/^AKT/_P8P_\`Q5'_``G?A#_H
M:]#_`/!C#_\`%4`=!17/_P#"=^$/^AKT/_P8P_\`Q5'_``G?A#_H:]#_`/!C
M#_\`%4`=!17/_P#"=^$/^AKT/_P8P_\`Q5'_``G?A#_H:]#_`/!C#_\`%4`=
M!17/_P#"=^$/^AKT/_P8P_\`Q5'_``G?A#_H:]#_`/!C#_\`%4`=!17/_P#"
M=^$/^AKT/_P8P_\`Q5'_``G?A#_H:]#_`/!C#_\`%4`=!17/_P#"=^$/^AKT
M/_P8P_\`Q5'_``G?A#_H:]#_`/!C#_\`%4`5?B'+>6_@74I;'1H-9N5\K983
MVIN4E_>IG,8Y;`RWMC/:NJKS[QKXETC6?"5[I^@>.=#L=3FV>5<?VLD6S$BL
MWS(2PRH8<>M=#_PG?A#_`*&O0_\`P8P__%4`=!17/_\`"=^$/^AKT/\`\&,/
M_P`51_PG?A#_`*&O0_\`P8P__%4`=!17/_\`"=^$/^AKT/\`\&,/_P`51_PG
M?A#_`*&O0_\`P8P__%4`=!17/_\`"=^$/^AKT/\`\&,/_P`51_PG?A#_`*&O
M0_\`P8P__%4`=!17/_\`"=^$/^AKT/\`\&,/_P`51_PG?A#_`*&O0_\`P8P_
M_%4`=!17/_\`"=^$/^AKT/\`\&,/_P`51_PG?A#_`*&O0_\`P8P__%4`=!17
M/_\`"=^$/^AKT/\`\&,/_P`51_PG?A#_`*&O0_\`P8P__%4`=!17/_\`"=^$
M/^AKT/\`\&,/_P`51_PG?A#_`*&O0_\`P8P__%4`=!17/_\`"=^$/^AKT/\`
M\&,/_P`51_PG?A#_`*&O0_\`P8P__%4`=!17/_\`"=^$/^AKT/\`\&,/_P`5
M1_PG?A#_`*&O0_\`P8P__%4`=!17/_\`"=^$/^AKT/\`\&,/_P`55G3O$NA:
MO.UOI>M:=?3JI=H[6Z25@N0,D*2<9(&?<4`:]%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`%>\_P"/27_=-,T[_CQC_'^9I]Y_QZ2_
M[IIFG?\`'C'^/\S7"_\`?5_A?YHO['S+=%%%=I`E9]M_R%+CZ?X5H5GVW_(4
MN/I_A7%B_P")2_Q?HRX;/T-&BBBNX@****`"BBB@`HHHH`****`"BBB@`HHH
MH`*H:GJMGHUDUY?S^7`&5<A&=F9CA555!+$D@``$FK]<KXMUO7="T^ZN=,T1
M;]50+!Y#22S>:QQEHEC/R#DDAL\=.:`(-*U[1-'T>$1WT]TM]>W<T2V]E-)+
MN:=Y70Q(K.I3?M.0.1R!G%=<K!T##.",C(P?R->1_P!@I:>'+&9'\4W.L+#>
MO%=VMK-;AKR9E<EX]JLH+`8+@1X!W'I7JUE]I^P6WVS;]J\I?.V]-^!NQ[9S
M0!9JM>WEMIMC/>W<R0VT"&261S@*HY)-6:P]>U/5-)M'O+/2DU""*)GDCCE?
MSV8#Y5CC6-M^3C^(8]Z`,S2]<T6V36=674)'BO+]&:$VDJS12>1%&(_**^82
M1'O'R\ANF!D]-97EMJ-E#>6DR3VTZ"2*5#D,IY!%>5Z/87Y@L/$=]%J%QJ']
ML_VAJD?]G3QM$IMWB1(HV0-($!094$]:[WP797%AX0TZWO(FAN!&6>)\;H]S
M%@IQW`('X4`=!115&^?48Q"+"UM9R7`E^T7+0[4[E<(^X^QQ]:`,-=3T6TUO
MQ!K;:FC1VEM!;7B)&S>08S*_49W$B;&T#(V^^!O6&H0ZC;"XA2Y1"2,7%M)`
M_'^Q(JM^E>>Q>'+>Q7QI8OI.I1Z1)=6?E)IT95WC6*+<8^[`$'=MRQ^;&6KJ
MO"`OAI]Y]K-U]E-VYT_[9O\`/%OA=OF>9\^=V_&[YL8SS0!TE%%4[^2^CM6;
M3[>">XR-L=Q,T*$=\LJ.1_WS0!SFIVVCZC\1-'GEU4)J.AVMS<_9%'\$H2/>
M[=%`&>."<@]`<[FE:W8:U%))83&58V"N"C1L,C(.&`."#D'H1R":XK6?#$]S
MXDUD6&GBWEU+P[<123QJ=C7+L``9,#)Z=<'`Z`5J^$+:Z?5M3U.2VN;:"6TM
M+9([B%HFWQ*^\A3CC+@9Z';P2,&@#LZ***`.0\>:;9WEAI-]?ZBUC;Z3JUMJ
M!9;=IC*48JL85><L7`&`3[&NDL;V+4+5+F%)U1LX$\#POP<<HX##\17/>*+6
M74+6:UU339Y-'2:&59=,N)&NBR,K9,:H"%!'\#,W`P/2SX,&I#PZO]HFZW>?
M-]G^UY\[[/YC>5YF[YMVS;G=\WKSF@#HZ***`..^)=G8:IX'O-*O]1:P2]>.
M-)4MGN'+*XDPL2?,QPAZ=`">@KJ;6[@O;2&[MIDEMYD$D<B'*NI&00?3%<SX
MPBGBU'P]JR6MQ<6^GWDCW"6\+2N%>"2,$(H+-\S*.`<9ST!-7/`^G7.D>!M$
MT^\0I<P6<:2(3DHV.1^'2@#HJ***`,;Q,+!_"^K1ZK/)!I\EK+'<2Q@EUC92
MI*@`Y.#QP>>QJ/PG'%;^%=,LX&N72SMH[7S+BTDMG?RU"[O+D`89QG^IIOBZ
MV@O?#=U;W4&H3VSE/-33Q^^VAU)VCJ>G(7YL9P"<5%X0%\-/O/M9NOLINW.G
M_;-_GBWPNWS/,^?.[?C=\V,9YH`Z2BBB@#/U35K#1;07.H726\+.L:LW\3,<
M``#DDD]JR=+OM,T.[_L&74`]]/=7$RCRF50TTLDXC+<J&"L<`G)"D@8JC\2-
M'75/#B30V#7=];W-N8/+C+NBFXB+E0/]E>3Z`]LUF3Z7J"^,9X!97#"ZUR#4
MDN4C/E+`ENJ-N?H#N7;MSD[L@8S0!Z/1110!5U'4;32;":^OIT@M85+R2.<!
M0*YY-5TK0=4N));FYGDUV7[?!#;6,TS!%A@B)(C5B!\JG)`^_CM3_'VD1:SX
M(UBW:Q-W.EI/):QA"[>=Y3JI51U;YN/<^M<]XAT^9;33[FSMM:37XM*6"PE@
M#B!)25)679TY4%O,^3`]10!Z313$W;%WXWX&['3-/H`HZEJ-KI=C+>WDPBMH
M@"SD$XR<#@<DDD``=<USZ:WHEMJ-UXB?47\JZAALC`;6021M`TSMN3&\8$N3
ME1M"Y)P>-7Q+JMQHGA^\U&SL+C4+J&/]S:V\;.TCDX`PH)QD\GL,UYQIVF7E
MK;V6M30ZE>W<JWW]I`:?/&QNIXX@FR-T#;`(PFX#`ZDCF@#UR.5)HUDC8.C@
M,K`Y!!Z$5)63X9L)],\+:/I]T=UQ:V4,,ISG+*@!_45K4`12RQP1/+*X2-%+
M,S'``'4FN2;Q'X?N=13Q$-4=8M-M7MI(6M90[BYDA,;JI4,P)BPI52&W<'BN
MJNKC[-:RS^7++Y2,^R)2SM@9PH'4GL*\JTJT_P"$ALM5UCQ/8ZXMY>W%N\EI
M:V-Q"UI!$Y:)58J#(0<LQCRV3Q0!ZE8WL6H6J7,*3JC9P)X'A?@XY1P&'XBK
M=<YX,&I#PZO]HFZW>?-]G^UY\[[/YC>5YF[YMVS;G=\WKSFNCH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`KWG_'I+_NFF:=_P`>,?X_
MS-/O/^/27_=-,T[_`(\8_P`?YFN%_P"^K_"_S1?V/F6Z***[2!*S[;_D*7'T
M_P`*T*S[;_D*7'T_PKBQ?\2E_B_1EPV?H:-%%%=Q`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`%>\_X])?]TTS3O^/&/\?YFGWG_'I+_NFF:=_QXQ_C_,UPO_?5_A?YHO['
MS+=%%%=I`E9]M_R%+CZ?X5H5GVW_`"%+CZ?X5Q8O^)2_Q?HRX;/T-&BBBNX@
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@"O>?\`'I+_`+IIFG?\>,?X_P`S3[S_`(])?]TT
MS3O^/&/\?YFN%_[ZO\+_`#1?V/F6Z***[2!*S[;_`)"EQ]/\*T*S[;_D*7'T
M_P`*XL7_`!*7^+]&7#9^AHT445W$!115"#5],N=1FTZ#4;66^@&9K:.96DC'
M'+*#D=1U]:`+]%5KR]M=/M7N;RYAMH$&6EFD"*OU)X%1Z?JEAJUO]HTZ_MKR
M'./,MIED7/U4D4`7:*I6>I6.H&?[%>V]T8)#%-Y$JOY;CJK8/!'H>:M,P12S
M$!0,DD\`4`/HK+L=?T;4[E[;3]6L+N>+B2*WN4D9?J`21T/Y5J4`%%%4[34+
M*^,XLKR"Y,$IAF$,JOY<@ZHV#PP[@\T`7**S8==TB?4GTR'5;*6^C&7MDN$:
M51QU0'(ZCMWJ>_O[33+1[N_NX+6VCQOFN)!&BY.!EB0!R0/QH`MT5S__``G?
MA#_H:]#_`/!C#_\`%5MQRI-&LD;JT;`,K*<A@>A!H`EHHIJNKKN1@R^H.:`'
M45#++';PO--(L<4:EG=S@*!R22>@IMI=VU_:QW5I<17$$HW1RPN'1QZ@C@T`
M6****`"BBB@`HHHH`***I3ZE8VMY;V=Q?6T-U<9\B"255>7'7:I.6Q[4`7:*
MSY=7TR#5(],EU*T2_F7=':/.HE<<\A"<D<'H.QI_]I6!U+^S/MMO]O\`+\W[
M-YJ^;LSC=LSG&>^,4`7:***`"BJ:ZC927[Z>EW;M>1H)'MQ*ID53T8KG('O5
MR@`HJI>7]KI\(FO;F&VB+A`\T@12Q.`,GN3T%+?7]GIMJUU?7<-M;I]Z6>0(
M@^I/%`%JBJUG>VFHVL=U9W4-S`XRDL,@=&^A'!JS0`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`%>\_X])?]TTS3O\`CQC_`!_F:?>?\>DO
M^Z:9IW_'C'^/\S7"_P#?5_A?YHO['S+=%%%=I`E9]M_R%+CZ?X5H5GVW_(4N
M/I_A7%B_XE+_`!?HRX;/T-&BBBNX@J:E?P:7IEWJ%RP6"UA>:1CV502?Y5X#
MX<@NO#E]X9^(=YYBMXAU">'4%/S!$G;]T1Z*-N[UZ?2O5/B=IFMZYX-FT?0K
M8RSWTL<,S>8J"*'.68[B,C@#`YY-<)K/[/.AP:'>2:1=ZK/J20LUM%-/$$DD
M`X4_(,9/'4=>M`&AJFB0?$/XOZEI.M23R:/H-M$5LDD*+++(H;<2,'H<<'/`
MYQG,-_X8T_X;?$+PO?\`AKSK2RU6Y_L^\LO,:17W?=;YB3P3D\\8'3FI[SPO
MXZM[K3?&6BQVR>(6T]+75=-N74I<,HQD,K8).!_$,<<]17/>'/"7CFQ\8^'-
M3\2:1<76GVL[K#;0W@F^PE\#>VYF)7/S?>.,=1C!`.S^$'^N\:?]C%<_TIGQ
M7^TZMJ/ACP?'=S6MMK=U)]KDB."8HP"5_'=].!G-<[I]G\5O"FKZ^N@^%].N
M;*_U.>[22YGC+$,W&,3+@8`X(S72ZQX9\5>-/!VEWM^+?1O%^G7#7-N(2#$K
M!B`I(+\%0IZGGJ,<4`8?CGX6^'_#'A.X\0^&HY]+U;2]MS%<)<.V_!&00Q(Z
M9Z8Y]N*S_B/\7[>3PP^BZ>VJV.MR06EQ]I@(B10Z1RD!@X<?*V.G7BLOQ'X3
M^*WB-M1FU'3(X[:7R_M5I97P`O0A`!16=PI`4'HOT)XKUOQ)X6_X3;X>1Z*I
MDT<3QP,$EB$C0!2K;"H8#(QCK0!F6GC*[^(WA.ZD\$&6PN5N5MI)]0C4&)2,
MLZA6;)`(Q[_G63\&=/*>'?%>FF[F++K%Q;FY!_>'Y%7?DY^;OSGFO6Z\[\#:
M)KOAK1_%LDVFYO+G5+F\L8/-C/G@J-G(;"Y(QR1B@#C?%_A[P[X8E\*^%O#%
MHA\2-J$4RW053<K&"2SR.`"0<]#Q@'CBO8]<T/3O$>D3:5JMN;BRGV^9%O9-
MVU@PY4@]0.]>0>"M(\<>&]7O=8U/P*VIZS?RYFU"35[=3&A/*JO.!]#T`'`%
M>Y4`>#:!\-?"5[\6/%>B7&D;].L8;9[:'[3*/++QJ6^8/DY)/4FO0/$7B6_T
MK5]-\(^%K&TGU::V,H^V2,(+6!?E#/CYFR1@`<TW0-`U2S^+'BO6[BUV:=?P
MVR6TQD4^84C4-\H.1@@]0*B\5>']<MO&ECXQ\.VD%_<PVK6=S82S>29HR2P*
M.>`P)[T`8VI^,O$5WX7\8Z'=6UE8>)-)L&FDDBD?R98"F6DA/W@P7.,]&VY/
M4"3P;>>-+3X5Z1]BT_2+J:2.-;60S-'%;V^S(DGW'+,#U"5/I_@[7M8_X2W6
M-=2WL-1URP:PM[-)/-%K'Y94;W'#')!./0\\X'.W/A3QI>^#_#EA=>'(Y8M"
MF$<^DMJ*!-2C`79)N!PN"#\K>O?I0!N:;XTU76[+QGH&M0Z:;[2[!V-QILK-
M!(&C8X&[D$<`\]<\#%=)\*O^27^'O^O4?S-<AX?\%:YINK^+;A]"L].MM6TL
M1VMO8S(8HI`A41_PG<>"6V@$D\UW'@'2[W1?`>D:9J$/D7EO;[)8]P;:V3W4
MD'\#0!PVD_$[Q-XAOY)M(LM`EM4N3%_9$MX8M2=`V-P#D(/7!]"*ZCQ3XLU>
MV\0V'AGPU9V<VLW4!NG>_=A#;Q`XRP3DDD$#'ZUPWBGP1XB\2/<VEQX'T0ZE
M)(2GB&RO?LR+SPS1<NQP,');D^U=1KOAGQ!I7B71O%6@VT>L7MI8#3[NTFG$
M+7"=G5VX!R23G]:`)I?'>L:!X(U36?%>AK:7EC,8(D@D_=WC9VJR9RRJ6SUS
MQSSTJ&+QEXKT#5]+B\9:;ID-AJ\PM[>73Y7+6TK?=24-USTRO`P346J^&?%W
MCKP'JVG^(Q86%Y/,)K"WB;=Y(4Y"2N,AO[N0/?GI3)]'\8>-]9T6+Q'I%KI&
MG:1=K>2217:SM>2I]W8`/D7KD-S@^M`$VE>+_%^O^,M9TG3K+2%LM(U%(IY[
MCS0S0$D$*`2#)@$Y.`...:Q]0^+]\MSJ-]IY\/+I&G3/$UI>7^R^NPG!:)0<
M`9Z`@DX]ZZSP3H&I:/XB\7W=]:B*+4=2\ZV?>K>9'@\\$D=>AQ7&0^!-;T&Z
MU#3K/P1X;UR*YNGGM-5U#R_]'1CG9*A7>V/]DT`>NZ7J,&KZ39ZE;$FWNX4F
MC)&#M8`C/YUY_P#%Y3I__"+>)$^7^R]7B\V3@;(7X?)/8[5'XUT`O-5TCQ1H
M&A06.GKI4UI)Y[V\?E^7(B\"-`WRITZ@]0,T[XC>'Y?$_@+5=*MH_,N98P\"
M;@N9%8,HR2`,D8Y]:`/(_$D]Q-\0]2\>QW"_8=!UBTT_V\H`K-V[,P_[Z/H*
MU;CQ;%H?CSQCXG=8;B07-MHFG^9($0/C,@9_X5!3+&MO1_A]J$7P0U'P]?VX
M_MJ^6:XE1I58M<;MT>Y\X)^1.<UCV'PLUN?X90V]];P_\)"FKG5)(;R19(YV
MSM*.5W`AE&?J>>IH`Z3PM\1[BZUV71M<N-"N95M'O$O=#N_.@*K]Y&!)96`Y
M]ZPH?C+>".+6[H^'5T.64)]ACOMVI1(6VB1D!(/')4#.*WO#/AN]O+N\DU'P
M/X?\-6CVSVZK;)%+=LSC#,)(\*J8)&,9_"N>T7P-K^EV]MH,G@3PK=B"3#:]
M=QQR++%N[Q`"0O@]SCC\:`%U_P`7V/@WXL>(]4N"LCMH\"6L`/,\A(VJ/;U/
M85ZGX>?69-%MI-?6U7477=*EJC*D>>B_,S$D=SFN$UCX<#Q'\0-<N-4TZ-M*
MN=*2VM+G*$Q3#`RBYRI'KC%=;X(77(/"MI9^([<Q:E:@P.XD5Q,J\+("">HQ
MUP<YXH`\X^+>F>(+B\MM3O[V)=&MM5M8["SB'+EOO22'USD`>A[=_0_$_A31
MM>O+#4]<E=K72O,D^S2LOV9\CEI58'.`,CD51^)>A:EXB\/V-MI=O]HEBU*"
M=U#JF$4G<<L0./3K6-\7](\7>(+*QTCP_I[W.FR,9+_RKJ*%W`(VH"YX'4]"
M,X],$`K_``C>&]U_Q?J6CVXMO#<]W&EE$B!$+JI#LJC@`_*?Q'I7K%<?X&DU
M:&P.FWG@Y/#MG:QJML$OX[D/US]P<'OD]<UV%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`5[S_CTE_P!TTS3O^/&/\?YFGWG_`!Z2_P"Z
M:9IW_'C'^/\`,UPO_?5_A?YHO['S+=%%%=I`E9]M_P`A2X^G^%:%9]M_R%+C
MZ?X5Q8O^)2_Q?HRX;/T-&BBBNX@****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`B\J/SO.\M?-V[=^.<=<9]*EHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`*]Y_QZ2_[IIFG?\>,?X_S-/O/^/27_=-,T[_CQC_'^9KA?^^K
M_"_S1?V/F6Z***[2!*S[;_D*7'T_PK0K/MO^0I<?3_"N+%_Q*7^+]&7#9^AH
MT445W$!1110`4444`%%%%`!1110`4444`%%%%`!1110`45@^%9YKG2+B2:62
M5QJ5^@:1BQ"K=RJHY[!0`!V``K>H`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`**Y7XAPWEQX%U**QUF#1KEO*V7\]T;9(OWJ9S(.5R,K
M[YQWKJJ`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`KWG_'
MI+_NFF:=_P`>,?X_S-/O/^/27_=-,T[_`(\8_P`?YFN%_P"^K_"_S1?V/F6Z
M***[2!*S[;_D*7'T_P`*T*S[;_D*7'T_PKBQ?\2E_B_1EPV?H:-%%<IXG\;V
MWAC4+2P?1]8U*YNHWE2/3+83,%4@$D;@?XA7<0=717'Z9X\BU"UU&YF\.>(M
M,CL+9KEVU"Q$(D51DJA+<M@=.*RXOBO'<1)+%X(\:212*'1TTH,K*1D$$/R"
M*`/1**YSQ-XOLO"MA!>WMK>3))DE+9%9XU5=S.P+#Y0.N,GD<5OB2,PB8./+
M*[MV>,=<T`245RUAXXT[4;C088[:]0ZVEQ):EU0#9#@EFPQP&!!7&<@\XKJ:
M`"BBB@`HHKB=7^(UMI.O7>D1>'?$6ISV@C,SZ=9"9%WKN7)W`CCU'8T`=M17
M%M\0[:'PW/KESX>\06BQW*6RVMQ9".XE9R`I1"WS#+8Z]<U#9?$NQN+^"VOM
M`\1Z,D[B*.YU/3C%"7)PJ[@3@DGC/%`'=4444`<]X-_Y`ES_`-A74O\`TMFK
MH:Y[P;_R!+G_`+"NI?\`I;-70T`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`<?\4/[(_X5UJO]O?;O[,_<^=]AV>=_KDV[=_R_>VYSVS7
M85POQ<GCM/A?K,T]G!>HODY@G+A'S/&.2C*W'7@CIZ<5W5`"8I<4E9]IK6EZ
MA,8;+4;.ZE"[BD,ZN0.F<`].1^="387-&BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBL7Q'XELO#-E%/=QW,\D\GE6]M:Q&669\$[44=
M3@&@#:HK`\->*['Q3!<M:0W=M/:N([FTO8#%-"Q&0&4^H]ZU;^_M=+L9KZ]F
M2"UA0O)*YP%`H`M45A1>*]+;PC'XGEED@TQ[<7)>5?F"'ID#//L*S]%\>6.L
MZBEB^F:QI<TQ(MFU*R:!+G`R?+8Y!.!G!P<=J`.MHJ*:>*V@DGF=8XHU+N['
M`50,DFJVFWR:EI]O?1QS11W$8D19DVN%/(R.W'..OK0!>HK.UC5;30]*GU._
MD\NVMUW.P4L?0``<DDD`#WK$\.>.[#Q%?_8/[.U;3+TQ&:.#4[0P-+&,`NG)
M!&2.]`'645D^(/$%CX9TIM1OVD\H.L:I%&7>1V.%55'4DUG^'/&=AXDFN+9+
M/4M/O;95DFM-2MC!*J,2`V#D$'!Z&@#IJ*XFQ^).CWVJPVHL]6BL[B016VJ3
M6;)9W#DX54D/7)R!D`''TSVU`!17/>)?%=GX7AMVN+>^O;BY<I;V=C`9II2.
MNU>.`.3DU+X<\2V7B:PEN+1+F"2&3RKBVNHC%-`^`=KJ>AP1[4`;E%<SXC\:
M6/ANZM[-K+4M1OYT,J6FFVQFE\L$`N1D`+D]2:>?&NACPL/$7VA_L!.P`1-Y
MGF;MOE[,9W[N,>M`'1T5RWA[QI:>(+QK)M-U;2KT(9$M]5M3`\J#`+)R0P!(
M!YR,ULZ7JD&K6AN(%=`LC1O&X`>-U)#*P!/((H`L7G_'I+_NFF:=_P`>,?X_
MS-/O/^/27_=-,T[_`(\8_P`?YFN%_P"^K_"_S1?V/F6Z***[2!*S[;_D*7'T
M_P`*T*S[;_D*7'T_PKBQ?\2E_B_1EPV?H:->;>,O^$@_X63H/_"-?V9]O_LZ
MZS_:7F>5LWQ9^YSGI^M>DUB7&A&X\76.N_:-OV2UFMO)\O._S&0[MV>,;.F.
M]=Q!B7/_``E/_"!>(_\`A*/['\_[#/Y/]E^;MV^4V=WF<YSZ5D^$/^%E?V/H
M.[_A$_[(^SV^<?:?/\C:O_`=^W\,^U=[JUA_:NBWVG^;Y1N[>2#S-N[;N4KG
M'&<9Z4:38?V5HMCI_F^:;2WC@\S;MW;5"YQSC..E`&%+;)KOC?4(+B/?9V6F
M"U.3P7N"3(,>H2./_OJN=%_=K\-&\-+(W]KK=?\`"/!@_P`_7:),^OD?O*[K
M2]+73I]0G\P237MT;B1PFW^%55>ISA549_E5#_A%8SXS'B`W3%1%Q:%!M$^"
MGG!O7RR4QCIWH`P-8LX-.^)7P]LK6,1V]O:W\4:`<*JQ1@#\A6YXX:^M_"\^
MHZ=+.EQISI>%(6(,J1L&>,@'D,@88/M4^I^'3J/BO0]=^U>6=*6Y40>7GS?-
M55^]GY<;?0YSVK;DB26)HY%#(X*LIZ$'J*`//O$&IZUK.J7H\+W$I>PT8SQ+
M&P"S7$_^JSDX)5%9@#QEA63X!UFV_P"$FALI/$GB9+RXBD:72/$</SR.,?-$
M^`%`PWRC.1V&#72^&OA[;^'/"^HZ-;ZI>>9>2L_VR-C'+$``L:J<G[BJH]#S
MQ@XHTOP9JR:U:ZCXA\53:T+!F>RB-E';^4Y4J68IRYVG'./6@#MJ\K?_`(3'
M_A9OBW_A%?["V8LO/_M3SLY\D[=OE_CG/M7HFFVU]:02K?Z@;Z1IY'1_)6/9
M&3E4P.NT<9ZFJFFZ"=/\2:WJ_P!I\S^T_(_=;,>5Y:%>N><YST&/>@#D?'$N
MOQ?#ZPEU6"PN=:35+1C!8NR0R,+@;%5I.1D;02>ASVINH?\`":^-;:/1]2\*
M0:%8-<0S3W<FIQW#;8Y%?:BH/O$J!D\<UU_B/0CXAL;>U^T^1Y-Y!=;MF_/E
M2!]N,CKC&>WO6Y0`5D:_J&IZ;IC3Z1H[ZO>;PJVRW$<`QW9G<X``]`3DCC&2
M->B@#E?`$MQ/X4$UY;?9+J2_OFFM_,$GE.;N8LFX<-@Y&1UQ755SW@W_`)`E
MS_V%=2_]+9JZ&@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`&GI
M7@WA#Q'XHT?29;?1-&^VVS3EVD^S2RX?:H(RI`Z`<>]>]"L;0/#UEX;LY[73
MQ*(99VGVR-NVD@#:#C.`%'7)]S6U*I&$9)J][&<X.333L8/Q$O+R+X9WMT+F
M;2;O9;L\D-QM>`F6/<HD!'J5R.N:S="\7>-KW7+6VOO#92UEDVRR?9I8=B]V
MW.2..N.^,#DUI_%:"SN?AGK,>HWLEG:%(V>9(/-8$2H54)E<EF`7D@#=DD`5
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MR)X6*HLC*H^QS28`/]Y6PWU'!ZBHK6^OI?C?";@RP.\"I);^;N$8-MO,>1P0
M'Y],\UZQ_.L/_A%M,_X2S_A)/+E^W>7LQO\`DSMV[L>NWY>N/;/-;1K0L_=M
MHUH0X2TUOJ;]%%%<QL%%%%`!1110`4444`%%%%`!1110`4444`%<=K(!^*'A
M97QM6SOW0'IO_<C/UP3^9KL:YSQ1X:F\01V<UGJD^EZE8RF6UO(8U<H2I4AE
M;AE(/(XS@4`4;$%/B[JX0`*^C6K/CNPEF`_2M;Q#HNG:M9;[^U2X^R!Y85DY
M57V\-CH2.V>E4O#?A>YT4:C=WVLS:EK-^%$U]+"J`!00BI&.%49)QW)-:]I9
MW::&EE?7_P!KN_(\N6Z\D1^8V,%M@X'T%`'/^`;2WOOAAX=ANH(KB+[%"VR5
M0ZY7!!P>X(!'H14;SIXO\6:>]CE]+T2X>:2\4_)-<;&01QG^(*&8L1QG`ZYQ
M)/X-N_\`A6T7A*RUM[.6.V2V-\D&25&-V%W#&X9'WN,U5\/^$/%VBW-C'-XX
MCN=,M<*;&/18(%9`,!0RG*_A0!=^(LC?\(Q'9]([^_M+.7C.8Y)E5Q^*Y'XU
M%K/Q0\&>'=6GTG5-7^S7EOM$D0M9FVY4,.50CH1T-:7C+29]8\,W$-H,WD+1
MW5LN<;I8G$BKGT)7'XUIZ7?PZKIEMJ%ON\JXC$BA@00".A!Y!'0CU%`'G6O>
M._#?B_3K&#0]2^UB'6=.-POD21@(;A<9WJ,\BNB\3`KX\\%21K^\-Q=QL1U\
MLV[$CZ95#]0*V_$.B0>(M$GTRXDDB$FUDFB(#Q.K!E=<]P0#6)X>\(:I8:NF
MJ>(/$L^NW<$30VI:U2W2%6QN.U2=S'`&X]J`#QB`WB/P6C_ZO^UF8CMN%O+M
MJKK\\-G\2+.YGR+8:#>M=$=3&KQG],G\ZT=4\*76LZ,;6^UN;[;%?&\LKV&!
M(WMB&)10.C84E23]X$YJ/0O!US:7-Y>^(-<FUV^NK;[(TDEND$:0Y)*K&O`S
MGD]\"@#A8XO$=GX3T9]7M;%?!EK+;3)'"[&^CA5P8C+GY"`=FX+SCN<'/M%>
M?V_P\U+?#8:AXLO+WPY`R&+3)+>-6(0@HKS#YG4$=,#.!FNGMCJ0\2ZAYT[O
MIOD0^0AA50DF7WX;JV1M)SP.W>@#'NOF^+^EA^BZ)<E,_P![SH0?TI-#!3XF
M>+41<1-!8R-@<&0K("?KM5?R%6O%'ABYUR6SOM+U>72-5LMPANXX5F&QL;D9
M&X8':._44W2?"U[I6C:E&NNRSZWJ!+RZK+;J2)-H52(ONA5`&%Z4`:&LVNH+
M:W5WX?M],&N.B1I-?(VQD#9VNR?,0`6('J?K7.^!(;;^RK^QU2UA.IZ=JDL]
MX9-LB+</^]\V-BHP,/QP".GN;>L^$=1O+U-4T?Q%/I.L&W2VN+D6L<R3JIR-
MT;<`@EL$$=>]4-5^'=S>^$Y]%M?$$T-S>W8NM0OY[997NCC[I4%5"\(,=,+C
M!R:`+>GL/%GC&V\06ZE=)TN&:WM)SQ]LDD*[W3_IFH3`/\1)(X`)ET23[+\2
M?$VGQ\0SP6M]CTD8-&Q_$1I^5,\/^'/%NEZC!)J7C5=1T^)2ALETB&W!^7"X
M93D8X.!Z8JSX9A:[UO7/$3CY+Z5+>T/K;P@@-_P)VD(]1MH`Z*\_X])?]TTS
M3O\`CQC_`!_F:?>?\>DO^Z:9IW_'C'^/\S7"_P#?5_A?YHO['S+=%%%=I`E9
M]M_R%+CZ?X5H5GVW_(4N/I_A7%B_XE+_`!?HRX;/T-&BBBNX@****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`.>\&_\@2Y_["NI?^ELU=#7/>#?^0)<_P#8
M5U+_`-+9JZ&@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M#COBA=:?9?#K5;G5=,_M.R3RO,M//:#S,RH!\Z\C!(/'7&.]=C7.^-?^$B_X
M1"^_X13/]M_N_LV?+_YZ+N_UGR_<W=?YUT5`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`5[S_CTE_W33-._P"/&/\`'^9I]Y_QZ2_[IIFG
M?\>,?X_S-<+_`-]7^%_FB_L?,MT445VD"5GVW_(4N/I_A6A6?;?\A2X^G^%<
M6+_B4O\`%^C+AL_0T:***[B`HHHH`****`"BBB@`HHHH`****`"BBB@`JO<W
M5O96TMS=3QP6\2EI)96"J@'4DG@"K%>=_$VW&L>!?$`O=.OK>.PA>6!Y)HQ%
M<,`<,%1R2!U`<#D@XR.`"_!X-\,V&GW=]X@TO09'>[N;F6]N;>)ALDG=TW.Z
M]E91SP,8'%:$7@OP9/$DL7AC09(W`972PA((/0@[>167XHU6T-WI$)N55-+O
M[:ZU+>"J10O'*$=F(QC>H/7C&3BM+P%'-#X.M!,I&Z6=X@1C$33.T?'8;"M`
M$_\`P@GA#_H5-#_\%T/_`,34%UX/\$6-K+<W?AWP]!!$NZ266QA1$'J25P!7
M3UQ/C.[D!LQ=:==0Z;9ZC:SSWTAB,#('!S@.7`5B"2R@#:3G'4`;IO@?PE$V
MJ:C/HGAZ6PNIUN+:06L3)'!Y$2GDK@#>CMQQ\V>I-7[/PEX&U&T2ZLO#WAVY
M@D&4E@LH'1OH0N#7'/?1K\-KO2W\U[JZ>YO;6/:Q"VWVSY93V,:AT8KG)7IQ
MTZCX?R&;3M6E,L=SYFIS2"[@7;!<Y"G?$,MA>W4Y*DY.:`-+_A!/"'_0J:'_
M`."Z'_XFFMX'\'(I9O"VA!0,DG3X<`?]\UT5<?\`$.74)O".LZ?9Z5>W'GZ?
M-_I$)C**=I^4KO$A)QCY5/WA[X`*FE^"_!^HZM=:K9:1X<O=*GM8(8!;VT,B
M+*CS&1AA=O(>,9!R=F#T%7[+PSX!U(SBQT+PU=&"0Q3""T@?RW'56P.#[&L#
M1M6LC+XEDT^Y3R-7O!#I4D*EDGE6R3=L(&."C#/3*D=:7X97!:X>VB:*Y@@T
MJS22X6V6-[>8!@]JQ4`_)@':V64N<GF@#JO^$$\(?]"IH?\`X+H?_B:/^$$\
M(?\`0J:'_P""Z'_XFN@K+U>XNX;7R[2QN;EY@8]\#1CR<C[[;W4X'^SN/M0!
MQDO@+PEKOBO2=0TJT\/&PTHW4=_:VUM$XFE955$=5&/E^9OFY!`P.21OCP=X
M)^UFT'AOP^;@()##]AAWA2<!L;<XR",UQ?@'4[#3IH+IY/*MX-$TS3;DJC'9
M>^9(IB8`<."Z@@]-PSBK_A1M5;XFZE/JNE7=K>W>G+))YDL+)$@F<1JNR1N-
MH`SC)8,2`"*`.M_X03PA_P!"IH?_`(+H?_B:/^$$\(?]"IH?_@NA_P#B:Z"J
M=_<S6MJTL%C<7L@(`AMVC#GW!D95X^M`'`>)?`/AO6;[2K'1-/\`#EM=Z?J5
MO>:A`L,:2-;#=N1E122&R.&PIQUK>'AKP`=3.EC1/#)U`)O-I]EM_-V_WMF,
MX]\5R.C7D.G:Y#<:BSPW.G3ZO>:D&4N\%NS[E+[<\$!"N.NWC.*L3:SI.O?%
M"RTVPN-,LX=-N!>W#LRQSWUTT11$1>&;"-\QP>@':@#L_P#A!/"'_0J:'_X+
MH?\`XFC_`(03PA_T*FA_^"Z'_P")KH*0YP<=:`/-?%O@#PWXF\+ZKI/AC3_#
MEOK"-&AECAC1K=@ZL0QC4LI*AAC'.?2N@7PKX#DOY+!-`\.->1H'>W6S@,B*
M>A*XR![UR'A*_CTB6RO+^<QQ:3H<L>L/M+&*?SE8!P`3NXE;'7#9Z&K6D+,?
M&=G;%P;Z#6M1N;M?XA:NCB)C_LG,0'8[?]DT`=A_P@GA#_H5-#_\%T/_`,31
M_P`()X0_Z%30_P#P70__`!-=!10!Q&J>"O!6HV]_H5MIGA^TU.:T<+Y5G"9X
M`RE5E"@!N"<@\<CK4.C>#_!NFZ?I6A:GI?AJ;6TLHEE0V\+2S.J`.X#+N8$@
MG)'UK(B<1>-HX@2E[!KMS>W0P0PM3:%5D(ZE#\B@],C'45'J?B;0_$OCC2-+
MTZ\T^U@\VUU2[OG=(9;EL!K>%`V&9B"N>,A3CC.*`.X_X03PA_T*FA_^"Z'_
M`.)H_P"$$\(?]"IH?_@NA_\`B:Z"B@#DY_#'@&UO;>RN-#\-0W5SGR()+2!7
MEQUVJ1EL>U5-/\">%='TN4ZOH?A__C[N)!-+:1;522=VB3<RC&%9%QT&,#C%
M<]XR4CQ?J-NP/VR]_LC^S5(^:3RKMFEV>NT'<V.@.3Q3OB+J<^M:;%+I]G=W
M>C6MPA>>W:-`UTERL>Q@[JV%VMT4@EE.0%)H`[;_`(03PA_T*FA_^"Z'_P")
MH_X03PA_T*FA_P#@NA_^)K;1F:-6*,A(!*-C(]CC(_*I:`.3O/#'@'3?)^WZ
M%X;M?/D$47GVD">8YZ*N1R3Z"J"^"_"&AMJ]_K6D>'(;&:[22W>XMH52&/R8
MDVDLH"YD5S@<?-GJ365\3RD-]*]T/W5QX?U"SM=PR'NG,6R-?5V`.!U.#CI3
M_%.HV\TVB>9J@L8M,N)+?4;IX0PMIFM24R9%*<[\9((^?'4T`=5'X(\'2H'3
MPOH3*P!5ET^$@CU'RT__`(03PA_T*FA_^"Z'_P")I_@^6>;P;H\MS8QV,SVD
M9>VCB\I8CM'`3^$>W:MV@#EKSPEX&TZT>ZO?#WAVV@C&7EGLH$1?J2N!6?\`
M\(1X2M=4OM8NM&\/)H[V,`C+VL0CC96F9Y#E=H!5X_FSSMYZ"K7C1Q;77AR\
MN'6/3[74_,NY';"1KY,H5G/0#<5Y/<BN0NK^"+X9:7I)+0WEN;*\(EB94M(#
M=?NY9`0!L4)RN0<#J.M`';VO@_P1?6L5S:>'?#T\$J[HY8K&%T<>H(7!%3_\
M()X0_P"A4T/_`,%T/_Q-9WPXY\*.W#![^[<3*,1W`:9SYD8[(V<J,GCN>M=C
M0!S_`/P@GA#_`*%30_\`P70__$U3TWPYHUAK]GKFA6>DVEB+&X@E>RC2/S2[
MPLIR@PP`C?DGC/N<;NJZ=#JNF2V-P\JPRX#^5(48@$$C(YP<8/L37E]I=(_P
M%M=&@,C:E?:%.]O;QHS-*J`;\8&/XQQU.>,T`>IV&HV6JVHNM/N[>[MV)"S0
M2+(A(X.&4D5<KB_`LMO>:EXFO]/D233+F^B-M+$<QR;;:)7*GH?F!!([@CM7
M:4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`5[S_CTE_W
M33-._P"/&/\`'^9I]Y_QZ2_[IIFG?\>,?X_S-<+_`-]7^%_FB_L?,MT445VD
M"5GVW_(4N/I_A6A6?;?\A2X^G^%<6+_B4O\`%^C+AL_0T:***[B`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`*]Y_QZ2_[IIFG?\>,?X_S-/O/^/27_`'33-._X\8_Q_F:X
M7_OJ_P`+_-%_8^9;HHHKM($K/MO^0I<?3_"M"L^V_P"0I<?3_"N+%_Q*7^+]
M&7#9^AHT445W$!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`5[S_`(])?]TTS3O^/&/\?YFG
MWG_'I+_NFF:=_P`>,?X_S-<+_P!]7^%_FB_L?,MT445VD"5GVW_(4N/I_A6A
M6?;?\A2X^G^%<6+_`(E+_%^C+AL_0T:**Y&TLEU3Q+X@6YN=0V6\\*1)#?S1
M*@,*$X5'`ZDFNY*YFW8ZZBN4L]9N[)-2LI$EOY[*\6WB=CC*.BNK2,!A0H8@
MMCL.I-4=3\4W<VCZQ#:+;1ZC8"(NT%WO0*YX*OLSNXP00.O6GRL7,CN:*YS4
M-=O;+<&L+=3#`)9Y)[PQ19P25C<I\Y&.<A1R,XK5TK48M7TFTU"%66.YB655
M;J,C.#2L]QW6Q>HKDXO%=T]G/J,FE"/3X+EX)9?M&7`60H7"[>5'4\@CG`.,
MF5O%$D<FIS2V2I8:7*\=Q,9B7)"!AL3;SG<!RPZ]Z?*Q<R.GHKGX]>NH+J&W
MU/3EMC<1220&*?S<[!N*,-JX?'.!D<'FFZ1KUSJ5M'?/901Z?+&95GBNQ*R#
M&<2+M&TX/12V#2LQ\R.BHKFK7Q+/*+&ZGT_RM.OY%CMIQ-N<;AE"Z;1M#<8P
MS=1G%5[?Q;<R6D5_)IJI8/=FT:3[1N=6\TQA@NW!7..X/L>M/E8N9'6T5QMO
MX@OK._UXWT*RQQ7L5O:113%F+NB;4`*@`'=DG/&2.<9-Y_$C:<;Q-7M!;RV]
MM]J'D2^<LJ9VX4E5.X'`P1_$.:.5AS(Z2BN4_M#59/%NDP7MK]CCD@N'V17)
MD1\>7@-\J_,,GCD<\$UL:I?RZ?#$T-N;B65]B[F*1IP3ND?!VKQUP>2`!S18
M=S3HKDAXS3[#>.]O";JUN8[5DCN@T):3&T^;@87GD[<C!X-;FFW5Y<Q,;RSC
M@8$;6AG$T<BD9RK84_FH]LTFF@33-&BL34]7N;*Y\BVM8G(C\QYKN<V\(&2`
MH?8V6X)QC@<D\BJ=KXK_`+4M[#^RK19KF[B>;9-+L2-$;:V7"M_%P,`Y]J=F
M',CIZ*XC1M8FDN;..[CN3-<:K>1*'N6'DA0YVD#AP`,`'@<$=*TT\3F3P_8:
MH+/'VNZCMO*\W[FZ7R]V<<XZXQ0XL2DF=)17.V/B"ZU*YE^SZ?&UK%<O;2-]
MI'G(58J6:,K@+QG[V<=JH:?K]_;0ZE)?P)(W]I&UM(X9RQ9S@!.54!1US]>.
M.3E8<R.QHKFI?$QT];N/4[+R[RWCCD2*WE\Q9@[;%",57G=P<@8SZ57M=0U.
M3QO;VU]!]E3^S99#%%<F6)SYD8!Y"_,.1T[\$YHY6',CK:*YOQ'?:E::EH45
MDL1CN+PI*'F*;AY;G;PIXXSGU`'?(A3Q5,;74+Z73@EG9W,MJ&%QF2619-BA
M5V@88D=6&#^='*PYE>QU5%8$6N7,5[]CU.P%O.UN]Q"+>4SB14QN7[JG>,C@
M`YSP:JP^*9CJ5I97-G:Q37H?[/&MYOD5E4MME78-G3'&[!HY6/F1U-%<3I7B
M/54TG2DGLXKJ\U"XFBC87)`^7>V6.S@?*1P#P,\]*M?\)5>K!=7$NE*D-A<?
M9[QOM.2#E>8QL^<88'G9]#1RL7,CK**YVZ\0W*R7[6.G"YMM/)6X<S;&+!0Q
M6-=I#$`CJ5YXJ/\`X2:YNKVYM],T^.Z6"VBNO->Y\L.D@8@#"GYOEX['U%'*
MQ\R.FHS7(1:Y>ZAXAT%[)%&G7MC)<%7D*MUCY(VGE=W`S@Y/3`SM:QJ?]FV\
M(CA\^ZN9A!;Q;]H=R">6YP``23@\#H>E%F"DF:M%<))K5[#JFO-J$$JK;I8*
MMO'=L$!>1@61P`<'(SP,[<'BL_5[W7FF\07"$)Y%W#:(4U&5!$C^5]U`FTD[
M^6/(R<9P,M19+FCTNBN8CU6\A,VGV.G"YDL(T-R9+UVVLPW;$=E+2-C!^;;U
M'([%MXHEU+4X+;2[))H9;**^\^:?RPJ.S+C`5OF&WIT//(QRN5CYD=/17,1>
M*97@@U%[`)I%Q*L4=R)LR?,VU7,>W`0G'.XGD<5%+XLN(H=1N_[+!L=-N7@N
M)#<8<A<99%V_-P<D$CVS1RL.9'645ST^N7CZE=6FEZ:MZ;+8+AFN1$=S#<%0
M%2&;:<G)4<CGT2XU^Z-Q>)8:8+J.PQ]I9IQ&P;:&V(,$,P4C.2HYQFBS'S(Z
M*BJUG=PW]E!>6[;H9XUD1O52,BN3EU6ZN-)6_%Q)%!?ZDEOO#X\FW#E`5]"Q
M7KU^?KP,"0-G:T5Q=Y?SZ9/K6EZ:;JY>'3?M$,;2//*DS%EP&)+'/RG&3CVS
M4EDK6D$UO!'JL.KR6D@MO[0O6E69E`^8*9'4?,5Z@'!Z8S1RBYCL**X;3[G4
M8A<0)+?(EU'#'"U[OWQS88SN-_(55P?[N<`=:ZW3[JTN[-)+&ZCNK<#:LL<H
MD!QQ]X$Y-#5AIW+=%<[/)+JOB6XTMIYX+2TMHY9!!*8VE>0L`-RX8`!#T(R3
M[54URUO='\,Z_)#J-PT`M&>WWNS30,%.<2$[B.A&3D'/-%A7ZG74E<_<7DME
MJNC2-)(8+X?99$8D@/L+HP'8_*X/KD9Z"NAHL-,**Y&TLEU7Q+X@6YN=0V6\
M\*1)#?S1*@,*$X5'`ZDFGV>L7=DFI64B2WT]E>+;Q.QQE'175I&`PH4,06QV
M'4FBPN8ZNBN&U/Q3=S:/K$-HMM'J-@(B[07>]`KG@J^S.[C!!`Z]:UK_`%V]
ML@P:QME,,`EGDGO#%%G!)6-RGSD8YR%'(SBCE8<R.CHJCI6HQ:OI-IJ$*LL=
MS$LJJW49&<&L1/&$7V;1Y'M=KZA.8)4$N?LY5MC9..<.57M]X4K,=T=317,G
MQ-)/<?9K.R6:XEN9H+<--M1UBP'D8[3M`8[>`V>/7B.?Q7+&L,*Z<&U!K\6,
ML'GX6-S&7#!]O*D`<X!P3QD8I\K%S(ZJDK`;6M0DNI;.UTV*:ZMHT>['VHJB
M%@2$1MF6;`SR%'(R1FM+3+^'5--M[^WW>5.@=0PP1[$>HZ46&FF7J*Y6Z\6R
M64T3W-E'#:RW2VRB2YVW&2VT-Y)7[IZ_>SCG%-E\67$4.HW?]E@V.FW+P7$A
MN,.0N,LB[?FX.2"1[9HY6+F1UE%<]JOB"?3I;C99Q>3;QB22:[N?(#\9(CRI
MWD#KR!D@9],A_$S1ZG-JL*RS6']DVMV8&D*A$>1][XY&X+R?7;C-"BV#DD=Q
M17/:IXFCTR:Y46_G16UH+J619`-NYMJ#IC!PQSG@+2C7I[73[J^U&RCCAAC#
MI):7(G2;)QM4D*=V<#ICD<^ARL?,C?I:YY=?EL[CR=9M$LR]O)/&\<_FJ50`
MN&.U<,`0<#(ZX-9MQK&IW.H^''>S:SM;NZW+LN2S.GDN0LB@``]#C+#CKQ19
MB<D=G167K.J'28+:40^;Y]W#;8W;=OF.%W=#G&<XJEJ?B5-,NM1CDMV9+*TC
MN2ZM][>S+C&.`-N2<]#[4)-C;2.AHKE;[6[R+P[J=[?:<@AAMS*K6>H$I*.X
M$@575AZ@8]#1<^*;R)M8>#2A+!I+XG=KG:SIL#DH-IRP!/!('3GG@Y6+F1U5
M%<\_B"XENIHM-L!=);1I).SS>61O&X*@VG<VWG!VCD<U?T/4_P"V=$L]2,/D
M_:8A)Y>[=MSVS@9_*E9CNBU>?\>DO^Z:9IW_`!XQ_C_,T^\_X])?]TTS3O\`
MCQC_`!_F:X7_`+ZO\+_-&GV/F6Z***[2!*S[;_D*7'T_PK0K/MO^0I<?3_"N
M+%_Q*7^+]&7#9^AHUS,5EK5AK>KW=G:Z?<07TL<B>;=O$R[8U0@@1,.J^M=+
M5&YU;3;&XCM[O4+6WGE_U<<LRHS\XX!.37>C-HP+OPM<36))-O<W<M\+ZYBF
M!6&?"[1&>&(4#;C@\KG%02^&-4N&UMY#8PG4+:&.**$MMB:,L=I.T9!S][`Z
MGCCGI;K5]-L9#'=ZC:V[C`*RS*A&<XZGO@X^E7@0R@@@@\@CO3YF+E1RL^B:
ME+JMQ?\`V?3));J!(_,F=G:S(&"(_D^=2>>J<UJ^&].FTCP[8Z=<&-I;:$1L
MT9)4D>F0*JV7B1+WQ)<Z4+8HD>\0W!?(F9-HD`&.-I<#KS@^E%CXFBO?$NHZ
M(\#0S6I'EN6R)QM4MCC@C>N1SP0:'<2M>Y@Z1INHZMX>N]-S:KIUQ?W(DE);
MS53[0VY`F,'.#\V[C/0XK8_X1I[BP\0V-U*JQZI<M+&T?S%%*(HR",9RF<>E
M3?\`"2Q"RO;B6WD'V>]:RCBC.YIGR`H&<8))_#UJ6/5=0ANH(]2TQ8(;AQ'%
M)!<&8JQ!($@V+MZ8R"PSW[T-L$D9VF>&Y;?4HKLZ9H=@8$=0UE;J6E<C`8DH
MI0`9^4$YSUQ3(_#%S<ZM%=7-II]D5#K<2V$C;KL,A7#J4``YSR6.0.>]:9UB
M[NKB>/2;&.ZC@D,<DTUSY2EQ]Y4PK%B#P<X&>,U$GB53)9`VDB+/=-9W!=L-
M;S!<JI'0AL8!![KUS1=A:)FZ;X.-G-81'3M$C2R=6-[';*9YPH^7(*81LX)8
M,3QQC/%A/#5XOA6+2S+#YZ7XN2VX[=OVGS<9QG.WCIU_.MB]U0VNJZ=81P>;
M)=LY8[]OEQHN2W3GDJ,?[54M)\2KJVJWEBML8UAW&";?D3JKF-R!CC##'?J#
M1=O4+16A1OO"MS?3ZJK_`&1[>ZN8KR+S07_>(J+L=",%"%/.<\]*8G@\7$%_
M'+8Z7IGVBV\B-=/A4E6SNWERBD\A?EQCCOVZ>YO;6S56NKB*`.2%,KA<D`DX
MS[`GZ"H5US2'$!35+)A.=L)%PA\P^B\\GZ478<L3-CT_6;GQ!8:A??8HXK2*
M:,I!(SER^WYN5&/N].<>I[2>(-*N=3-A)!';7`M9S*]I=DB*;Y2!DA6P5)R.
M#R*TKO5-/L)(X[R]MK=Y3B-9IE0N?8$\TMWJ5EI_E_;;RWMO,;;'YTJIO/H,
MGDTM1V1S]EH6JVDVL7&W39'OI(G6W8-Y054"E#QQP!AL'_=JUX?T.72KB\N#
M#;6<=QL"V-HY:&,KG+#*KRV><*.@ZU:L=?M9]#CU6\DAL8'9E)FF`5<,5'S'
M`YQ2W6M1PW&E)`$N(M0F,2S1R`J`(V?<,9W?=Q^-%WL%DM2A?Z+>OXC.J006
M%VKP+"HO'8&V(8DL@"MG.>1E?NCGTHZ1X9U70[:QE@DM;F]MXIK>5'=HXY4>
M4R*P8*2K#TP1R1GO7:54^WV?EQS?:H/+ED\J-O,&'?.-H/<Y!&/6B[#E1QEK
M83V/B/1;2ZN+:6]^W7E]*D#'Y8Y$<!B#R!E@/3/<U9'AS68["QTM9+$V=GJ$
M=PLQ=_,DC67S-I7;A6`[Y.<=LUTMSJ4,,\<*W-IN\S;*LEP$9/D+<#!R<#.#
MCC)SQ6';^-]/N(;">%H6AN;R6VD<SK^YV!R&;&1@A`1TX8&G=O4FT5H)?^'[
M[4M1CFEMM,AFAN$D34K<NMQY:MG9MV]QE3\Y')..U,N_"UQ>1W\$Z6<D;7XO
M[;S075FP`4D0KC&,C()ZYP,<]-9WUK?VXN+.YAN822!)"X=21UY'%4+37[&\
MUJ^TN*>(W%H%+@2J2<]>,Y^7@'T)HNQV1BCPBT]K=G[%I6F2R"(V\=C""J.C
M[PS/L1FR0O&``!Z\U?M-.U>7Q1%JU^+..*.R>V$4$C.=S.C;LE1P=O3M[YK6
MM]4TZ]$K6M_:SB$XE,4RL$_WL'C\:A&O:.=VW5;`[3AL7"<'!;GGT!/T!-%V
M%D0ZWIUU>2Z;<6?DM+977G[9G*JXV,A&0#@_-GIVK-/A:2Y\.ZEIER\.ZZOI
M;N-MI=1F7S$#`XSV!'UK:77-)D$!75+)A.=L)%PA\P^B\\GZ5+-JNGV]VEG/
M?VL=U)]R%YE5V^BDY-*[0[)G.6_A60FZ86FE:2\EI);H=.A4L6<8\PN45ACL
MH]>2>*9;>&M12^T606NEV5MITC%XK5F)ES&R[L[%P<G[O/4_-70ZSJUMHFDW
M.H73`10(6P6`+G'"C/<]!56T\0V;:3;7VHWFG6HN,B,K>J\;>P<A<GU`'&*=
MWN*T=C/TW0+^VDTE9C;>5I]S/)N21BTB.K@'!48.7Y&3TZ]JDN?#]W-I>N6J
MO`)-0N_/B8DX5<1C#<=?D/3/:MFZU;3K%5:\O[6W5EWJ9IE0%<@9&3TR1S[B
MH-<U<:/I\=UY0F5YXH<;]H`=PN[.#TSFE=W'9(PK_P`(E[^_E@T_1[HWKF47
M%]"&DMV*@'`V'>.,@$KR3UK3TS1);#5;Z?,(MYK2W@B"#:08PX.5`"@?,,`?
MD*U;;4;&^C:2SO+>XC0X9X95<*?<@\4VTU73]0:1;*_M;EH_OB&97*_7!XIW
M8<JO<Y_3/#VH:<?#K!K61M/LVM+@;V`(;9ED.WG&SH<=>M:FM:9/?K9SVK1"
MZLK@7$7FYVL<%2IQR`58\\XXX-6[35=.OY98K*_M;F2+_6)#,KE/J`>*=#J=
MA=7,EK;WUM+<1?ZR&.56=/J`<BDV[@DK',3^'=8OY]6N+I[*-[S['Y<<<CL(
MQ#(68%BHSD'@X'7H.M6;SP[>3PZTJO!F^O8+B(DGA4\K(;CK^[.,9[5H:9KB
MW]I97++!`MS'(Y22X^<!#CY1CYAZGC''7-6[;5]-O)_(MM0M9YMH?RXIE9MI
MZ'`.<>].[%9'/:EX5,NL7M]%IFD7QO=A8W\>6@<*%RIV-N&`#M^7D'GFKNE>
M'Y=.UC[09(7MQIT5IA$$9+J[L3L4!5!W=!6NNJ:>U\;%+ZV:\49-N)5,@'^[
MG-7*3;L-15[G#6/@DV7V>U&G:*(;>4,M]]G5KAT#9"E60@-C@ON/J`#5ZY\-
MWDWA[Q!IRR0"749YI86+':H?&-W'!X[9K=;5=/2]%FU];"ZW;!"95WEL`XVY
MSG!!^AIUOJ=A>3R6]M?6TTT7^LCBE5F3Z@'(IW>XN6.QCMI>J:?JVH76EK9R
M1WY1Y!<R.IAD50NX!5.\$`'&5Y'7GC/O?";MJ-Y=1Z?HU\UZ5=Y+Z'YH'VA2
M5&UMR\9VDC!SSS71-K.EI=/:OJ5H)T94:(S+O5B0`",Y!)(Q]:5=2MTMI[BY
MN;.&&*5T:07`*K@X^8D#:WJ.Q[FB[0-)DMC:+8V,%HF"L,80%45`<#&=J@`?
M0#%<]86-V-!N=%@DB%Q97)79-&&CFA+[U5@0>&0[<CH0?2N@&IV!M$NQ>VQM
MI"%2995V,2<`!LX-.L]0L]1B,EC=V]S&IVEH)`X!],@TKLJR,*ST&YA6[NK<
M6FFW<MNMO!%:H)(8`K,V>57=N+<\#C'UJW#8W]WJUM?:C';0M:)(L4=O,T@8
MO@%B65<8`Q@9Z]:W:SH=9TR[E\FVU&TFEWE-D<ZLVX#)&`>H`)Q[47;%9(S]
M6T.;5X-3269$:>W-M;$#<(U."Q/3EFQD>BK[U+HNFW5G<:A=W@MTN+V5',,#
M%DC"HJ##$`DG;GH/3MFK\>JZ?+>O91WUL]W']^W693(OU7.14::SICW*6RZC
M:-/(Q5(A.I9B"00!G)(((/TIW=K!97N5;S3KN+5CJNFF%KAXA!+!.Q1)%!)4
M[@"5(RW8YS5/4=*U?5M'U:"YN8$FO+8PPV\;$Q0Y!Y+[=S$D]<#@#`ZYT-8U
MVRTBUG:6YM_M*0/-';/,J/+M4G`!Y[>AJ9]8L;>VMIKV\MK4W"J46:95R2,X
M&<9I*X-(S;^V:\UK1+)<'["WVR<CHN$:-!^)9B/]PUMV_GF,&=(T?)RJ.6&,
M\<D#MCMQTYZU%=:II]AC[9?6MMD9'G2JF1G'<^M7*&-(YN*RUJPUO5[NSM=/
MN(+Z6.1/-NWB9=L:H00(F'5?6JUWX6N)K$DFWN;N6^%]<Q3`K#/A=HC/#$*!
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M<L!U/3`%:NM^(;+1+.ZDDN+=[J&!YTM'G5'D"@G`'7MUP:GU#5H-,T2;5+DA
M888?,(+`9..%!/<G`'J2*=V*T;F-JGA=9]9N=0BTS2;\W2('748^8F48#*=C
M9&,97CIU%;NE6/\`9NEV]F"C&)`I,<2QJ3W(50`!G/`J"#Q!I4EG!<OJ5E&D
MZJR%KA,')Q@'//((^H-6O[3L/MWV#[=;?;,9^S^:OF8]=N<TFWL-);G(2>$M
M3.FBPC331LNTN'O26\ZYQ('^<!/E;@<Y;.!T[:%SX;O)O#WB#3ED@$NHSS2P
ML6.U0^,;N.#QVS6[/JVFV=TEK<ZA:0W$GW(I)E5V^@)R:HKXFTPZQ?Z9)=01
M/90I+([RJ!@[MW?C:`,^FX4[L5HHS[WP_?MJNI75O'83-?1JBW-P3YEJ`FW"
MJ%.Y<C=C<O)/6H])T)M'B$VJS6BVD>CP6,Y,A"Y0ON))`&TAAS]:WO[=T<"8
MG5;$"`XF/VA/W9_VN>/QJ6?4K&VLA>SWMM%:,`1.\JJAST^8G'-%WL%EN<SX
M4TR^@\/74WFQRW5PVV![I"5:",!(PP!S@J"?J^<'I36\'->C4?.M[+38[N`(
M;>S8RQ/(&#B5P50$@J!C'()R>:Z<ZE8QV\5PU[;K!-Q'(95"OP3P<X/`)X]#
M5#4?%&E6.C#4UO+6XMC*L2-'.A5F)`P&SC@9)]@:+N^@6BEJ9EMX26267[3I
M>C6,+V\ENZV$"EI=XVEBY12@QGY1GKR33X]'UR>YT1;I['R-,EW,Z.^^?$;(
M&VE<*>>F3U/(QBNGCGBE@69)%>%E#K(I!4J1D$'TQWJK;ZUI=TVVWU.SF.&.
M(YU;[N-W0]LC/IFE=CY45O$.F3ZIIT26K1K<07$5S'YN=K-&X8*2.0#C&<''
MI5&'3-9_M;4=2E_L]);FTBABBR\J*59R0QPN0=W7CKTXYUDUK2WBFE34K-H[
M<`S,)U(CSTW'/&?>I%U.P>T2[2]MGM78*DRRJ48DX`#9P22<47:5@LF[G)W/
MA&]N;35Q%;Z?IKWMHUN+:UE9HG<G/F.=BX/;A2>3R:TSH%V;7Q-#OAW:H7,'
MS'"YA6/YN..1VSQ6W-?6MNT@GNH8C&@D</(%VIG&XYZ#((S1:ZC97QD6TN[>
MX:)ML@AE5RA]#@\&G=ARHX^>X'A[4;J.&_T^*:Z@B$D=W(\;"14V!XOE_>Y`
M4;1@Y`YYK?\`"-K-9>$=*MKB-HYH[9`Z-U4XZ'WK;I:3E=`HV=RO>?\`'I+_
M`+IIFG?\>,?X_P`S3[S_`(])?]TTS3O^/&/\?YFN!_[ZO\+_`#1K]CYENBBB
MNT@2L^V_Y"EQ]/\`"M"L^V_Y"EQ]/\*XL7_$I?XOT9<-GZ&C7FGB&ZC>+Q9`
M;N*UFD1E%EY>^>ZQ$-KC<3\AZ?*H`P3G/->E]J2N].QE)71Q.@1Q7.N:I)(J
MR%M)LEW'G*LLF1]#@5;T;4?[-^&5A?L#(T.GH57J7;:`J_B<#\:ZRBARN"C8
M\]GTC5O#^C:=J-S=V<PTR;[3.D=LR2,)"1-E_,(/#L?NC.T=*L1Z:^J3:_-8
MR*E];:HMQ9R]MX@BX/\`LL"5/L:[JBGS,7(CS;3)IK_0YM66TF#6VO-=2VP&
MYU485Q@=2NXG`Z[:ZZ/Q)I]U<PV^G3I?3R.`R6SAO)7NTG]S'/!Y)XK:P*,4
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MR<XYK/T!CHUQ`_B1E@\W2;>&%KH\9!?S(^>K<I\O4_A7H>*7%%PY3R[3S+:V
M/AJ\6XMK'3XH;E5FO8"\4,AD^7<-Z[25#`$GCD=ZN6$9%_I$JW"SPW&LS2Q/
M';>3$<V[Y,8WL2I.3G/))/3FO1:*.8.4K0W,-RC-!*DJJY1C&P8!@<$''<'J
M*\\U"VF-WJVDQ1,5TN275[<\XW-M>,#_`(&9OR%>AVELELD@4LQDD:5F8Y)+
M'/Y#H/8"K-).PVKGGMH3='0-5=&5M2UB2Z`/4(89%C!_X`JU7L3#,GAZT?8\
ML&NW7FQ'DHV9V7<.QQ@C\#7I5%/F%RG-Z$`OBGQ,B@!?/@;`&.3"N36)KXEE
MNO%-E;OBZGMK=TB'+R1#(DVKD%AC(X]<=Z[^BDI:W'RZ6.`C<7^II/#JEE=K
M;Z?/&_V"S,:(A`PDC&5L$$`A<9&#TI+2WA?1_A^AC3:6C<C'<6SMG\^:[^BG
MS"Y3SK4X(DT+Q](L:AS<$E@.>(8V'ZDGZFI]:N;?3+S5GM;VRFGG99+C2;ZW
M+-<N$4`1="<A1C`<9],&N^HHY@Y3!\6,S^!]89D*,;"4E3V.P\5F+=6NF>)I
MKO5Y8H+:;3X([6:<A4X+F1`3QN.5..I'TKL:*2>EAN.MSSOP[;,->T(3P,D8
MM;][:.1<%(C,NP8/3Y"..P.*W/'GD_\`".I]H3?#]MM?,3;NW+YRY&._':NI
MHQ3YM;BY=+'G^M7-O?7FIWNFQQ7]F-,\BY,1)CD8R#:"R$;MJ[R0#G!QWJ!)
M8+WQ99!M474('TNXBDDM(0L>WY<JFS))Z_+DD<<>OHV*7%','*>>VUS-NCT_
M2KW3]6864L5O<11!+BRQ'\H<@D`%@HQA3GL<5%I.ZX;P]:1:C:--92*QM;6P
M9)H`$(<3$S'8#T)(^8X(!KT:BCF#E/.K'_CQ\._]>%__`.RU8LH4BT3P"T*J
MCY0`@8^];.6_,\FN]HHY@Y3R[3DN#I.FZ5-J-JNH17:226L5D3=I*),N[$RC
MY3SE]N"I..H%>E0W,$[RK%+'(T+;)%1@2C8S@XZ'!''O5C%58;6.WGN)5+%Y
MW#N6.<84*`/08'\Z3E<<8V.2^S3SWGCD6*XOI`B1,/O;OLR[<'ZG]:I::3>7
M6@06NI6;O:`_N+.P*/;KY9!6;=*=@SC@KDL!Q7H=%/F%RGE\MS8+X;T+39?+
M.K6^I6WGP[?WD<OFC>[#&0&R?F/!W#&<U=MF2WU2UO+S"Z?!JVH>9(X^2*0L
M=CL>@&-XR>A(KJ8O#ZB6$SZA?75O#()8H+B1657!R#NV[VP>1N8_H*VJ;D)0
M9YOJ(BO)+J>!1)I=UK-AY3`?NY6W*)&7U!X&1P2#70Q2P6?C;5YIID@A&G6T
MDLCMM48>49)/'0#FNGJ"[MEO+2:VD9U25"C%#@X(P<'M4\W0?+U,WQ/#<W7A
M74HM/RUS+:N(MG5B1T'N:YNXOM+O_$OAE='>%YX4N$!B`_<CR3A&_NG/\)Y&
M#Q7:SVZ3VCVVZ1$="F8W*,HQC@CD'W%4+;0U@O([NXO[R]FB5DA-PR8C#8S@
M(JY/'4Y/O0G9#:;9P^E"5]/T336U&T%_;7,;R6<5B3=1NI_>-(3+P""=S[>0
MW`.0*LI!$/`E[((U#_VR7W#KN%X`#GUQQ7HV**;D)1//=5GL[/2_%]KJC(+R
MZ:62&.3[T\?E#RR@[A<'IT().*3S9K'5[F:ZO]/LX;BR@2!K^T:42QA/F1")
M%YW9)3!)R*]#Q2XHY@Y3@M!M#!KV@P3^9(T6B2[3/'L<#S(P`5W-@[3C&37:
MVMS#=P":VECFB)(#QL&4D'!Y'H01^%6*K6=K'96_DQ%BN]G)8Y)9F+,3^)-)
MNXTK'F6J7B/H%V@O8H)QJ8E;34CS+$1<`EY&8EN0-V[Y1R`..#IZI<65GIGB
M^UU5E%Y=-+)%&Y^>>/RAY>SU"X/3[I!)Q7H6*Q;S01>RW`EU'4%M;D8FM!(I
MC<8P0"5+*".H5@/S-4I(EQ9R<,LUAJ4TUW?Z?9PW%A;I"U_:-*)8Q'\T:$2+
MSNR2F"3D5U.@136?@^SC83S216ORK(GER$8^52-S;3C`ZFMM45$"*`%48`'8
M4^I;N4HV/+(+J*5/"8AU"!S%>Q[K2WCP+0,C`H[$EMV2%^8@DY./2Y!%&G@&
MWE5`LG]MA]PZ[OMNW/UQQ7H]%/F%RGFNL7%E9^'/%MEJ1C&H3RSRI&X^>92`
M8F4=6"KM&1TVG.*Z_649_!FH(BEG;3Y`JKR2?+/`K;Q12;&HG%:/+:7_`(KL
M;F!XIU&B!5D0AA_K<,`?J"#6);)='28=*N-2M(]1%\)'M4L&:Z\WS<^9DS`%
M>^_&-O'M7J&*,4^87*>8>([E&TSQ3"UW#:S2%_\`0DCWSS[5`$A+$G:0!T`"
M@=0>1+K,R+#XG620"6YT*!X@QYD"K+N(]<9&?J*])HQ1S`X')_8[>+QMH@2%
M!Y6E3!,#[N&B`Q^!/YUSED9[6/1KPW5K:64$M_&)[J$R0Q2&X(7(#KM)4$`D
MX'([UZA24<P.%SS9;59H]*=Y([JWN/$(FC*VODQ-^Y<EHU+L2I8$Y)Y.3TYJ
MUKBI%)XG9<*@EL)I".@PZ[F/X+R?05Z!11S!RG.^*-U_X0NVLC]HCEC1_P!S
M\WFP[E+A<=<INQCKFL*^OM+O_%=G)ILL,VS2[M7DA(*@`)M7([CGCJ,UV]U;
MBZMG@:26,.,;X7*./<$=*HV>C+;78NY[RYO;I8S$DUQL!1"02`$51R0,G&>.
MM":2!IMG+6BQVN@^"KR9533[>%'N'/W(V,!V._H`Q/)Z%@:K:F5N3K6H60\S
M3/M=A-YL8RCLD@,LBX^\`NS+#CY3Z5Z/11S=0Y=+'FWB6_L]1D\0RV<RW,`T
M2-?,B.Y6_>O]TC@_A6[;SV=_XGTJ31VB>*UMIH[DP](T.W9&V.C;AG:>1@UO
MZIIL6JZ;/83.ZQ3IL<QD!@/;(-7>E#>@*+N+1114EE>\_P"/27_=-,T[_CQC
M_'^9I]Y_QZ2_[IIFG?\`'C'^/\S7"_\`?5_A?YHO['S+=%%%=I`E92SQP:A.
MSD@'C@5JU`8(7?+1(2>I*URXFA4J<KIM)IWU]+%P:5[D7]IV_P#>;_OFC^T[
M?^\W_?-2_9X/^>,?_?(H^SP?\\8_^^16?)C?YH_<_P#,.:GYD7]IV_\`>;_O
MFC^T[?\`O-_WS4OV>#_GC'_WR*/L\'_/&/\`[Y%')C?YH_<_\PYJ?F1?VG;_
M`-YO^^:/[3M_[S?]\U+]G@_YXQ_]\BC[/!_SQC_[Y%')C?YH_<_\PYJ?F1?V
MG;_WF_[YH_M.W_O-_P!\U+]G@_YXQ_\`?(H^SP?\\8_^^11R8W^:/W/_`##F
MI^9%_:=O_>;_`+YH_M.W_O-_WS4OV>#_`)XQ_P#?(H^SP?\`/&/_`+Y%')C?
MYH_<_P#,.:GYD7]IV_\`>;_OFC^T[?\`O-_WS4OV>#_GC'_WR*/L\'_/&/\`
M[Y%')C?YH_<_\PYJ?F1?VG;_`-YO^^:/[3M_[S?]\U+]G@_YXQ_]\BC[/!_S
MQC_[Y%')C?YH_<_\PYJ?F1?VG;_WF_[YH_M.W_O-_P!\U+]G@_YXQ_\`?(H^
MSP?\\8_^^11R8W^:/W/_`##FI^9%_:=O_>;_`+YH_M.W_O-_WS4OV>#_`)XQ
M_P#?(H^SP?\`/&/_`+Y%')C?YH_<_P#,.:GYD7]IV_\`>;_OFC^T[?\`O-_W
MS4OV>#_GC'_WR*/L\'_/&/\`[Y%')C?YH_<_\PYJ?F1?VG;_`-YO^^:/[3M_
M[S?]\U+]G@_YXQ_]\BC[/!_SQC_[Y%')C?YH_<_\PYJ?F1?VG;_WF_[YH_M.
MW_O-_P!\U+]G@_YXQ_\`?(H^SP?\\8_^^11R8W^:/W/_`##FI^9%_:=O_>;_
M`+YH_M.W_O-_WS4OV>#_`)XQ_P#?(H^SP?\`/&/_`+Y%')C?YH_<_P#,.:GY
MD7]IV_\`>;_OFC^T[?\`O-_WS4OV>#_GC'_WR*/L\'_/&/\`[Y%')C?YH_<_
M\PYJ?F1?VG;_`-YO^^:/[3M_[S?]\U+]G@_YXQ_]\BC[/!_SQC_[Y%')C?YH
M_<_\PYJ?F1?VG;_WF_[YH_M.W_O-_P!\U+]G@_YXQ_\`?(H^SP?\\8_^^11R
M8W^:/W/_`##FI^9%_:=O_>;_`+YH_M.W_O-_WS4OV>#_`)XQ_P#?(H^SP?\`
M/&/_`+Y%')C?YH_<_P#,.:GYD7]IV_\`>;_OFC^T[?\`O-_WS4OV>#_GC'_W
MR*/L\'_/&/\`[Y%')C?YH_<_\PYJ?F1?VG;_`-YO^^:/[3M_[S?]\U+]G@_Y
MXQ_]\BC[/!_SQC_[Y%')C?YH_<_\PYJ?F1?VG;_WF_[YH_M.W_O-_P!\U+]G
M@_YXQ_\`?(H^SP?\\8_^^11R8W^:/W/_`##FI^9%_:=O_>;_`+YH_M.W_O-_
MWS4OV>#_`)XQ_P#?(H^SP?\`/&/_`+Y%')C?YH_<_P#,.:GYD7]IV_\`>;_O
MFC^TK?\`O-_WS4OV>#_GC'_WR*/L\'_/&/\`[Y%')C?YH_<_\PYJ?F1?VG;_
M`-YO^^:/[3M_[S?]\U+]G@_YXQ_]\BC[/!_SQC_[Y%')C?YH_<_\PYJ?F1?V
MG;_WF_[YH_M.W_O-_P!\U+]G@_YXQ_\`?(H^SP?\\8_^^11R8W^:/W/_`##F
MI^9%_:=O_>;_`+YH_M.W_O-_WS4OV>#_`)XQ_P#?(H^SP?\`/&/_`+Y%')C?
MYH_<_P#,.:GYD7]IV_\`>;_OFC^T[?\`O-_WS4OV>#_GC'_WR*/L\'_/&/\`
M[Y%')C?YH_<_\PYJ?F1?VG;_`-YO^^:/[3M_[S?]\U+]G@_YXQ_]\BC[/!_S
MQC_[Y%')C?YH_<_\PYJ?F1?VG;_WF_[YH_M.W_O-_P!\U+]G@_YXQ_\`?(H^
MSP?\\8_^^11R8W^:/W/_`##FI^9%_:=O_>;_`+YH_M.W_O-_WS4OV>#_`)XQ
M_P#?(H^SP?\`/&/_`+Y%')C?YH_<_P#,.:GYD7]IV_\`>;_OFC^T[?\`O-_W
MS4OV>#_GC'_WR*/L\'_/&/\`[Y%')C?YH_<_\PYJ?F1?VG;_`-YO^^:/[3M_
M[S?]\U+]G@_YXQ_]\BC[/!_SQC_[Y%')C?YH_<_\PYJ?F1?VG;_WF_[YH_M.
MW_O-_P!\U+]G@_YXQ_\`?(H^SP?\\8_^^11R8W^:/W/_`##FI^9%_:=O_>;_
M`+YH_M.W_O-_WS4OV>#_`)XQ_P#?(H^SP?\`/&/_`+Y%')C?YH_<_P#,.:GY
MD7]IV_\`>;_OFC^T[?\`O-_WS4OV>#_GC'_WR*/L\'_/&/\`[Y%')C?YH_<_
M\PYJ?F1?VG;_`-YO^^:/[3M_[S?]\U+]G@_YXQ_]\BC[/!_SQC_[Y%')C?YH
M_<_\PYJ?F1?VG;_WF_[YH_M.W_O-_P!\U+]G@_YXQ_\`?(H^SP?\\8_^^11R
M8W^:/W/_`##FI^9%_:=O_>;_`+YH_M.W_O-_WS4OV>#_`)XQ_P#?(H^SP?\`
M/&/_`+Y%')C?YH_<_P#,.:GYD7]IV_\`>;_OFC^T[?\`O-_WS4OV>#_GC'_W
MR*/L\'_/&/\`[Y%')C?YH_<_\PYJ?F1?VG;_`-YO^^:/[3M_[S?]\U+]G@_Y
MXQ_]\BC[/!_SQC_[Y%')C?YH_<_\PYJ?F5;B_@D@=%)RRD#BIM._X\H_Q_F:
MD%M!_P`\8_\`OD5*JJBA5``]!Q2I4:T:WM*LD]+:+S&VN6R'T48HKT+F9__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g238691mmi003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g238691mmi003.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!#`0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P``1"`!D`.`#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#T:BBBOST]
M(**H7FKVMGE=WF2?W4/\S6/<Z]=39$>(5_V>OYUK&E*1TT\+4J:I61TS,JC+
M,!]35=]1M(^#.I/MS7)-.[G+NS?4YH#ULL/W9UQP"ZLZG^UK3LS'\*4:G;GI
MNKF%DJ9)*'12&\'!'2K>PMW(J598GZ.*YQ93ZU,DQ'>HY$NAA+"KH=%L8C(P
M1[&F]*R(KMUZ,:OPWX<;9!GW[TG"#V=CFE1G$L449!&5.116+33LS(****0!
M1110`4444`%%%%`!1110`4444`%%%%`!7.ZOKC,[6UHQ50<-(._L*N>(;\VE
MCY2'$D_`/H.]<HIKLH4DUS,]3!8927M)?(ES1FIK:PO+S_CVMI91ZJN14LVC
MZE`,RV,RCUVY%=W))J]CT74@G9M7*F:4&G"WG.?W,G'7Y31%'),X2)&=CT51
MDU-BKH4&I8R"P#'C/.*L#0]5"[OL$V/]WFJ[1R0OLD1D8=F&#4RA*.Z,N>$M
M(NYTVJZ+::=I`N(6=Y&9<,Q['VK$5JZCQ#_R+</UC_E7)J:UQU.,*B45961Y
M^#E*=)N3N[LLJU3(^#40@G"[C#(%QG)7BA&KSI1:W-6D]C4MIR"`3Q5ZLB%N
M16L/NCZ5C(\^M&S%I"RA@"P!/3)I:Q+"SBU-KFXN2S/YA5?FQL%*,4TVR(04
MDY2=DB]IMY)>+.9`H\N0J,>E6PRL2%8''7!KF(7=+,VRR%5ENMC.#SBKNI64
M.FPQ7-H6CD5P#\WWZUE37-8Z:F'CSVO:^QN4TLH(!89/3FJNJ'_B57!Z?NZQ
MY+")=`6\RYG`#!MQXYZ5$8)J[9E2HJ:NW;6QT>Y=VW<,^F>:&95&68`>YK`O
M;".VTV.[5W-P"I,A8Y.:F@A34]3N3=998<*L><#ZT_9JU[Z%>PCR\U]%Y?UW
M-G(QG(QZT9&<9&:YNZ!M!?V<;LT2JK*"<[3GI3[VV-E9P['=I+H@2L6ZCT]N
MM/V2[[E?5EI[V^WYG0*RMG:P..N#3JP&MKE)89+;3VMV1AD^9G</0UOUG**B
M85::A:SN%%%%09'(^*9MVJ)'V2,?K4.A6`U35H;5CA#\S_[HZT>*`4UHD]&C
M4BF:#J0TO5H;IAE!E7^AZU[6&4;0YMCZ""E]4_=[VT]3I_$VL3Z7+%IVG,+=
M%3+%`,^P%4]"\37R:C%#=SM-#*VP[NJD]#FK_BC1Y-6\G4M-VW`V;6"'J.Q%
M9>B>'+^74HGN;=X(8F#LSC&<=J]"I[95_=O;IVL>?26&>%]^U[._>_YFUXKU
M+4-.=%AD3[/<(5*LF2#WYHT6`:=X5:_M85>Z>,ODC)Z]/PK+\8ZI!>W45M;N
M'$&2S#ID]J/#WB8:=$+.Z0M;Y^5QU3\.XINK!8AW>FR?8S6'J/!QY8ZWNUW1
M4'B35R^_[:WTVC%,U'4YM4DBEG51(B[25XSS72W.@Z3K:FYT^=(W/4Q\@GW'
M:N7O].N=,N/)N4QG[K#HP]JY*\*\(^\[Q?S1U8>IAZDO=CRR72UF=7XB_P"1
M:A^L?\JI:3HT<$']I:G\D2#<L9[^Y_PK;N9;2'3;1[U`T64&3T4XX)K)\607
M;&.X5R]H`/E7HI]379B*<5)UFKV2T_5GFX>I)Q5%.UV]?T10U76I=2D*(2EN
M#\J>ON:HH:@4U*AKPZLY5).4GJ>M&G&G'EBM"];C<ZJ.YK9Z5F:9'ND+D<*/
MUK4KCGO8\W$/WK!6<^D`3O)!<R0K*<R(O1JT"0H)8X`ZFL>UOY+O5''VQ4B1
M\)&!_K!1!2U:%14[2<7L6(]&MDM)+8LS([[P3U4TB:0#(C7-U+<+&<HC<`58
M_M*R\SR_M,>[IU_K4LUQ#;H'FD5%/0D]:?-,?M*VSOJ%S`+FVD@8E1(,$CM4
M+Z>CZ:+$R-L"XW8YIWVR&:UE>WF5BBD\=JCTF>2XTV*65MSMG)I>\E<E*<8W
MVL_Q)+JR2ZLQ;,Y51CD#GBH;C2Q)/]H@G>WF(P67N*C34!%J5VES.%BCV[`W
M:KT-Q#<1^9%(KH.I!Z4_>B4W5I^G^93&C0BUEA,CEYOORGDFK%S9175J+>7)
M4`8(Z@CO2+J5D\GEK<H6)P!FJKZJ(]7^SM*@@"\D]F]*/?;&E6D^MUJ.CT?Y
MT,]W-,L9RBDX`K2K-&JI_:K0&9!"$X/^UZ59EU"T@D\N6=%8=1Z4I*;W)J1J
MR:YD6:*B:Y@149I5"R?=.>#2PS13IOB<.N<9%19F/*[7L<SXRMR'MKH#Y<%&
M/OU']:P(?GD1,XW,!GTR:[S6++^T-+FMP!O(RGU'2N"LK6XO+U+.&,F9VV[?
M0]\_2O5PDN>'+U1[N!JJ5"S?P_D>AZA8W^BZ3#!X?A8[CF9Q\S'CJ`:YR[O/
M$DT9CNOM@3N-A4'\JV+W7+OPK;P:?)*+^Y*[B[C`1>F/4U`GQ!N/X]/C_"0U
MZ]7V;=G)Q\NAP4(UU'F5-3\^K^\Y@AD.&4J?<8JW)I]Y#;QW#6[^3(NY7`R"
M*[""_L/%FEW2/;>7+$N3NP2IQP0:Y_3/%E_I]NEOLBFB084,,$#ZURRHTXM7
MEH]F=<<16J)J,+2B]4W^3*FES7D%]$UGY@D+`84'GV-=;XR>+^S85?'G&0%!
MW]ZRF\:W&T^38P1,?XLYK%N;ZXOKG[1<R&1_?H/;%#J0ITI4XN]_P,W1JU:T
M:LX\O+YW;.P\2#_BF8?K'_*JOA[68YH?[+OCN5QMC9NX_NFL>\\0WU_:&UG\
MKRSCA4QC%9RM@\9%*IBOWRJ0VM8SIX)^Q=.IO>Z-G6='DTNXW*"UNY^1O3V-
M4HP20!WJ_:^);R.V^SS1QW*`8'F#G'OZU)IT'VF8W31)&@/RH@P,UQ8ETE[U
M-_(I3J4X/VO3KW+]I!Y%NJ'[QY:IZ**\MNYYC;;NPQG@USZ+MCU9D4;E/RX'
M3Z5T%0Q6<,+RNB',QR^><U<)<MS6E44$[^7YF%!;S3:0%7[&(2,EFSN!]_>F
ME9_MUI$SPR%(OW9<DH:U&T.P,I?RV`)R4#?+^56+C3[6YA6*2(;4^[MX*_2M
M?:JYU/$POZWZ&6UO.EZ\LCVR,86#1Q'[PQUQ5W0_^01#^-26^E6ELK!$)+C!
M9CDXJ>WMX[6%8800B]!UJ)S35C&K6C*'*O+]3+ABMI?$%UYZJS``H&Z>]4KW
M]Q<7\=IQ$47>%Z#D9K9GTJTN)'DD0[WQE@<$?2I;:QM[6$Q1QC:WWMW);ZU2
MJ):FBQ$(^]J]$K=-#':UGETQ1_H21;00X)!'OGUJ2*,?V["LVQCY`W'L3CK5
ML:'8+)O\MB,YV%OE_*IKG3;6Z=7DCPRC`*G'%#J('B(;7T=^G?YE/8@\02@(
MO^HR`1WJGIB7$T$I1;5RS'S/.SNK9GTZVN94ED0[T&`0<5'<:/9W,IE9&5CU
MV-C-"J1M84:\.6S[+\/F9$ELPMK2WDE21#<D#RVR`.XKH88(K:/RX4"*.PJ'
M^S[79"@CVK"VY`..?>K51.?,95JWM$DO,*YC5(Y/#VN0Z[:H&B9L2I[GK^==
M/4<T,=Q"\,J!T<8(-50K.C-21-&K[.6NJ>C7D5+R[\+^*HD:6\$$Z#"LQV,O
MMSP:RW\,Z/`=TOB&+R_]G!;]#7/:UHLNCW..7MW.4DQ^A]ZHHPKZ!UX55S\J
M9Z]'"M07L:KY?DSKKK6M-TW3I+#0E=FFXFN'ZD>U<^K8XJLK5*K5A4DY[G73
MH1I)VU;W;W98!IX:JX:I`U8-%-$P:G`U"&JYI]G+>SB.,''\3=E%9RLE=F<V
MHJ[+6G6;WDVT<*.6/H*Z=$6-`B#"J,`5';6T=I`(HQP.I[FIJ\^I/F9X.(K.
MK+R"BBBLCG#O6")07OO/N)8T6=0"O)'M6]7,7'W;_P#Z^4K:DKW.O"J[:]/S
M.@@NHIY9(4)WQ8#`BH6U:S6(R;VP'V#"\L?:L_4Y6T^]^T(.)X-G_`JKRP-:
M-IY>0PKLY?;G:QYJE33U[EPP\&DWU_IFW;ZC;W,IB7>D@&=DB[215?77>/3P
MR,5/F+R#BH(TA?5+=FU'[1*N=H5!C'H2*FU__D&C_KHM)12FK$QA&-:%B>XU
M.VM&6.1F:0J#M1<FD&K6;6S7`D.Q2`PQR"?:J5A)':ZG=K=,J.^"C/W'L:H:
MB4FN+R:#F'Y%+#H3D4U3BW8N&'A*7*[]-3976[%IEB#MEC@-MXS3Y]6M+><P
ML79U^\$7.*JZLB)IUKA0-LB8XJ*QNH=.N;J*[!5V?<'VYW"DH1:ND2J,)1YH
MI^AH1ZK9RQRR++\D6-Q(]:2+5K665(_WB%_NETP&KG7S*MU+&K+&)U8C'W1S
MVK2G$$\<8EU;S`6!5509!_"J=**-)8:G'O\`TO0OOJ]G'(8F=MZOLQM[U>K'
MTF-#J-\[`,RN`"16Q64TD[(Y*T8PERQ"BBBLS$BN+>&[@>"=`\;C!!KC-7\+
M7-D7GLP9K<<[1]]1_6NXHK>E7E2>FQT4,34H/W=NQY4LG.*E62O0+[0].U`'
MSK90Y_C3Y36/)X(A)/E7TBCT90:]".+I2WT/8AF-&2][0YH2T[S@.]="G@A<
M_/?MC_92M2Q\-:;9$-Y9G<?Q2\_I2EB:26FH3Q]"*T=S!TK1[K4<2$&*#^^W
M\7TKKK6UALX1#`NU1^9J4````8`Z`4M>?5K2J/R/(KXF=9ZZ+L%%%%8G,%%%
M%`!4)M;=MV84.XY;CJ?6IJ*=[#3:V(Y((I@!+&KA>1D=*62*.9"DB*ZGL13Z
M*+L+LA@M+>VSY$*H3U(%/DBCF79(@=<YP13Z*+O<')MW;U(9[6WN0!-"KXZ9
M'2E%K;B$0B%/+'.W'%2T478<TK6N,>&.50KHK*#D`CI5*:WU$7+20S1/&WW5
ME7.SZ5H44U)HJ,W$HV&GFU69IG$LDYR_'%316-I#)YD5NBOZ@58HH<FPE4G)
MMM[C$ACC9F1%4N<L0.M/HHI$-WW"BBBD`4444`%%%%`!1110`4444`%%%%`!
B1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`?_V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
